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Abstract 
It has been hypothesised that a trait-like vulnerability to sleep disruption exists. This has 
been demonstrated in response to physiological stressors such as caffeine and phase 
advance. From this work the Ford Insomnia Responsivity to Stress (FIRST) questionnaire 
was designed, which aims to specify those who are vulnerable to stress related sleep 
disruption. Further to this, neuroticism and emotion focused coping have been shown to 
characterise the insomnia population, and suggested that these constitute risk factors for 
the development of an insomnia syndrome. However, there has been very little work 
which aims to define an at-risk population and none which aims to characterise this 
population from both a physiological and psychological perspective. The aim of this thesis 
is to define the vulnerable population with regards to psychology and psychobiology. . It 
was hypothesised that the vulnerable group would show greater stress reactivity, 
physiologically, higher levels of neuroticism relative to the resilient group, lower levels of 
conscientiousness and a greater inclination toward rumination and worry. 
Over three studies measures of sleep, personality, stress perception and coping styles 
amongst others were taken as well as measuring, separately, 3 indices of physiological 
stress response: 
Cortisol output: Salivary free cortisol was taken whilst a sample of good sleepers 
completed the Trier Social Stress Test (TSST) (n=32). Results indicate that the vulnerable 
group show significantly greater levels of cortisol at base line (p<0.05).This was mediated 
by conscientiousness (β=0.39). They were also higher in negative affect, rumination, 
stress and worry (p<0.05).The vulnerable group also showed an increase in insomnia 
symptoms in response to real life stress. This was also related to conscientiousness (r= 
0.55, p<0.05)  
Cardiovascular response: Heart Rate (HR) and Cardiac Vagal Tone (CVT) were measured 
while participants (n=31) completed a relaxation (baseline) and stressful task. There was 
found to be a main effect of group on HR response to the stress task relative to baseline, 
but this did not maintain when psychological variables of interest were entered (n=31) 
into the model. Conscientiousness was related to lower CVT change, interpreted as lower 
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CVT flexibility. Psychologically, the vulnerable group were again found to score higher on 
neuroticism, perceived stress and rumination relative to the resilient group (p<0.05).  
Brain activation: fMRI data was collected whilst participants completed a stroop task, in 
which a siren indicated an increase in task difficulty (stress cue) (n=24). It was found that 
the vulnerable group showed significantly less activation bilaterally in the inferior parietal 
lobule (IPL) (p<0.001). In the left IPL activation was mediated by neuroticism 
(β=0.607).There was also significantly greater activation in the left postcentral gyrus (PG) 
(p<0.001), compared to the resilient group. This was mediated by FIRST score (β=-0.61). 
Again, the vulnerable group scored higher on measures of neuroticism and lower on 
conscientiousness (p<0.05). 
Psychometric information gathered across the 3 studies was collapsed into one dataset 
(n=84). ANOVA revealed that the vulnerable group had significantly higher scores on 
measures of neuroticism, perceived stress, state stress, depressive feelings, depressive 
thinking, brooding, worry, emotion focused and problem focused coping and significantly 
lower scores on conscientiousness and extroversion (p<0.05). 
Results indicate that the vulnerable group are higher on neuroticism across all 3 studies, 
and score higher on rumination and stress questionnaires in 2 of the studies. Physiological 
data suggests that the vulnerable group are more sensitive to stress anticipation, as 
opposed to showing greater reactivity to stress. 
It is concluded that neuroticism is a risk factor for developing insomnia and that the 
vulnerable population show greater physiological responses whilst anticipating stress, a 
phenomena which represents the interaction between personality, rumination and the 
physiology of the stress system.  
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Definitions/Abbreviations 
The table below lists abbreviations with corresponding full term and a brief definition. 
Below are definitions of words used within the thesis which have a particular meaning 
within the context of the research presented. 
Abbreviation Full Term and Definition (where 
appropriate) 
ACTH Adrenocorticotropic Hormone: Produced 
by the pituitary gland, leads to the release 
of cortisol 
AC-PC Anterior-Commissure-Posterior 
Commissure: AC-PC refers to the AC-PC 
line. fMRI scans are collected through the 
AC-PC line i.e. the scanner collects data at 
an angle relative to the mid-point of these 
2 structures 
APS Arousal Predisposition Scale 
 
AUC Area Under the Curve: Provides an index of 
change over time, and is generally used in 
measuring the half life of drugs or in 
investigating hormone levels. A 
mathematical technique based on integrals 
AUCb Area Under the Curve relative to baseline 
AUCg Area Under the Curve relative to absolute 
xiv 
zero 
AUCi Area Under the Curve relative to increase  
BDI Beck Depression Inventory 
BOLD Blood Oxygenated Depended Level: the 
signal that fMRI records to provide brain 
activation levels 
BSM Behavioural Sleep Medicine 
CAR Cortisol Awakening Response: The typical 
pattern found upon awakening, where 
cortisol levels peak within 30 minutes from 
awakening 
CRH Corticotrophin-Releasing Hormone: 
Produced by the thalamus, triggers ACTH 
release from the pituitary gland and so an 
increase in cortisol 
CVT Cardiac Vagal Tone 
DASS Depression Anxiety and Stress Scale 
DASSA Anxiety sub-scale of the DASS 
DASSD Depression subscale of the DASS 
DASSS Stress subscale of the DASS 
DSMIV Diagnostic and Statistical Manual, fourth 
edition 
xv 
EEG Electroencephalogram: measures electrical 
impulses in the brain 
EFC Emotion Focused Coping: the likelihood 
that someone will focus on the emotional 
rather than the practical aspects of a 
problem  
EKC/ECG Electrocardiogram: measures heart-rate 
ERP Event Related Potential: any stereotyped 
electro-physical response to a stimulus 
FIRST Ford Insomnia Responsivity to Stress Test: 
Questionnaire designed to measure the 
likelihood that someone’s sleep will be 
disrupted in response to stress 
fMRI  Functional Magnetic Resonance Imaging: 
Technique for looking at brain activation 
patterns  
GABA γ-Aminobutyric acid: Chief inhibitory 
neurotransmitter in the mammalian central 
nervous system 
HADS Hospital Anxiety and Depression Scale: 
Questionnaire for measuring anxiety and 
depression levels  
HPA Hypothalamic-Pituitary-Adrenal axis: Part 
of the neuroendocrine system, largely 
responsible for controlling reactions to 
stress 
xvi 
HR Heart Rate 
ICD-10 International Classification of Diseases, 10th 
edition 
ICSD-2 International Classification of Sleep 
Disorders, 2nd edition 
ISI Insomnia Severity Index: Questionnaire 
designed to measure insomnia severity 
over the past 2 weeks 
LVS Linear Vagal Scale: Method for extracting 
vagal tone 
MMPI Minnesota Multiphasic Personality Index: 
Questionnaire assessing personality. 
Arguably better suited to measuring 
psychopathology than theoretical 
constructs of personality 
MRI Magnetic Resonance Imaging 
MSLT Multiple Sleep Latency Test: A test for 
measuring daytime sleepiness 
NEO-ffi NEO-Five Factor inventory: NEO represents 
3 of the 5 main personality domains 
(described below). Questionnaire for 
assessing personality based on the five 
factor model 
NEOO Openness subscale of the NEO-ffi  
xvii 
NEOC Conscientiousness subscale of the NEO-ffi 
NEOE Extroversion subscale of the NEO-ffi 
NEOA Agreeableness subscale of the NEO-ffi 
NEON Neuroticism subscale of the NEO-ffi 
nREM  Non-Rapid Eye Movement: a stage of sleep, 
also known as deep sleep 
PFC Problem Focused Coping: Measured by the 
brief-COPE questionnaire: the likelihood 
than an individual will focus on the 
practical aspects of a problem 
PI Psychophysiological Insomnia 
POMS Profile of Mood-states Questionnaire: 
Measures mood based on six factors: 
anxiety-tension;depression-
dejection;anger-hostility;fatigue-
inertia;vigour-activity;confusion-
bewilderment 
PSG Polysomnography: considered the gold 
standard in object sleep measurement. 
Takes ECG, EEG, EMG, and respitory 
measures throughout the night to measure 
sleep, sleep stages and make diagnosis of 
any sleep disorders 
PSQI Pittsburgh Sleep Quality Index: Index which 
measures sleep quality over the last month  
xviii 
PSS Perceived Stress Scale: Questionnaire 
designed to measure perception of stress: 
i.e. the extent to which one is likely to view 
a situation as stressful 
PSW/WORRY Penn State Worry Questionnaire: Designed 
to measure levels of worry 
PTSD Post Traumatic Stress Disorder: a 
Psychological disorder characterised by an 
intrusive ‘reliving’ of a negative event 
QRS Name for 3 of the graphical deflections 
seen on an electrocardiogram output (Q 
wave, R wave and S wave). Used to infer 
heart rate based on the distance between 
the 2 R-waves 
REM Rapid Eye Movement: A stage of Sleep 
characterised by rapid eye movements. 
Traditionally associated with dreaming, 
muscle atonia and an active EEG  
ROI Region of Interest: Specific brain area 
selected for further investigation, usually 
apriori 
RSQ Rumination Scale 
RUMB Brooding subscale of the RSQ 
RUMB Depressive thinking subscale of the RSQ 
RUMR Reflective thinking subscale of the RSQ 
xix 
SE Sleep Efficiency: Percent of time spent in 
bed spent sleeping 
SFC Salivary Free Cortisol: Cortisol levels in the 
saliva 
SI Situational Insomniacs: Good sleepers who 
find their sleep is disrupted in response to 
certain situations 
SOL Sleep Onset Latency: Time take to fall 
asleep 
SPM Statistical Parametric Mapping: Software 
used to analyse fMRI data 
SQA Scottish Qualifications Agency: Questions 
for chapter 5 are taken from exam 
administered by this organisation 
STAI State-Trait Anxiety Inventory: 
Questionnaire designed to measure state 
(dependent on situation) and trait 
(enduring characteristic) anxiety levels  
SWS Slow Wave Sleep 
TIB Time in Bed 
TPQ Tri-dimensional Personality Questionnaire: 
measures personality on 3 domains: 
novelty seeking harm avoidance and 
reward dependence. Each domain is 
posited to relate directly to activation of 3 
neurobiological subsystem: dopaminergic, 
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serotonergic and noradrenergic 
TSST Trier Social Stress Test: Robust lab based 
psycho-social stress test 
TST Total Sleep Time 
UGSC University of Glasgow Sleep Centre 
VAS Visual Analogue Scale: A line in which 
either end represent an extreme feeling or 
opinion. Individual is asked where they sit 
on that line in reference to the particular 
question 
VLPO Ventrolateral Preoptic Nucleus: Group of 
neurons in the hypothalamus, active during 
nREM sleep. Thought to control transition 
from sleep to wake  
WASO Wake After Sleep Onset: Time spent awake 
during the night before final awakening 
 
xxi 
Definitions 
Hyperarousal: Taken from the hyperarousal model, describes the notion than an 
individual or a group of individuals demonstrate chronically increased nervous system 
activity, relative to a healthy group. This is present throughout the 24h cycle. 
Arousability: Is used to mean the propensity an individual has to become aroused i.e. how 
they respond to their environment. A predisposition to arousability is used to describe an 
individual who is more prone to arousal of the central nervous system.  
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Outline 
This section will provide a brief narrative account of the thesis, chapter by chapter.  
Chapter1: 
Chapter 1 provides a broad justification for the study of insomnia generally. Firstly the 
cost of insomnia is considered. This is explored from 2 points of view: the cost to the 
individual in terms of quality of life, reduced functioning and an increased likelihood of 
developing a secondary mental illness. Next, the cost to society regarding absence from 
work, increased accidents at work and decreased productivity are outlined. Adding to this 
is the cost of medication prescribed for insomnia. Cost-effectiveness of psychological 
interventions is considered.  
Following this the theoretical models of insomnia which are pertinent to the theories 
advanced in this thesis are delineated: The 3-P model, the hyperarousal model, the 
cognitive model, the neurocognitive model, the attention-intention-effort pathway and 
the animal model. These models will be referred to throughout the thesis.  
This chapter concludes that the cost of insomnia is high, and so research which aims to 
better understand the aetiology, prevention and improvement of treatment is essential. 
The models put forward so far make no attempt to explain which factors may predispose 
an individual to insomnia. This therefore represents a gap in the literature, and a lack of 
empirical research aimed at understanding predisposing factors.  
Chapter 2: 
Chapter 2 outlines the rationale behind believing that a vulnerable phenotype exists, and 
theorises on which constructs may define this phenotype. Firstly, familial aggregation of 
insomnia is investigated in order to demonstrate that there may be an inherited 
vulnerability.  Next, genetic factors are considered and specifically the 5-HTT serotonin 
transporter polymorphism, suggesting that vulnerability to insomnia may be more related 
to a fault in the stress system rather than the sleep system. 
xxiii 
Experimental work is then considered. Works which have shown a trait like vulnerability 
to sleep disturbance are evaluated.  The role of psychological mechanisms is then 
considered, with a focus on neuroticism, conscientiousness and emotion focused coping. 
Theories on how genetics, psychobiology, personality and coping style interact are then 
put forward. 
Chapter 3: 
Chapter 3 outlines methods generic to all studies. Firstly, the screening process is 
explained. This process is exactly the same for chapters 4, 5 and 6, with additional 
screening steps added to chapter 6, pertaining to the use of fMRI.  
The same psychometric scales are used throughout all 3 experimental chapters. These 
scales are outlined in chapter 3 with regards to their psychometric properties and a 
justification for why those scales in particular were chosen for the measure of the 
construct of interest. 
Lastly pilot fMRI data is presented. This is here to outline the procurement of 
competencies relating to this brain imaging method. Its purpose in this chapter is not to 
outline experimental work or findings, but rather to represent skills acquired during the 
course of the Ph.D., and prior to running a larger fMRI based study 
Experimental Chapters: 4-6: 
Chapters 4-6 outline experimental work. These studies were initially designed to 
investigate stress reactivity in those defined as vulnerable compared to those defined as 
resilient to stress-related sleep disruption. Stress reactivity is measured using 3 different 
indices of the physiological stress response: salivary free cortisol (SFC), heart rate (HR) 
and Cardiac Vagal Tone (CVT) and then functional Magnetic Resonance Imaging (fMRI ). In 
each study 2 groups are constructed retrospectively based on Ford Insomnia Responsivity 
to Stress Test (FIRST).  
In each chapter, psychological variables are analysed first, then the physiological data is 
presented and where appropriate interactions between the 2 are investigated. Finally 
xxiv 
results for each chapter are discussed, highlighting limitations, implications and future 
directions.  
Chapter 7: Psychological Variables Across 3 Samples 
To provide support to the experimental work conducted, data sets across all 3 samples 
were convolved giving a larger sample size in which to investigate psychological 
differences between the groups.  
Chapter 8 Overall Discussion 
 
This section focuses on the results of all 3 studies together. Given that each chapter has 
its own discussion section, the aim of this section is not to regurgitate this information, 
but to pull it all together into a theory of vulnerability to insomnia. Results of the 
experimental chapters are outlined briefly. Psychological variables are discussed 
separately from psychobiological variables and then there is discussion around the 
interaction between these two. These are then taken together to suggest a theory of 
what defines the vulnerable phenotype. Implications of this work as a whole, and future 
directions are then considered.   
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Chapter 1: Defining Features, Prevalence, Cost and 
Conceptualisation of Insomnia 
1.1  Defining Features 
The core symptomatology of insomnia as defined by the major disease and sleep disorder 
classification manuals- DSM IV [1], ICD-10 [2], ICSD-2 [3]- is a difficulty initiating or 
maintaining sleep, non-restorative or poor quality sleep and daytime impairments- either 
specific symptoms in terms of fatigue for example, or more global impairment such as 
social functioning (ICSD-2 and DSM-IV respectively) which are attributed by the patient to 
night-time sleep. For a diagnosis to be made these symptoms need to present for at least 
3 nights a week [4] and not resultant from environmental disruptions- i.e. noise, bed 
partners, temperature- and be present for at least 1 month [1, 4]. 
 Table 1 1 DSM-IV vs. ICSD-2 for Insomnia Subtypes 
 
Currently, there are 2 dominant classification systems for insomnia: DSM-IV and ICSD-2, 
which differ somewhat in their conceptualisation of insomnia and insomnia subtypes. The 
ICSD-2 provides a long list of insomnia disorder sub-types, whilst the DSM-IV focuses on 
only a few (table 1 1: DSM-IV vs. ICSD-2 insomnia sub-typing).  
 
 
  
 
DSM-IV 
 
ICSD-2 
Primary Insomnia Adjustment Insomnia 
Psychophysiological Insomnia 
Paradoxical Insomnia 
Idiopathic Insomnia 
Insomnia related to another Medical 
Disorder (Axis I or II) 
Insomnia Due to General Medical 
Condition 
Substance Induced Sleep Disorder 
Insomnia Due to a Mental Disorder 
Insomnia Due to a Medical Condition 
Insomnia Due to a Drug Substance 
 Inadequate Sleep Hygiene 
Behavioural Insomnia of Childhood 
Non-organic, Unspecified 
Physiologic (organic), Unspecified 
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Insomnia Sub-type Symptoms 
Psychophysiological 
Insomnia 
Heightened arousal; Learned Sleep preventing 
associations; Decreased functioning during wakefulness 
Paradoxical Insomnia Complaint of severe insomnia in the absence of objective 
sleep disturbance; Daytime impairment not commensurate 
with degree of sleep disruption 
Idiopathic Insomnia Longstanding complaint with insidious onset during infancy 
or childhood; Causes distress or functional impairment; Is 
not better explained by any other disorder or condition 
Table 1 2 ICSD-2 Insomnia Subtypes 
 
Further, the ICSD-2 provides specific diagnostic features for each primary-insomnia 
phenotype (table 1 2 outlines the ICSD-2 diagnostic criteria for insomnia phenotypes), 
whereas the DSM-IV tends to view primary insomnia as only diagnosable if present in 
isolation. Understanding these insomnia sub-types, and having them thoroughly and 
correctly classified is important for research in this field, with work suggesting that 
different subtypes may present different aetiologies (work on familial aggregation, 
discussed later, suggests that those with a family member diagnosable as suffering from 
insomnia are more likely to report earlier onset, for example.) along with negative 
attitudes towards interventions[5]. It is important to note also that in the DSM-V the 
diagnostic features of insomnia will be altered, meaning a shift away from ‘Primary 
Insomnia’ which could not be diagnosed in the presence of another illness, to ‘Insomnia 
Disorder’. This means that insomnia can be diagnosed alongside another disorder, rather 
than being relegated to the position of symptom. The DSM-V also highlights time courses 
for insomnia: acute, sub-acute and persistent, which the DSM-IV failed to do. This is 
linked more closely to the ICSD-2 and the notion of adjustment or acute insomnia. This 
highlights a general shift in the literature and the way in which insomnia is perceived: as a 
disorder in its own right with its own aetiology, treatment and consequences, 
independent of other factors.  
 
1.2  Prevalence 
Due to differing classification systems, amongst other things, the true prevalence of 
insomnia remains elusive. Ohayon[6] provides a comprehensive review of the 
epidemiological studies conducted up until that point: the prevalence of insomnia as 
defined by the DSM-IV is reported as 6% if the most stringent criteria are applied. That is 
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to say this number represents those who would receive a diagnosis of primary insomnia, 
as defined by the DSM-IV. Around one third of the population are reported as endorsing 
at least one insomnia symptom. Since 2002 a handful of other studies have been 
published in varying populations, reporting similar figures: in a French-Canadian cohort, 
insomnia syndrome is reported as being present in 9.5% of the population and 29.9% 
report insomnia symptoms[7]. This study used a combination of DSM-IV and ICD-10 
criteria for insomnia diagnosis. In a Swedish cohort,[8] the prevalence of insomnia is 
reported as 6.5%, insomnia defined as a problem initiating or maintaining sleep or non-
restorative sleep associated with daytime consequences at least 4 nights a week , 
however there was no minimum length of time applied to the presence of these 
symptoms to inform the diagnosis of insomnia. A study focusing mainly on children in 
Hong-Kong [9] found that insomnia was present in 4% of children, 12% of adult women 
and 9% of adult men, when diagnosis is based on a combination of DSM-IV and ICSD-2 
criteria.   
These 3 studies report similar figures in 3 differing populations, and all use very similar 
criteria in the diagnosis of insomnia- based mostly on DSM-IV guidelines. However, it has 
been pointed out that estimates range from as low as 5% to as high as 50% depending on 
criteria used [6], thus emphasising the point that a greater degree of standardisation 
needs to occur in this field of research if we are to truly understand the prevalence of 
insomnia. 
 
1.3 Cost 
The cost of insomnia is intrinsically linked to its prevalence: obviously the more common 
a condition is the greater its burden is going to be, relatively. Therefore until there is a 
consistency within the insomnia epidemiological research, the burden of insomnia will be 
constantly misunderstood. There are however, some methodologically strong studies 
which aim to delineate the cost of insomnia from various viewpoints, using similar criteria 
for the definition of insomnia as those in the studies mentioned above. In one of the 
more thorough assessments of the economic burden of insomnia, conducted in the 
province of Quebec, Canada, it was reported that the total annual cost of insomnia is $6.6 
billion (Cdn $), in this one province alone. The authors report that this is likely a 
conservative estimate, but clearly demonstrate that there is a massive societal cost 
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attached to untreated insomnia, the largest contributor to the cost (76%) being that of 
lost productivity and work absence[10]. However it should be noted that it was the 
participants who relayed the attribution of this productivity loss to sleep: this has an 
inherent bias given that it is highly likely that insomnia suffers will underestimate their 
performance and are possibly more likely to attribute loss of productivity to sleep loss 
and not other factors, as per Harvey’s cognitive model[11]. 
 
Kyle et.al.[12] highlight the burden of insomnia to the individual, in terms of health 
related quality of life, concluding that treating insomnia with either pharmacological 
treatments or psychological interventions leads to improvements in quality-of-life 
outcomes across several domains from physical through to emotional functioning.  This 
improvement in quality of life to the individual is important when considering the cost-
benefit of insomnia treatment. Botteman[13] highlights the cost- and clinical-
effectiveness of pharmacological treatments for insomnia and points to the work of 
Morgan et.al.[14] who have demonstrated the cost-utility of CBT is well within the range 
considered to be acceptable by the NHS, meaning that the cost of implementing this 
treatment is far out-weighed by the gains to quality of life in the patient, as well as being 
a clinically effective treatment. Further to this, it has been shown those with remitted 
insomnia have lower healthcare and productivity costs vs. non-remitted patients[15]. The 
gain made in productivity under-writes the majority of treatment costs. Furthermore 
costs associated with psychological treatments could be minimised with the 
implementation of a stepped care model, which works on the premise that the majority 
of people will see improvements with the least intensive treatment type- i.e. online 
therapy or group sessions-and only the severe cases will see a specialist BSM 
practitioner[16]. 
 
It could be argued that again, cost-utility estimates are conservative given the emergence 
of data showing that insomnia is a risk factor for mental and physical ill-health. A recent 
meta-analysis concluded that the likelihood of developing major depression is two-fold in 
those who have insomnia vs. good sleepers[17], supported by work showing that the 
relationship between insomnia and depression is mediated by insomnia subtype[18]. 
Further, Taylor [19] concludes that treating insomnia may lead to better outcomes and 
improved quality of life in a range of comorbid disorders, from heart-disease through to 
cancer, and that rates of these disorders are higher in a poor-sleeping population. Brower 
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et.al. [20] demonstrate that treating sleep complaints in those receiving support for 
alcoholism halves relapse rates. Thus, there are clear benefits on an individual level, but 
also a wider societal level to treating insomnia in an otherwise healthy population, and 
also in those with comorbid conditions. Understanding the aetiology of insomnia and the 
differing subtypes is pivotal in providing individually-tailored, and therefore more robust, 
treatments but also in preventing chronic insomnia and therefore reducing the bill 
associated with sleep loss that arises from both direct and indirect costs.  
 
1.4 The Insomnia Models: Concepts and Evidence 
A thorough understanding of insomnia is fundamental in reducing the burden of this 
disorder. The mechanisms which lead to the manifestation and maintenance of sleep 
disruption remain elusive, in that there is no absolute answer as of yet. The major models 
of insomnia demonstrate how conceptualisation and understanding of chronic insomnia 
has evolved over-time, whilst also pointing a way for further research: what is still unclear 
and how might an understanding of this enrich the field of sleep research and therefore 
sleep-treatment and prevention programmes? Outlined below are the models which have 
proven most influential and which frame the rationale for this thesis. 
 
1.4.1 The 3-P Model 
 Spielman’s stress-diathesis, or 3-P model of insomnia[21] (Figure 1 1) purports that there 
are 3 components in the aetiology of insomnia: Predisposing factors- personality, coping-
style, and genetics; Precipitating factors- life-stressors; and Perpetuating factors. In 
Spielman’s initial outlay of this model these perpetuating factors are considered within a 
behavioural framework: sleep disruption is the result of classical conditioning. A sufficient 
stressor will lead onto disrupted sleep (in those who have some kind of vulnerability). The 
insomnia becomes early or sub-chronic insomnia due to maladaptive ‘coping strategies’ 
such as staying in bed longer to promote sleep opportunity. These coping strategies- 
which will later be referred to as safety behaviours- encourage the maintenance and 
continued development of early insomnia into chronic insomnia via classical conditioning: 
the sleeping environment becomes associated with wakefulness.  
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Spielman’s broader stress-diathesis model is appealing in that it appears intuitively 
obvious, highlighting the close relationship between sleep disruption and stress. 
 
 
Figure 1 1 Spielman’s 3-P Model 
 
 It has been widely endorsed throughout the sleep literature and, in terms of 
psychophysiological insomnia (PI), has proved a useful framework in conceptualising how 
this disorder develops and is maintained. However, the specific elements of each 
component remain equivocal. Physiological, behavioural and cognitive mechanisms have 
been studied in order to elucidate the aetiology of PI within this frame-work. These 
factors will be explored within the context of other models or theories of insomnia, as 
essentially these models are attempts to better understand the factors which underlie 
these 3 broad components, out-with a purely-behavioural- and wholly reductionist- view-
point.   
 
1.4.2 The Neuro-cognitive Model 
The Neuro-cognitive model[22] (Figure 1 2) is essentially a behavioural explanation of the 
aetiology of insomnia, but with a particular focus on cortical arousal, as measured by high 
frequency EEG. While the behavioural model can explain some of the phenomenology 
associated with insomnia, such as the reverse first-night effect (whereby insomnia 
patients show improved sleep when in a novel environment, as opposed to disrupted 
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sleep as seen in good sleepers in this situation)[23] and the interventions derived from it 
have shown clinical efficacy [24] it cannot explain, what Perlis et.al. term ‘the 4 paradoxes 
of insomnia’. Namely: that insomnia patients will report being awake during PSG verified 
sleep; PI patients will consistently overestimate how long it takes them to fall asleep and 
how long they are awake for during the night; when treated with hypnotics PI report 
disproportionate improvements in sleep relative to objectively measured improvement; 
and finally benzodiazepines do not normalise sleep, but still result in improvements in 
subjective reports. 
 
The authors attempt to explain these paradoxes via the measurement of high-frequency 
EEG activity, an index of cortical arousal which is tightly associated-if not analogous to- 
cognitive arousal, whilst differentially associated with the various stages of normal sleep 
[25].  It has been known for some time that insomnia patients display increased high-
frequency EEG activity- in the beta and gamma range[26]. It is proposed, therefore, that 
as one develops chronic insomnia, as guided by the principles of a behavioural model, 
there is an increase in high frequency EEG at sleep onset. This would indicate that there is 
maintenance of sensory processing and memory formation in a PI population[27]. 
Increase in high frequency EEG may then explain why an individual perceives sleep as 
wakefulness, due to the brain still processing environmental information, creating a more 
easily perturbed sleep. Misperceiving total sleep time and sleep latency may be due to a 
real perception of disengagement- how long it takes to inhibit high frequency EEG/ 
cognitive processes. As for the paradoxes surrounding drug use it is argued that 
benzodiazepines promote mesograde amnesia[28] and discourage memory formation, 
thus masking the effects of high frequency EEG whilst not producing improved PSG scores 
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Figure 1 2 Perlis et.al. Neurocognitive model 
The model has remained largely untested, with focus largely being on lower frequency 
EEG [29]. However, Perlis et.al.[30], in a small sample (n=9 per group) showed that PI 
versus good sleepers and poor sleepers with major depression demonstrate greater 
beta/gamma activity and that this occurs maximally in shallow sleep stages, as the model 
would predict and is a feature specifically of PI, and not insomnia and major depression. 
Bastien et.al.[31] have demonstrated, in line with the outlined model, that insomnia 
patients show reduced event related potentials (ERP’s) relating to sleepiness in the 
evening, and increased ERP’s relating to information processing, suggesting that an 
inability to inhibit waking processes and a propensity toward increased cortical arousal 
may both contribute to poor sleep. Nofzinger et.al.[32] have shown that beta EEG activity 
is conversely related to sleep quality, and also to differential brain activation patterns in a 
PI group. 
This model represents an expansion on traditional behavioural conceptualizations, 
highlighting the interplay between psychology and biology and so in this sense is the first 
explicitly, fundamentally psychobiological model of insomnia, and has considerable 
overlap with the hyperarousal theory discussed later. Whilst paving a way for our 
understanding of the neurobiological mechanisms of insomnia, it does ignore certain 
aspects. Namely, the cognitive processes involved in insomnia, alluding to them 
vicariously through a presumed biological index. No hypotheses are made regarding how 
worry or rumination may feed increased gamma-activity at sleep onset, for example.  It is 
unsatisfactory, also, in its lack of consideration for the daytime consequences of 
insomnia. A perceived impairment in daytime functioning is an essential feature of 
Chapter 1  33 
insomnia in both the DSM-IV and ICSD-2. The model provides conjecture on what 
maintains disrupted sleep, but fails to explain insomnia in full.  
 
1.4.3 The Cognitive Model 
The cognitive model of insomnia[11] delineates the cyclical nature of the cognitive 
processes involved in the maintenance of insomnia, highlighting night-time and daytime 
cognitions and behaviours (Figure 1 3). It begins with negatively toned cognitive activity- 
rumination and worry. Anecdotally, the insomnia population is characterised by a ‘racing 
mind’. This is also evidenced experimentally. Watts et.al.[33] have suggested that those 
suffering with insomnia feel less in control of their thinking, and further, split insomnia 
patients into 2 groups: worried insomnia sufferers and non- worried insomnia sufferers. 
The main difference between these groups is that worried insomnia-sufferers 
ruminations revolved around work whereas the thoughts of the non-worried insomniacs 
revolved around the sleep process itself. Nicassio et.al. [34] have shown that insomnia 
sufferers have more negative thoughts at bedtime than good sleepers, and more recent 
work has suggested that emotionally laden thoughts are the ones most likely to interfere 
with the sleep process[35].  
 
 This rumination, or racing mind, perpetuates insomnia as it leads to further cognitive but 
also somatic arousal (tension) and so eventually learned associations between the 
sleeping environment and feeling tense. It is important to note here that although the 
focus of this model is, obviously, the cognitive processes driving insomnia it is not 
dissociated from somatic or physiological arousal. Cognitive arousal leads to physiological 
arousal, as Lundh and Broman[36] point out in their paper discussing sleep interfering 
and sleep interpreting processes whereby cognitive or physiological arousal would be an 
interfering process as it impacts directly on sleep; dysfunctional beliefs about sleep or 
anxieties about sleep would be sleep interpreting processes as they lead to increased 
cognitive arousal.  
 
It has been demonstrated that insomnia patients hold dysfunctional beliefs and attitudes 
with regards to sleep, and its impact the following day [37-39]. These are maintained via 
safety behaviours. Again, in parallel with the anxiety literature, safety behaviours are 
overt or covert strategies aimed at avoiding a feared outcome. However, they are likely to 
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interfere with the disconfirmation of the dysfunctional belief or attitude[40]. It has been 
suggested that insomnia patients employ certain safety behaviours in order to conserve 
energy, for example by only engaging in mundane activities or cancelling social 
engagements, or increasing sleep opportunity- by increasing time in bed[41, 42]. Such 
behaviours are posited to reinforce faulty beliefs about sleep and its daytime 
consequences and in the case of the latter example solidify the association between the 
bedroom environment and arousal. The cycle is complete, and becomes self-fulfilling.  
 
Figure 1 3 Harvey's Cognitive Model[11] 
 
1.4.4 Attention-Intention-Effort Pathway 
The Attention-Intention-Effort (AIE) pathway (figure 1 4)[43] explains insomnia with 
regards to the interaction between behavioural and cognitive processes, and how these 
interact with the physiology of arousal. This explanatory model has strong overlaps with 
aspects of the cognitive model, in that is provides theoretical explanations as to how 
faulty cognitions, and the ensuing arousal, may be maintained. In accordance with the 
cognitive model, rumination or worry about sleep and its negative impact the next day 
leads to a narrowing of attention to cues which indicate a lack of sleep or are indicative of 
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sleep loss/ wakefulness: selective monitoring or attentional biases to sleep cues. This line 
of thinking with regards to understanding the aetiology of insomnia is supported by work 
in anxiety which has demonstrated that those who are of an anxious disposition will 
display an attentional bias toward threat cues, and that this can be detected via various 
cognitive paradigms[44-46]. It has also been shown to exist in insomnia patients using 
various paradigms, of a similar nature to those employed in the anxiety literature [47-49]. 
Such an attentional bias heightens awareness to sleep loss, and therefore highlights the 
intention to fall asleep, thus leads to increased effort to fall asleep and therefore 
increased arousal [43].  This is what the AIE states: attention to lack of sleep leads to a 
direct effort to fall asleep. Effort by its very nature leads to arousal (either somatic or 
cognitive). This then further undermines the automaticity of the sleep process and further 
highlights cues which indicate a lack of sleep and so the cycle continues.  
 
During the day this attentional-bias may manifest as selectively attending to cues which 
indicate reduced performance, and attributing this to sleep. Such an attentional bias has 
not been demonstrated experimentally. However, there is a well documented 
discrepancy between objective performance and subject performance in insomnia 
patients. Orff et.al.[50] show there is no differences on neuropsychological tests between 
an insomnia and good-sleeping group. The discrepancy between objective performance 
and subjective daytime complaints is explained in terms of attentional biases toward 
deficits: the patient becomes overly aware of mistakes made and so inflates their ‘failure’ 
at the task. Bastien et.al [51] extends a similar argument to Orff et.al., stating that 
differences in objective vs. subjective measures may be due to the insomnia population 
having to put in more effort to maintain good performance. This area has been 
thoroughly reviewed by Fulda and Schulz[52], concluding that there is little evidence of an 
objective deficit. Similarly insomnia patients are shown to consistently over estimate 
variables which equate to sleep loss [53]or to misperceive their sleep [54]. One possible 
explanation for this is the development of an attentional bias toward cues which 
reinforce the worry that one is not sleeping, and therefore an inflation of the problem. 
Both the day and night time misperceptions endow negatively toned cognitions, and 
potentially lead to further somatic arousal. 
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figure 1 4 Attention-Intention Effort Pathway for the maintenance of Insomnia. Taken from Espie et.al. 2002
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1.4.5 The Hyperarousal Model 
The hyperarousal model of insomnia states that insomnia is a disorder of the 24h cycle- 
unlike the neurocognitive model which is concerned only with problems at sleep onset, 
but similar to the cognitive model which takes into consideration the daytime 
consequences of insomnia- by which insomnia sufferers demonstrate consistently 
increased somatic and cognitive arousal. Unlike the aforementioned models, there is no 
explicit role of learned/ operant conditioning, the evidence for this model focusing on the 
physiology of sleep rather than the cognitive/ behavioural changes that are thought to 
occur in insomnia. Rather than competing with the 3-P, neurocognitive and cognitive 
model, it compliments them: acute insomnia caused by a stressor which then, in those 
who focus cognitively on their insomnia- i.e. sleep related ruminations- becomes an 
independent chronic condition. The hyperarousal model emphasises the interaction 
between both psychological and neurobiological systems in the aetiology and 
maintenance of insomnia and in this sense is integrative (figure 1 5). The theory has been 
reviewed comprehensively elsewhere [55, 56] so only the most relevant evidence is 
discussed here.  
 
Bonnet and Arand [57] for example have demonstrated increased sympathetic nervous 
system activity, as measured by low frequency spectral power EKG, in the evening and 
throughout the sleep cycle, relative to sleep stage in chronic insomnia patients; Vgontzas 
et.al.[58] show that cortisol secretion- a marker of hypothalamic-pituitary-adrenal axis 
activity (HPA)- is significantly greater in the early part of the night in poor sleepers, but is 
also more pronounced across the 24h cycle, demonstrating the same circadian pattern as 
good sleepers, but with a greater number of cortisol and ACHT pulses throughout the 
circadian cycle and, particularly pronounced differences in the ‘valleys’ of the pulsatile 
curves, thus suggesting a disorder of the central nervous system rather than one of sleep 
loss or circadian misalignment. The same group have also demonstrated that 24-h urinary 
free cortisol levels are mildly, although significantly, correlated with total sleep time 
(r=0.33) 
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Figure 1 5 Neurocognitive model of insomnia 
 5-HT: Serotonin; ARAS: ascending reticular activating system; SL: sleep latency; TST: total 
sleep time; VLPO: ventrolateral preoptic area of the hypothalamus; WASO: wake after sleep 
onset. Acute insomnia: 1–90 days; sub chronic: 3–6 months; chronic>6 months. Note: the 
cognitive-behavioural and the neurobiological domain are depicted in a parallel way – it is 
assumed that both domains are strongly interconnected and not independent of each other. 
From Riemann et.al.[56] 
 
. This may be compounded by the fact that sensitivity to stress hormones (corticotrophin 
releasing hormone (CRH)) seems to become greater as we age [59]. This should be a 
consideration when investigating hormonal activity and insomnia: absolute values may 
not capture the full extent of the hyperarousal, as sensitivity seems to change with age 
and probably on an intra-individual level. It may serve to have a secondary measure of 
sympathetic nervous system activity alongside cortisol levels in order to assess sensitivity 
differences across sleep groups and ages, such as spectral EKG, or core body temperature.  
 
Nofzinger et.al.[60] have demonstrated that there is a smaller relative decrease from 
REM to nREM sleep in whole brain glucose metabolism, coupled with an increase in 
metabolism during wakefulness and consolidated nREM sleep. Winkelman et.al.[61] 
demonstrate reduced GABA in the PI patients brain, again suggesting that this population 
are constantly over-aroused, given GABA’s function as a global inhibitor.  
 
The hyperarousal theory has widespread support, through various different domains and 
does not occlude other theories of insomnia, expanding on the neurocognitive model, 
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whilst not discounting a cognitive approach to insomnia as indeed in this domain too 
insomnia patients seem to be ‘hyperaroused’.  
 
The common thread throughout all sleep models is the idea that stress (precipitant) leads 
to sleep difficulty, due to the resultant increased- or an over sensitivity to- arousal, and 
that this is then maintained via learned associations, increased worry, and a 24h arousal 
to combat lack of sleep (perpetuating). However, there is a paucity of research on what 
factors may predispose an individual to developing, and possibly maintaining, a sleep 
complaint after the resolution of a stressful life event- such as bereavement or sudden 
unemployment -and secondly how these factors interact with and mediate each other: 
that is to say there is a need to profile an ‘at risk’ population through a stronger 
understanding of the aetiology of primary sleep complaints and how this relates to the 
biological and psychological stress systems, a sentiment echoed in  
Drake et.al.’s[62] review of the development of insomnia in relation to comorbidity:  
Insomnia seems to be associated with a constantly increased sympathetic nervous system 
and this may account for the common psychiatric and physiological co morbidities- such 
as depression, anxiety, heart disease etc [19]- associated with chronic insomnia. 
Understanding which factors pre-date insomnia and which result from sleep loss will help 
in better understanding how to treat and prevent the disorder. Understanding causality is 
difficult because studies which support the models are, largely, conducted on those 
already diagnosable as suffering from insomnia meaning that there is very little 
information regarding what may act as a predisposing factor to insomnia. The causality of 
the demonstrable hyperarousal remains unknown, as does the nature of the relationship 
between psychological variables such as worry, rumination and neuroticism and 
arousability in this population. The animal model of insomnia may help to better 
understand the mechanisms through which stress affects the sleep system, on a very fine-
grain scale.  
 
1.4.6 The Animal Model 
Saper, Chou and Scamell [63] propose the idea of a ‘sleep switch’. Their paper outlines 
the neural mechanisms responsible in switching from awake to sleep and back. The 
switch is thought to dwell within the hypothalamus (figure 1 6). This model, and how it 
applies to the interaction of stress and sleep, has been further elucidated by Cano 
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et.al[64]. Their animal model for stress induced insomnia supports the hyperarousal 
theory, in that it suggests that there is a hierarchical organisation of neuronal groups 
responsible for the switch between wakefulness and sleep, and sleep disruption. The crux 
of this is the VentroLateral Pre-Optic nucleus (VLPO) switch. Located in the hypothalamus, 
this group of neurons is active mostly during nREM sleep. It secretes inhibitory 
neurotransmitters- GABA and galanin- which act on the locus ceruleus, a group of nuclei 
in the brain-stem involved heavily in the physiological stress/ panic response. It is 
proposed that the VLPO acts as a ‘flip-flop’ switch, by which it inhibits waking responses 
to allow sleeping responses to happen. However, upon dealing with stress this switch is 
unable to remain in the ‘off’ position due to increased activation of the limbic system, 
which in turn activates physiological responses, leading to sleep disruption. The 
methodology employed in the genesis of this model provides a more ecologically valid 
stress-induced insomnia state, in that the animals experience no sleep deprivation and 
although the stressor is more homogeneous than stressors experienced by people it 
provides an elegant method by which to investigate the effects of a species-specific 
psychological stressor on sleep-patterns and indeed did create a sleep pattern similar to 
that seen in human insomnia patients. That is to say: increased SOL, decrease in REM and 
more sleep disruption. Thereby, the model proposed highlights areas which may merit 
further research in a human population and more interestingly, corroborates the work 
done by Nofzinger et.al.[60], showing similar brain areas to be implicated in the 
disruption of the sleep cycle across species. In terms of predisposition to insomnia, it 
implies that stress-sensitivity is perhaps more implicated than a problem with the sleep-
system, per se.  
 
This model highlights again the role of the stress-arousal system in insomnia, 
demonstrating that although the sleep systems remain fully active- i.e. promoting sleep-, 
sleep disruption still occurs and is only attenuated upon deactivation of parts of the 
limbic-arousal system. The authors point out that this may have implications in 
understanding how best to treat insomnia: through the dampening of the stress response 
rather than the promotion of the sleep system- adding to the argument posed by Espie 
et.al.[43] and Bastien et.al.[31] in understanding the difference between hyperarousal 
and faulty inhibition.  
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Figure 1 6 From Saper et.al. Animal 
Model[63] 
 Inhibitory pathways shown in red, and 
the excitatory pathways in green. The 
blue circle indicates neurons of the 
LDT and PPT; green boxes indicate 
aminergic nuclei; and the red box 
indicates the VLPO. Aminergic regions 
such as the TMN, LC and DR promote 
wakefulness by direct excitatory 
effects on the cortex and by inhibition 
of sleep-promoting neurons of the 
VLPO. During sleep, the VLPO inhibits 
amine-mediated arousal regions 
through GABAergic and galaninergic 
(GAL) projections. Most innervations 
of the TMN originates in the VLPO 
core, and input to the LC and DR 
predominantly comes from the 
extended VLPO. This inhibition of the 
amine-mediated arousal system 
disinhibits VLPO neurons, further 
stabilizing the production of sleep. The 
PPT and LDT also contain REM-
promoting cholinergic neurons. The 
extended VLPO (eVLPO) might 
promote REM sleep by disinhibiting the PPT–LDT; its axons innervate interneurons within the PPT–LDT, as well 
asaminergic neurons that normally inhibit REM-promoting cells in the PPT–LDT. Orexin/hypocretin neurons (ORX) 
in the lateral hypothalamic area (LHA) might further stabilize behavioural state by increasing the activity of 
aminergic neurons, thus maintaining consistent inhibition of sleep-promoting neurons in the VLPO and REM-
promoting neurons in the PPT–LDT. Unbroken lines represent neuronal pathways described in the text. Broken 
black lines indicate influences of specific regions on behavioural states. Abbreviations: DR, dorsal raphé nucleus; 
HIST, histamine; LC, locus coeruleus; LDT, laterodorsal tegmental nuclei; PPT, pedunculopontine tegmental 
nuclei; REM, rapid eye movement; TMN, tuberomammillary nucleus; VLPO, ventrolateral preoptic nucleus. 
Chapter 2: Who is Predisposed to Insomnia: A Review of Familial Aggregation, Stress-Reactivity,    
Personality and Coping Style  42 
 
 
 
Who is Predisposed to Insomnia: a Review of Familial 
Aggregation, Stress-Reactivity, Personality and 
Coping Style 
 
The aetiology of Insomnia from onset through to the development of an insomnia 
syndrome is poorly understood. Apart from a few epidemiological studies there is very 
little work investigating what may predispose certain individuals to insomnia. It has been 
estimated that 23-33% of the population are currently experiencing trouble with their 
sleep[7], while ~6-10% [65, 66] are suffering from chronic insomnia. This raises questions 
as to the factors that drive the minority into a chronic condition, and why some people 
experience sleep disruption in response to certain situations while others do not seem to 
develop a sleep-complaint. This chapter aims to review what is known about vulnerability 
to insomnia and suggest possible mechanisms that may lead to poor sleep in response to 
life-stressors. Two viewpoints are presented: first, the genetic and psychobiological 
factors that play a role; and secondly, psychological influences of personality and coping 
style will be examined. The interaction of these factors and the ways they may mediate 
one another in the onset and maintenance of insomnia will be examined within the 
framework of the 4 dominant models of insomnia: The 3-P (stress-diathesis) model[21], 
the hyperarousal theory of insomnia (for a review see Riemann et.al[55]. ); the neuro-
cognitive model of insomnia[22] and the cognitive model[11](these models are outlined 
in chapter 1). The notion that a predisposed phenotype does exist will be discussed with 
reference to studies on the familial aggregation of insomnia and a discussion of which 
genes may be driving this, with a particular focus on genetics which may control response 
to stress. Lastly, psychological factors will be considered, concluding that a vulnerable 
phenotype does exist and that it is likely characterised by faulty stress-management, at 
both a physiological and psychological level. The merit of a more profound understanding 
of predisposing factors is in the ability to help prevent insomnia in those who are 
vulnerable, the development of education programmes, and in the provision of further 
insights into developing more robust, individually tailored, treatment programmes. 
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2.1 Familial Aggregation: At risk from birth  
 A strong genetic component has been demonstrated in healthy sleep, both in humans 
and in animals, leading to the mapping of several loci which may be involved in sleep 
regulation. Studies on normal sleep in twins have also demonstrated strong concordance 
in slow wave sleep, suggesting ~50% heritability, similarities in sleep onset latency and in 
sleep disruption that are not solely accounted for by environmental factors [67-70]. 
Further to this there seems to be a strong familial component in other sleep disorders 
such as narcolepsy, parasomnias, sleep apnoea, idiopathic insomnia, hypersomnia and 
delayed sleep phase syndrome. This would all suggest that there might be a genetic/ 
familial component to Psychophysiological Insomnia (PI), and this has an obvious bearing 
when considering predisposing factors and in understanding the psychobiology of PI. 
 
Work on familial aggregation of PI is somewhat sparse (table 2 1 provides a summary of 
published studies which have a particular focus on familial aggregation and insomnia); 
however, there is a small body of work which does imply a role of heritability in the 
development of PI and that this may be related to anxiety, depression and stress-
reactivity all of which are demonstrably intricately related. Dauvilliers et. al.[71] 
conducted analyses on 181 insomnia sufferers who were classified as either primary 
insomnia (n=77) or insomnia due to a psychiatric disorder (n= 104), in order to 
differentiate aetiologies. This work represents the most rigorous protocol in terms of 
screening procedures and history taking within the familial aggregation literature. The 
Spielberger State-Trait Anxiety Inventory (STAI) and Beck Depression Inventory (BDI) were 
used to help diagnose depression and anxiety, when scores correlated with observations 
from clinical interview allowing for classification of ‘insomnia due to psychiatric disorder’. 
Participant diagnosis for insomnia was achieved via clinical interview on the basis of DSM-
IV and ICSD criteria whereby insomnia was diagnosed based on clinician agreement. 
Further to this, PSG was conducted to rule out other sleep disorders and a physical 
examination was also carried out by sleep-specialist physicians, thus allowing for 
assessment of the relative contribution of psychological, behavioural and medical factors 
to insomnia.  This cohort represents the most thoroughly defined group within the 
published work in this field.  
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 Results from the Primary Insomnia group suggest that the risk of developing insomnia is 
6.65 times greater in those who have a first degree relative with PI, with the mother 
being the most commonly affected relative (42%). Interestingly, the risk value decreased 
to 1.63 for psychiatric insomnia, suggesting differing degrees of genetic contribution.This 
work is the first work to validate family history, and also to employ a control group of 
probands spouses (n=90) who were assessed with the  Insomnia Severity Index (ISI) and 
via clinical interview. This goes someway to controlling for environmental factors i.e. if 
the current sleeping environment was contributing to poor sleep, this should be evident 
in those sharing the environment. However, the family members’ sleep and health status 
was poorly defined: sleep status was confirmed only with the ISI, and there was no 
mental health or sleep history taken. This limits the inferences that can be made about 
common pathways between psychiatric disorders and sleep. Further the ISI only gives 
information on current sleep state, which may not provide an accurate picture of familial 
aggregation of insomnia: it could potentially be the case that a first degree relative may 
suffer periods of transient insomnia, which the ISI may fail to capture. This pattern could 
potentially be seen also in their relation. Furthermore, the study in no way allows 
inferences regarding familial environmental factors- i.e. factors in the childhood home 
which may have encouraged faulty attitudes towards sleep, and so doesn’t allow one to 
conjecture on what may drive the heritability. Given the reportedly high accuracy with 
which patients can perceive and identify insomnia in family members (ROC analysis 
AUC=0.97;p<0.0001[71]) is it not possible that concern over sleep is learned implicitly in 
some cases? It would be interesting in a study such as this to investigate differences in 
polysomnographic (PSG) sleep, in order to establish a familial aggregation of paradoxical 
insomnia. Further to this, the age of the cohort ranged from 16-86. It is largely accepted 
that sleep becomes more problematic, subjectively, as one ages. Having an elderly 
representation in the sample may dilute the results somewhat as they may represent a 
population which are more vulnerable to insomnia for different reasons and so may 
report symptomology of insomnia, in the absence of familial aggregation.  
 
 Bastien and Morin[72] recruited a sample of 285 well-defined patients reporting to a 
sleep clinic and found that 35% of participants reported a first or second degree relative 
with a current or past sleep problem. The mother was the most commonly affected 
member, with 45% of mothers having a past problem and 39% a current problem with 
insomnia. Further, there was a trend towards a higher familial incidence in those 
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reporting earlier onset vs. those reporting a later onset- as suggested previously, 
representing the fact that insomnia in an older sample is likely due to differential 
aetiological factors. There was no attempt in this study to follow-up family members, or 
to verify the existence or severity of insomnia. 
 
Beaulieu-Bonneau et. al [73] have supported this work, demonstrating, in a population 
based sample, a strong association between maternal insomnia (19.7% of cases report 
their mother as suffering with insomnia) and increased risk in offspring.  There were 
significant group differences between those with a current sleep problem or reported 
past problems vs. good sleepers who endorsed never having any sleep problems. 
Furthermore, those who demonstrated a vulnerability to insomnia- i.e. currently 
diagnosable as an insomnia sufferer, or reporting past episodes of poor sleep- showed a 
trend toward reporting more anxiety related symptomatology and predisposition to 
arousal. This is important when we consider insomnia in light of the hyperarousal model 
(outlined in chapter 1), and may tentatively suggest that there is a predisposition to 
‘hyperarouse’ in response to stress, which might eventually lead to chronic hyperarousal 
and insomnia. It also supports findings by LeBlanc et.al.[74] who demonstrate that 
arousal predisposition creates an odds ratio (OR) of 1.12 for the incidence of a new case 
of insomnia syndrome. The absolute differences in familial incidence between the good 
sleepers and the vulnerable group are relatively small (29% vs. 37%) and the groups are 
poorly defined, not assessing for psychiatric conditions that we know impact on sleep, or 
other comorbid conditions. The presence of an afflicted family member was identified 
based only on the participants’ response to a ‘yes’/ ‘no’ question and so may be biased- 
maybe not however, if PI are as accurate at assessing family members sleep as has 
previously been suggested.  
 
 Although there is no objective measure of sleep in the majority of these studies, they 
indicate that there is a familial component in self-reported insomnia. LeBlanc et.al. [74] 
point out that family history was the second strongest predictive factor in new case 
insomnia syndrome in their study. In terms of differing aetiologies, all of these studies 
report an association between early onset of sleep problems and reporting of ‘positive’ 
first-degree relatives. The implication here is that there is a familial predisposition in 
some: a vulnerable phenotype. It could be hypothesised that the mechanism here is 
through stress reactivity, making some more negatively responsive to stress and so more 
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likely to have an earlier onset- a stronger predisposition- of insomnia, or to report more 
periods of transient insomnia, whereas in those with no familial history it takes a longer 
period of consistent or a more severe life stressor before sleep disruption is evident, or 
perceived as a complaint. Drake et.al.[75] support this notion, showing that 37.2% of 
variation in responses to a validated and reliable questionnaire assessing vulnerability to 
sleep disruption (Ford Insomnia Responsivity to Stress Test (FIRST)) is accounted for by 
familial aggregation. This relationship remained after controlling for potential confounds 
including age, gender, shift schedule, and psychiatric history.  
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Table 2 1 Summary of Published study with a Focus on the Familial Aggregation of Insomnia/ Sleep Disruption
Authors Objectives Participants Methods Results Interpretation Critique 
Dauvilliers 
et.al. 
2005 
Evaluate the prevalence of 
insomnia in first-degree 
relatives of chronic insomnia 
sufferers; differentiate 
chronic insomnia sufferers 
from those with psychiatric 
insomnia 
181: 
77 chronic insomnia 
patients; 104 patients with 
a co-morbid psychiatric 
complaint 
 
Insomnia mean age: 45.07 
(S.D.= 13.53) 
 
Mean age of Onset: 32.17 
(SD=13.39) 
Clinical interview; BDI; STAI; PSG in 
cases where other disorders were 
suspected (n=92). 
 
ISI used to validate insomnia in 1
st
 
degree relatives in a sub-
sample(n=74) 
 
Spouses also completed ISI 
72.2% of insomnia patients reported 
familial insomnia;  
43.3% in psychiatric group; 24.1% in non-
insomnia control group. 
 
Mother most commonly affected 
 
Family history related to earlier onset in 
insomnia group 
Familial 
aggregation 
present in 
insomnia, 
justifying need for 
further genetic 
studies 
particularly in 
those with early 
onset 
ISI may not be sensitive to recurrent periods 
of transitional insomnia; no mental health/ 
sleep history of family member 
 
Wide age range may dilute results 
 
Only aggregation study to employ PSG, get 
some form of confirmation about family 
members insomnia (ISI) 
 
Attempts to control for effects of current 
sleeping environment (spouses ISI). 
Bastien 
and 
Morin, 
2000 
Evaluate Familial incidence of 
insomnia among those with 
insomnia complaints 
285 insomnia patients 
from a sleep clinic 
 
Mean age 41.7 (SD= 13.96) 
 
Mena age of onset: 31.8 
(SD=16.4) 
Semi-structured interview for 
diagnosis of insomnia 
 
Family history of 1
st
 and 2
nd
 degree 
relatives: is an affected member 
present and what is the nature of 
their sleep problem 
35% of insomnia patients report family 
history. 
 
Mother is most commonly affected 
member 
 
Family history is related to earlier onset, 
and with sleep onset, as opposed to 
maintenance problems.  
Family history is 
likely a potential 
risk factor for 
insomnia, 
however this 
study cannot 
elucidate familial 
from social 
factors i.e. is poor 
sleep learned?  
1
st
 and 2
nd
 degree relatives considered. 
 
Probands relatives only assessed indirectly via 
propand 
Beaulieu-
Bonneau 
et. al 
2007 
Assess rates of family history 
of insomnia in good sleepers 
and insomnia patients. 
 
What characteristics do those 
with family history have in 
common? 
545 insomnia patients 
(203 with family history of 
insomnia) 
 
403 good sleepers 
(117 with family history of 
insomnia) 
 
Mean age:  43.9 (S.D.= 
14.1) 
Initial telephone screening then 
postal survey: ISI, PSQI, BDI, STAI, 
APS 
 
Questions about family history: “Do 
any of your immediate family 
members presently have or ever 
had sleep difficulties?”Follow-up 
questions to specify which 
relative(s) had a sleep problems 
and what type of problem. 
Is it current or past? 
31.9% reported at least 1 first degree 
relative with insomnia 
 
Mother was most frequently affected 
 
Patients with a current or past history 
were more likely to report a family 
member with insomnia compared to good 
sleepers who had no past episodes (39.1% 
vs. 29%) 
Provides further 
support for the 
role of family 
history in the 
development of 
insomnia 
No direct assessment of family members.  
 
Entirely survey based.  
 
Large sample 
Drake 
et.al. 
2008 
Assess the degree of familial 
aggregation in vulnerability to 
stress related sleep disruption 
in siblings 
46 (23 sibling pairs) 
 
Mean age 51.1 ( S.D.=12.1) 
Non-twin sibling pairs recruited. 
ESS, FIRST 
DSM-IV criteria used to exclude 
insomnia 
TST, TIB  for weekday and 
weekends taken at interview 
SE calculated from this 
Correlational analyses showed 37.2% of 
variance in stress-related sleep disruption 
is accounted for by familial aggregation. 
This remained when controlling for age, 
psychiatric history and shift work  
Suggests that 
vulnerability to 
sleep disruption 
may run in 
families, 
particularly in 
relation to stress 
No validated measure of sleep 
Sample is older on average than other studies 
Poorly defined sample 
 
The implications of this work needs follow up.  
 
Only study to look at sibling pairs.  
 
  
2.2 Genetics: Stress Rather Than Sleep 
2.2.1 Twin Studies 
Twin studies provide a valuable tool for understanding the heritability of a disorder, 
allowing one to investigate the co-occurrence of a specific outcome relative to the degree 
of genetic similarity in a twin-pair (mono- or di-zygotic). Twin studies can also help to 
control for shared environmental effects if both twins are raised in the same household. 
The higher degree of genetic similarity in twins is a strength compared to studies of 
familial aggregation. The twin study approach compares similarities within mono-zygotic 
twins to similarities within di-zygotic twins, allowing for the analysis of variance which is 
attributable to genetic and/or environmental influences. Twin-studies in the insomnia 
literature further support the presence of genetic factors that increase vulnerability to 
insomnia. It will be suggested that this is more likely related to the stress system rather 
than the sleep system.  
 
Twin studies to date all suggest that insomnia-related traits are heritable. Partinen et.al. 
[76] found the heritability for sleep disruption and sleep length 44%. Barclay et.al[77] 
reported that genetic influences were present on 6 out of 7 components of sleep quality 
as measured by the PSQI, with a range of heritability-estimate from 0% to 46%, with the 
rest of the variance accounted for by non-shared environmental factors. This contradicts 
Partinen’s finding somewhat, however, as Barclay et.al. point out the sample here is 
relatively young and so may be less susceptible to the genetic influences on sleep 
duration. The participants in this sample did not score in the extreme upper limit for any 
of the components of the PSQI, suggesting that they are not likely to suffer from an 
ongoing chronic insomnia; therefore what they are reporting on is a population with 
some insomnia symptoms. The reported variances may then speak more closely to a 
genetically controlled response to what is causing the mild disruption, rather than to a 
genetic common ground to the sleep system (I’m not arguing that there isn’t one, but 
that this maybe isn’t what Barclay et.al. have tapped into). This will be discussed more 
thoroughly when we look at specific genetic polymorphisms. 
 
This point is maybe made clearer when we look at recent work by Drake et.al.[78]. In a 
comparable twin cohort it was found that there is a significant overlap between sleep 
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reactivity to stress- the likelihood that sleep will be disrupted in response to stress- and 
insomnia symptoms in terms of their genetic influences. Sleep-reactivity to stress was 
measured by the FIRST. The FIRST is a questionnaire which has been shown to 
differentiate those likely to show objective sleep disruption in response to stress, versus 
‘stable’ sleepers (discussed in more detail later). It is argued that the findings from this 
study reflect the notion that sleep-reactivity may represent a genetic vulnerability to 
insomnia- interestingly the heritability was 43% for males and only 23% for females, 
suggesting different degrees of genetic influence between the genders. Insomnia in this 
sample was based on DSM-IV-TR criteria taking into consideration sleep and daytime 
impairment factors. Wust et.al.[79] have shown 48% heritability in cortisol awakening 
response, implying a genetic influence on HPA axis reactivity. Taking this all together, it 
could be the case that the heritability factor is one of an over-sensitive stress system, 
rather than an ineffective sleep system.  
 
2.2.2 Genetic Polymorphism: 5-HTTLPR Serotonin Transporter 
Polymorphism 
When we look next at the identification of genetic polymorphisms that may affect sleep, 
there is further support for the proposed notion that genes may exert their influence on 
insomnia through sleep-reactivity, or a differential stress response which may affect 
sleep. For example, Way and Taylor[80] using a laboratory based psychosocial stressor 
(the Trier Social Stress Test) found that genetic polymorphisms (5-HTTLP) are associated 
with increased cortisol response to the stress task.  This same polymorphism has been 
found to be associated with vulnerability to sleep disruption. (See below) It would have 
proven interesting in the Way and Taylor study to have sleep history and current sleep 
assessed in this study in order to indicate causality i.e. does the polymorphism lead to 
increased cortisol response, or does it affect sleep and this increases cortisol response to 
stress? This work does imply however that the mechanism through which genetics 
contributes to insomnia may be via stress systems, and that there is a definite inclination 
toward disrupted sleep in some, echoing the findings of Drake et.al.[78]. 
 Brummet et.al. [81] have demonstrated a significant interaction of life stress- caring for 
an Alzheimer’s patient- and the 5-TTLPR genotype. Those who possess homozygosity for 
the s-allele demonstrated greater sleep disruption, as defined by the PSQI, in response to 
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care-giving stress compared to controls. This suggests a trait-like vulnerability to 
experience insomnia during periods of stress, the mechanism of which is the production 
and re-uptake of serotonin. The s/s allele of this gene seems to inhibit the re-uptake of 
serotonin. This appears counter intuitive. However there is an argument to suggest the 
expression of 5-HTT is critical in the development of the neonatal brain, but independent 
to its function in adults [82-85]. The presence of this homozygous genotype modulates 
responsiveness to stress indirectly via brain development early in life, particularly in 
emotion regions: this has implications when we will subsequently consider the role of 
personality and coping style in the onset and maintenance of PI and also when taking into 
account aspects of cognitive hyperarousal.  
 
It is assumed in this study that each individual experiences the same stress in the same 
way i.e. there is no measure of subjective stress levels or of cognitive hyperarousal. Such 
information could provide useful insight into how stress biology affects cognition and vice 
versa.  It can be concluded from this study that the presence of the s/s allele leads to a 
greater likelihood of a subjective complaint.  
 
Deuschle et. al.[86] have also found an association between serotonin transporters length 
polymorphism and primary insomnia. Particularly interesting in this study is that they 
found no association between s-allele and PSG recordings, thus suggesting that the 5-
HTTLPR s-allele genotype has a stronger relationship with self-reports of insomnia rather 
than objective measurement of sleep, supporting the previously mentioned study. Unlike 
the previously mentioned study, participants were screened for major depressive 
episodes, an important consideration given the relationships between depression and 
sleep and depression and serotonin transporters. The authors conclude that the 5-HTTLPR 
s-allele, combined with stress, contributes to the hyperarousal seen in PI, for example, in 
the increased activation seen the hypothalamic-pituitary-adrenal axis (HPA) during the 
early evening in PI sufferers, and that it may make them more vulnerable to negative 
conditioning of sleep related stimuli, due to the uncoupling in the brain in the areas of the 
pregenual cingulate and amygdala, areas which contribute to extinction of negative 
affect[87]. That is to say that carriers of the s/s allele of the 5-HTT find it more difficult to 
extinguish negative learning. This could suggest a possible genetic pathway by which 
insomnia is not only precipitated but also perpetuated. It also implies a trait-like 
hyperarousal as both a precipitant and perpetuator. This is in-line with other work which 
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has demonstrated that those who are in possession of at least one s-allele on the 5-HTT 
gene are more likely to develop depressive tendencies, depressive disorders and/or 
suicidal ideation, but only if such individuals also encounter severe, or many life stressors 
[88, 89].  A recent meta-analysis[90] has reviewed work highlighting the role of the s/s 
allele in modulating amygdala function in response to aversive stimuli. It seems that the 
s/s allele does confer a tendency to preferentially process aversive stimuli; however the 
authors conclude that the effects may not be as strong as initially though, due to the 
heterogeneity of studies and consistent under-powering. What the meta-analysis 
highlights however is a consistency in this finding, and an area of research which may 
prove to further elucidate the mechanisms by which the 5-HTTLPR polymorphism may 
lead to disrupted sleep and then insomnia (and speculatively, what drives the relationship 
between insomnia and depression).  
 
Of course there is a lot of work still to be done in this area: looking at a broader range of 
stressful life events, further investigation into the common biological, genotypic, 
pathways between stress, insomnia and depression and work looking at possible 
protective factors. Secondly none of this work allows any inference about environmental 
factors to be made. For example, as in Drake et.al. [75], sibling pairs are the population of 
interest. While it is likely that siblings have had a similar environment growing up, there is 
no information on how environmental influences may have become divergent over-time. 
While all this work does support the idea that there is a trait-like vulnerability to sleep 
disruption-and therefore insomnia- it remains unclear what the environmental and 
genetic interactions are, what genotypes and loci are implicated and to what extent all of 
this implicates insomnia as a risk-factor for the development of further psychiatric 
problems, which seem to be under the control of similar systems. Work in this field would 
also benefit from better defined groups: absolutely screening for other sleep disorders 
and in the case of the majority of the work, taking a more complete psychiatric and health 
history from all participants and in the case of familial work, more stringent testing and 
screening of the ‘positive’ relatives. What has been done so far constitutes a starting 
point, and certainly highlights exciting and novel pathways for sleep research and 
although by no means equivocal, does serve to underscore the importance of stress, 
familial aggregation and genotyping in the aetiology of PI. At the core of this research is 
the notion that arousability, certainly from a biological perspective, may pre-exist PI. This 
Chapter 2   52 
 
work all serves to imply that insomnia is a disorder of genetic and environmental 
interaction and is, essentially, a stress disorder. 
 
2.3 Defining the vulnerable 
The work supporting the hyperarousal model of insomnia (see chapter 1) demonstrates 
that there is a clear psychobiological component to the maintenance of this disorder- an 
interplay between cognitive and physiological arousal. This too can be integrated into the 
3-P model as factors which perpetuate PI. However, it has also been observed that an 
increased arousal may precede the onset of insomnia rather than being a symptom of or 
compensatory mechanism (as suggested by Drummond et.al[91]) to sleep deprivation. As 
already mentioned, Leblanc et.al.[92], report the greatest predictors of new onset 
insomnia syndrome in a population based sample as arousability, measured by the 
arousal predisposition scale (APS), with an odds ratios of 1.2; family history of insomnia 
(OR= 2.96) ; higher bodily pain and lower self-rated health. The first 2 mentioned 
variables do suggest a trait-like, possibly inherited, vulnerability. The work on familial 
aggregation and genetics also supports the idea of a vulnerable phenotype, which 
responds more sensitively to stress. Arousability as measured by the APS may reflect a 
vulnerability to the hyperarousal seen in insomnia as it asks questions behaviourally 
reflective of an up regulation and sustained activation of the sympathetic nervous system 
such as ‘I get flustered if I have several things to do at once’ or ‘Strong emotions carry 
over for one or two hours after I have left the situation which caused them’.  
 
Experimentally, Bonnet and Arand [93] have shown sleep disruption to be consistent 
across different stressors:  
1. ‘first night effect’: Spending the night in a new environment is considered a mild stressor, 
and leads  to sleep disruption in good sleepers 
2. Caffeine prior to sleep onset: Caffeine represents a mild physiological stressor. Being a 
stimulant, it is known to disrupt sleep. Participants were given 400mg half an hour prior 
to sleep onset.  
3. 3h phase advance: Participants lights out (bed-time) is 3 hours earlier. This means that 
they are trying to sleep at a time when their circadian rhythm would not normally allow.  
4.  6h phase advance: Participants lights out is 6 hours earlier.  
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It was found that those who demonstrated a clear sleep disruption on the first night in 
the sleep laboratory also demonstrated greater sleep disruption across the other 3 
conditions, despite being good sleepers at screening and on baseline night (2nd night in 
the lab). The ‘situational insomniacs’ (SI) (i.e. those who demonstrated sleep disruption in 
response to the 3 stressor conditions, relative to baseline) compared to the ‘super 
sleepers’ (those whose sleep maintained across all conditions relative to baseline) also 
demonstrated increased heart-rate, increased low-frequency (indicative of sympathetic 
nervous system activity) and decreased high-frequency (a decrease in parasympathetic 
nervous system activity) EKG spectral power, and mimicked what would be expected of a 
PI group in Multiple Sleep Latency Tests (MSLT) scores. That is to say, greater MSLT scores 
suggesting a difficulty with de-arousal as longer MSLT times reflects an inability to fall 
asleep and is characteristic of the insomnia population. This suggests that the SI group- 
the vulnerable population- are more sensitive to stressors, both physiological- caffeine- 
and psychological- first night effect. Further, that the observed sleep disruption seen may 
be secondary to increased sympathetic nervous system activity: this is a marker for 
vulnerability to sleep disruption. Interestingly the SI group demonstrated no mood or 
personality differences- measured using the Minnesota Multiphasic Personality Inventory 
(MMPI)- at baseline, thus implying that the relationship seen between increased 
depression and anxiety scores and insomnia is resultant from sleep disruption and not 
vice-versa: insomnia is a precursor to mood disorders. Considering the polymorphisms 
which have been implicated, it could be hypothesised that this is most likely via the 
mechanisms that drive arousability and then hyperarousal  
 
Drake et.al[94] , using the FIRST, found that those scoring high on the FIRST demonstrated 
greater MSLT scores, in accordance with the previously mentioned study.  PSG scores 
during the first night in a sleep laboratory were also worse in those scoring higher on the 
FIRST. The PSG results remained significant even after exclusion of those with a past 
complaint of insomnia, and groups showed no differences on sleep diary measures 
obtained for 2 weeks prior to coming to the lab, thus indicating that the sleep disruption 
is likely due to ‘the first night effect’, rather than a faulty basal sleep system. Differences 
in MSLT scores became non-significant when those with a past complaint of insomnia 
were excluded. This is not surprising given the evidence suggesting that a past episode of 
insomnia is the greatest predictor of a new episode [74, 95]. Taken as a whole, the work 
suggests that a vulnerability to sleep disruption exists in good sleepers, prior to any 
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complaint and can be measured psychometrically, and further, that the severity of sleep 
disruption (i.e. on the MSLT) is plausibly worse in those who have experienced an episode 
of subjective sleep disruption in the past: past sleep disruption leads to a greater risk of 
future, and more severe, sleep disruption. What could be investigated further is the idea 
that a past episode leads to a weak learned association between bedtime environment 
and sleeplessness that becomes more easily aggravated in those that are already 
vulnerable- as has been suggested by Deuschle et al[86] stating that the 5HTTP-s allele 
may discourage distinction of negative learning due its expression in brain areas which 
are known to control this, and is more prevalent in those vulnerable to stress-related 
sleep disruption. This may mean then that behavioural conditioning is easier in the 
vulnerable group whereby a few nights of bad sleep due to the presence of a stressor 
may create negative associations around sleep during this period. This learning is not 
extinguished as effectively during preceding nights of good sleep and so in the face of a 
new stressor these negative associations are more easily activated. In this way it becomes 
easier to induce a new period of insomnia. This is of course speculative, but could provide 
an interesting avenue of research in terms of helping us better understand the 
mechanisms that drive chronic sleep disruption, and indeed which mechanisms bridge the 
gap between acute and chronic insomnia in the small percentage that does progress.  
 
Interestingly, Pezawas et.al.[96] note that whilst performing an emotional task known to 
engage the amygdala, those with the s-allele of the 5HTTLPR polymorphism have 
increased amygdala reactivity to the task, and also are more anxiety prone in terms of 
their ‘temperament’, as measured by the Tridimensional Personality Questionnaire (TPQ). 
The TPQ is a psychometric test which aims to define personality in 3 components: reward 
dependency, harm avoidance and novelty seeking. It has been used widely in the field of 
personality genetics and different interactions of these 3 traits are thought to correspond 
to differences in dopaminergic, serotonergic and noradrenergic systems[97] . The authors 
interpret this as being reflective of the 5-HTT polymorphism’s role in depression genesis 
and maintenance; however it may be better interpreted as reflective of emotional 
arousability and may represent a pathway through which sleep disruption leads to 
depression. Furthering this hypothesis are 2 meta-analysis conducted in 2004[98, 99] 
which both conclude that the 5HTTP-LR polymorphism is tightly associated with anxiety-
like traits, particularly neuroticism as measured by the NEO-ffi and a trend toward 
association with harm avoidance on the TPQ. This will have a particular bearing when we 
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go on to discuss personality as a risk factor in the development of insomnia. In the 
context of understanding the role of 5-HTTPLR polymorphism in the aetiology of 
insomnia, what these studies suggest is that the short allele contributes to a phenotype 
who is more reactive to stressful situations in terms of their physiological response, more 
reactive to emotional stimuli in terms of their brain activation patterns but also may be 
more prone to perceiving events as negative or stressful in terms of their personality- i.e. 
higher in neuroticism.  
 
It is highly plausible therefore that a vulnerability to insomnia does exist and that this is 
driven by a tendency toward hyperarousal. If we accept that vulnerability does exist- that 
insomnia is not simply the result of learned associations, but the interaction between 
environment and a vulnerable phenotype- then we need to define and understand the 
mechanisms behind it, both biological and psychological. Physiologically, the evidence to 
date would support the contention that insomnia is a disorder of the stress-system. It 
makes sense then that psychologically we would want to investigate variables which 
regulate stress-perception, particularly given the evidence described above that such 
personality dimensions may be under the control of the same polymorphism implicated 
in the onset of sleep problems.  
 
2.4 Personality and Coping style: Influence and mediation  
What we know so far regarding the genetics of insomnia is suggestive, and it is obvious 
that the indicated polymorphism is not influence enough to account fully for stress-
related sleep disruption: a large proportion of ‘carriers’ do not report disrupted sleep and 
vice versa- not to mention the fact that sleep regulation is likely an interaction between 
various genotypes, neurotransmitters and endocrine responses- sleep is a tightly 
regulated homeostatic drive. Besides other biological factors, a person’s psychology is 
likely to mediate their response to stress, and so their vulnerability to stress related sleep 
disruption and so insomnia.  
 
Lundh and Broman[36] discuss the differences between sleep-interfering and sleep-
interpreting processes, whereby hyperarousal would be seen as a sleep-interfering 
process, as arousability leads directly to sleep disruption. Sleep interpreting processes are 
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psychological constructs which lead to an over inflation of the sleep problem, or which 
lead to cognitive arousal, which in turn then triggers sleep-interfering processes (figure 2 
1). 
 
 
Figure 2 1 Lundh and Broman [36] Sleep Interpreting and Sleep Interfering Processes 
 
The model highlights the interplay between subjective, cognitive and somatic arousal. 
Nicassio et.al.[34] and Lichstein et al [100] both demonstrate that cognitive arousal is 
perceived more strongly by insomnia patients than is somatic arousal. However, as Lundh 
and Broman point out, cognitive arousal- conceptualised as the racing mind, rumination, 
worry- is, in itself, physiological arousal in so much that negative thinking at sleep onset 
will lead to an emotionally induced physiological response. Taking this stance on insomnia 
highlights the importance not only of physiological markers to insomnia, but also 
psychological precursors and so the role of the interaction between the 2: cognitive 
arousal begets physiological arousal and vice versa; the degree to which a situation or 
stressors elicits an arousal- either in the terms of H-P-A activation, or a ruminative/ worry 
cycle- is bound to be driven by 1) an individual’s basic physiology but also 2) psychological 
response, that is to say, their interpretation of how stressful the stressor actually is. This 
becomes a chicken and egg scenario. The point however is not which comes first, but that 
both lead to increased stress-reactivity and so an increased vulnerability to insomnia. 
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Considered below are psychological factors which may act as markers to stress-related 
sleep disruption. 
 
Brosschot et.al.[101] define worry as a constructive problem solving process which is 
thwarted by cognitive predispositions, such as anxiety, and further conclude that 
preservative cognition- rumination and worry- work directly on somatic disease via 
cardiovascular, immune, neuroendocrine and neurovisceral systems i.e. similar to the 
hyperarousal demonstrated in insomnia, and the proposed pathway between insomnia 
and illness- and further highlighting the bi-directional relationship between cognitive and 
physiological arousal. In this way, worry becomes a deconstructive process. It may be that 
cognitive predispositions which lead to preservative cognition are also likely to lead to 
vulnerability, given that worry and rumination are characteristic of the insomnia 
population, as for example in Harvey’s cognitive model. Daytime [102]and pre-sleep [35] 
worry have been shown to characterise the insomnia population, and to differentiate 
them from good sleepers Further to this worry has been shown to delay sleep onset in 
good sleepers[103].  
 
Van de Laar et.al. [104] have reviewed the role of personality factors in insomnia so this 
won’t be covered in fine detail here. Rather this information will be used to suggest a 
model by which personality, in interaction with coping style, creates an at-risk phenotype. 
They conclude that the insomnia population consistently show traits associated with 
‘neuroticism’, ‘internalization’, anxious concerns and traits associated with perfectionism, 
and further, that future longitudinal studies should not view personality as a single 
predisposing factor, but assess it as a part of a larger group of interacting psychological 
and physiological factors involved in the predisposition to and perpetuation of chronic 
insomnia. Personality is not a discreet construct, but one which interacts with genes, 
environment and coping style. 
 
 This complex interaction has been demonstrated in other psychological disorders, 
particularly in depression. This will be used here in order to outline possible research 
avenues in insomnia, drawing parallels with the depression literature to provide clues as 
to how personality and coping may affect insomnia-vulnerability but also indicating how 
sleep may lead onto the genesis of mood disorders via these same mechanisms.  
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It is largely accepted that high levels of neuroticism predict experiencing a clinically 
significant depressive episode [105-107]. The mechanisms by which temperamental 
predispositions instigates depressive symptoms is not entirely clear. However, recent 
work has suggested that there is an interaction between neuroticism, conscientiousness, 
emotion focused coping and genetics. Leandro and Castillo [108] have shown in a sample 
of 274, strong positive correlations between neuroticism and emotion focused coping and 
avoidance coping, and that conscientiousness is associated with more positive coping 
styles. However, these results are correlational. They do, at best suggest that one of the 
factors through which neuroticism may lead to depression is through affecting coping 
style. Saklofske et.al.[109] have shown that perceived stress in a student population was 
significantly and positively correlated with neuroticism, emotion focused coping and 
negative affect. Conscientiousness and positive affect seemed to be protective against 
the perception of stress, or at least the reporting of stress. Again, the results are largely 
correlational but highlight the fact that negative affect is a combination of both 
personality and coping style, and specifically neuroticism and emotion focused coping.  
 
When individuals who have never been depressed are compared to those who have, it 
has been shown that neuroticism as measured 6 years previously is related to current 
levels of depression in both groups and also associated with cognitive reactivity in both 
groups. Neuroticism seems to predict a ruminative response to low mood which could 
possibly mean that neuroticism leads to a process whereby in the face of low mood, one 
reflects on the mood and what caused it rather than engaging in a more active coping 
style. In terms of those who have suffered depression in the past, the higher they scored 
on neuroticism the more likely they were to respond to mild negative moods with 
thoughts of hopelessness or suicidality. The authors explain this in terms of ‘differential 
activation theory’: Associations are learned during a previous depressive episode linking 
depression, rumination and negative affect. An individual who has not had a previous 
episode does not experience this learning. In this explanation, neuroticism encourages 
depressive thinking, but in the previously depressed group, this seems to be more severe. 
This may be reflective of extreme emotion focused coping. An alternate explanation may 
be related to the previously mentioned genetics which seem to prevent the extinction of 
learned negative associations. Again, this is speculative but has some support in that 
neuroticism and anxiety/ depression do seem to have an overlapping genetic 
contribution[110] and the polymorphism most extensively studied/ implicated in sleep, 
Chapter 2   59 
 
stress, anxiety and depression is the same: the 5-HTT serotonin transporter 
polymorphism.  
 
It seems then that the role of personality and coping style in insomnia may be similar to 
that of depression. However, the extent to which personality factors mediate, and 
encourage the onset of insomnia is poorly assessed, as the majority of work to-date is 
defining those already suffering with a diagnosable complaint, and making judgements as 
to what is likely to be a predisposing factor is further complicated by the fact that 
insomnia seems to predict changes in personality, as suggested by Danielsson et.al[111], 
demonstrating that sleep-onset problems in adolescents predict neuroticism in middle-
age, and not, as would be expected, the other way around. Possibly because sleep loss in 
adolescents may alter the development of neuroendocrine systems and gene expression, 
plus, lead to heightened anxiety, worry and rumination around bedtime. This may then 
result in the development of a neurotic trait, which in later life predicts and perpetuates 
insomnia. This study defined adolescent neuroticism based on the 16 factor Cattell [112-
115] model of personality, and at follow-up on Eysenck’s personality questionnaire[116]. 
Results would appear stronger and more reliable if the questionnaires used were 
consistent if for no other reason than to ensure a standardization of neuroticism at both 
time points. Secondly, it could be that personality is still developing during adolescence so 
scores obtained at younger ages may not be representative of true personality[117]. 
Other, possibly mediating factors were not measured, like other personality traits and 
coping styles- reflecting back on the depression literature it seems that an emotional 
coping style may be the mediator between neuroticism and depression, and that this may 
be learned over time and so possibly coping style may at baseline undermine 
relationships between neuroticism and sleep. Further, the study only considered sleep 
onset latency, assessed via one question, with no assessment of daytime functioning or 
distress, and is therefore unrepresentative of an insomnia syndrome. 
 
Williams and Moroz [118] support the idea that neuroticism does predict sleep disruption 
during a period of transition but that this is mediated by conscientiousness- as with 
depression, conscientiousness seems to have a protective role- and daily hassles. Using 
subscales of the PSQI the authors assess how personality traits predict different aspects 
of sleep and sleep complaints in response to stress. The main findings were neuroticism 
(N) was negatively and conscientiousness (C) was positively related to sleep quality. Poor 
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sleep predicted greater depressive symptoms and poorer functional status for high-
N/low-C participants, but not for other N and C profiles. That is to say that high N/ low C 
individuals are more likely to report impaired functioning due to sleep loss. This may be 
because high N individuals have a stronger propensity toward negative affect, coupled 
with low effortful-control- i.e. low C- may result in a propensity to interpret incoming 
information as a signal for daytime dysfunction which may then be attributed to poor 
sleep. High C may mediate this due to the possibility that sleep disruption, or more 
specifically less time in bed may be attributed to working harder, or in this population, 
staying up later to study- so high N high C may create a perfectionistic type personality 
who does not attribute daytime signs of tiredness to sleep loss, but rather to 
achievement. This, once again is speculative, however intuitive.  Blagrove and 
Akehurst[119] have shown that N predicts mood disruption as measured on the POMS in 
sleep-deprived good sleepers and that change in reasoning performance was correlated 
with change in mood. Thus, providing further indication that N may make lead to 
increased vulnerability to sleep loss, and more sensitive to the negative effects of sleep 
loss. Possibly via similar mechanisms to which Williams and Moroz outline: certain N and 
C profiles may make an individual more aware of mistakes they are making, which may 
then cause anxiety over future errors, increasing the likelihood that they occur. This was 
not assessed in the study, but would provide a good understanding as to how these 
variables interact in the onset and perpetuation of insomnia. 
 
 In the face of ambiguous stimuli those with high scores on the neuroticism subscale of 
the NEO-ffi demonstrate a stronger inclination toward avoidance of and are reported to 
be more likely to interpret ambiguous stimulus as negative [120]. Such a profile-high 
N/Low C- may also lead to more worry and rumination around sleep onset as one 
becomes unable to control their ‘racing mind’. There is an intuitive relationship between 
neuroticism and worry: neurotics are inclined toward anxiety-like responses, and 
conversely, worry may lead to neuroticism [121, 122]. Vincent et.al.[123] have also 
demonstrated that N is linked to short sleep (OR= 1.30). In terms of the phenomenology 
of insomnia it is easy to see how neuroticism may perpetuate the disorder as one 
interprets incoming signals from the environment as signs of not sleeping, or signs of 
functioning being reduced and this being attributed to sleep loss which then reinforces 
worry about sleep in an individual who is already prone to the effects of negative affect 
and probably inclined towards worry anyway. The role of neuroticism in predisposing an 
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individual to insomnia is again probably due to how it affects stress-perception and 
reaction to stress. High neuroticism is the experience of negative affect- i.e. being more 
likely to interpret incoming information as having a negative valence (and so possibly 
more likely to employ an emotion focused coping strategy). This means you are likely to 
experience more stress in your day to day life. The associations between N and worry 
create a situation where sleep can become easily compromised. 
 
Personality variables, although equivocally, have a role to play not just in stress 
perception but in physiological reactions to stress. Nater et.al.[124] have found that 
neuroticism is associated with increased cortisol secretion throughout the day, and that 
the relationship between affect and stress-reactivity is mediated by conscientiousness, in 
so much that high C leads to a greater reduction in cortisol in response to positive affect- 
so it would seem that high C leads to a reduction in worry and also a greater detainment 
of positive affect. Mikolajczak et.al.[125] demonstrated in healthy men that flexibility of 
cortisol waking response (CAR) is predicted by, amongst others, neuroticism.   
 
Although the work on biomarkers of personality is recent, sparse and conflicting there is 
an agreement between probable vulnerability traits, and the physiology of hyperarousal 
and stress reactivity, and the cognitive aspects regarding worry and avoidance in 
insomnia. What has been suggested so far in this review is a strong role for stress 
reactivity being a precursor to insomnia; however this is likely to be mediated by 
neuroticism and conscientiousness. With regards to how such personality variables may 
influence stress-reactivity, it is important to understand the other variant in stress-
perception: coping style. 
 
Coping style is defined as the response an individual makes to a stressor. In transactional 
models of coping, cognitive appraisal of the stressor is emphasised, highlighting the role 
of the individual in response to stress: a particular stressor will not have a blanket 
effect[126, 127]. Coping style then is key in understanding individual response to stress, 
and so is likely a strong mediator in understanding the psychobiology of individuals 
vulnerable to insomnia. Biobehavioural systems predict 2 models coping response: 
retreat or a ‘shut off’ response- i.e. retreating to sleep- or a ‘turn on’ response- i.e. 
hypervigilance [128] and these map directly onto specific coping styles, and the effect 
they have on sleep. Disengagement may lead to longer sleep, whereby sleep becomes an 
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escape, however emotion focused coping may lead to shorter or disrupted sleep and this 
may lead to increased worry and rumination coupled with an unwillingness’ to disengage. 
Sadeh et.al.[129] demonstrate that in a group of good sleeping students, those who are 
high on emotion focused coping are more likely to show, in sleep diaries and actigraphy, a 
decrease in total sleep time during a stressful period- the week prior to an important 
interview. Morin et.al[130] have shown those who use emotion regulation strategies are 
likely to perceive their lives as more stressful, and that such techniques are more 
common in an insomnia population. Further, a recent meta-analysis [131] suggested link 
between ‘problematic’ coping strategies and neuroticism, one of these being emotion 
focused coping, implying a mediation of personality on chosen coping strategy. 
Interestingly, problem focused coping has been linked with a lower cortisol response 
throughout the day in healthy older adults[132], suggesting that this may be protective. 
 
Contemporary models of coping imply that there is a choice in which strategy a person 
applies in a particular situation. Personality however is defined as ‘ the system of 
enduring inner characteristics of individuals that contribute to consistency in their 
thoughts, feelings and behaviours’[133]  It seems probable then that personality will 
affect choice of coping strategy in a given situation: Individuals who experience greater 
negative affect- neuroticism- may be more inclined to engage in emotion focused 
strategies. This has a bearing on stress-perception and so the stress response, which in 
turn predicts sleep disruption which may then be maintained by ongoing negative 
cognitive activity, a hypervigilance for and attentional bias to cues which indicate lack of 
sleep, and so further worry, rumination and anxiety around sleep. Neuroticism and 
emotion focused coping and measures of arousal have been shown to characterise those 
rated as vulnerable to sleep problems (β=0.413 and β=0.222 respectively), based on the 
FIRST, and that vulnerable patients demonstrated comparable cognitive emotional 
arousal to insomnia patients[134], implying further that an observable predisposition 
does exists, one which is defined by not only physiological arousal but by cognitive-
emotional arousal associated with neuroticism and emotion focused coping. 
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2.5 Discussion 
It is accepted that stress interferes with sleep, and stressful-life events precipitate 
insomnia [135, 136]. However, there has been little work investigating predispositions to 
stress reactivity and how this affects subsequent sleep. There is clear evidence in the 
sleep literature that a trait-like vulnerability exists, that this may be inherited, and some 
work to suggest that this is mediated by different psychological variables- particularly 
neuroticism and emotion focused coping. It is suggested that vulnerability to insomnia is 
the result of both genetic, physiological systems and an individual’s propensity toward 
stress-perception. Once again we are faced with a chicken/ egg scenario: does a genetic 
propensity toward increased stress-reactivity lead to neuroticism, EFC and so rumination 
and worry or does neuroticism etc result in an increased stress response- i.e. to what 
extent does cognitive arousal lead to physiological response and vice versa? In order to 
address this question longitudinal studies are required, assessing personality and coping 
style changes over time, and further, how this relates to stress-response not just in terms 
of cortisol and HPA axis activation but using other more global measures such as whole-
body metabolism. 
 
What this chapter highlights is a need to better understand the vulnerable phenotype, 
which in the long run may help us prevent, reduce the cost of, and improve our 
treatments of insomnia. It is suggested that stress-reactivity is the main predisposing 
factor. This, however, is a composite of various domains, and the interaction of these. 
Neuroticism predicts increased stress-reactivity and negative affect, and increases the 
perceived negative effects of sleep loss. This in itself may create worry over sleep. N may 
also lead to the deployment of negative coping styles in response to stress- EFC- as an 
increase in negative affect may seem to warrant a focus on emotion rather than practical 
problem solving. Both these factors are then likely to interact with the suggested 
polymorphism to create an individual that is vulnerable to stress related sleep disruption 
both psychologically and physiologically.  
 
All 3 factors seem to pre-exist insomnia and are not subsequent to it, while also 
characterising the insomnia population. Understanding the links between all 3 in the face 
Chapter 2   64 
 
of different kinds of stressors and how they influence different physiological systems is 
crucial to our understanding of the aetiology of insomnia from the point of good sleep.
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Chapter 3: Methods and Competencies 
To avoid unnecessary repetition, before experimental works are presented, an 
explanation of methodologies common to all experiments will be provided, as well as a 
delineation of skills practiced and gained throughout the course of the Ph.D. programme. 
Methods specific to a particular piece of work will be outlined in the relevant chapter.  
Initially, an outline of generic recruitment and screening processes is provided. Secondly, 
psychometric properties of scales employed through all 3 experimental studies are 
presented.  
 
3.1 General Methods: 
3.1.1 Recruitment and Screening 
Participants for the most part (in all studies except a pilot study, reported later in this 
chapter) were recruited through the School of Psychology at the University of Glasgow. E-
mails advertising for participants were sent round the ‘subject pool’. This is an online 
database which students can sign up to if they wish to be contacted about taking part in 
research. It allows researchers to contact participants with consideration for inclusion and 
exclusion criteria- i.e. only those who have indicated a willingness to participate in brain 
imaging studies, or only those who are native English speakers for example. Further to 
this, posters advertising the study were placed in the waiting room of the School of 
Psychology. Willing participant left their name and/or contact number or e-mail address.  
Interested participants were contacted and screened by the researcher, using the 
University of Glasgow screening questionnaire (appendix I). This was conducted, without 
exception, over the phone. In brief, the interview asks questions regarding sleep onset 
time, wake after sleep onset time and how often during a week these aspects of sleep are 
seen to be problematic. It also asks questions regarding total sleep time and time in bed. 
In order to diagnose insomnia, there must also be the presence of daytime impairment, 
so participants are also asked how their sleep affects their function during the day and in 
which domain. Further to this the participant is required to give information on estimated 
weekly alcohol intake, the presence of any other sleep disorders, and any ongoing 
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physical and psychological disorders. If any are reported they are asked which treatments 
they are or have received for these.  
 
In addition to the standard questions, for the purposes of the studies presented here 
participants were also asked about recreational drug use and caffeine intake. Primarily, 
participants were excluded if they reported the presence of any sleep disorder, or current 
psychological disorder even if medicated.   Those who regularly used recreational drugs 
were also excluded (see appendix II for full exclusion criteria applied to all studies, except 
the pilot study discussed later in this chapter).  
 
3.1.2 Questionnaire assessment 
Psychometric assessment is a key tool within any area of psychological research and is 
employed extensively throughout the work presented here. As the same constructs are 
measured in all of the main studies, it is prudent that the tools used to measure them are 
presented here and referred to in proceeding chapters (appendix III provides the 
questionnaire booklet that participants were given). Primarily, 3 constructs were of 
interest: neuroticism, emotion focused coping and conscientiousness. Scales were based 
on their ability to reliability measure these constructs, and independently from 
psychopathology. A further consideration was participant burden, so the brief version of 
certain scales was employed (such as the brief-COPE). Groups are constructed using the 
Ford Insomnia Responsivity to Stress Test (FIRST) score. The other measures represent 
independent variables or co-varying factors. Sleep scales were employed as a second 
check that participants were sleeping well, and not suffering from insomnia. 
 
Ford Insomnia Response to Stress Test (FIRST):  The relation of insomnia to stress has 
been evaluated using the FIRST [94], where subjects are asked how likely they are to have 
difficulty sleeping following nine different types of stressful situations- such as knowing 
they have a presentation to give the next day. Responses are recorded on a 4-point 
categorical scale (not likely, somewhat likely, moderately likely and very likely). Patients 
with high FIRST scores are categorized as vulnerable to insomnia, while a low FIRST score 
indicates resilient sleepers. Reliability of this 9 item scale is high (Cronabach’s alpha = 
0.83). Drake et.al.[137] show that those classed as vulnerable show a more pronounced 
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reaction to a small dose of caffeine prior to bed, as measured by latency to persistent 
sleep, relative to the vulnerable group. Thus supporting the validity of this questionnaire, 
but also showing that relatively benign stimuli can be troublesome for those who are 
predisposed.  The utility of this scale in selecting those who are vulnerable or resilient to 
stress related sleep disruption will be discussed in more depth in light of the experimental 
findings.  
 
Pittsburgh Sleep Quality Index (PSQI): The PSQI has been shown to have high validity and 
reliability (cronbach alpha of 0.83), and has been used extensively on various populations. 
Although not a specific diagnostic tool for insomnia, the PSQI has a sensitivity of 89.6% 
and a specificity of 86.5% for detecting sleep difficulty[138] The score obtained- global 
PSQI score- comprises 7 components: subjective sleep quality, sleep latency, sleep 
duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and 
daytime dysfunction over the last month. The questions are marked on a 1-3 Lickert scale, 
with 3 representing the extreme negative. A global score of 5 or greater is considered to 
indicate a poor sleeper. The scale was originally used in primary care setting in older 
adults, although has been shown to have moderate to high validity and reliability in other 
populations and has been used in populations similar to the one in this study [47, 139, 
140]. The high sensitivity of the scale ensures that those scoring below the cut off are 
good sleepers, but does not provide a diagnosis of insomnia to be made, but rather ‘poor 
sleep’. 
 
Insomnia Severity Index (ISI): The ISI[141] is a 7 item scale assessing perceived sleep 
difficulty and perceived consequences of insomnia and level of distress regarding 
insomnia, the contents of which correspond in part to the diagnostic criteria of insomnia 
as according to the Diagnostic and Statistical manuals 4 (DSM-IV). Recent validation of the 
scale as a screening measure for insomnia, and as an outcome measure of treatment has 
recently been assessed by Bastien et.al.[142]. They report that the internal consistency of 
the ISI was 0.74 (cronbach alpha) and that it had moderate correlations with sleep diary 
data. It has also been demonstrated in the same paper that the ISI is sensitive to 
detecting changes in perceived sleep quality in response to treatment, and demonstrate a 
good convergence between subjective ratings of severity and clinician ratings. It also 
provides cut-off points, allowing to measure, as the name suggests, an understanding of 
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the severity of an individual’s sleep problem. In this way, it provides a good compliment 
to the PSQI within the context of the studies presented within this thesis.  
 
 Perceived stress Scale(PSS): The PSS[143] is a self report measure consisting of 14 items 
which ask the participant to rate on a 5-point Lickert scale (from 0- never to 4, very often) 
how often they felt or thought a certain way over the past month in response to stress. A 
high score indicates an individual who perceives stressful life events as out of their 
control, and unpredictable. Looking at stress perception is important in the context of 
understanding stress reactivity and its interactions with personality, given the rationale 
outlined in chapter 2: that personality may impact on stress response due to an increase 
perception of stress. The test retest reliability is adequate at 6 weeks follow up. The 
Cronbach’s alpha is reported by Drake et.al. as 0.84, 0.85 and 0.86 across their 3 initial 
samples. This provides a measure of stress perception, rather than stress-levels.  
 
Brief-COPE: The brief-COPE[144] is a shortened version of the COPE inventory[145]. It 
consists of 14 scales each with 2 items (28 items in total). It is answered on a 4 point 
Lickert scale, to represent the extent to which an individual believes they use a certain 
strategy to cope with stress (1= I haven’t been doing this at all to 4- I’ve been doing this a 
lot). It has been well validated for use in various populations experiencing different 
psychological and physiological conditions.  The 14 scales can be grouped, allowing for 
comparisons between emotion and problem focused coping.  
 
Depression Anxiety Stress Scale (DASS-21): The DASS-21 is the abbreviated version of the 
DASS-42 [146]. It is composed of three scales: Depression, anxiety and stress. Cronabach’s 
alpha for each of these, respectively being 0.88, 0.82, 0.90, and 0.93 overall, thus 
demonstrating adequate reliability. It asks participants to respond on a 4 point Lickert 
scale according to how applicable each statement is to them (0 being ‘does not apply at 
all’ to 3 being ‘applied to me very much, or most of the time’).  
 
NEO-ffi: The Neo-ffi [147]is a brief- 60 item version- of the NEO-PI-R-180 items. It is a 
measure of the five factor model of personality, scoring on the following domains: 
Neuroticism, extroversion, openness, agreeableness and conscientiousness. Each item is 
scored on a 6-point scale, with several items reversed scored. Two week test-retest 
reliability has been found to be relatively high (0.86 to 0.90 for the five scales)[148]. The 
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internal consistency is reported as ranging from 0.68 to 0.86[147].  The NEO provides a 
more specific conceptualisation of personality compared to, for example, the Minnesota 
Multiphasic Personality Inventory. It has been used extensively in understanding the 
relationship between personality and stress responses, and so is used here because it is a 
psychometrically sound tool, and will allow a certain level of comparison between the 
experimental work here and other published data.  Further to this it provides an overview 
of personality based on theoretical constructs, in a way that does not infer 
psychopathology, such as the MMPI might.  
 
Ruminative response scale of Ruminative Style Questionnaire (RSQ):  The Ruminative 
Responses Scale of the RSQ [149] includes 22 items asking people to rate to what degree 
they generally indulge in specific behaviours or thought process when feeling ‘sad, blue or 
depressed’, on a scale from 1 (almost never) to 4 (almost always).Items relate to thought 
processes that are self focused, symptom focused or consequence/ cause focused. Nolen-
Hoeksema reports the alpha coefficient to be to be 0.90 and the test-retest reliability at 1 
year follow-up to be 0.67. It has also been suggested that this scale comprises 2 separate 
components of rumination: reflection and brooding and that high levels of either can 
have differential effects on treatment outcomes for depression[150])The Response styles 
questionnaire itself has adequate predictive validity [149]. Recent work in insomnia has 
suggested that rumination maybe more important in understanding and treating the 
insomnia population than worry, although this needs further investigation [151] 
 
Penn State Worry Questionnaire (PSW): The PSW[152] is a 16 item scale asking 
participants to rate how typical each item is of them, rating from 1 (not typical of me at 
all) to 5 ( very typical of me), with some items reversed scored such as ‘I never worry 
about anything’. In the initial validation of the scale it was demonstrated that worry is a 
separate construct from depression or anxiety and that the scale itself did not overlap 
with other pre-therapy measures ( STAI, BDI and the cognitive somatic anxiety 
questionnaire). It has a high internal consistency (coefficient alpha= 0.93 and 0.94). The 
test-retest reliability has been shown to be high at one month follow up (r (46) =0.93). 
Worry and rumination are suggested to be different constructs, with worry being defined 
as concern over the future, and rumination being concern over past failures and 
losses[153]. It is suggested that worry and rumination may differentially affect sleep. It is 
therefore important to capture both when assessing vulnerability factors [151]. 
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3.2 Competencies: MRI, programming and sleep measurements 
As alluded to previously in this chapter, a small pilot study was carried out prior to 
commencing a larger MRI based study (see chapter 6). The main purpose of this was 
firstly, to gain insight into the use of MRI and subsequent data analysis.  Secondly, the 
paradigm employed in the larger MRI study is novel to the sleep field, and so it was used 
on a small number of patients to ascertain the extent to which it did lead to differential 
brain activation in insomnia patients versus good sleepers, before being employed in a 
population of good sleepers who have been classed as either vulnerable to stress related 
sleep disruption or resilient.  Methods and findings will be outlined briefly here.  
 
3.2.1 Aims:  
To assess the extent to which those suffering with Psychophysiological Insomnia (PI) show 
increased activation in the insula in response to anticipation to a mild stressor.  
It is hypothesised that the PI group will show grater activation of the insula in response to 
an anticipatory cue, and greater activation in areas responsible for successful task 
completion.  
 
3.2.2 Methods: 
3.2.2.1 Participants: 
Participants were recruited through the University of Glasgow Sleep Centre, responding 
to posters placed in local G.P offices and community buildings such as local libraries. 10 
participants were recruited, 5 good sleepers and 5 PI. 4 were excluded due to excessive 
movement in the scanner, rendering their data un-analysable. This left a sample of 3 
insomnia patients and 3 good sleepers.  
 
3.2.2.2 Questionnaires: 
Participants completed a battery of psychological questionnaires, however given the 
small sample these were not analysed. Sufficed to say that no-one scored highly enough 
on the Hospital Anxiety and Depression scale (HADS) [154, 155] to suspect that they had a 
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comorbid condition. The PI group all scored above 15 on the ISI, and the good sleeping 
group scored as good sleepers.  
 
3.2.2.3 The Paradigm: 
A stroop task was employed. This was programmed using e-prime 2.0. The stroop task 
involves showing participants a word, printed in colour. The task is to identify the colour 
the word is printed in and ignore the words meaning.  Words used are the same as in the 
bigger study and were either sleep related, anxiety related, neutral or positive in valence 
and had been previously validated (insert refs from chapter 6). Responses were made 
using the thumb and index finger of each hand, with each button corresponding to a 
particular colour. Participants were given an opportunity to practice responses, until they 
felt comfortable enough to continue with the scan.  
 
Words would be presented on the screen for 1700ms with a 600ms fixation point 
between words. A siren would sound randomly and the task would speed up, requiring a 
faster response. Words were presented for 300ms with a 100ms fixation. It would then 
return to normal. This would repeat. The siren was intended as an anticipatory cue to the 
stressor.  
Image acquisition was carried out on a Siemens 3T scanner, with a TR of 2 seconds.  
 
3.2.3 Analysis: 
Analysis was carried out using SPM8. Given the small sample size, uncorrected p-values 
are reported. Data were first pre-processed to account for roll pitch and yaw movement, 
and images were normalised to a standard brain image provided by SPM. This accounts 
for differences in brain shape, size and location of structures.  A Gaussian filter of 4x4x4 
was applied, smaller than the SPM default, reflecting the difficulty of measuring insula 
activity.  
 
3.2.4 Results: 
It was found, comparing speeded and normal conditions between groups, that the PI 
group show greater activation in the temporal, parietal and occipital lobes and around 
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limbic areas in the speeded (stressful) condition relative to good sleepers( global maxima 
t= 12.96, p< 0.001 [-30 50 30]) (figure 1)  
 
Region of Interest (ROI) analysis, carried out using MARSBAR, revealed the PI group to 
show greater activation of the insula during anticipation relative to good sleepers.  
 
3.2.5 Conclusions: 
Obviously, the sample here limits any real conclusion that can be drawn from this study 
and it is worth highlighting again that the point of including this here is to demonstrate 
steps that were taken to pilot the experimental paradigm and gain a certain amount of 
competency with fMRI acquisition and analysis.  
 
What the results do suggest however is that the paradigm is sufficiently stressful to 
induce differential brain activation in PI versus good sleepers, and that this activation 
relates to an increase in activity in areas needed for successful completion of the task, 
suggesting that the PI need to work harder to complete the task. The results from insula 
analysis suggest that the PI group show a stronger anticipation to stress as hypothesised, 
and the task seems to be able to elicit this.  
 
Chapter 3   73 
 
 
Figure 3 1 Brain activation in the insomnia group> good sleeping group. 
 Red represents areas of greater activation in the PI group relative to good sleepers during the speeded 
task 
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4.1 Introduction 
As delineated in previous chapters, there is strong evidence to suggest that certain 
individuals are more vulnerable to stress-related sleep disruption than others (Bonnet 
and Arand [156] for example). Drake et.al.[94] have devised the Ford Insomnia 
Responsivity to Stress (FIRST) scale, which has been shown to accurately separate those 
who demonstrate disrupted sleep in response to stress from those who do not. 
 
Such vulnerability is due, probably, to various factors including genetic polymorphisms 
which seem to induce a more sensitive stress response, or a predisposition to arousal[81], 
personality[104] and coping style [129]. Williams and Moroz [118] have shown that 
during a period of transition, high levels of neuroticism predict sleep disruption as a result 
of daily hassles, whilst conscientiousness seems to be protective, especially when coupled 
with low neuroticism. Sadeh et.al.[129] demonstrated that emotion focused coping 
predicts sleep disruption as measured by sleep-diary and actigraphy in the week prior to 
an important interview. However, there has been no work which aims to systematically 
define this vulnerable phenotype with consideration for all of these various domains: 
physiological stress and how this maybe mediated by personality and coping style to 
make an individual more likely to experience disturbed sleep. 
 
In terms of stress-reactivity, the hyperarousal theory of insomnia (for a review see  
Riemann et.al[55]) posits that the insomnia population show increased arousal relative to 
good sleepers, not just at night time but throughout the 24 hour cycle. One line of 
evidence for this theory points to the hypo-pituitary-adrenal axis (HPA). Vgontzas 
et.al.[58, 59] have demonstrated differential cortisol profiles between insomnia sufferers 
and good sleepers, throughout the 24h cycle but especially in the first half of the evening, 
which implies that the HPA is more active in those sleeping badly, indicating a sensitive or 
over-active stress response. Based on the hyperarousal theory and the evidence that 
exists to support the notion of a vulnerable phenotype it is hypothesised that one of the 
defining characteristics may be a more sensitive physiological stress response, or a 
vulnerability to physiological hyperarousal, rather than a vulnerability of the sleep system 
per se. This would mean that vulnerability is conferred due to a more sensitive stress 
system, reacting non-commensurate to the stressor. Further to this, it is well established 
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that mood disorders are related to HPA dysregulation[157], and one of the most 
consistent findings in psychiatric disorders is hypercorticolism[158]. Given the close 
relationship between insomnia and mood disorders, particularly the idea that insomnia is 
the strongest predictor to new onset depression[159], it can readily be hypothesised that 
the common thread may be HPA dysregulation, which predisposes to insomnia, opening 
the doors to the associated sequelae.  
 
Further to this certain personality factors seem to play a role in mediating biological 
stress responses (as measured by cortisol secretion). Oswald et.al.[160] demonstrated, 
using the Trier Social Stress Test (TSST) - a robust, laboratory based psychosocial 
stressor[161] -, that cortisol responses varied according to personality traits but also 
gender. Women who are high in neuroticism (i.e. high in negative affect) show a blunted 
cortisol response. Men with low extroversion also show a blunted cortisol response. 
Overall, openness- which generally represents good psychological well-being- was 
associated with a lower cortisol response. Such work serves to underline the value of 
assessing personality when considering stress response. In a sample of 104 working men, 
Nater et.al.[124] demonstrate that neuroticism is associated with increased cortisol 
output throughout the day, and conscientiousness with decreased cortisol output, but 
only if positive affect is also present. 
 
Based on the evidence to date, reviewed briefly here and in more detail elsewhere in this 
thesis, it is hypothesised that those who appear to be vulnerable to stress related sleep 
disruption as predicted by the FIRST will show greater stress reactivity as measured by 
salivary free cortisol in response to the TSST. This will be mediated by personality and 
coping style, whereby neuroticism and emotion focused coping predict higher cortisol 
response. It is further hypothesised that conscientiousness will mediate the relationship 
between neuroticism and cortisol response. The aim here is to comprehensively describe 
the vulnerable phenotype from both a psychological and physiological stance. Other 
psychological variables known to characterise the insomnia population, such as worry and 
rumination will also be measured in order to conjecture on whether such constructs pre-
exist a complaint of insomnia, or are encouraged by it.  
 
In order to determine the extent to which these factors predict disrupted sleep in 
response to stress, participants will be followed up during a self-defined stressful and 
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normal week-2 weeks in total.  It is hypothesised that the vulnerable group will show 
greater increases in sleep disruption during the stressful week compared to the resilient 
group and that this will be predicted by cortisol responses to the TSST (stress-reactivity), 
neuroticism and coping style. Again, it is hypothesised that conscientiousness will be 
protective.  
 
4.2 Materials and Methods 
4.2.1 Participants:  
Participants were recruited from undergraduate psychology classes (n=50). They were all 
screened using the University of Glasgow Sleep Centre screening form (appendix I), and 
based on this, reported being good sleepers. As we were looking for good sleepers only, 
in order to assess vulnerability prior to any period of insomnia, anyone reporting 
insomnia symptoms or symptoms of another sleep disorder were excluded. Participants 
who reported a past episode of insomnia lasting more than 1 month were also excluded. 
Other psychological disorders or disorders of the central nervous system were excluded, 
as were individuals on any medications known to affect H-P-A regulation. Given that we 
were recruiting from an undergraduate sample, only people who were of a ‘typical’ 
student age were included (17-25 years) to prevent effects of age influencing the data. 
Those successful on screening were invited to the Psychology department to take part in 
an experiment investigating extraversion (in order to hide the true meaning of the 
experiment. See appendix IV for information sheet given to participant, and appendix V 
for consent form). Participants then completed the TSST, in which the outcome measure 
was salivary free cortisol (SFC). Ten were excluded for scoring too high on sleep measures 
and 6 were excluded due to insufficient saliva for analysis [n= 34; 18=female; average 
age= 21.1 (SD= 1.5) (table 4 1)]. Participants were paid for participation.  
 
 Age (SD) Gender (no. female (% female)) 
Resilient 21.12 (1.73) 7 (38.9) 
Vulnerable 21.15 (1.46) 8 (50) 
Table 4 1 Mean age (standard deviation in parenthesis) and gender (number and percent female) for 
resilient and vulnerable group 
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Participants completed a series of psychometrics upon completion of the TSST, to assess 
coping style, personality, rumination, worry, stress anxiety and depression. These 
questionnaires have been outlined in chapter 3 and can be viewed in appendix III.  
 
4.2.2 The Trier Social Stress Test: 
As already mentioned, the TSST is a robust laboratory based stressor, comprising of 2 
components: a speaking task and a math task. In this way it taps into different kinds of 
psychosocial stress: social anxiety and performance anxiety. It has been used on various 
populations such as the depressed and anxious [162] and to validate stress management 
techniques such as compassion meditation[163], whereby the physiological response to 
the TSST has been shown to decrease in those trained in meditation. This has also been 
shown for mindfulness based stress management techniques [164]. Such works highlight 
the utility of the TSST as a lab based stressor, and more importantly the idea that 
physiological stress response can be mediated by psychological inputs.  
 
4.2.2.1 TSST Procedure 
On arrival the participant is welcomed by the experimenter and taken to experiment 
room 1 where they are asked to relax. After a 10 minute period a saliva sample is taken. 
In order to collect the salvia the participant is asked to put a swab under their tongue- the 
optimal positioning for gathering SFC- and told to keep it there for 2 minutes (the 
Chapter 4   78 
 
experimenter times this). This time should allow optimal absorption of saliva. 
 
Figure 4 1 Flow Chart of TSST 
 
The participant is then taken to experiment room 2, where they were faced with 2 
interviewers. These were experimental confederates taking part in the study on a 
voluntary basis-, who are instructed to remain impassive throughout the study- i.e. not 
engage in any positive way with the participant. They are also instructed to maintain eye 
contact with the participant at all times, while taking notes.  Appendix VI provides 
instructions that were given to the confederates. They also ran through some dummy 
trials in order to learn the flow of events. The participant also sees a laptop set up with a 
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camera, and a stop-watch. At this point the instructions are played to the participant over 
the laptop: they will have to deliver a speech in as though presenting at a job interview 
for which they are given 10 minutes to prepare, and informed that a second task will 
follow.  They are asked to make a believable impression as the panel may ask follow up 
questions. They are also informed that they will be recorded throughout the talk for 
further analysis of body language and voice-pitch and continuity and that the panel are 
expertly trained in body and voice analysis- see appendix VII for transcript of recording 
played to participants. After instructions they are taken back to room 1 where they are 
given 10 minutes to make notes on their speech. They are informed in the recording that 
these notes are not to be taken into the interview room, but merely to allow the 
participant to organise their thoughts. After this 10 minute period a second saliva sample 
is taken. During the speech the panel are instructed not to engage with the participant as 
long as they are talking fluently. If there is a pause of 20s or more within the 5 minutes 
they are to ask questions such as ‘What qualifies you for this position?’ After the five 
minute period, one panel member informs the participant about the next task: to count 
backwards from 6033 in blocks of 13. If a mistake is made they must restart. This task 
lasts 5 minutes or until the participant reaches 0. The participant is then led to room 1 
where another saliva sample is taken.  At this point they are left to complete the 
questionnaires and saliva samples are collected every 10 minutes- 5 samples in total. 
Lastly the participant is debriefed and released. See figure 4 1 for flow chart of events. 
 
Saliva swabs were stored at -20oC, in an on-site refrigerator. Although cortisol is a 
relatively stable hormone, keeping its integrity for several hours at room temperature, it 
is advisable that samples are cooled straight away to ensure accurate analysis, especially 
if samples are to be stored until the end of a study. SFC was assessed by Salimetrics, LLC. 
using time-resolved fluorescence assay. 
 
4.3 Analysis: 
Data were first inspected for normality of distribution, using kurtosis descriptive statistic. 
All data appeared to be normal- see appendix VIII for values for each variable. Therefore 
parametric tests have been used. Correlation was then employed to assess potential 
overlap between psychometric constructs and to provide initial indication as to which 
variables may be related to vulnerability to sleep disruption, in the sample as a whole 
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initially and then within groups. Independent t-tests were carried out to assess 
differences in psychometric variables between the groups. 
 
In order to understand the cortisol output in terms of change over time- as an indication 
of stress-reactivity- area under the curve was calculated for each participant using 
trapezoidal integration. This gives one outcome measure for the change in cortisol levels 
over the 5 time points. AUC with respect to ground, with respect to baseline and with 
respect to increase were calculated [165] (figure 4 2). AUC provides an index of change, 
allowing analysis of cortisol change over time without many multiple comparisons, and so 
conserves power. 
 
 Figure 4 2 .Graphic depiction of AUC.  
Taken from Fekedulegn et.al. (2007). Graph A represents repeated measures of different magnitude or 
intensity at each time point (I1, I 2, 13), and changes in the response over time, or sensitivity (S1, S 2). 
Graph B represents the 3 kinds of AUC. 
 
 
Independent sample t-tests were carried out initially to investigate difference between 
groups in AUC and psychometrics. A mixed-design general linear model analysis was then 
computed to assess interactions between cortisol output and psychometrics. Based on 
the visual representation of the data individual time-points were also investigated.  
Exact p-values are reported with effect sizes reported as Cohen’s d.  
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4.4 Results: 
Two groups were created post-hoc based on FIRST scores: A vulnerable group (n= 18) and 
a resilient group (n=16). Groups were created based on the median score for the FIRST, 
which was 19.5 for this sample, in practice meaning that anyone scoring 19 or below was 
classed as resilient and anyone scoring 20 or above was classed as vulnerable.  This is in 
line with published figures, reporting a median of 20 in a sample of 104[94]. Resilient and 
vulnerable groupings were calculated in that sample via use of the median also.  
 
4.4.1 Psychological Variables 
4.4.1.1 Correlation: 
Bi-variate correlational analysis was carried out over the whole sample primarily to 
indicate which psychometric variables showed a relationship with FIRST scores. Further, 
to indicate if there was any strong overlap between psychological constructs measured by 
the psychometrics. It is important for further analysis that one can be sure of the 
independent nature of the proposed constructs when considering their relationship with 
the FIRST and their potentially mediating effects on physiological stress response. Scatter-
Plots depicting significant correlations can be seen in appendix IX. The Full correlation 
matrix can be seen in appendix X.  
 
It was found that FIRST score correlated significantly with PSQI (r(31)=.36, p=.034); DASSS  
(r(31)=.47, p=.005); NEON (r(31)=.49, p=.003); RUMD  (r(31)=.43, p=.01); and WORRY  
(r(31)=.473, p=.005), and showed a trend toward RUMR (r(31)=.37, p=.06). It is worth 
noting here that the correlation with RUMR indicates that the critical r value is .36, 
meaning that correlations below this value which may be meaningful will not be 
considered so in this analysis.  
 
 All correlations are representative of weak to moderate associations. From the 
correlation matrix, it can be seen that where there is correlation between constructs, for 
example neuroticism and PSS, that these associations are weak to moderate (r values 
between .3 and .7). While this demonstrates a relationship between the variables of 
interest, it does suggest that they have substantial unshared variance. 
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4.4.1.2 Between-group analysis 
 Figure 4 3 shows the between group differences on the different psychometric scales.  
Independent sample t-tests were calculated to assess the difference. It was found that 
the vulnerable group scored significantly higher on the neuroticism subscale of the NEO-
ffi (t (32)= -2.912, p=.006, d=.99); the depressive thinking subscale of the RSQ (t (32)=-
2.389, p=.024, d=.81); the stress subscale of the DASS (t(32)= -3.015, p=.005, d=1.03); the 
PSW (t(32)= -3.321, p=.002, d=1.13) and on both the emotion (t(32)=-2.375, p=.024, 
d=.82) and problem focused coping ( t(32)= -2.399, p=.022, d=.83) subscales of the brief-
cope. Table 2 shows the averages and standard deviations.  Cohen’s d in all cases 
represents a large effect size, where d>.79. 
Figure 4 3 ‘Vulnerable’ Vs ‘Resilient’ on psychometrics.  
Abbreviations: PSS= Perceived Stress Sale; DASSD=Depression; DASSA=Anxiety; DASS=Stress; 
NEO=openness; NEOC=Conscientiousness; NEOE=Extraversion; NEOA=agreeableness; 
NEON=Neuroticism; RUMD=Depressive thinking; RUMB=Brooding; RUMR=reflective thinking; 
COPEP=Problem focused coping; COPE= Emotion focused coping 
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4.4.2 Cortisol 
If more than 2 time-points were missing from the cortisol data then the participant was 
excluded. Where 2 or less were missing these values were replaced by the group mean 
for this time point. A total of 5 time-points were replaced in this way.  
 
In order to assess differences on stress reactivity between group’s independent t-tests 
were carried out on the 3 AUC values. There were no significant differences between 
groups in terms of AUC with respect to ground (t (32) =1.721; p=0.095, Cohen’s d= 0.6) or 
AUC with respect to increase (t (32) =.25, p=.801) (table 3). GLM mixed design analysis 
showed a significant effect of time (F (4, 1) =7.912, p=.003) but no significant group by 
time interaction. Individual time points were then investigated (figure 4), using 
independent samples t-test. It was found that the vulnerable group had significantly 
higher SFC at time point 1 and 2 compared to the resilient group (t (32) = 2.641, p= .013 
and t (32) = 2.662, p=.012 respectively), and this was shown to have a large effect (d= .92 
and .93 respectively). There was no significant difference at any other time point. 
Appendix XI provides supplementary data, graphing the SFC response in the 10 poor 
sleepers which have been excluded from this analysis, but which may be of interest to the 
reader, and will be considered in the discussion. 
 
 
Scale Resilient (SD) Vulnerable 
PSS 12.5 (7.1) 14.75 (6.0) 
DASSD 4.00 (4.5) 6.00 (5.1) 
DASSA 3.33(3.6) 4.63 (3.2) 
DASSS 7.11 (4.8) 13.00 (6.5) 
NEOO 50.11 (5.8) 53.00 (6.2) 
NEOC 51.61 (8.6) 49.56 (5.0) 
NEOA 53.5 (9.2) 52.50 (7.7) 
NEON 29.29 (7.6) 38.75 (11.0) 
RUMD 19.00 (5.5) 24.38 (7.6) 
RUMB 8.39 (3.6) 10.19 (3.9) 
RUMR 9.06 (3.1) 11.44 (3.9) 
COPEP 10.00 (3.0) 12.44(2.9) 
COPEE  11.00 (4.4) 14.31 (3.7) 
WORRY 38.33 (7.7) 49.06 (11.0) 
Table 4 2 Mean and standard deviation on the psychometric scales for each group.   
Highlighted in red are variables which differ significantly (p<0.05) between groups. 
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Step-wise Regression analysis was carried out in order to assess which factors contributed 
to the significant difference in baseline cortisol measure (table 4 4: regression output). 
Based on the between group differences in the psychometrics and our initial hypothesis- 
that greater neuroticism, low conscientiousness  and greater EFC would lead to higher 
stress reactivity- NEON, NEOC, worry, DASS, RUMD, COPEP and COPEE were all entered 
into the model. The only covariate to survive the stepwise regression was NEOC.  The 
regression co-efficient values suggest that as conscientiousness increases, so too does SFC 
at T1. 
 
Within group correlations were then conducted, to get an insight into what factors 
conscientiousness is associated with, in each group. Frequency analysis was also 
conducted in order to get an idea of the distribution of high C high N, low C low N etc 
 AUCg (SD) AUCi (SD) 
Resilient 264.36 (135.5) 42.79 (104.67) 
Vulnerable 195.16 (102.93) 51.21 (86.49) 
Table 4 3 AUC with respect to ground and increase for each group. Standard deviation in parenthesis 
Figure 4 4 Average Cortisol out-put at each time point for each group   
Significant between group difference at time 1= before instruction and time 2= after 
hearing instructions for task and preparing. Time points 3-5= after task.  Bars represent 1 
standard error. 
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between the groups. In the resilient group conscientiousness did not correlate 
significantly with any other variable. Within the vulnerable group conscientiousness 
significantly correlated with cortisol output at time point 1 and 2 (r (15) =.51, p=.046; r 
(15) =.69, p=.003, respectively) (Appendix XII shows scatter-plots depicting these 
relationships). Chi-square analysis reveals no significant difference in combination of 
conscientiousness and neuroticism distribution between groups (x2 (1, N = 32) = .513, p = 
.637). 
 
 
 
4.5 Part 2: Follow-up 
Upon completion of the TSST participants were invited to take part in a follow up study, 
to assess the degree to which sleep was disrupted in response to real life stressors, and if 
this varied by FIRST grouping. It was hypothesised that those who score higher on the first 
will show an increase in number of insomnia symptoms during the stressful week, 
compared to the normal week. It was further hypothesised that this would be mediated 
by neuroticism, conscientiousness, EFC and stress-response as measured by cortisol. 
 
4.5.1 Methods: 
Participants were given 2 weeks of sleep diaries, and instructed to fill these out during 
‘working week times’- i.e. Monday to Friday. These diaries are the standard University of 
Glasgow Sleep Centre diaries (appendix XIII). The participant is instructed to fill the diary 
B SE B Beta
Step 1
constant 7.52 1.16
Group -2 0.76 -0.42
Step 2
Constant 1.24 2.08
Group -1.71 0.73 -0.36
NEOC 0.12 0.53 0.39
 
 
Table 4 4 Regression co-efficients. 
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in as soon after wakening as possible. They are asked every morning about their sleep the 
night before. It assesses sleep parameters such as how long it took to fall asleep, how 
many awakenings they had, when they went to bed and got out of bed in the morning 
and how many hours sleep they achieved, and also asks participants to rate quality of 
sleep in terms of how tense they felt in bed and how satisfied they were with the 
previous night’s sleep.  
 
Participants were instructed to fill the diaries out during a ‘normal’ week. That is to say a 
week in which they do not anticipate any unusual stressors such as increased work-load, 
presentations, exams etc. and again during a week which they anticipated to be more 
stressful than usual. This could be a week leading up to exams or in which they had 
course deadlines. In order to assess that both weeks were perceived to vary in stress, 3 
questions were added to the sleep diary: 
 
‘In the last week how often have you felt nervous and/or ‘stressed’? 
0             1            2            3            4 
Not at all         Fairly Often               Very Often 
 
 
1. Have there been any events in the last week which have caused increased stress? 
 
 Yes/ no 
 
2. If so, what? 
 
  
4.5.2 Participants: 
A total of 18 participants returned the sleep diaries. Given that all participants from part 
one agreed to take part, this represents a 36% drop out (6= female; average age 20.93 
(SD= 1.33)). Reasons for drop out were not generally given, but when provided it was due 
to forgetting to complete the diary. Four were excluded for scoring too high on the PSQI 
and ISI (given the nature of the study, the second part commenced before responses to 
questionnaires in the first part had been scored) Final n= 14; 6 vulnerable.  
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4.6 Analysis: 
Due to the small sample size and the non-normal distribution of the data (Kurtosis and 
skew in appendix XIV), Mann-Whitney analysis is carried out.  Standard deviations are 
reported. This is not conventional for Mann-Whitney data, but may be more meaningful 
to the reader. Median and interquartile range values can be found in appendix XV.  
   
4.7 Result: 
In order to test that the stressful week was indeed considered more stressful than the 
normal week, a Mann-Whitney test were carried out on subjective stress ratings between 
the weeks. Results showed both groups subjectively rated week 2- the high stress week-
as significantly more stressful than week 1 (U= 21,p=<0.05 and U=36, P<0.05 
respectively). There were no significant differences between the groups on stress ratings 
for either week and no significant difference in change in stress scores between the 
groups. Without exception the reported stressor was increased workload.  
 
As would be expected in a sample recruited as good sleepers, there were no significant 
differences in sleep parameters- SOL, WASO, number of awakenings, TST, TIB or SE in 
week 1. 
 
 Number of insomnia symptoms was also calculated for each participant for each week. A 
symptom was counted if: 
SOL≥30min 
WASO≥30 min 
These parameters are based on Edinger et.al.’s Research Diagnostic Criteria [166]. A score 
of 1 was given for a particular night if either SOL, WASO or both met this criteria, meaning 
a maximum of 5 and a minimum of 0 were the possible extremes for each participant. 
Calculating number of symptoms will give an insight into the extent to which sleep is 
disrupted, in the absence of a diagnosable disorder. 
 
During the high-stress week there is a trend toward number of awakenings to be greater 
in the vulnerable group (U= 36.5, p=0.099), and SE to be decreased (U=11.0, p=0.093). 
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The vulnerable group show significantly increased change score in number of symptoms 
from week1 to week2 compared to the resilient group (U=39.0, p<0.05) (figure4  5).  No 
other change scores differed significantly. Descriptive statistics for the sleep variables are 
shown in table 4 5 and figure 4 6 (SOL and WASO). Change score in sleep variables are 
represented in figure 4 7. In terms of psychological variables (table 4 7) the vulnerable 
group were significantly higher in all subscales of the DASS (DASD: U= 42, p<0.05; DASA: 
U=4 40.5, P<0.05; DASS: U=39.5, p<0.05); the reflective thinking subscale of the 
rumination scale (U= 41, P<0.05) and in neuroticism (U= 76.5, P<0.01). No other variables 
differed significantly. The groups also did not differ significantly in their responses to the 
TSST, either on individual time points or AUC (table 4 6). Due to the small sample, and 
only having 2 groups data are not corrected for multiple comparisons.  
 
 
Figure 4 5 Average change score in insomnia symptoms between weeks, showing decrease in the resilient 
group and increase in the vulnerable (U=66.0, p<0.05) 
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Table 4 5 Average Values on Sleep Diary Variables for Normal and Stressful Week for Each Group (S.D.) 
            
       
 
 
Figure 4 6 Average SOL and WASO between weeks between groups.  
No Significant differences. Bar represents 1 SE 
 
 
 
 
 
 
 
 
 
 
 
Sleep Paramaeters: Means (Standard Deviation)
SOL WAKENING WASO TST TIB SE
Normal Week Resilient 15.28 (8.89) 0.3 (0.34) 6.9 (10.53) 487.3 (49.28) 547.70 (73.30) 89.66 (9.00)
Vulnerable 14.16 (9.91) 0.48 (0.32) 5.96 (5.33) 482.74 (51.51) 542.47 (57.86) 89.17 (5.55)
Stressful Week Resilient 13.75 (7.54) 0.3 (0.45) 2.625 (3.87) 450.175 (29.55) 493.525 (45.79) 91.965 (6.60)
Vulnerable 24.5 (23.79) 0.78 (0.60) 13.98 (17.50)424.14 (60.19) 490.14 (78.15) 86.909 (4.30)
SOL and WASO Between Groups Across Each Week
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Figure 4 7 Change in sleep variables between normal and stressful week 
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The symptom change score correlates significantly with cortisol at time one (r= 0.55, 
p<0.05), and AUCg (r=-0.622, p<0.05). The amount of variance accounted for here is quite 
large, and so caution should be applied to the interpretation of such results, given the 
small sample. It is possible that these represent a type II error.  
 
 
 
 
 
 
 
 
 
  
T1 
 
T2 
 
AUCg 
 
AUCi 
Resilient  
4.98 (2.55) 
 
5.34 (2.24) 
 
295.45(125.01) 
 
79.28 (100.89) 
Vulnerable  
3.40 (1.43) 
 
3.44 (1.56) 
 
175.20 (100.45) 
 
39.11 (63.92) 
Table 4 6 Descriptive statistic for salivary free cortisol between the vulnerable and resilient group 
 
Scale 
 
Resilient (SD) 
 
Vulnerable 
 
PSS 
 
9.50 (4.14) 
 
15.13 (7.95) 
 
DASSD 
 
0.67 (1.03) 
 
6.75 (6.14) 
 
DASSA 
 
1.33 (2.42) 
 
5.50 (3.16) 
 
DASSS 
 
6.00 (3.10) 
 
14.25 (8.58) 
 
NEOO 
 
45.33 (6.63) 
 
55.25 (6.71) 
 
NEOC 
 
54.50 (9.87) 
 
47.25 (9.82) 
 
NEOE 
 
59.00 (4.43) 
 
49.75 (5.15) 
 
NEOA 
 
56.17 (6.49) 
 
47.37 (7.25) 
 
 
NEON 
 
 
35.33 (7.66) 
 
 
41.50 (13.15) 
 
RUMD 
 
17.5 (6.75) 
 
24.13 (6.15) 
 
RUMB 
 
7.67 (3.08) 
 
11.00 (4.38) 
 
RUMR 
 
7.17 (2.32) 
 
12.13 (4.64) 
 
COPEP 
 
9.83 (3.19) 
 
13.00 (2.98) 
 
COPEE  
 
11.17 (5.56) 
 
15.13 (3.04) 
 
WORRY 
 
41.00 (5.69) 
 
47.25 (12.98) 
Table 4 7 Mean and Standard Deviation for Psychological variables for follow up sample 
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4.8 Discussion 
Autonomic arousal is thought to characterise the insomnia population, not just at night 
but throughout the 24h cycle [55]. Vgontzas et.al. [58, 59] have supported this notion, 
demonstrating increased HPA activity, as assessed via cortisol output, to be higher in a 
group of insomnia patients compared to controls. Based on this idea coupled with the 
fact that a predisposition to insomnia has been posited to exist, it was hypothesised that 
those vulnerable to insomnia would demonstrate increased stress reactivity- increased 
change over time in SFC- to a laboratory based psychosocial stressor. This then is a 
precursor to hyperarousal. The FIRST questionnaire is designed to differentiate those who 
are vulnerable to stress-related sleep disturbance from those who are resilient. Results 
will be discussed first in terms of cortisol and then psychological variables before 
discussing the follow-up study. 
 
It was found that the paradigm did show a robust effect, whereby the main effect of time 
is significant. We can be confident therefore that the paradigm is indeed affecting HPA 
activity. However, our results did not show any significant differences for cortisol change 
over time- i.e. stress-reactivity (AUC). There was however a trend for AUCg, and this 
showed a strong effect, suggesting the study may have been underpowered. However, it 
was demonstrated that the vulnerable group had higher cortisol levels on average at 
every time point, and significantly so at time points 1 and 2. This suggests firstly that the 
trend for AUCg is an artefact of baseline levels, given that AUCg considers differences 
from absolute zero rather than from respective baselines i.e. the trend denotes 
differences in baseline and not in reactivity, as area under the curve in this calculation 
would be higher in the vulnerable group, simply because it has a higher starting point that 
isn’t accounted for in the AUCg calculation and not because reactivity is any different. 
Secondly, this may represent either an insomnia-like ‘hyperarousal’ in this group, 
whereby they are exhibiting a psycho-biological vulnerability to insomnia, and thus 
implying that the hyperarousal that has been demonstrated in insomnia is not due to lack 
of sleep but rather cause of and maintenance of. If this is the case it may explain why AUC 
was not significantly different, as you wouldn’t necessarily expect stress-reactivity to be 
greater if the differences can be explained purely by elevated baseline levels. Given the 
piloting nature of the study, it is possible also that to detect such differences, if they do 
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exists, one would need more power. Alternatively, it may be the case that the vulnerable 
group show a heightened stress response to the anticipation of stress, which has 
increased their baselines levels of SFC. This will be discussed further within the context of 
the psychological differences. This also highlights the importance of a longer baseline 
period in order to support the conclusion we have drawn, but also if one believes 
anticipation to be responsible for the baseline differences shown here, then a true 
baseline has not really been recorded so a longer period of relaxation prior to beginning 
may be merited, or obtaining cortisol baseline levels at a different time from running the 
paradigm. Balodis et.al.[167] present an interesting discussion on the use of physiological 
variables in assessing stress reactivity and support the idea of a longer baseline period to 
truly assess baseline levels. Given the data we have however, the conclusions presented 
here are sensible.  
 
The finding of greater baseline levels but not in stress-reactivity is inconsistent with our 
hypothesis, but provides an interesting avenue for future research. Further to this, on 
examination of appendix X which shows the pattern of response for the vulnerable group, 
resilient group and the 10 who were excluded for scoring as poor sleepers on the PSQI or 
classed as insomnia sufferers on the ISI. Bearing in mind that all these individuals endorse 
being good sleepers at baseline, this pattern of response may indicate a pathway into 
insomnia. What we see is a consistently increased response in the vulnerable group 
compared to the resilient group, which is significantly different at baseline. In the poor-
sleeping group we see again a consistently increased response, but also a much sharper 
increase and decline in SFC i.e. a more labile stress-reactivity. This is of course 
speculative, but may suggest that what is demonstrated here are increasing levels of 
expression of vulnerability to insomnia whereby a vulnerable individual who is currently a 
good sleeper demonstrates increased baseline levels, and an individual who is vulnerable 
and currently experiencing mild sleep complaints begins to demonstrate an abnormal 
stress-response. Given that a past period of poor sleep is the strongest predictor of a new 
episode of poor sleep (LeBlanc et.al[74].), this seems a sensible conclusion to draw 
whereby repeated stress, coupled with a propensity toward negative affect, leads to 
continued HPA dysregulation and so an increase wear-and-tear on the system until a 
constant hyperarousal and insomnia develops. It needs to be emphasised though that this 
is mere speculation based on visual differences in the data. Given the small sample size, 
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this was not analysed and no hypotheses were constructed a-priori with regards to a poor 
sleeping population.  
 
We have demonstrated that good sleepers who score high on the FIRST are significantly 
higher on measures which typically characterise the insomnia population, those being 
factors associated with negative affect, stress, rumination and worry. This implies that 
these qualities increase the likelihood of an individual developing a sleep complaint in 
response to stress, given that everyone in the sample endorsed good sleep during 
screening and on psychometrics.  
 
In terms of increased baseline levels of SFC, this may be explained by anticipation of 
stress: If you have an individual who is prone to negative affect (neurotic) and rumination 
and worry it may be the case that coming in to do an experiment but not knowing exactly 
what the task is may be enough to elevate their stress-response as they already begin to 
ruminate and conjecture on what the task is and how well they will perform. An increased 
anticipation to stress is also reflected at time-point 2, after hearing what the task is and 
preparing. To tease these 2 theories out it would be beneficial to conduct this study with 
more baseline measures over a longer period at the start of the task, as suggested 
previously. Greater insight into the stress response would be gained by including more 
direct measures of stress such as oxygen metabolism, heart-rate or galvanic skin 
response. This would provide an insight into the stress-system as a whole and may allow 
for conjecture on parasympathetic versus sympathetic nervous system activity. A 
 Investigation of other aspects of the stress system will provide a fuller explanation of the 
stress-reactivity in this population and may help to over-come the problem of large inter- 
and intra-individual variance in cortisol secretion, which has been widely documented in 
the stress and anxiety literature.   
 
Regression analysis suggests that conscientiousness is the only factor which has a 
significant mediating effect on baseline levels of cortisol. As outlined in previous chapters, 
there is strong evidence to suggest that conscientiousness is protective against insomnia, 
particularly if it is coupled with low levels of neuroticism [118]. Whilst the vulnerable 
group did show, on average, lower scores on the conscientiousness subscale of the NEO-
ffi, as would be expected, this did not reach significance. Further to this regression 
analysis would suggest that as conscientiousness increases so too does cortisol output at 
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time 1, given the positive value of Beta.  This seems contradictory to the published data, 
and to our hypothesis. Given the nature of the task, it could be that conscientiousness 
would create an increased stress response, as this factor is likely to create a certain 
amount of performance anxiety, especially given that the vulnerable group in this study 
are characterised by increased neuroticism. This may undermine the protective aspects of 
conscientiousness by producing a phenotype which feels the need to do everything 
‘right’, coupled with an increase in negative affect and rumination which may exacerbate 
worries about not being able to get it ‘right’. In this sample, there were no significant 
between-group differences in terms of frequency for those scoring high on neuroticism, 
and low on conscientiousness or any other combination of these variables, so conclusions 
are, at the moment, speculative. In the vulnerable group conscientiousness correlated 
positively with baseline SFC, but not in the resilient group. Implying, therefore, that in the 
vulnerable group, who are characterised by neuroticism and other variables which may 
indicate sensitivity to negative affect, that conscientiousness does have a negative effect 
on SFC. Given the nature of the task an individual who is prone to organisation, 
thoroughness and effortful control may experience the TSST as more stressful given the 
time constraints in which to prepare for the task and the complete lack of control. This is 
then compounded by increased neuroticism, which encourages the interpretation of 
events towards being negative in valance. This is supported by previously mentioned 
work showing cortisol is reduced as a function of conscientiousness, via positive 
affect[124]. Conscientiousness exerts a protective effect by encouraging responses to 
positive events. If conscientiousness is then coupled with high neuroticism, which 
encourages negativity then conscientiousness may encourage an increased stress 
response by creating a perfectionist personality type, and there by loses its protective 
function.  Again, this is supported by the work of William and Moroz[118] who suggest 
conscientiousness is protective, only when coupled with low neuroticism.  
 
While these results are compelling, it needs to be highlighted that this work was carried 
out on a relatively small sample so results are suggestive. Secondly cortisol is known to 
have large intra-and inter-individual variability- as can be seen in the data presented 
here-, compounding the small sample size problem. This work would benefit from more 
participants and a secondary, more stable measure of the stress response. The results 
however do suggest that this is an area which merits a more intensive research effort. 
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4.8.1 Follow-up: Which factors predict Sleep Disruption in 
Response to Stress 
To fully assess if the FIRST does actually identify those who are vulnerable to sleep 
disruption in response to stress a follow up study was conducted. In conjunction with 
phase1, this will allow conclusions to be drawn regarding the existence of a vulnerable 
phenotype but also what factors may define this group psychologically and 
physiologically, giving more gravitas to the arguments presented in the previous section.  
 
As would be expected the groups did not differ on any sleep variables during the non-
stress week, and none met criteria for insomnia confirming their good-sleeper status. 
Sleep diaries were given with the instruction to fill one out during a normal week, defined 
as one in which no unusual stressors were anticipated, and one during a stressful week. 
Subjectively, both groups rated their selected stress week as significantly more stressful 
so the manipulation appears valid.  
 
Despite the high drop-out, the group who participated in the second part of the study 
seem to resemble the group in the first phase psychologically, in that the vulnerable 
group are higher in neuroticism, aspects of rumination and stress, suggesting that the 
FIRST is related to these constructs, and that this finding is reliable. 
 
Results from the sleep diary further suggest that the FIRST does adequately specify those 
who are vulnerable to sleep disruption in response to real life stressors- namely, work 
load. The most interesting finding is the differences in symptom change score between 
the groups. The vulnerable group show a significantly higher change score compared to 
the resilient group, representing a significant increase in insomnia symptoms. While no 
participant in the final sample reached diagnostic criteria for insomnia during week 2, 
their sleep had become noticeably affected by stress, but only if they are vulnerable. It 
was demonstrated also that baseline levels of SFC in part 1 were significantly correlated 
with change scores. Between group correlations suggests that in the vulnerable group 
they are related positively, but for the whole sample related negatively. This may be due 
to the resilient group showing a reduction in symptoms during week 2 relative to week1. 
This again in itself is interesting. The resilient group show a decrease in number of 
symptoms. This could be explained by differences in personality perhaps. If the resilient 
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group are lower in neuroticism and slightly higher on average in conscientiousness then 
increased workload may create a better sleep if the individual feels a sense of 
achievement at the end of the day and is not prone to worry about the increase in 
workload. Folkman [168] discusses the case for positive emotion in stress reactivity, 
talking about the notion of positive stress: If an individual is excited by the prospect of a 
challenge and believe they can handle the challenge then this stress has a positive effect. 
This is one possible explanation for the finding of reduced symptoms in the resilient 
group, whilst highlighting the notion outlined in chapter 2, that conventionally mild 
stressors may be enough to induce stress-like changes in a vulnerable individual because 
they are more prone to negative affect and worry: more likely to view a situation as 
negative, rather than challenging. Therefore, it takes a small stressor perceived as a large 
stressor to induce changes in stress physiology and then affect sleep.  
 
This work demonstrates that the vulnerable population have a distinct psychological 
profile, and elevated baseline measures of SFC, suggesting that both the psychology and 
physiology of the stress-system create the vulnerable phenotype. Conscientiousness 
seems to mediate the stress response; however more work with larger samples would 
help clarify this relationship. Based on previous work it is likely that this interacts with 
neuroticism in its effects on HPA activity. It also supports the FIRST in its ability to 
differentiate between a vulnerable and resilient population.  
 
4.8.2 Implications 
In a broader sense, the import of this work may prove to be in highlighting the need to 
educate about sleep before the onset of an insomnia episode. Preventative techniques 
such as mindfulness base stress management will likely prove to reduce levels of 
insomnia in the general population, and therefore reduce the associated negative 
sequelae of outcomes if they are introduced to the vulnerable population, especially 
considering the usefulness of these techniques in reducing SFC in response to TSST [164].  
If the hypotheses presented here can be verified through replication and improvement, 
then it provides a strong advocacy for prevention, rather than cure.  
 
Chapter 4   97 
 
4.8.3 Future Directions 
Future work needs to focus on the role of psychological and physiological variables in the 
onset of insomnia symptoms. Whilst this work provides an important first step it has 
several limitations, such as small sample size, possibly too short a baseline to fully support 
the conclusions drawn and the use of only one marker of physiological stress. Secondly, 
the stressors in both parts of the study are based on performance (given that the 
reported stressor in the follow up period was unanimously workload). Investigating 
response to more emotional based stressors may also provide an interesting insight.
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Chapter 5 Heart Rate, Cardiac-Vagal Tone and Personality and 
Coping in the Vulnerable 
5.1 Introduction 
 
In order to verify the results from the Trier study presented previously, we investigated 
stress-reactivity in an arguably more direct manner: assessing heart-rate (HR) and cardiac-
vagal tone (CVT) in response to a performance based stressor.  
Autonomic arousal as measured by HR has been shown in a small number of studies to 
characterise the insomnia population. Bonnet and Arand [57] demonstrated in a sample 
of 12 objectively (PSG) defined insomnia patients, compared to age- sex and weight- 
matched controls that the insomnia patients show an increase in heart-rate and 
significantly increased low-frequency and decreased high frequency power in the EKG 
throughout the sleep cycle. This translates to mean that the insomnia group demonstrate 
increased sympathetic nervous system activity, which the authors describe as 
‘sympathetic hyperactivity’, during sleep. This provides some support for the notion of 
hyperarousal in this population. It would have proven interesting to investigate if these 
differences were present throughout the 24h cycle and not just during sleep, providing 
further support for the hyperarousal theory of insomnia. This study is not the first to 
demonstrate increased heart-rate in this population, but it is the first to control for sleep 
stages, taking into account natural variation between sleep stages. For example, nREM is 
characterised by an increase in parasympathetic activity (decreased heart-rate) and REM 
sleep is largely characterised by sympathetic nervous system activity (increased heart-
rate) [169]. Periods of wakefulness in the insomnia group were also accounted for- 
considering that heart-rate will be increased during wakefulness, relative to during sleep. 
These are important considerations when investigating HR throughout the sleep cycle, as 
each stage of sleep has its own characteristic pattern of HR and transitioning between 
stages is a complex process in terms of the interaction between the different parts of the 
nervous system[170]. Studies to-date however do suggest that the insomnia population 
show increased sympathetic nervous system activity as measured via HR while asleep and 
in response to exercise and stress as demonstrated in classic studies[171-174]. This may 
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represent a pathway into cardiovascular disease, which has been associated with 
insomnia [175]. 
Such work implies that the CNS is chronically altered in the insomnia population, and not 
just in its response to stress. Further to this and of more relevance from the point of view 
of this thesis, is the effect of acute stress on HR and how this leads to disrupted nocturnal 
sleep. Hall et.al. [176] conclude from their study that acute stress alters HR variability 
during sleep. In a sample of 59 PSQI-defined good sleepers it was found that acute stress 
alters HR variability during sleep, and this was significantly associated with a decrease in 
sleep maintenance and a decrease in delta wave counts- i.e. reduced deep sleep. The 
stressor employed was one of anticipation, rather than completing a stressful task: those 
in the stress condition were told that the following morning they would have to prepare 
and give an oral presentation, which would be assessed on content and quality, whilst the 
control group would be asked to sit quietly and read a magazine whilst HR and blood 
pressure were monitored. What this study really demonstrates therefore is that 
anticipation to stress affects HR during the night. It would have been interesting in this 
study to assess which other factors may mediate this effect. Worry was controlled for as 
was ambient stress levels, however, personality, rumination and coping style were not. 
Such factors may have a bearing on how strong the physiological anticipation to a 
stressful situation is. Brosschot et.al.[101], upon review of the literature surrounding 
stress-related physiological activation highlight the need to better understand how 
factors such as worry and rumination may increase the physiological stress response in 
anticipation to the stressor, and further maintain the activation in the resolution of the 
stressor. Indeed Brosschot et.al.[177] report that trait worry and trait anxiety lead to 
heightened HR but reduced heart-rate variability throughout the course of one day, and 
that these effects further impinged on sleep the following night.  
Both the work by Hall and Brosschot suggest that physiological response to stress during 
the day represents a risk factor for disrupted sleep at night. It is possible therefore that an 
increased sensitivity of the cardiovascular system may be endemic to the vulnerable 
population.  
Cardiac Vagal Tone (CVT) is a marker for parasympathetic nervous system activity, and 
works in tandem with HR. Baglioni et.al.[178] have found that CVT is greater in insomnia 
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patients compared to good sleepers, in response to emotional stimuli. Higher CVT has 
been associated with greater reactivity to stimuli [179]and has been suggested as a 
predictor of stress vulnerability and stress-reactivity in both animals [180] and humans 
[181], whereby decreased vagal tone indicates an increased stress response. It has been 
shown that active coping tasks lead to an increase in HR (sympathetic nervous system 
activity) and a withdrawal of CVT (parasympathetic nervous system activity) [182] and 
dysregulation of CVT have been implicated in both anxiety and depression [183, 184]. 
The present study aims to assess HR and CVT in response to an active coping task, 
between a vulnerable and resilient group. As well as assessing worry and rumination, 
personality factors and coping styles will also be measured. This will allow a certain level 
of discursive comparison between results of this study and the TSST study.  It has been 
delineated in previous chapters the pathway by which personality and coping style may 
contribute to a hypersensitivity to stress: neuroticism represents an increase in negative 
affect, and an increased likelihood of interpreting challenges as threatening [185-187]. 
This leads to an intensification of stress response and therefore a greater vulnerability to 
stress [188]. 
5.2 Aims 
The primary aim of this study is to investigate stress reactivity in individuals vulnerable to 
sleep disruption, as assessed by the FIRST, in an attempt to support what has been found 
in previous work which has used cortisol in response to a psychosocial stressor (TSST). 
ECG recording provides the primary outcome measures, thus allowing inferences to be 
made about sympathetic (heart-rate) and para-sympathetic (cardiac-vagal tone) nervous 
system activity. Again, psychometrics measuring personality, coping style, worry, 
rumination, depression, anxiety and stress have been used to further assess which 
factors, psychologically, define the vulnerable population and how these may mediate 
physiological responses to stress. 
 
5.2.1 Hypotheses 
As with the previous study, this work is exploratory in nature. Hypotheses are based on 
the results of our previous study. 
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Heart-rate 
It is hypothesised that the vulnerable group will show significantly increased arousal at 
baseline, relative to the resilient group, as measured by HR. 
It is hypothesised that the vulnerable group will show greater heart-rate throughout and 
greater CVT throughout the paradigm compared to the resilient group, but the change 
between conditions will not be significantly different (i.e. stress-reactivity will be the 
same between groups) 
Psychometrics 
It is hypothesised that the vulnerable group will show a similar psychological profile to 
that seen in the insomnia population: higher in neuroticism, worry, rumination. 
Conscientiousness will mediate the relationship between group and baseline heart-rate, 
as suggested by the previous study. 
The vulnerable group will subjectively rate the task as more stressful. 
5.3 Methods and Materials 
5.3.1 Participants 
Participants were recruited as per the previous study: through advertisements in the 
University Of Glasgow School Of Psychology. All participants were screened using the 
standard UGSC screening form (Appendix I). Full exclusion criteria can be seen in 
appendix II). In brief, participants who were deemed to suffer from insomnia or any other 
sleep disorder were considered ineligible to participate. Individuals currently diagnosed 
as having an ongoing mental illness or receiving any kind of psychological intervention 
(pharmacological or psychological) were also excluded. Participants who reported having 
heart problems, issues with blood pressure or were taking medication for such disorders 
were also excluded. Participants who had taken part in the previous study were also 
excluded. 
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On top of the standard questions asked in the screening form participants were also 
asked if they regularly took recreational drugs. If they reported taking drugs frequently 
they were excluded from the study. A question asking about caffeine intake was also 
added (‘How many caffeinated drinks do you drink a day?’). If more than 5, they were 
excluded.  
In total 31 participants completed the study: 13 vulnerable and 18 resilient (table 5.1 
shows the demographics). Groups were constructed post-hoc based on median split of 
the FIRST. It was planned to exclude individuals who scored too high on the PSQI and ISI, 
however no-one did so in the analysis of the psychometrics the full sample was included. 
For the ECG data 4 participants were excluded due to increased artefact in their data, 
rendering it un-analysable. The total number of participants in this section of analysis is 
28: 12 resilient and 16 vulnerable (demographics displayed in table 5.1). Age did not differ 
significantly between the groups, however gender representation did and so this will be 
entered into analysis as a covariate.  
Psychometrics  Age (mean(SD)) Gender (% female) 
 
Resilient 22.23 (2.49) 72.2 
 
Vulnerable 21 (1.61) 92.3 
ECG    
 
Resilient 20 (2.48) 61.5 
 
Vulnerable 18 (1.61) 94.4 
Table 5 1 Age and gender for sample.  
Psychometrics reflects full sample. 'ECG' shows age and gender after excluding those with 
excess artefact in the data 
 
5.3.2 Measures 
The Psychometric measures are outlined in chapter 3, and can be seen in appendix III. To 
assess heart-rate, ECG was recorded continuously throughout the experiment and 
analysed in accordance with the Netscope method [189]. Therefore, heart-rate and 
cardiac-vagal tone (CVT)- based on the Linear Vagal Scale (LVS) [190]- were measured. 
This allows for a measure of both sympathetic and para-sympathetic nervous system 
activity, which can be thought of as opposing forces operating on the nervous system: 
Sympathetic nervous system activity leads to a quickening of heart-rate, whereas CVT 
slows it down. Understanding both gives a greater insight into how stress-reactivity may 
create an at risk phenotype: which force leads to the disruption.  
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In addition to the psychometrics and heart-rate measures, subjective stress was 
measured throughout the experiment. At the end of each period of relaxation, at the end 
of each period of stress and before beginning the experiment participants are asked to 
rate how they had felt during the previous minutes. They were presented with a visual 
analogue scale (VAS) which ranged from 0 (very calm) to 10 (very stressed). This would 
serve as a manipulation check, ensuring that the paradigm was stressful, subjectively. 
 
5.3.3 Procedure: ECG set-up and Stress-paradigm 
Participants who were successfully screened over the phone were invited to meet the 
experimenter at the University Of Glasgow School Of Psychology. They were instructed to 
avoid smoking or imbibing caffeinated beverages for at least 1 hour before coming in to 
the study.  They were given an information sheet (appendix XVI) and given time to read 
this and ask any questions before signing the consent form (appendix XVII). Upon 
completion of this they were taken to a small room where the experiment would take 
place. The room was quiet, and had been tested for any electrical interference which 
might cause artefact in the ECG. Participants were run between 1300 and 1800 hours, all 
in the same room. 
To record the ECG, four self-adhesive Ambu wet gel disposable ECG electrodes with 
popper lead connections were attached to the individual’s torso. To ensure a strong 
connection, the skin was first prepared with an alcohol wipe and abrasive pad. Electrodes 
were placed one beneath left clavicle and one above the waist. Ground and reference 
leads were placed beneath the right clavicle roughly 1cm apart. ECG was recorded using a 
Lifelines Trackit Ambulatory device, with a poly-patient connector unit added on.  
Once the electrodes were fitted and it was checked that the Trackit was recording 
properly participants were led to a semi reclined cushioned chair. This meant that they 
were in a semi-supine position, the intention being to reduce muscle movement and 
tension. The computer screen from which the participant would see the task was 
positioned roughly 50cm away, and the response pad was placed near their dominant 
hand on a small table, so that they could comfortably respond to the tasks. The 
participant was instructed that it was very important that they remain still throughout the 
experiment as body movements can have a large impact on the ECG recording, and so 
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were told to make themselves as comfortable as possible. Once the participant had 
instructed the experimenter that they were comfortable the lights were turned off and 
the experiment was started. The experimenter remained in the room with the 
participant, seated behind them. This was to allow the experimenter to record the verbal 
response to the VAS but also to note down the times at which the relaxation and stress 
phases began, as a safe-guard against any problems with the programme failing to record 
this information.  
Before the paradigm began the participant went through a short training phase, in order 
to get them used to the button responses required for the rest of the experiment. The 
experiment would not continue until this was successfully completed. Response key can 
be seen in figure 51.  
  Figure 5 1 Response key 
 
Once this was completed the VAS was administered. A line appeared on a screen with a 0 
and one end and a 10 at the other. Participants were asked to respond verbally, choosing 
a number corresponding to how stressed they felt, 0 being not at all and 10 being very. 
The experimenter noted the response. The baseline condition was then run (the same 
procedure is applied to the relaxation condition mentioned later) in which the participant 
heard some relaxing music and saw on the screen a calm scene- a list of the music and 
accompanying images can be seen in appendix XVIII. This lasted for 5 minutes and was 
intended to induce relaxation.  
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After 5 minutes a message would be displayed telling the participant that the next phase 
was about to commence. During the stressor condition participants were presented with 
multiple choice questions, adapted from past foundation and general level standard 
grade examinations (SQA, 2010, figure 5 2 shows an example. Further examples can be 
seen in appendix XIX). Participants were told prior to commencing the experiment that 
they would be required to answer as quickly and as accurately as possible, and that their 
performance would be timed. To increase the pressure, a ticking clock played throughout 
the stressor phase, counting down the amount of time they had left in which to respond. 
Participants were given feedback on their performance in the form of a green tick when 
correct, a red cross when wrong and ‘out of time, too slow’ when they failed to answer 
the question within the time limit (these are also displayed in appendix XVIII). There were 
24 questions for each stressor phase. The condition ended once each question had been 
seen. At the end of the stress phase the VAS was administered.  
At the end of this stressor phase a relaxation phase took place and then a break, to allow 
the participant to move about. The participant dictated the length of the break. The 3 
conditions were then repeated: baseline (relaxation); stressor; relaxation. This paradigm 
has previously been validated in our lab (unpublished data) and is similar to paradigms 
investigating mild stress on heart-rate, representing an active coping task. The paradigm 
was run using Superlab 4 (Cedrus Corporation, San Pedro, C.A.).  
 
Figure 5 
2 
Example 
question 
given 
during 
the 
stress 
condition 
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5.3.4 Refining the ECG Data 
Continuous ECG data was recorded throughout the duration of the study, while another 
channel recorded the timing pulse generated by Superlab in order to accurately time the 
onset of each phase (as stated this was also recorded manually). In order to obtain HR 
and CVT, data was processed using Neuroscope (Medifit Instruments Ltd., London). This 
process was carried out for each individual participant. First, a period of 50-100ms 
surrounding the QRS complex was selected (figure 5 3). Figure 5 4 shows an example of 
the selection process from the data. The software uses this selection as a template R 
wave, to then identify every R wave in the data thus allowing the R-R intervals to be 
calculated. R-R interval is the distance between 2 R waves. This was used to calculate HR 
and CVT values. These values were then processed using a second Neuroscope 
programme. Continuous HR and CVT data are displayed in the form of a tachogram, based 
on previously calculated RR intervals. Specific time periods are then selected using the 
cursors- the dotted lines shown in the figures. One minute epochs were selected, and 
mean HR and CVT calculated. Therefore, the data used in analysis is the average HR and 
CVT for each minute of the baseline, stress and recovery phases.  
In some cases artefact was found. In the case of suspected artefact a Clinical Scientist was 
consulted as a second opinion and artefact removed manually (figure 5 5).  
 
Figure 5 3 Defining QRS complex.  
The Peak represents is the R wave. The distance between the peaks is the R-R interval. The 
dotted lines around the R wave are cursors used to select exemplar QRS complex. 
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Figure 5 4. HR and CVT Data refining.  
Taken from the end of baseline ECG data. Number 1 is the start of the selected epoch, and 
number 2 is the end of the selected epoch, at the beginning of the stress phase.  The x axis 
is time and the Y axis is the value. The top graph represents HR and the bottom CVT.  Data 
was selected in this fashion, using the 2 cursors to obtain HR and CVT values for every 
minute epoch of the paradigm.  
 
Figure 5 5 Example of ECG artefact 
Left hand picture is before; Right hand picture is after artefact is removed. The first 2 peaks 
in the left hand graph are areas which are removed. 
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5.4 Results 
5.4.1 Psychometrics 
The median score of the FIRST was 18. This similar to published data. Drake et.al [94] 
report the median to be 20, and in the previous study the median is reported as 19.5. 
Data were inspected for normality. Kurtosis and skeweness scores indicated that all the 
psychometrics were normally distributed (< +/- 3, as per Field, 2010) (appendix XX). The 
data was inspected initially via Pearson correlation. Full correlation table can be seen in 
appendix XXI. Scatter-plots displaying the relationship between FIRST and other 
psychological variables (where a significant correlation was found) are displayed in 
appendix XXII. It was found that first scores showed weak to moderate correlations with 
PSQI (r(29)=0.43, p=0.15), ISI (r(29)=0.60, p<0.001), PSS (r(29)=0.61, p<0.001), DASS_S 
(r(29)=0.55, p=0.002) and Neuroticism (r(29)=0.39, p=0.31). Neuroticism also correlates 
with DASS_S and PSS, but only moderately (r (29) =0.5, p=0.005); r (29) =0.63, p<0.001, 
respectively). This goes some way to supporting what can be seen in the previous study.  
To asses between group differences, one-way ANOVA was carried out on the variables 
hypothesised to show differences- neuroticism, conscientiousness, rumination, worry, 
emotion focused and problem focused coping. T-tests were also carried out on anxiety 
and depression and on the sleep scales (DASSA and DASSD, PSQI, ISI) to ensure that 
groups did not differ significantly on these possibly confounding factors. Table 5.2 shows 
the mean and standard deviation for all the psychometric variables between groups. This 
is plotted visually in figure 4.1. Data is reported in the standard APA format, with F values 
and exact p-values, except where p<0.001.  Effect sizes are reported as Cohen’s d. It was 
found that groups differed significantly on Neuroticism (F (1, 30) = 5.5, p = .026, d=0.86), 
PSS (F (1, 30) = 13.2, p = .001, d=1.31) and RUMB (F (1, 30) = 5.29, p = .029, d=0.86). All 
showed large effects. They were also significantly different on in ISI scores (F (1, 30) = 
15.54, p < .001), with the vulnerable group scoring higher on all the mentioned variables. 
No-one in the sample scored high enough on the ISI to be classed as having insomnia, so 
this between-group difference is not clinically significant, especially considering the non-
significant difference in PSQI scores. However, analysis was re-run with gender and ISI 
entered into a general linear model as covariates. Neuroticism, PSS, and RUMB remained 
significant. This is supportive of what was found in the previous study, where the 
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vulnerable group are shown to be higher in variables denoting negative affect, rumination 
and stress. 
 
 Vulnerable (mean (SD)) Resilient (mean (SD)) 
PSQI 4.56 (2.15) 3.23 (1.69) 
ISI 5.33 (3.25) 1.46 (1.61) 
FIRST 21.72 (3.48) 14.46 (2.02) 
PSS 17.94 (5.46) 10.31 (6.18) 
DAS_D 7.88 (6.61) 4.15 (5.06) 
DAS_A 5.76 (5.91) 4.00 (4.07) 
DAS_S 13.06 (7.52) 5.54 (4.70) 
NEO_O 50.39 (5.93) 50.23 (8.41) 
NEO_C 47.00 (10.35) 50.69 (9.16) 
NEO_E 50.17 (8.66) 53.23 (9.44) 
NEO_A 53.89 (6.62) 55.77 (7.15) 
NEO_N 37.50 (9.13) 30.00 (8.29) 
RUM_B 24.22 (6.21) 19.62 (4.31) 
RUM_D 9.33 (3.36) 7.54 (2.26) 
RUM_R 9.67 (4.00) 8.00 (2.63) 
EFC 13.34 (3.33) 13.08 (4.65) 
PFC 12.11 (2.35) 11.69 (3.38) 
PSW 42.94 (14.24) 38.77 (8.41) 
Table 5 2 Means and standard deviations for the psychometrics for each group.  
NB: Highlighted red are variables which differed significantly 
 
 
Figure 5 6 Spider chart showing between group differences on psychometrics.  
Red line represents the vulnerable group. * indicates significant between group difference 
(p<0.05). Created using z-score data. PSS= Perceived Stress Sale; DASS_D=Depression; 
DASS_A=Anxiety; DAS_S=Stress; NE_O=openness; NEO_C=Conscientiousness; 
NEO_E=Extraversion; NEO_A=agreeableness; NEO_N=Neuroticism; RUM_D=Depressive 
thinking; RUM_B=Brooding; RUM_R=reflective thinking; COPE_P=Problem focused coping; 
COP_E= Emotion focused coping 
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5.4.2 Heart-rate and Cardiac-Vagal Tone 
Again, data is presented in the APA format, with effect sizes reported at Cohen’s d, except 
in the case of ANOVA based analysis where partial eta squared is reported. Before HR/ 
CVT data was assessed, responses for the VAS scale were inspected to ensure that the 
task was deemed subjectively stress inducing. Baseline subjective stress was compared 
between groups. This did not differ significantly between groups (t (1, 30) = 0.573, 
p=.572). To assess that the paradigm was considered stressful, paired t-tests were 
performed to assess differences between baseline 1 and stressor 1 and between baseline 
2 and stressor 2. The difference between baseline 1 and stressor 1 was significant (t (1, 
27) =-7.215, p<.001). The difference between baseline 2 and stressor 2 was also 
significant (t (1, 27) =-8.32, p<0.001). Subjectively, over both phases participants rated the 
stress condition as significantly more stressful than the baseline. 
Kurtosis and Skeweness values for the average CVT and HR data for each phase of the 
study indicate that some of the data is not normally distributed between groups. Further 
to this, there was found to be outliers in every condition of the paradigm. As the study is 
exploratory in nature, data was log transformed, rather than deleting the outlying cases, 
in order to preserve power and to allow the use of parametric testing with the natural log 
transformation. This normalised outliers and distribution. Average HR and CVT for each 
baseline, stress and recovery phase for each group can be seen in table 5 3. Figure 5.2 
depicts the mean HR minute by minute over the 3 conditions, before and after the break. 
Figure 4.3 shows the same information except with CVT.  
  Resilient  Vulnerable  
 
 HR(SD) CVT(SD) HR (SD) CVT(SD) 
Phase 1      
 
Baseline 77.09 (12.76) 16.36 (10.28) 74.42 (11.10) 13.95 (10.88) 
 
Stressor 83.34 (11.38) 13.16 (9.71) 80.52 (11.29) 11.12 (8.27) 
 
Recovery 76.88 (11.09) 16.25 (9.77) 74.01 (9.88) 13.80 (11.45) 
Phase 2      
 
Baseline 76.29 (11.60) 16.71 (10.37) 72.66 (9.61) 14.77 (9.10) 
 
Stressor 78.90 (11.06) 16.48 (11.03) 77.25 (11.16) 12.97 (10.68) 
 
Recovery 78.25(10.21) 17.15 (12.93) 75.10 (7.55) 13.47 (10.07) 
Table 5 3Average (Standard Deviation) HR and CVT  
. 
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Figure 5 7Graph showing the average HR for each minute of the paradigm for both groups. 
 It appears that the first phase has more of an effect on HR. 
 
 
Figure 5 8 CVT for both groups averaged at each minute throughout the paradigm 
 
Initial analysis was carried out on phase 1 only. This is because there was more missing 
data towards the end of the paradigm- possibly because participants were getting 
restless, and so moving more and creating artefact in the ECG recording.  
Baseline levels were computed first. The log transformed average HR for baseline 1 was 
compared between groups in an independent t-test. Contrary to hypothesis, there was no 
significant difference at baseline (t (26) =.53, p= .60, d=.61). Repeated measure general 
linear model analysis revealed that there is a significant effect of condition on HR 
(F(2,1)=15.006, P<0.001, partial eta square= .347) and a significant effect of group 
(F(2,1)=.4.90, p=.037)but no condition by group interaction (f(2,1)=.96, p=.76). This 
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remained the case when age, gender and ISI were entered into the model as covariates. 
When psychometric variables of interest (neuroticism, PSS, EFC, RUMB and 
conscientiousness, based on hypotheses and significant between group differences) were 
entered into the model as covariates, the main effect of group becomes insignificant, 
although still pointing toward a trend ( f(1,2)=3.748, p=.07, partial eta squared=.18). 
There is also a main effect of EFC= (F (1, 2) =5.404, p=.033, partial eta squared=.24). 
Parameter estimates suggest that as EFC increases, the difference in HR between 
conditions decreases.  
Pairwise comparisons, corrected for multiple comparisons using bonferonni correction, 
revealed that there was a significant difference between Baseline and stress (p<0.001) 
and stress and recovery (p<0.001) but no significant difference between Baseline and 
recovery (p=.72). Demonstrably, the paradigm is inducing a physiological stress-response, 
whereby heart-rate increases in response to the stressor relative to baseline and 
recovery, and during the recovery phase heart-rate drops again to a level comparable to 
baseline. Given that the group by condition interaction is non-significant, this implies that 
the change in response between conditions is similar between groups, thus implying no 
significant difference in stress reactivity between the groups.  
Cardiac vagal tone was analysed in the same way. There was no significant difference in 
cardiac vagal tone at base-line (t (26) =.66, p=.56, d= .23). Repeated measure general 
linear model analysis shows a trend for condition to have an effect on CVT (f (2, 1) =3.343, 
p=.065, partial eta squared = .2), controlling for age, gender, ISI, neuroticism, EFC, RUMB, 
PSS and conscientiousness. There is no group by condition interaction (f (1, 2) =.197, 
p=.168, partial eta squared=0.21) or main effect of group (f (2, 1) =.226, p=0.641, partial 
eta squared=.012). There was a significant interaction between conscientiousness and 
condition (f(1,2)=4.03, p=.042, partial eta squared=.182).To better understand this 
relationship within-group correlations were carried out, revealing that in the vulnerable 
group conscientiousness correlated negatively with change in CVT between the stress and 
relaxation conditions ( (r(15)=-.67, p=0.006) ( Pairwise comparison generated from the 
GLM reveals that the significant differences lie between baseline and stress and stress 
and recovery). 
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5.5 Discussion 
Work Presented previously suggested that those vulnerable to insomnia demonstrate 
heightened levels of physiological arousal at baseline, as index by SFC. And that this was 
mediated by conscientiousness. Further it was found that the vulnerable group showed 
greater levels of negative affect, rumination, worry and perceived stress.  To further test 
these findings, HR and CVT were measured in a new cohort of participants, whilst they 
engaged in an active coping task. Measures of personality, coping style, stress, 
depression, rumination and worry were taken. It was hypothesised that the vulnerable 
group would show elevated levels of HR at baseline compared to the resilient, and lower 
levels of CVT throughout the stress task, compared to the resilient group as lowered CVT 
has been shown to be a reliable index of stress vulnerability and further that active coping 
task lead to lower CVT in primary insomnia patients [178]. Further, it was expected that 
the vulnerable group would be higher in neuroticism, rumination, worry and perceived 
stress, as per previous work.  Results will be discussed first looking at the psychological 
variables, then HR and then CVT.  
Data from the psychometrics supports the idea that the vulnerable population seems to 
be characterised by neuroticism, brooding (the RUMB subscale of the RSQ) and perceived 
stress, as measured by the PSS.  This supports what has been found in the previous 
chapter. Again, this suggests that the vulnerable group are prone toward negative affect 
and rumination and perceiving life as more stressful than the resilient group. Contrary to 
hypothesis, the groups did not differ at all on coping style, both groups showing nearly 
identical scores on the problem focused and emotion focused coping measures.  
Heart-rate data and CVT demonstrates that the paradigm is inducing stress at a 
physiological level, showing a main effect of time. The vulnerable group also tended to 
lower HR, but this did not interact with condition. This may highlight a basic difference in 
the stress system between these groups which is not related to stress reactivity.  This 
finding however did not hold up when psychological covariates were entered into the 
model, meaning that an individual’s psychology may account for more of the variance in 
physiological stress response, than grouping by the FIRST. To check that the lower median 
reported in this sample was not responsible for these results i.e. if the vulnerable group 
were not vulnerable enough, analysis were carried out with groups defined based on a 
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score of 19.5 as per the Trier study. This did not alter the findings. CVT did not show a 
main effect of group or a group by time interaction. The negative correlation between 
change in CVT and conscientious shows that as conscientiousness increases change in CVT 
decreases. Based on this it could be speculated that those high in conscientiousness show 
a less flexible CVT response. Friedman [183] highlights the need to focus more on 
flexibility of the CVT response rather than absolute values, demonstrating that in anxiety 
there is generally a lower HR variability and a less flexible CVT response. Whilst such 
conclusions cannot be drawn from the data presented, it does provide an interesting 
speculation, especially when combined with results from the previous study: The 
vulnerable group report greater levels of neuroticism. Within this group 
conscientiousness is demonstrably related to changes in CVT between stressful and 
relaxing conditions. In line with conclusions drawn from the previous chapter and studies 
from the wider field[118], it could be hypothesised that conscientiousness coupled with 
high neuroticism may lead to a vulnerable phenotype which is characterised by reduced 
vagal tone flexibility. Again, it needs to be highlighted that this is speculative. The sample 
here is relatively small, and the data only hints at such conclusions. However, these 
theories seem sensible based on what has been reported within this thesis and 
elsewhere.  
The lack of baseline elevation in HR in the vulnerable group, and indeed, a lower average 
HR is an interesting finding.  In evaluating the Trier Kirschbaum et.al.[161] report no 
correlation between HR and cortisol output, although both react to the task. A stronger 
understanding of the interactions of the various parts of the autonomic nervous system 
will help clarify what this pattern of results means. In Post-Traumatic Stress Disorder 
(PTSD) patients it has been found that although there is an elevation relative to controls 
on all measures of autonomic activation, none of these measures correlate with each 
other[191].  It may be the case then that HR is a less robust marker of vulnerability to 
sleep disruption than cortisol is, the vulnerability being attached to the endocrine system. 
Conversely it may be that the vulnerable group do in fact show decreased sympathetic 
and parasympathetic activity. As stated, lower CVT is reported as a marker of depression, 
anxiety and stress-vulnerability so this may not be surprising. Perhaps in a small, healthy 
sample of good sleepers these differences are too subtle to really explore.  
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In terms of comparing between studies to gain insight into the interactions of the nervous 
system, there may be little merit in comparing the TSST with a computer based stressor.  
5.5.1 Future Directions 
This work needs to be replicated on a bigger sample, in order to allow the various 
highlighted factors to be properly investigated. The hypothesis and theories put forward 
in the previous section of the discussion may be better tested in the context of a more 
robust stressor, simultaneously collecting physiological data to understand the 
interactions between various parts of the nervous system in creating a vulnerable 
phenotype. 
The main findings from this work are that, on average, the vulnerable group show 
differential HR and CVT levels, irrespective of condition, highlighting the idea that it is 
perhaps not stress-reactivity which defines a vulnerable phenotype but a basal difference 
in the autonomic nervous system.  
The findings from the psychometric variables support the idea that as a group, those 
vulnerable have a specific psychological profile and that this can be detected by the FIRST.  
Experimentally, there needs to be work with large samples using robust stressors, such as 
the TSST, and measuring various indices of physiological stress response in order to fully 
understand the driving mechanisms behind a vulnerability to sleep disruption, in a sample 
which is otherwise young and healthy. 
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Chapter 6: The Vulnerable Brain: The Role of the 
Insula in Defining the Vulnerable Phenotype 
6.1 Introduction 
Consistently, previous chapters have demonstrated that the FIRST can  differentiate those 
who are vulnerable to sleep disruption, and that those who are vulnerable show a specific 
psychological profile which has been consistent across the 2 studies presented. The 
previous studies further suggest that the vulnerable population may show greater H-P-A 
activity. This is manifest as a general increase similar to the hyperarousal thought to exist 
in insomnia, meaning that they have consistently higher cortisol levels across all 
measured time points. Similar findings regarding cortisol have been demonstrated in the 
insomnia population [58, 59]. Given that this was only significantly different at baseline, 
this may imply a stronger response to anticipating stress. Secondly, it seems that the 
vulnerable population show cardiovascular activity patterns which mimics that of 
depression or anxiety- a lower CVT overall (however these results were not significant). 
This suggests, however tentatively, that the vulnerable population may show dysfunction 
in the para-sympathetic nervous system, before the onset of any sleep disorder, or other 
ensuing psychological disorder (such as depression, a condition for which insomnia is a 
risk factor).  
The aim of the current study is to further understand the psychobiology of the vulnerable 
population by investigating brain activation patterns in response to a mild stressor, using 
fMRI. We will focus mainly on the brain networks involved in autonomic regulation, in 
particular the insula. 
Brain imaging and its contribution to sleep will be reviewed briefly. The insula will be 
explained and the rationale behind the belief that this may be a promising region of 
interest (ROI) for sleep and stress researchers.  
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6.1.1 Neuroimaging Studies of Insomnia 
Given the outline in Chapter 1 regarding the cost of insomnia, the benefits of effective 
treatments based on a thorough understanding of sleep dysfunction- from a subjective 
and objective stance- , and the aetiology of sleep disorders are important. The literature 
has previously had a strong focus on cognitive deficits and quality of life in insomnia [12, 
52, 192]; however, there has recently been a growth of research employing neuroimaging 
techniques to investigate sleep disorders, thus allowing for a better understanding of the 
function of sleep and the underpinnings of its dysfunction, and allowing researchers to 
infer how this may relate to cognitive processes. Functional neuroimaging studies, using 
functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET), 
of normal sleep have demonstrated differential brain activity in slow-wave sleep (SWS) 
and REM sleep. During REM sleep there is a significant increase in activity in paralimbic 
and limbic areas, with least activation in areas of the brain responsible for executive 
function such as prefrontal cortex. SWS is characterised by a general de-arousal of the 
brain, specifically in thalamic structures, thus suggesting the function of NREM sleep is 
restorative or conservative [91, 193]. In the ‘insomnia brain’, it has been suggested by 
ERP studies, that the deregulation of the central nervous system does not occur as 
effectively as it does in good sleepers, a problem that may be compounded by the 
dysfunction of brain areas known to inhibit certain cognitive processes resulting in the 
inability to disengage from waking processes[194]. Such findings have lead to the 
hyperarousal theory of insomnia [60]which has been supported by functional 
neuroimaging studies. Nofzinger et.al.[195]were the first to investigate brain 
hyperarousal in insomnia using PET. They found a smaller decrease in relative metabolism 
from waking to NREM sleep in the ascending reticular activating system, hypothalamus, 
thalamus, insular cortex, amygdala, and the hippocampus in insomnia patients when 
compared to good sleepers.  The anterior cingulate and medial prefrontal cortices also 
showed relatively smaller decreases in activation (table 6 1 provides information on some 
of the functions associated with the mentioned brain regions. This is not exhaustive, but 
is intended to provide an idea of what these areas do and why they might be important in 
understanding sleep-wake cycles and disorders of sleep.),. In terms of the reported 
experience of insomnia the involvement and hyperactivity of these areas seems plausible. 
An unrestorative sleep could be due to hyperarousal of sensory processing systems, 
combined with an inadequate disinhibition of areas responsible for consciousness control. 
Chapter 6    118 
 
Attentional biases, increases in stress perception (or negative affect i.e. neuroticism) and 
problems with memory could be resultant of abnormal function of limbic and paralimbic 
areas. Further, cognitive deficits reported by insomnia patients could reflect the 
detrimental effect sleep loss has on hippocampal volume, as shown by a recent pilot 
study[196] (although this failed to be replicated in one study [197],but found to be 
depended on insomnia severity in another [198], so needs further replication before any 
solid hypotheses can be made). The causal pathway is however unclear here, and a 
smaller hippocampus may be the result of increased levels of cortisol caused by stress, 
rather than sleep loss. Possibly, smaller hippocampal volumes may predispose to 
insomnia. Thus, stress may cause sleep problems or may be caused or heightened by a 
lack of sleep. The direction of these relationships remains elusive. The implicated brain 
regions- and the reported subjective daytime effects- highlight and reinforce an already 
intuitive relationship between sleep and stress. 
6.1.2 Stress and sleep 
The relationship between sleep and stress is discussed elsewhere in this thesis and so is 
only summarised here. A widely recognised model of insomnia is Spielman’s [21]stress 
diathesis (3-P) model: it is suggested that there are 3 components to the development 
and maintenance of insomnia: Predisposing factors such as rumination, which make a 
person more vulnerable to insomnia. Precipitating factors, or triggers for insomnia - i.e. 
stressful life events like the death of a loved one or losing your job - will cause an already 
vulnerable person to develop a sleep complaint. Finally perpetuating factors maintain the 
insomnia once the precipitating factor is no longer present. Recent studies suggest that 
poor sleepers show an attentional bias toward sleep cues, and this may perpetuate their 
insomnia. Their attention is drawn to stimuli which represent sleep, this in turn reinforces 
the insomnia, as it means their focuses is constantly taken back to sleep. Espie’s 
attention-intention –effort model explains how attentional bias may maintain 
insomnia[43] One’s attention is drawn to sleep cues, which highlight the intention to fall 
asleep. This then leads to an effort to sleep which causes further arousal and thus the 
cycle continues. All of these processes undermine the autonomy of good sleep. The 3-P 
model emphasises the importance of the relationship between sleep and stress: the 
inextricable links between these two states.  Stress has a detrimental effect on sleep, and 
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a lack of sleep seems to effect perceived stress[199]. The relationship between stress and 
sleep is complex and cyclical.  
Brain Area Location Examples of Attributed 
Functions 
Ascending Reticular Activating 
System (ARAS) 
Composed of several neuronal 
networks connected the 
brainstem to the cortex 
Arousal; Sleep-wake transition; 
pain perception; attention; 
basic ‘ancient’ functions 
Hypothalamus Below the thalamus, above the 
brain stem 
metabolic processes and 
regulation of the autonomic 
nervous system; circadian 
cycles, thirst, hunger, sleep,  
Thalamus Between the cerebral cortex 
and midbrain, near the centre 
of the brain 
Relaying sensory information 
to the cerebral cortex, 
alertness, consciousness and 
sleep 
Insular Cortex Bilateral, in the sullcus 
between the temporal and 
frontal lobes  
consciousness, homeostasis, 
perception, motor control, 
emotion perception: attaching 
salience to incoming cues 
Amygdala Part of the Limbic system. Bi-
lateral in the medial-temporal 
lobes 
Emotion processing, emotional 
memory 
Hippocampus Part of the Limbic System; 
Medial Temporal Lobe 
memory, space 
Anterior Cingulate Frontal part of the cingulate 
cortex, surrounding the corpus 
callosum (which transmits 
information between 
hemispheres) 
autonomic such as heart rate 
and blood pressure; cognitive 
functions such as reward 
anticipation decision making 
an d emotion 
Medial Pre-frontal Cortex Anterior part of the frontal 
lobes 
Executive function; Emotion 
inhibition or inhibition of urges 
which are socially 
unacceptable; Personality 
expression.  
Table 6 1 Brain areas Highlighted in the Insomnia Literature; their location and some 
proposed functions 
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The HPA is central to the stress response. Cortisol, produced by the adrenal glands, is 
responsible for restoring homeostasis after the effects of stress. Many studies have been 
carried out investigating cortisol levels in insomnia. Most of these studies would indicate 
that insomnia is indeed a disorder of 24 hour hyperarousal- not just during the night. 
Insomnia sufferers tend to show higher levels of cortisol throughout the day, and 
specifically in the evening and in the 1st half of the night, and a correlation has been 
shown between urinary free cortisol levels in insomniacs and total wake time[59]. Broadly 
speaking, sleep has a blunting effect on H-P-A activity[200]. The fact that insomnia 
sufferers show higher cortisol levels throughout the 24h cycle shows that it is an illness of 
hyperarousal and disinhibition rather than an illness of sleep loss. This also implies that it 
is affected by- if not is a disorder of- stress. For a comprehensive review of insomnia and 
the stress system see Basta et.al[201]. Whether specific parts of the brain are chronically 
hyperaroused (that is to say chronically hyper-active) is yet to be explored, but such 
findings do suggest, at least, an increased stress response, whilst implying that insomniac 
brains will demonstrate clearly the negative effects of prolonged cortisol exposure (for 
example, reduced hippocampal volume). 
Brain imaging studies of psychological stress and anxiety implicate similar neural 
networks as those thought to be associated with insomnia. Wang et.al.[202]used 
perfusion functional MRI to look at patterns of cerebral blood flow under psychological 
stress and found that areas of the prefrontal cortex, the insula and the cingulate cortex 
were more active in those who showed a higher stress response to the task. The right 
prefrontal cortex showed sustained activation after the task, as did the insula, thus 
implying heightened vigilance to threat cues and negative emotion. Further, the limbic 
system has been shown to be hypersensitive i.e. shows a stronger Blood Oxygenated 
Level Dependent (BOLD) response- simply put, greater oxygen consumption in these brain 
areas-in response to stressful tasks in clinically anxious patients. Specifically in the 
amygdala, insula, anterior cingulate gyrus and medial prefrontal cortex, in various anxiety 
disorders, as well as being highlighted in the insomnia literature. This network of 
structures is important in generating effective responses to incoming stimulus and 
regulating the affective state of the individual. Paulus has written an extensive review on 
neuroimaging studies and anxiety[203]. 
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Given the similar neural substrates underlying stress/ anxiety and insomnia, the increase 
in cortisol cause by all 3 states and the hyperarousal found in both anxiety and insomnia it 
is appropriate to suppose that insomnia could be viewed as an anxiety/ stress disorder, 
and furthermore, anxiety literature may provide a roadmap for sleep researchers, as 
anxiety research is far more developed. Further credence for this outlook is provided by 
the two most prominent models of insomnia. Firstly, Spielmen’s model states a period of 
stress which results in insomnia. Secondly Harvey’s cognitive model of insomnia highlights 
the daytime impairments that insomnia patients experience and how this leads to 
engagement in avoidance behaviours, a pattern that has been well documented in 
anxiety literature.  
Recent research into anxiety has focused on the involvement of the insula, which forms 
part of the paralimbic system and is located deep in the lateral fissure. Due to its location 
in the brain it is difficult to measure- i.e. it is a relatively small structure, folded deep in 
the lateral sullcus between the temporal and frontal lobes-, which is why it may not have 
been investigated extensively to date. Paulus and Stein[204] have recently reviewed the 
involvement of the insula in anxiety disorders. One of the main functions of the insula is 
that of interoception, or embedded cognition: the sense of physiological conditions of the 
entire body. It is where signals representing the internal state of the body are integrated.  
It also has afferent and efferent connections with the amygdala, nucleus accumbens, 
medial cortex and anterior cingulate [204]. This means that the insula is perfectly 
positioned to attach salience to incoming environmental and somatic stimuli and 
integrate this into affective and physical state. The insula is seen to be more active in 
people suffering from anxiety, particularly when faced with the anticipation of a stressful 
event, rather than during the event itself [205] while also being correlated with 
intolerance of uncertainty[206] i.e. the insula is more active in anxiety prone individuals 
when they are faced with ambiguous stimuli. It is known that anxious individuals are 
more likely to interpret stimulus as dangerous. This might suggest that the insula has a 
key role to play in attaching salience to incoming stimulus: possibly a tendency to attach 
threat is a result of hyperactivation. Such a conjecture would fit with the predictive 
function of the insula- that is to say its role in anticipating how the body may feel given a 
certain stimulus, whether it is internal or environmental. The connections to the medial 
prefrontal cortex and anterior cingulate cortex means that the activation of the insula has 
an effect on self referent processing and the degree to which executive control is 
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deployed- it has been demonstrated that the degree of insula activation predicts safety 
behaviours- such as avoidance- during risky decision making tasks[207]. Further to this 
connections to the amygdala and nucleus accumbens mean that it may affect emotion 
processing and motivation. The interaction between the insula and the amygdala may be 
important in understanding both sleep and stress/anxiety responses: The insula 
interpreting incoming stimulus, and how this may affect homeostasis and the amygdala 
producing an emotional response to this. A hyperarousal of such a system may result in a 
hyperawareness of environmental and internal stimulus, and an increased emotional 
response. Through this system ambiguous stimuli may be more likely to be interpreted as 
negative or threatening when coupled with negative beliefs and faulty cognitions.  The 
exact role of the insula in anxiety is only beginning to be understood, but it seems to be 
centrally involved in anxiety disorders and normal emotion and motivational processing.  
6.1.3 Insula and Vulnerability to Insomnia 
The insula has been implicated in the work supporting the hyperarousal theory of 
insomnia [60]. The anxiety literature provides a broad understanding of the role the 
insula may have to play in stress perception, and in the activation of a stress-response. 
Stein e.tal.[208] have shown that insula activation is greater in healthy controls prone to 
anxiety, versus those who are not prone (as measured by the STAI) in response 
categorisation of emotional faces. Further, this relates to neuroticism. 
Based on what we know about the functions and connections of the insula as delineated 
above, it is hypothesised that: 
I. Greater insula activation may characterise those who are vulnerable to stress-
related sleep disruption, in response to stress-anticipation. It is expected that 
this will be mediated by conscientiousness, considering the data presented 
previously. 
II. The vulnerable group will show a psychological profile consistent with our 
previous work: high in negative affect, worry and rumination.  
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6.2  Approach and Methods 
6.2.1 Screening and Recruitment 
Participants were recruited and screened as per chapter 3. Additional exclusion criteria 
for MRI safety can be found in appendix XX. In brief, anyone with metal implanted in their 
body were excluded. Those who passed initial screenings were invited to the School of 
Psychology to collect the information sheet (appendix XXIV), sign the consent form 
(appendix XXV) and collect a 2 week sleep diary to further ensure that only good sleepers 
were selected. 
6.2.2 Procedures and Methods 
Participants who were screened successfully with the sleep diary and actiwatch were 
invited to the scanning facility at the Centre for Cognitive Neuroimaging at the University 
of Glasgow. Prior to this they had completed a series of questionnaires assessing 
personality, coping, stress, anxiety, depression, rumination and worry (see appendix 
III).Once checklists had been completed (see appendix XXIII) to ensure the participant was 
MRI safe, the study task was explained. Once any queries were dealt with the participant 
was asked to change into MRI clothes and placed in the scanner. The participant 
completed a practice session; 2 attention bias sessions (not included in this thesis); a 
stress session; a resting state scan (again not included in this thesis) and a structural scan. 
Participants were given a small remuneration for their time.   
6.2.3 fMRI Paradigm 
The paradigm employed is designed to assess hyperactivity of the insula in response to 
anticipated stress. A modified emotional stroop paradigm was used. The task involves 
identifying the ink colour that a word is presented in. Participants were asked to press the 
button corresponding to the colour of the ink. Accuracy and speed of response is affected 
by the nature of the word- i.e. anxious individual will have longer reaction times and 
lower accuracy to anxiety related words, and insomnia patients show the same responses 
to sleep related words, an effect known as attentional bias. The mechanisms of this 
however, are unclear with some authors suggesting it is a more a measure of delayed 
disengagement rather than attention bias (see Phaf et.al.[209] for a meta-analysis of the 
stroop). This aspect of the task is not important given the questions being answered here, 
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and served mainly to lull the participant into a false sense of security. The stress paradigm 
was run next after 2 attention bias scans. During this paradigm participants completed 
the same task as the emotional stroop condition; however words were not blocked as 
they were in the attention bias task (i.e. 16 neutral words then 16 sleep words)  but 
rather collapsed into one list and randomised (a list of words used can be seen in 
appendix XXVI). The task would start as the previous attention bias tasks had but every so 
often a 500hz siren would sound indicating that the task was about to speed up. This 
would happen randomly, after at least 5 words of the slowed condition had been shown. 
At least 5 words were presented to allow brain activation patterns to ‘normalise’ back to 
baseline levels. There was a 6 second pause between the siren sounding and the speeded 
condition starting. This was built in to account for the delay between stimulus and BOLD 
response. During the speeded condition words were presented for 560 ms and the 
fixation cross for 100ms, as opposed to 1000ms and 300ms in the attention bias tasks. 
Participants were reminded prior to the task commencing of the importance of accuracy 
of response, in order to make the task more stressful. The siren served as an anticipatory 
cue. Participants heard the siren 30 times in total. Analysis of this task will focus on insula 
activation in response to the siren. After this scan, high resolution T1 weighted structural 
images were taken in 192 axial slices and isotropic voxels (1mm3; field of view: 
256x256mm2, TR=1900MS, TE=2.92 ms, time to inversion= 900ms, FA=9o). The anatomical 
scan is used in the pre-processing of fMRI data, in order to align functional images 
correctly  
Functional images covering the whole brain (slices-32, field of view= 210x210mm, voxel 
size= 3x3x3mm) were gathered on a 3T Tim Trio Scanner (Siemens) with a 12 channel 
head coil. Echoplanner imaging sequence (interleaved, TR=2’s, TE=30ms, Flip angle= 80o) 
was used. There were 555 EPI volumes acquired throughout the stress paradigm (i.e. 555 
images of the whole brain). 
6.2.4 Participants: 
Thirty- five participants agreed to take part in the study. Nine failed to show up for scan 
times, one was excluded after it was discovered that dental work rendered her ineligible 
for participation and another was excluded for showing poor sleep on the sleep diaries 
(SE of less than 80%) (n=24). 2 groups were created post-hoc based on the scores to the 
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FIRST questionnaire (see chapter 3 for an explanation of the questionnaire). The median 
value for scores on this questionnaire was 18, a similar number to our previous studies. 
Anyone scoring 18 or below was classed as resilient. The gender split is heavily biased 
toward females (15%= male). Table one shows age, gender and sleep-diary variables for 
each group. Some participants failed to return sleep diary information. In such cases the 
ISI and PSQI were relied upon to assess sleep status. Some participants failed to return 
sleep diaries so sleep diary data is available for 9 resilient participants and 12 vulnerable 
participants.  
 
6.3 Analyses 
6.3.1 Psychological and Sleep Variables 
In order to compare the psychological profiles of the vulnerable and resilient group, 
psychometric scales will be analysed as per previous chapters. Normality was first 
inspected (see appendix XXVII for values). The depression sub-scale of the DASS (DASSD) 
was found to be non-normally distributed and so was log transformed. This normalised 
the distribution All sleep variables were normally distributed. One-way ANOVA was 
conducted on Sleep Onset Latency (SOL), Wake After Sleep Onset (WASO); Total Sleep 
Time (TST) and Sleep Efficiency (SE), to assess if subject sleep differs between the groups 
and therefore whether this should be a consideration in future analysis.  
 Age (SD) Gender (no male(% 
male)) 
SOL WASO TST SE 
Resilient 22.75 
(3.62) 
3 (25) 14.54 
(7.41) 
7.37 
(5.75) 
464.68 
(30.60) 
90.66 
(5.00) 
Vulnerable 23.5 
(4.44) 
1 (7.7) 17.00 
(11.38) 
7.17 
(5.48) 
454.10 
(41.07) 
88.00 
(4.31) 
Table 6 2 Age, Gender and Sleep 
NB: SOL=Sleep Onset Latency (time to fall asleep); WASO=Wake After Sleep Onset (time awake 
during the night); TST=Total Sleep Time; SE=Sleep Efficiency (percent of time in bed spent  
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Whilst the vulnerable group show, on average, worse sleep than the resilient group (as 
can be seen in table 6 2), none of these differences are significant (SOL: F(1,19)=.317, 
p=.580; WASO: F(1,19)=.939,p=.939; TST:F(1,19)=.525;SE:F=(1,19)=1.724, p=.205), and the 
absolute differences are minimal. It can be assumed then that differences found in other 
variables are not due to current, subjective, sleep status and that the entire sample 
represents a good-sleeping student population.  
Bi-variate correlation was carried out across the whole sample in order to investigate how 
the FIRST relates the other psychological variables across the whole sample ( full 
correlation matrix can be found in Appendix XXVIII; scatterplots for significant 
correlations for the whole sample can be found in appendix XXIX ). It was found that the 
FIRST correlates significantly with  the PSS (r(23)=.565, p=.003); DASSS (r(23)=.527, 
P=.007); NEOC(r(23)=-.483, p=.024);NEOE (r(23)=-.518, p=.008); NEON (r(23)=.669, 
p<0.001); RUMB (r(23)=.590, p=.026); RUMD (r(23)=.590, p=.002). The direction of these 
relationships supports what has previously been stated in this thesis regarding the FIRST: 
that it is positively associated with measures of negative affect, stress and worry, but 
negatively associated with protective factors such as conscientiousness and extroversion  
Differences in psychological variables of interest (see table 6 3 for averages and standard 
deviation; figure 6 1) were calculated using one-way ANOVA. Effect sizes for effects of 
interest are given as Cohen’s d. PSQI did not differ significantly between groups (F (1, 23) 
=.070, p=.793), nor did ISI (F (1, 23) =.138, p=.714).Neither did age (F (91, 23) =.395, 
p=.536).These factors would have otherwise been considered as covariates. In this 
instance the only factor which will be entered as a covariate, outside of the psychological 
variables of interest, is gender.  
Figure 6 1 Plot of Psychological 
Variables. 
 Computed using z-scores. 
*p=<0.05. PSS= Perceived Stress Sale; 
DASSD=Depression; DASSA=Anxiety; 
DASS=Stress; NEO=openness; 
NEOC=Conscientiousness; 
NEOE=Extraversion; 
NEOA=agreeableness; 
NEON=Neuroticism; RUMD=Depressive 
thinking; RUMB=Brooding; 
RUMR=reflective thinking; 
COPEP=Problem focused coping; COPE= 
Emotion focused coping 
PSQI
ISI
PSS
DASSD
DASSA
DASSS
NEOO
NEOC*
NEOENEOA
NEON*
RUM
RUMD
RUMR
COPEP*
COPE
WORRY
Vulnerable
Resilient
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Table 6 3 Means and Standard deviations for Psychological Variables.   
 *p<0.05. See abbreviation list and chapter 3 for full explanation of abbreviation 
 
One-way ANOVA revealed that the vulnerable group were significantly higher on 
measures of neuroticism (F (1, 23) =7.02, p=.014; d=-1.06) and problem focused coping (F 
(1, 23) =6.108, p=.021; d=-.99), and significantly lower on conscientiousness (F (1, 23) 
=6.91, p=.015; d=1.06). There was also a trend for the vulnerable group to score higher on 
the DASSS (F (1, 23) =3.89, p=.061; d=-0.78) and on depressive thinking (F (1, 23) =3.87, 
p=.062; d=-.80). This goes someway to supporting previous work which has shown that 
the vulnerable group are prone to neuroticism, and this data would suggest also tend 
toward rumination and greater level of state-stress.  Contrary to hypothesis, they show a 
greater level of problem focused coping, however this has also been shown in previous 
studies presented in this thesis.  
6.3.2 Image Processing and Analyses 
Data gathered from the scanner was analysed using SPM8 (Wellcome department of 
Imaging Neuroscience, London, UK). Region Of Interest (ROI) analysis was carried out 
using MARSBAR[210]. 
 Vulnerable (mean (SD)) Resilient (mean (SD)) 
PSQI 4.25 (1.25) 4.08 (1.85) 
ISI 3.42(2.68) 3.00 (2.92) 
FIRST 22.00 (2.70) 15.08 (1.67) 
PSS 17.67(6.96) 13.23 (7.22) 
DAS_D 10.17(11.61) 3.23 (3.22) 
DAS_A 4.67(4.70) 4.00 (4.90) 
DAS_S 12.67(8.19) 7.08 (5.87) 
NEO_O 50.58(6.17) 51.08 (6.51) 
NEO_C* 48.5 (6.14) 55.85 (7.67) 
NEO_E 44.5 (7.43) 51.77 (6.77) 
NEO_A 54.5 (7.45) 58.69 (4.64) 
NEO_N* 41.83(10.31) 31.62 (8.97) 
RUM_B 24.72 (8.36) 20.15 (8.19) 
RUM_D 10.82 (3.28) 8.38 (2.79) 
RUM_R 10.91 (5.15 8.38 (3.78) 
EFC 13.67(3.03) 12.92 (3.82) 
PFC* 12.67(2.39) 10.15 (2.67) 
WORRY 49.67 (13.08) 46.31 (13.17) 
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Before fMRI data can be analysed, the images need to be manipulated to account for 
individual differences in brain shape, size and position of landmarks, and also for 
movement. The pre-processing of images involved: 
1. AC-PC plane correction. Structural images were spatially reoriented to 
position the AC-PC in the horizontal plane. Functional images were then re-
orientated to this.  
2. Images were then realigned to the first functional volume of the run.This 
step accounts for movements within subjects, or variances in head 
position. This stage generates a text file with movement parameters - roll, 
pitch and yaw. These parameters are entered into the final analysis as 
regressors of non interest to account for movement in the statistical 
models. 
3. Images are next co-registered to the mean volume to account for changes 
in head position between scans  
4. Structural images are then segmented. Output from this step is used to 
normalise images, so that they all sit on the same coordinate system. This 
step creates a probability map from the template: for each voxel, the 
probability of it being white matter, grey matter or cerebral spinal fluid 
(CSF) is calculated. Functional images are then segmented into the 3 
different kinds of matter mentioned above.  
5. Normalisation is the next step. The point of this step is to ensure that every 
participant’s brain sits on roughly the same co-ordinate system. The 
parameter files from the segmentation step are used to ensure that brain 
areas map onto a standard space. They were mapped onto Montreal 
Neurological Institute (MNI) space. 
6.  Images are then smoothed. This reduces the effect of inter-individual 
variability in brain anatomy and improves statistical power in the GLM 
analysis. Images were smoothed with a Gaussian function (4x4x4: it has 
been suggested that a smaller smoothing parameter is used when 
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investigating smaller areas of the brain which is why a filter of 4x4x4 is 
employed). 
6.3.3 Whole Brain Analysis 
The results presented here are uncorrected for multiple comparisons (statistical tests 
performed on 10000 voxels). This needs to be borne in mind when considering the results 
presented. The whole brain analysis data did not hold-up when correction for multiple 
comparisons were applied. However, given the piloting nature of this work it is 
reasonable to consider the uncorrected data as a viable first step, which may provide 
insight and direction for future research.  
Analysis was initially carried out on the entire group, in order to understand the effects of 
the paradigm in general. The analysis therefore considers data taken at the point of the 
siren, and for the 2 seconds afterwards (the minimum duration of the speeded task is 2 
seconds), compared to during the normal, non-speeded task. MNI co-ordinates are 
reported.  
Clusters of more than 20 voxels and p<0.001 are reported (see table 6 4 and figure 6 2; 
the full report of cluster activations are brain areas contained within each cluster can be 
seen in appendix XXX)). Amongst the regions that showed more activity during the stress 
(siren) trials as compared to the non-stress trials are areas related to emotion perception 
and arousal like the bilateral putamen and the thalamus. Lowering the extent threshold 
to 10 voxels also revealed activation in the hippocampus.  
 
Figure 6 2 Whole 
brain activation. 
 Difference 
between point of 
siren and 
baseline task for 
the whole 
sample. Clusters 
significant at 
uncorrected 
p<0.001; k≥ 20 
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Region K Maximum activation structure X Y Z 
Inferior Frontal 
Gyrus 
Siren> 
baseline  
4237 
Right Insula 40 24 2 
Left Frontal Lobe 
and  Basal Ganglia 
Siren> 
baseline  
41 
Thalamus -20 30 -2 
Left Frontal Lobe Siren> 
baseline 
41 
Left Insula -36 0 4 
Left Frontal Lobe Siren> 
baseline 
5942 
Postcentral Gyrus -46 12 48 
Left Cerebellum Siren> 
baseline 
58 
Culmen 0 -48 4 
Right Frontal Lobe Siren> 
baseline 
5924 
Postcentral 46 -12 48 
Parietal Lobe Siren> 
baseline 
95 
Superior parietal Lobule 
(Broadmann area 7) 
95 -60 48 
Table 6 4 Clusters of Activation with peak area of activation reported.  
All significant at uncorrected p<0.001.K= number of voxels in cluster; x, y, and z are MNI co-
ordinates for area of maximum activation within the cluster 
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6.3.3.1 ROI analysis: The Insula. 
ROI analysis was carried out for our a-priori region of interest: the insula. Analysis was 
carried out using MARSBAR. This is a toolbox which operates via MATLAB. It is designed 
specifically for ROI analysis. First, regions of interest were defined using MNI co-ordinates 
to select specific regions (see appendix XXXI for a visual representation of what the ROI’s 
looked like, and co-ordinates used.). Two regions of interested were created- one for the 
left and right insula. A between sample t-test was then run in MARSBAR comparing only 
these selected regions of the brain. The 2 sample t-test compares activation in voxels 
within the selected region between groups. 
It was found that both the right and left insula were significantly more activated in 
response to the siren relative to baseline (see figure 6 3): Left insula: t (24) =3.54, 
p=0.0018: Right Insula: t (24) =2.08, p=0.048 (both Bonferonni corrected for multiple 
comparisons). This supports the use of the paradigm, suggesting that in general 
population is sufficient to induce increases in insula activity, and conforms the findings of 
the whole-brain analysis.  
 
Figure 6 3 Bilateral 
insula activation in 
response to the siren.  
Two ROI’s, one on 
each hemisphere. 
Centre co-ordinate for 
each region: 45, 5,-4; -
47, 5,-1. For left insula 
corrected p= 0.0018; 
for right insula 
corrected p=0.048, 
siren>baseline 
 
 
 
6.4 Between Group Analysis 
In order to test if the differences between conditions differed between groups a between 
group analysis was carried out. A t-contrast was carried out looking at the change in 
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activation between conditions between groups. Table 6 5 outlines clusters of significant 
activation, and figure 6 4 shows whole brain activation, with uncorrected p>0.001. 5 
clusters were identified with a voxel size greater than 20. The full list can be found in 
appendix XXXII. The maximum difference in activation is in the left pre- central gyrus (PG), 
and this remained after bonferonni corrections (t (12) =2.63, p=0.007; [-28, -36, 52]). 
Further, the vulnerable group also showed less activation bilaterally in the inferior 
Parietal Lobule (IPL), which remained after bonferonni corrections: right (t (24) =3, p 
=0.007; [52, -46, 58; -44.62) and left IPL (t (24) =2.63, p =0.01. [52, -46, 58]) compared to 
the resilient group. 
  
Figure 6 4. Bilateral hypoactivation in 
the inferior parietal lobule and 
increased activation in the left 
Postcentral gyrus  
Vulnerable group >resilient group in 
response to the siren. Global Maxima 
-28, -36, 52, uncorrected p<0.001. 
IPL=blue; PG=red 
 
 
 
 
 
Table 6 5  Clusters of Activation for siren>baseline for the vulnerable group compared to the 
resilient group.  
All significant at uncorrected p<0.001.K= number of voxels in cluster; x, y, and z are MNI co-
ordinates for area of maximum activation within the cluster. 
Region K Maximum activation structure X Y Z 
Parietal Lobe Siren> baseline, between groups 
22 
Right inferior parietal lobule 52 -46 48 
Parietal Lobe Siren> baseline, between groups 
24 
Post-central Gyrus -28 -36 52 
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6.4.1 ROI Analysis Between Groups 
In order to test our hypothesis that the insula would be more active in anticipation to 
stress, ROI analysis was carried out investigating insula activation in response to the siren, 
between groups. Bilaterally, the insula was seen to be more active in the vulnerable 
group, but this was not significant (figure 6 5) for the Left (t (24) =0.21, p (corrected) =0.8) 
or the right insula (t (24) =-0.12, p (corrected) =0.70) between groups.  
To follow up the whole brain between group analyses results, beta values were also 
extracted for the bilateral IPL and the PG in order to assess relationships between 
activation in this area and psychological variables. The Beta values extracted were the 
average beta values for each participant at during the 2 conditions and can be seen in 
table 6 6. 
6.5  Relationship Between Brain Activation and 
Psychological Variables 
Given the results presented in the previous section, beta values for the left and right 
inferior parietal lobule were extracted (table 6 6). It can be seen that the vulnerable 
group had lower values on average in the right and left inferior parietal lobule, and as 
stated above this is significant. Paired t-tests show that in the resilient group the left IPL is 
significantly more activated than the right IPL(t( 11)=2.90, p=0.015). The left and right IPL 
were not differentially activated in the vulnerable group (t (11) = 1.11, p=0.29). For the 
overall sample activation of the left IPL was negatively associated with factors related to 
negative affect: FIRST (r (22) =0.61, p=0.002); PSS (r (22) =-0.43, p=0.04) and NEON (r (22) 
= -0.43, p=0.04) (see appendix XXXIV for full matrix and appendix; scatterplots can be 
found in appendix XXXVI). Within the vulnerable group activation in the left IPL correlated 
significantly and negatively with openness (considered a marker of generally good 
psychological health) (r(22)=0.61, p=0.035 (see appendix XXXV for full matrix and 
appendix XXXVII).Within the resilient group activation of the left IPL correlated negatively 
with FIRST (r(10)=-0.644, p=0.024); PSS (r(10)=-0.68, P=0.015); DASSS (r(10)=-0.061, 
P=0.034); NEON (r(10)=0.62, P=0.032); WASO (r(10)=-0.72, p=0.043) and positively with 
PFC (r=0.079,p=0.002) (appendix XXXVIII displays scatter-plots for these relationships). 
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For the overall sample activation of the left IPL was negatively associated with factors 
related to negative affect: FIRST (r (22) =0.61, p=0.002); PSS (r (22) =-0.43, p=0.04) and 
NEON (r (22) = -0.43, p=0.04).  
 
 
Figure 6 5 Graph Showing Beta values between groups of Left IPL, Right IPL and Post-
central Gyrus. Bar represent 1 standard error 
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AverageBeta Values for Each Group 
during anticipatory period
Resilient
Vulnerable
 Vulnerable Resilient 
 Mean (SD) Mean (SD) 
Left Parietal Lobule -0.38 (1.20) 0.61 (0.65) 
Right Parietal Lobule -0.71 (0.63) 
0.03 (0.55) 
Left Postcentral Gyrus 0.75 (0.63) 
0.23 (0.32) 
Table 6 6 Average Beta values and standard deviations for left and right inferior parietal 
lobule and left postcentral gyrus 
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Multiple regression analysis was carried out for the left IPL (given that the right IPL 
showed no correlations with any of the psychological data). This was to test the extent to 
which activation in the highlighted areas is mediated by psychological variables. Based on 
our initial hypothesis and findings from previous work NEON, NEOC, PSS, RUMB, RUMD, 
COPEE and FIRST score were entered into the model in a stepwise fashion. A significant 
model was found (adjusted R squared = 0.35, f (1, 21) =12.77, p=0.002) with FIRST score 
being the only significant predictor (β=-0.62, p=0.002).   
6.6 Discussion 
The aim of this study was to investigate whether those defined as vulnerable to insomnia 
demonstrate increased activation in the insula in response to stress anticipation. We also 
replicated results from our previous studies: it was found that the vulnerable population 
showed higher levels of neuroticism, perceived stress and rumination.  
In terms of the brain imaging data, the paradigm used was found to induce significant 
insula activation across the entire sample. On average, the vulnerable group showed 
higher insula activation in response to the siren compared to the vulnerable group. This 
was not significant, however. This suggests that the paradigm is robust and that the 
vulnerable population do not show differences in insula activation in anticipation to 
stress. Given the small sample size, the study may have been under-powered to show 
differences in insula activation between groups. Post-hoc power calculations show the 
power to be 0.053 (β-1). Therefore, the study is underpowered to show these effects at a 
statistically significant level, as (β-1) = 0.8 is considered the cut off for detecting 
differences at p<0.05. Power calculations were carried out using G-power, based on the 
effect size of the difference in insula activation between groups. 
 Increasing the sample, or the number of trials or employing more stringent cut offs in 
defining the groups may help to reduce problems with power in future studies. 
Compounding the problem of power is the nature of the sample. The work implicating the 
insula is conducted, largely, on clinical samples. The sample here is healthy. Perhaps the 
insula is a good marker in clinical disorder, but not as a predisposing factor. If insula 
activation does have a role to play in making an individual vulnerable then larger samples 
are clearly needed to detect this.  
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Interestingly, the inferior parietal lobule did seem to be differentially activated between 
groups. The inferior parietal lobule has been shown previously to be hypoactive in 
depressed, drug naïve adolescents[211], to have less density in individuals with social 
anxiety disorder[212] and to be hypoactive in PTSD patients in response to provocative, 
trauma related stimulus [213, 214]. The authors suggest that alterations of the IPL affect 
attention to conditioned fear response when under stress. Further to this, the inferior 
parietal lobule has been shown to play a role conditioned fear responses [215]. Perhaps 
the vulnerable population may demonstrate a faulty encoding process, whereby the siren 
becomes more readily associated with negative events- if we think about PTSD, the same 
processes may be happening but on a much more severe scale.  
IPL activation may be protective against stress vulnerability. Mindfulness-based stress 
therapy has been shown to increase activation on the inferior parietal lobule, and 
increase connectivity between this area and fronto-limbic structures. This implies that 
increased activation of the IPL is protective against stress vulnerability [216]. It has also 
been shown that successful treatment of depression results in increased IPL activation at 
follow-up[217] 
The parietal lobe is generally associated with integrating sensory information from 
different modalities, visiospatial processing and the direction of attention and object 
manipulation. Wagner et.al.[218] have put forward a theory of the parietal lobes role in 
memory retrieval, by which stimulus- sensory input- become attached to a history. This is 
known as the mnemonic accumulator hypothesis. In order to be acted upon, or for a 
decision to be made regarding sensory input, the input has to be interpreted. This is 
achieved via the integration of the accumulated history of that input. Essentially, the 
parietal lobe not only integrates sensory information but also the history of that sensory 
information i.e. its learned associations. Such a theory would explain the findings well 
suggesting that hypoactivation in this area represents a faulty retrieval of stimulus history 
i.e. interpreting it more negatively.  
 Given that the vulnerable group are demonstrably and consistently higher in neuroticism, 
this may make sense: a neurotic individual is more prone to negative affect and more 
likely to view ambiguous events as negative. This could be because their attentional 
system is more prone towards focusing on negativity. Or it could be that a more easily 
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learned negative association means that neutral events become more readily attached to 
negative feelings, leading to a neurotic type individual. Probably both explanations work 
in tandem. This makes someone vulnerable to insomnia by increasing the amount of 
negative emotions that they perceive, coupled with a likelihood for rumination (which, in 
this study has been associated with activation of the IPL) leading to disrupted sleep. 
Bringing this back to thinking about insomnia syndrome, someone who has been a good 
sleeper, and in facing life stress becomes a poor sleeper, may be more vulnerable to the 
threat of not sleeping well and this threat becomes more easily conditioned. Theoretically 
this relates well to the A-I-E and cognitive model [43, 219] delineated in chapter 2.This is 
of course speculative based on the finding that the resilient group show a negative 
correlation between neuroticism and IPL activation. To really test these theories this 
would need to be replicated in a larger sample, to understand how neuroticism interacts 
with IPL activation in the vulnerable population.  
In terms of hyperactivation, the vulnerable group showed significantly increased 
activation in the Postcentral gyrus (PG). The PG is traditionally associated with the 
homunculus: the representation in the brain of the body. Increased activation in the 
motor cortex may represent compensation: having to work harder to fulfil the task. The 
idea of compensatory recruitment has been suggested to operate in sleep 
deprivation.[220]. Alternatively to this, activation of the PG has been studied in various 
disorders and is posited to affect working memory negatively in depression 
[221],schizophrenia[222] and obsessive compulsive disorder[223]. Further, positive 
outcome in treatment for depression has been associated with increased PG activity[224]. 
Increased activation in the PG may then represent an increased effort to fulfil the task 
during the speeded condition, not just in terms of coordinating hand movement, but also 
in mobilising working memory, as participants need to remember which buttons 
correspond to which colour. Speculatively, these results support a theory in which these 2 
distinct areas interact to produce incongruent emotional responses to stimuli.  
Considering that PG activation was predicted by neuroticism score, this implies that 
activation in this area is the result of negative affect and this is somewhat supported by 
the literature on depression and recovery from depression. Activation in this area seems 
more related to neuroticism than vulnerability to sleep disruption, reinforcing the idea 
that neuroticism- as measured by the NEO-ffi and considered to be an enduring 
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propensity toward negative affect- may be a unique risk factor to vulnerability. Given that 
the vulnerable population tend to be high in neuroticism, such findings could be easily 
masked.  
The predictive value of FIRST score in IPL activation shows that as FIRST score increases, 
IPL activation is likely to decrease. This suggests that IPL hypoactivation is a marker for 
vulnerability to insomnia, whereas hyperactivation of the PG is a marker of neuroticism  
Overall these results support the idea that the vulnerable population are characterised by 
neuroticism, worry and an increase in perceived stress. In the brain, this seem to 
corresponds to a differential recruitment of areas involved in attentional deployment and 
the learning of negative associations similar to what has been reported in post-traumatic 
stress disorder, for example. The pathway into insomnia may therefore not be stress-
reactivity per se but rather a proclivity for negative associations. This then leads to an 
overall increase in perceived stress, not because areas of the brain which are primary to 
stress perception (i.e. the insula) are dysfunctional but because ambiguous events 
become more readily attached to negativity (possibly due to differential IPL activity), and 
then encoded more strongly in working memory (due to over activation of the PG). If this 
is in fact the case then the lack of support for the insula hypothesis is not surprising. 
Further to this, increased activation in the left IPL was negatively associated with 
psychological variables relating to negative affect and stress, suggesting that 
hypoactivation may be a risk factor, whilst increase activation represents a protective 
mechanism, or resiliency.   
Whilst these results were unexpected, they are none the less interesting, and may 
provide a novel area of further investigation for the field. It needs to be highlighted 
though that the sample here is small. However, given that differences can be found in 
people who report and are assessed as being healthy, good-sleepers provides valid 
support for the theory of a predisposed phenotype, and tentatively suggests the neural 
mechanisms which may underpin this i.e. those involved in attention and emotional 
learning. This work also provides further support for neuroticism as a key risk factor to 
the development of insomnia.
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Chapter 7: Psychological Variables Across the 3 
Samples 
  
7.1 Introduction 
Given that the same psychometric data was gathered across all 3 studies, this allows for 
comparisons to be made between the 3 samples. This will create a larger dataset and 
provide support and clarification for the results already obtained regarding psychological 
characteristics of the vulnerable group. 
7.1.1 Hypothesis 
The vulnerable group will score higher on levels of neuroticism, perceived stress, 
rumination, worry and emotion focused coping and lower on openness 
7.2 Methods and Participants 
Data sets were collapsed into one file. Those who were excluded from the analysis of 
psychological variables in the individual studies were removed from the respective data 
sets before the files were collapsed. This exclusion was based on ISI and PSQI score and 
sleep diary, where available (n= 84). Table 7 1 provides information on age, gender and 
the mean and standard deviation for psychometric scale scores.  
7.2.1 Analysis and Results 
Bi-variate correlation was conducted. This demonstrated that across the whole sample 
FIRST score correlated positively with PSS (r(82)=0.41, P<0.001), DASSD (r (82) = 0.32, 
p=0.002), DASSA (r (82) = 0.28, p=0.010), DASSS (r (82) = 0.47, p<0.001), NEON (r (82) = 
0.57, p<0.001), RUMB (r (82) = 0.29, p=0.007), RUMD (r (82) = 0.28, p=0.011), RUMR (r 
(82) = 0.36, p<0.001), COPEP (r (82) = 0.36, p<0.001), COPEE (r (82) = 0.21, p=0.013) and 
WORRY (r (82) = 0.42, p<0.001). It correlated negatively with NEOC (r (82) =-0.26, 
p=0.017) and NEOE (r (82) =- 0.41, p=0.007) (these relationships are displayed as scatter-
plots in appendix XXIX). 
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ANOVA was carried out to assess between group differences. It was found that the 
vulnerable group had significantly higher scores on PSS (F (1, 82) = 5.76, p= 0.019; d= -
0.53), DASSD (F (1, 82) = 10.24, p= 0.002; d= -0.69), DASSS (F (1, 82) = 16.78, p< 0.001; d= -
0.89), NEON (F (1, 82) = 23.32, p< 0.001; d= -1.05), RUMD (F (1, 82) = 5.01, p=0.03; d= 
0.50), RUMR (F (1, 82) = 7.86, p< 0.006; d= -0.61), COPEP (F (1, 82) = 18.36, p< 0.001; d= -
0.94), COPEE (F (1, 82) = 4.90, p< 0.003; d= -0.48)and WORRY (F (1, 82) = 6.11, p=0.015; d= 
-0.54) and significantly lower on NEOC (F (1, 82) = 12.37, p= 0.001; d= 0.77) and NEOE (F 
(1, 82) = 10.91, p= 0.001; d= 0.72) (depicted in figure 7 1)  
Figure 7 1 Mean score on the Psychological variables across 3 samples between groups.  
*p<0.05. PSQI=Pittsburgh Sleep Quality Index, ISI=Insomnia Severity Index; PSS=Perceived 
stress Scale; DASSD=Depression; DASSA=anxiety; DASSS=stress; NEOO=openness, 
NEOC=conscientiousness; NEOE=extroversion; NEOA=agreeableness; NEON= 
Neuroticism; RUMB=brooding; RUMD= depressive thinking; RUMR=reflection; 
COPEP=problem focused coping; COPEE=Emotion focused coping. Computed using z-
score*100 
 
7.3 Discussion 
This short chapter provides valuable support for the results found in the previous 
experimental chapters. Collapsing data-sets together to create a larger sample and so 
more robust results, further confirms that the vulnerable group are higher on 
neuroticism, perceived stress, state stress, rumination and worry compared to the 
resilient group. They also score significantly higher on both the problem and emotion 
focused subscale of the brief-COPE. 
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 Resilient  (SD) Vulnerable  (SD) 
Gender (% female) 61  75  
Age 22.07 (3.01) 22.83 (3.80) 
PSQI 3.86  (1.70) 4.38 (1.33) 
ISI 3.02 (2.74) 3.80 (2.71) 
PSS 12.93 (7.01) 16.50 (6.57) 
DASSD 3.55 (3.71) 8.50 (9.51) 
DASSA 3.73 (4.33) 4.65 (4.04) 
DASSS 7.09 (5.33) 12.80 (7.34) 
NEOO 50.68 (6.10) 51.55 (6.15) 
NEOC 54.11 (7.02) 48.75 (6.94) 
NEOE 51.68 (7.41) 46.53 (6.85) 
NEOA 56.57 (7.23) 53.70 (7.42) 
NEON 30.70 (8.30) 40.60 (10.44) 
RUMB 15.34 (8.77) 18.61 (9.84) 
RUMD 12.73 (6.66) 16.53 (8.69) 
RUMR 8.66 (3.43) 11.13 (4.54) 
COPEP 10.09 (2.74) 12.58 (2.56) 
COPEE 12.14 (4.07) 13.92 (3.25) 
WORRY 43.05 (11.67) 49.43 (11.96) 
FIRST 15.00 (2.13) 22.18 (2.43) 
Table 7 1 Means and Standard deviations for psychological and descriptive variables across 
all 3 samples, between groups 
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This may reflect an inability of this scale to differentiate between these 2 coping 
strategies or it may reflect a general heightened awareness of coping within the 
vulnerable population: possibly they are characterised by an inconsistent coping style, or 
a larger arsenal of coping mechanisms.  
The resilient group are shown to be significantly higher on conscientiousness. As 
discussed previously, conscientiousness is generally considered a protective factor. 
However, coupled with high neuroticism is can become a risk factors for sleep disruption 
[118]. It is not surprising therefore that the vulnerable group are lower on 
conscientiousness. The interaction between these 2 variables is interesting. The 
vulnerable population is seen also to be lower on extraversion. Extraversion can be 
considered as a trait which infers an out-going nature: getting pleasure from the company 
of others. It has been suggested that those high on extraversion show less cortical arousal 
to stimuli than those low on extraversion, and that their reactivity to sensory information 
is lower[225]. Although no hypotheses were made regarding extraversion, the finding 
that the vulnerable population are lower on this trait is not surprising and may merit 
further investigation, in terms of understanding the psychobiological profile of the 
vulnerable phenotype.  
Overall these results support the conclusions drawn so far: that the vulnerable group are 
higher on negative affect, rumination and stress, relative to the resilient groups. Further 
to this, extroversion becomes significant, showing that vulnerable group are lower on this 
trait. The same is true of conscientiousness. The effect size values, reported as Cohen’s d., 
indicate that the effects are strong for most of the variables (ranging from 0.5 to 1.05). 
These effect sizes are larger than what has been reported in previous chapters. The 
comparison across studies represents an important strength of the work contained within 
this thesis.  
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Chapter 8: Overall Discussion: Who is Predisposed? 
In this section the results from the 3 experimental chapters will be pulled together to 
outline a cohesive theory of vulnerability to insomnia (summarised in table 8 1). Results 
from the psychological variables will be reviewed first, and then the psychobiological data 
and then they will be pulled together. It is important to bear in mind however, that whilst 
constructs like neuroticism and conscientiousness will initially be discussed within 
psychology, that these are psychobiological constructs, theorised to have characteristic 
effects on the stress system.  
8.1 Psychology 
 Psychologically, the defining feature of this population seems to be a neurotic 
disposition, evidenced across all 3 studies. This is defined as tendency toward negative 
affect. That is to say an enduring tendency to experience negative, emotional stress. That 
being said, controlling for neuroticism does not eradicate the statistical significance found 
in the physiological measures, demonstrating that neuroticism alone is not enough to 
account for vulnerability. 
In both the Trier and the HR/CVT study the vulnerable group were significantly higher in 
aspects of rumination, as well as neuroticism and this showed strong effects. In the fMRI 
study rumination was strongly correlated with right inferior parietal lobule activation in 
anticipation to stress. It makes sense therefore that this would infer vulnerability to 
insomnia. If neuroticism is defined as an enduring propensity toward experiencing 
negative emotion, this increases the likelihood of experiencing stress as the individual is 
more likely to interpret situations as being negatively toned. Coupled with rumination; 
this may compound the effects of neuroticism, as negative emotions are reflected on 
excessively.  
In both the Trier and HR/CVT study, conscientiousness was shown to be associated with 
the respective physiological index of stress. It has been shown in the literature that 
conscientiousness, coupled with neuroticism leads to an increased likelihood of sleep 
disruption[118]. This may represent a perfectionistic personality type. Future studies 
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should measure perfectionism directly, using, for example, the Almost-Perfect Scale- 
Revised (PAS-R)[226]. This scale differentiates those who are high on perfectionism from 
those who are low but has the added benefit of allowing one to parse out maladaptive 
perfectionists (i.e. those who believe personal standards are not being met). In the fMRI 
study the vulnerable group were significantly higher in both conscientiousness and 
neuroticism. This is maybe one of the better defined groups as sleep diary data was 
gathered as part of the screening process. That being said, only one participant was 
excluded based on this, suggesting the other screening methodologies applied are 
probably sufficient (i.e. phone interview and assessment with the PSQI and ISI). Further, 
the fMRI study had the smallest sample.  Based on the theories put forward previously in 
this chapter, the sample in this study should represent the highest level of vulnerability, 
given that they are higher on neuroticism and conscientiousness. Taken together, these 
results highlight the need to measure both these variables, as in the first 2 
conscientiousness was the only significant mediating factor and in the third study, this 
particular construct seems to characterise the vulnerable group. Reflecting upon the 
vulnerable phenotype and the tasks employed in these studies this seems an intuitive 
conclusion to make. Whilst conscientiousness has been deemed as a protective factor 
when not coupled with neuroticism, the addition of a neurotic trait can make this 
maladaptive. If an individual is conscientious i.e. diligent, careful and neurotic i.e. 
susceptible to negative emotion, particularly in relation to stress, it becomes easy to see 
how this may act as a precursor to psychological dysfunction. In the face of stressful 
situations conscientiousness creates a drive to get things right.  
Trait neuroticism contributes towards anxiety that things might go wrong, and a 
perceptual bias toward cues (or a negative interpretation of ambiguous cues) which may 
indicate that it has indeed gone wrong. This creates a greater anticipation to stress, and a 
prolonged elevation of the stress response (i.e. a consistent pattern in the stress 
response). Rumination on the stressful event may then lead to a reliving of the stressful 
experience. In terms of the phenomenology of insomnia, this could easily become the 
‘racing mind’ and interfere with sleep.  The tasks employed in this study all emphasise the 
importance of performance, either in terms of responding correctly or quickly to stimuli, 
or the judgement of a presentation. The stressor reported in the short follow-up is 
unanimously increased work load which again could be considered a performance based 
stressor. Under such conditions, an increase in the desire to do well coupled with a 
Chapter 8: Overall Discussion  145 
 
greater likelihood of processing situations negatively could lead to belief that one is not 
performing correctly and an increase in anxiety results from this.  
Psychologically then the results of the 3 studies presented makes theoretical sense. The 
consistency in greater levels neuroticism across the 3 studies in 3 independent samples, 
and the consistent finding that conscientiousness and rumination are related to 
physiological measures demonstrates that the vulnerable population does have its own 
psychological profile, which differentiates it from the resilient population and further, 
that this can be detected using the FIRST. This is further supported by the analysis on the 
combined data-set, showing the vulnerable group are increase in negative affect, 
perceived stress, rumination and worry.  
Chapter 7 provides further support for the results found in the 3 experimental chapters. 
Across all 3 samples is can be seen that the vulnerable group are characterised by 
neuroticism, conscientiousness, perceived stress, depressive thinking, reflective thinking, 
state-levels of stress and worry. They also score significantly higher on problem focused 
and emotion focused coping. This may represent an unstable coping style. They were also 
found to be lower on extraversion. 
8.2  Psychobiology 
The biological indices of stress across the 3 studies prove to be quite interesting. It was 
hypothesised initially that the vulnerable group would demonstrate an increase in stress 
reactivity. However, this has consistently failed to garner support. Combined, the 3 
studies all suggest that the autonomic nervous system is differently active in the 
vulnerable group, however, the nature of this difference does not appear to be in terms 
of reactivity. Further to this, the inconsistencies across the 3 different methods may imply 
that different parts of the nervous system are affected differentially, and so may 
demonstrate varying degrees of utility in specifying the vulnerable population. Firstly, 
cortisol output was elevated during the anticipation phases of the TSST- time points 1 and 
2- in the vulnerable group. HR and CVT were consistently lower in the vulnerable 
population, and it has been argued that they demonstrate a decrease in CVT flexibility. 
There were no differences at baseline (in anticipation to the stressor). The fMRI study 
demonstrated that the vulnerable population showed greater activation in the left 
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postcentral gyrus (PG) and a bi-lateral hypoactivation in the inferior parietal lobule (IPL), 
in anticipation to stress. This has been argued as representing a deeper encoding of the 
negative association between the siren and the stressful task.  
Study 
Chapter 
Main Finding 
Chapter 4 1. The vulnerable population are higher on negative affect, stress and 
worry 
2. They show increased levels of cortisol at baseline (or in anticipation) 
3. This is mediated by conscientiousness 
4. They show an increase in insomnia symptoms in response to real life 
stress 
`Chapter5 1. The insomnia population are higher on negative affect 
2. They show reduced HR and reduced CVT consistently across stress 
and baseline measures. 
3. CVT change is mediated by conscientiousness. 
4. May indicate reduced CVT flexibility. 
Chapter 6 1. The vulnerable group show greater levels of neuroticism. 
2. The vulnerable population show an increase in activation in the left 
Postcentral Gyrus (PG) 
3. This is mediated by neuroticism 
4. The vulnerable group show hypoactivation bi-laterally in the Inferior 
Parietal Lobule (IPL) 
5. This is mediated by FIRST score 
6. This may reflect a stronger learned association between the siren and 
an increase in task difficulty. 
Table 8 1 Summary of main findings 
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Further to this, there was some interesting data on the cortisol profile of those who were 
excluded from the Trier study analysis for scoring as poor sleepers (see appendix X). This 
demonstrated that on average, this small group of poor sleepers had larger SFC levels at 
every time point, and further their reactivity pattern (i.e. the shape of the graph) was 
much sharper, showing a steeper incline in response to the stressor but also a steeper 
decline towards baseline during the final resting phases. It would be interesting to follow 
these results up with an insomnia group in order to do a more stringent comparison. 
What these results suggest however is that the vulnerable group show an SFC response 
which lies somewhere between that of a good sleeper and that of a poor sleeper: the 
pattern of results may indicate a pre-clinical sample, that is to say a true representation 
of the vulnerable population. In a broader sense, this may mean that vulnerability to 
insomnia is characterised by a strong reaction of the HPA to the possibility of stress over 
time and in the face of more or increasingly severe stressors this becomes a marked 
change in stress-reactivity, as sleep begins to deteriorate. The worsening of sleep may 
then lead to further dysregulation of the HPA axis, and so chronically increased levels of 
cortisol that has been evidenced in the insomnia population[58] 
Supporting this hypothesis is the brain activation of the IPL. If indeed it does represent 
the faulty encoding of emotional associations as suggested, then perhaps from a top-
down perspective this leads to more situations in which the individual anticipates stress 
over time: if negative associations are more readily encoded within this population then it 
becomes easier for random events to become associated. For example, a student has to 
give a presentation. It goes badly. For a resilient individual this is written off as a bad 
presentation. For a vulnerable individual the bad experience becomes associated with the 
negative outcome and so anytime a presentation is needed it is associated with negative 
emotions and so the association strengthens. Hyperactivation in the PG has been 
previously implicated in working memory. This may then provide credence to the theories 
delineated above. 
Thinking about the psychological implications of trait neuroticism, these associations may 
be compounded. Neuroticism leads to negative interpretations, which means that an 
even larger array of situations become negative, due to a focus- and subsequent 
rumination-on the negative aspects. To elaborate on the example given: A student gives 
an overall well received presentation. However, they forgot to mention one of their key 
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findings. This in itself is not a big deal, and probably there will be an opportunity to ask 
questions and mention this after and overall the presentation went down well and was 
considered interesting by the audience. However, the neurotic, vulnerable individual 
focuses on the aspect which they forgot, or the aspect which they failed. This again leads 
to an association between presenting and notions of ‘I am no good at this’; ‘this will go 
badly’; ‘I am anxious’. Coming back to sleep, this pathway may represent one way in 
which poor sleep is maintained. If an individual who is usually a good sleeper has a bad 
night’s sleep due to events that day or events coming up the next day which they are 
anxious about, and they embody the vulnerable phenotype then they may be more 
sensitive to the negative associations of sleep loss, or more likely to interpret lack of sleep 
as threatening. This mirrors somewhat the ideas put forward in the A-I-E pathway for 
explaining chronic insomnia[43] 
As outlined above, day-to-day stress levels increase as more and more situations become 
stress inducing. There are then more situations in which the HPA axis becomes over 
active, as the anticipation of stress becomes more frequent. The suggested lack of 
flexibility of CVT may represent an inability to dampen the processes of the autonomic 
nervous system. Over time, as sleep begins to falter and further impact on the central 
nervous system, this becomes the hyperarousal seen in insomnia and possibly a more 
reactive stress system.  
 
8.3 Strengths and Limitations 
Limitations for each chapter are presented in the discussion for each chapter, so only 
broad limitations will be discussed here.  
Whilst these results are interesting and complement each other nicely, several caveats 
must be considered. Firstly, the conclusions put forward in this overall discussion are 
largely speculative, based on sound theory but nonetheless still need to be tested. Whilst 
they are sensible, to really draw out these hypotheses a much bigger sample is needed, 
following changes in CNS indices over time, in relation to changes in sleep and number of 
perceived stressful life events. It would also be necessary, to truly answer the questions 
posed, to have the same sample undergo all 3 stress paradigms, so that relationships 
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between different components of the CNS can be directly compared, rather than 
speculatively across 3 different samples. 
The selection of the vulnerable group is based solely on the FIRST. This may then 
represent a very specific kind of vulnerability to insomnia. The validation of the FIRST 
scale was conducted using primarily physiological stressor- caffeine and phase advance 
((Cronbach’s alpha = 0.83, test retest reliability co-efficient = 0.92)[137]. The studies 
presented here, then, represent the primary example of the FIRST in relation to 
psychological stress. This then may provide some validation for the scale, given the 
consistency in findings. This however is a secondary outcome and not the aim of this 
thesis. Interestingly, the studies highlight the importance of stress anticipation. The FIRST 
scale however poses 3 questions regarding stress anticipation-how much your sleep is 
likely to be disturbed before a stressful event (items 1, 8 and 9).- and 6 questions about 
how you feel after a stressful event. Given the results presented, this might indicate a 
weakness of the scale if increased stress reactivity, or prolonged maintenance of 
increased stress levels is not what characterises this population i.e. the FIRST may select 
those who show strong anticipation to stress rather than those who are vulnerable to 
sleep disruption. . Further to this, the FIRST scale has not been validated against other 
scales which may measure similar constructs such as the Arousal Predisposition 
Scale[227]. The benefit of the FIRST over the APS however, is that the FIRST asks directly 
about how sleep will be affected given a certain situation, whereas the APS is a more 
general questionnaire assessing arousability. Given that the aim of this thesis is to 
differentiate those vulnerable to sleep disruption, the APS would at best have provided 
an interesting comparison between those who are high in arousability but not vulnerable. 
This may be an important comparison to make in future studies in order to allow 
inferences about protective factors, but not essential when considering vulnerability 
factors.  Supporting the use of the FIRST scale is the finding that the vulnerable group do 
show an increase in subjectively reported insomnia symptoms in response to real-life 
stress – although the stress reported is consistently work load i.e. performance based 
stressor. None the less, this does suggest that the FIRST is a valid scale.  
The small sample size and bias toward females in the 2 latter samples has to be 
considered also. Given that insomnia is more frequently observed in females[6], this may 
not be an issue, and may in fact add to the validity of the results.  Gender was covaried 
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for in analysis where appropriate and did not have a significant influence, but this may be 
an artefact of large under-representation of males in the latter 2 studies. 
The effects sizes reported throughout this thesis are mostly in the moderate to large 
range. This therefore implies that the effects found are genuine. If conducted in larger 
samples, this may help to illuminate on some of the inconsistencies between studies, 
particularly on some of the psychological variables and may further show significant 
results where only trends have been found here.  
8.4 Future Directions and Implications 
Considering the limitations outlined above, future studies should aim to recruit larger 
samples with an even representation of males and females. As already suggested, 
longitudinal work needs to be done, assessing changes over time to indicate which factors 
most strongly predict these changes. In an ideal situation, the study which will best 
answer the questions posed will follow a large genotyped cohort from childhood through 
to adulthood, periodically assessing them on various physiological and psychological 
domains. Realistically, the next step is replication. Further, replication on larger samples 
and follow-up times extending beyond 2 weeks. Once this has been achieved, , 
investigation of protective factors will prove merited for example looking at arousability, 
using the APS for example, compared to the FIRST, and assessing those who are 
predisposed to arousal, but not vulnerable, again considering both psychological and 
physiological domains.  
The implications of this work are primarily within the domain of prevention. Given the 
cost outlined in chapter 1, both to the individual and at a societal level, there is an 
obvious merit in preventative measures. The existence of a vulnerable phenotype, in 
practical terms, may not result in targeting individuals but will aid in our understanding of 
which factors needs to be targeted, generally. This will inform educational programmes 
and preventative interventions. Given the results of this thesis, prevention should focus 
on stress management and the rationalisation of intrusive or unrealistic thoughts: 
teaching objectivity, in order to reduce the negatively laden emotional burden of trait 
neuroticism. By proxy, this work may also provide some insight into the insomnia mind. It 
is posited that stress reactivity changes over time; however the constructs of personality 
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are considered enduring. This could possibly then provide direction for more robust, 
individually tailored treatment programmes for those suffering chronic insomnia.  
The results of this thesis also highlight the issue of transdiagnosis within mental health.  
The constructs hypothesised to characterise those vulnerable to insomnia are also known 
to be strongly associated with depression and anxiety disorders- such as worry, 
rumination and negative affect. In terms of the physiological stress response, 
comparisons are drawn between the vulnerable population, the insomnia population, the 
depressed population and in the brain imaging chapter, with the PTSD population. These 
factors may then not be specific to the development of insomnia, but rather to 
psychological disorder generally. Groups in this thesis were constructed based on a scale 
aimed at assessing vulnerability to sleep disruption, therefore only vulnerability to sleep 
disruption can be confidently concluded upon. It could be the case however, that 
targeting risk factors to insomnia may result in not only a reduction of insomnia 
syndrome prevalence but also a reduction in depression and anxiety disorders.  
8.5 Concluding Remarks 
The work presented in this thesis is piloting. No work has been published to date which 
aims to systematically define the vulnerable population. As such, this works represents 
novel and interesting avenues of research for the field. It has been demonstrated that 
differences between the vulnerable and resilient groups are considerably consistent, 
suggesting that this is indeed a distinct population, that can be reliably selected by the 
FIRST scale. Ultimately, this work represents a tentative first step in understanding the 
interaction between psychology and stress biology in defining the vulnerable population 
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Appendices 
I. University of Glasgow Standard Screening Form 
PLEASE MAKE SURE THAT ALL OF THE FORM IS FILLED IN CLEARLY INCLUDING WHO 
TOOK THE CALL AND THE DATE AND TIME.  NOTES SHOULD BE KEPT ON SEPARATE 
PIECE OF PAPER. 
 
Source 
 
How did you find out about the University of 
Glasgow Sleep Centre? 
 
 
 
 
Why have you contacted us?  
 
Method of initial contact (mobile, email, 
office phone)? 
 
 
 
Personal  
 
Full Name: 
 
Date of Birth: Age: 
Telephone: 
 
Address: 
Alternative Telephone: 
 
When is a good time to call? 
 
 
 
What GP practice do you attend, and who is 
the GP you normally see? 
 
 
 
Sleep  
 
Do you have difficulty sleeping at the moment? (Y/N) 
 
 
Have you always been a poor sleeper? (Y/N) 
 
 
How long have you had a sleep problem?(yr)  
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Do you have difficulty falling asleep? (Y/N) 
 
 
 
How many nights per week do you have difficulty falling asleep? (out of 7) 
 
 
 
How long does it normally take you to fall asleep?(min) 
 
 
 
Do you have a difficulty with waking up during the night?(Y/N)  
How many nights per week do you have a difficulty with waking up during the 
night?(out of 7) 
 
How long are you normally awake during the night, in total? (min) 
 
 
What time do you normally go to bed? (time) 
 
 
 
What time do you normally get up?(time) 
 
 
How long do you normally sleep?(hr/min)  
Do you any other difficulties with your sleep (e.g. restless legs, breathing problems, sleep walking)? 
Do you work shifts, night shifts? 
 
 
 
Roughly, how many units of alcohol do you drink per week? 
(Remember: One standard (175ml) glass of wine = 2 unit 
                                   One pint of standard lager = 2.3  units   
                                   Spirit & Mixer   = 1 unit) 
 
 
 
Does your sleep disturbance affect how you feel and function during the day 
(e.g. fatigue, sleepiness, concentration, memory, mood, motivation, irritable, 
work/social functioning etc.)?  If yes, specify most salient.  
 
 
 
 
Health 
 
Do you keep in good health physically? (Y/N) 
 
 
What physical health problems do you have (if applicable)? 
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What medicines do you take for your physical health? (if applicable) 
 
 
Do you keep in good health mentally? (Y/N) 
 
 
What physical health problems do you have (if applicable)? 
 
 
What medicines do you take for your mental health? (if applicable) 
 
 
 
Do you give your consent for us to contact your GP if necessary regarding your health? 
If you are not suitable for any of the studies ongoing at the moment are you happy for your details to 
be kept on a database so that you may be contacted in the future should a suitable study start? 
 
Notes 
 
 
 
For Office Use 
 
Enquiry taken by: 
 
At (time): 
 
On (date):  
 
Information sent: 
 
  [study name]    [study name]    [study name]    [study name] 
  [study name]    [study name]    [study name]    [study name] 
  [study name]    [study name]    [study name]    [study name] 
 
 
On (date): 
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II. Exclusion criteria (Chapters 4,5,6) 
 Presence Sleep disorder 
 If any of the following sleep symptoms are presented, even if participant does not 
reach diagnostic criteria: 
  complaint about sleep 
  Dissatisfied with amount of sleep  
  Feeling that sleep is non-restorative 
 Current psychological Disorders (Depression, Anxiety etc) 
 Currently receiving treatment for psychological disorders. 
 Disorders of the central nervous system (Cushington's disease, epilepsy for 
example) 
 Heart/ blood pressure problems 
 Currently taking medications, except contraceptive pill, or inhalers 
 Regularly taking recreational drugs (more than once a week) 
 Excessive caffeine intake (more than 5 caffeinated beverages per day) 
 Excessive alcohol consumption (more than 20 units per week, on average) 
 Travelled across time-zones in the last month 
 Participated in other studies which are part of this thesis 
  
Appendices    156 
 
III. Questionnaire Booklet 
 
 
 
 
 
 
 
 
 
 
Name:       
Age: 
Date of Birth: 
Gender: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please remember with while answering the questionnaires that 
your first response is usually the most representative. Don’t be 
tempted to over think the questions 
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PSQI 
 
INSTRUCTIONS: The following questions relate to your usual sleep habits during 
the past month only.  Your answers should indicate the most accurate reply for 
the majority of days and nights in the past month.  Please answer all the 
questions. 
 
1. During the past month, when have you usually gone to bed at night? 
 
Usual Bed Time:   …………………………………………………………… 
 
2. During the past month, how long (in minutes) has it usually taken you to fall 
asleep each night? 
 
Number of Minutes:  …………………………………………………………… 
 
3. During the past month, when have you usually got up in the morning? 
 
Usual Getting Up Time:  …………………………………………………………… 
 
4. During the past month, how many hours of actual sleep did you get at night?  
(This may be different than the number of hours you spend in bed) 
 
Hours of Sleep per Night: …………………………………………………………… 
 
 
For each of the remaining questions, circle the response that fits best.  Please 
answer all the questions. 
 
5. During the past month, how often have you had trouble sleeping because you… 
 
     
(a). Cannot get to sleep within 30 
minutes. 
Not 
during the 
past 
month 
Less than 
once a 
week 
Once or 
twice a 
week 
Three or 
more 
times a 
week 
 
    
 
 
(b). Wake up in the middle of the 
night  
      or early morning. 
 
 
Not 
during the 
past 
month 
 
 
Less than 
once a 
week 
 
 
Once or 
twice a 
week 
 
 
Three or 
more 
times a 
week 
 
 
 
    
(c). Have to get up to use the 
bathroom. 
Not 
during the 
past 
month 
Less than 
once a 
week 
Once or 
twice a 
week 
Three or 
more 
times a 
week 
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(d). Cannot breathe comfortably. 
 
Not 
during the 
past 
month 
 
Less than 
once a 
week 
 
Once or 
twice a 
week 
 
Three or 
more 
times a 
week 
 
    
 
(e). Cough or snore loudly. 
 
Not 
during the 
past 
month 
 
Less than 
once a 
week 
 
Once or 
twice a 
week 
 
Three or 
more 
times a 
week 
     
 
(f). Feel too cold. 
 
Not 
during the 
past 
month 
 
Less than 
once a 
week 
 
Once or 
twice a 
week 
 
Three or 
more 
times a 
week 
     
 
(g). Feel too hot. 
 
Not 
during the 
past 
month 
 
Less than 
once a 
week 
 
Once or 
twice a 
week 
 
Three or 
more 
times a 
week 
 
 
 
(h). Had bad dreams 
 
 
Not 
during the 
past 
month 
 
 
Less than 
once a 
week 
 
 
Once or 
twice a 
week 
 
 
Three or 
more 
times a 
week 
 
    
 
    
(i). Have pain. Not 
during the 
past 
month 
Less than 
once a 
week 
Once or 
twice a 
week 
Three or 
more 
times a 
week 
     
 
(j). Other reason(s), please describe 
_____________________________________________________ 
 
_______________________________________________________________________
____________ 
 
 
How often during the past month have you had trouble sleeping because of this? 
 
Not during the 
past month 
Less than 
 once a week 
Once or  
twice a week 
Three or more  
times a week 
 
 
 
 
6. During the past month, how would you rate your sleep quality overall? 
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Very Bad  
 
Fairly Bad Fairly Good 
 
Very Good 
 
 
7.  During the past month, how often have you taken medicine (prescribed or ‘over 
the counter’) to help you sleep? 
 
Not during the  
past month 
Less than 
 once a week 
Once or  
twice a week 
Three or more  
times a week 
 
 
8.  During the past month how often have you had trouble staying awake while 
driving, eating meals, or engaging in social activity? 
 
Not during the  
past month 
Less than 
 once a week 
Once or  
twice a week 
Three or more 
times a week
 
 
 
9. During the past month, how much of a problem has it been for you to keep up 
enough enthusiasm to get things done? 
 
No problem  
at all   
Only a very 
slight problem  
Somewhat of 
a problem 
 A very big 
problem 
 
 
 
 
 
10.  Do you have a bed partner or roommate?  Please circle: 
No bed partner or roommate 
Partner / roommate in other room 
Partner in same room, but not same bed 
Partner in same bed 
 
If you have a roommate or bed partner, ask him / her how often in the past month 
you have had…… 
a. Loud snoring 
Not during  
past month 
Less than 
 once a week 
Once or  
twice a week 
Three or more  
times a week 
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b. Long pauses between breaths while asleep 
Not during  
past month 
Less than 
 once a week 
Once or  
twice a week 
Three or more  
times a week 
 
c. Legs twitching or jerking while you sleep 
Not during  
past month 
Less than 
 once a week 
Once or  
twice a week 
Three or more 
times a week
      
d. Episodes of disorientation or confusion during sleep 
Not during  
past month 
Less than 
 once a week 
Once or  
twice a week 
Three or more 
times a week
 
e.  Other restlessness while you sleep: please 
describe________________________________ 
____________________________________________________________________
____________ 
  
Not during the  
past month 
Less than 
 once a week 
Once or  
twice a week 
Three or more 
times a week
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ISI 
 
 
1. Please rate the current (i.e., last two weeks) severity of your insomnia 
problems(s) by circling a response. 
None Mild Moderate         Severe       Very 
 
a. Difficulty falling asleep:       0    1      2  3 4 
b. Difficulty staying asleep:     0    1       2  3 4 
c. Problem waking up too early:    0    1      2  3 4 
 
 
2. How satisfied/dissatisfied are you with your current sleep pattern? 
 
Very Satisfied Satisfied Neutral Dissatisfied Very Dissatisfied 
      0           1       2          3   4 
 
 
3. To what extent do you consider your sleep problem to interfere with 
your daily functioning (e.g. daytime fatigue, ability to function at 
work/daily chores, concentration, memory, mood, etc.) 
 
Not at all  A little  Somewhat  Much  Very 
much 
Interfering                               Interfering 
 0      1        2       3         4 
 
 
4. How noticeable to others do you think your sleeping problem is in 
terms of impairing the quality of your life? 
 
Not at all  A little  Somewhat  Much  Very 
much 
Noticeable         Noticeable 
 0      1        2      3       4 
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5.   How worried/distressed are you about your current sleep problem? 
 
Not at all   A little  Somewhat  Much  Very much 
Worried         Worried 
 0     1        2      3       4 
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FIRST 
 
When you experience the following situations, how likely is it for you to have 
difficulty sleeping? Circle an answer even if you have not experienced these 
situations recently. 
 
Before an important meeting the next day 
 
 Not likely Somewhat likely  Moderately likely  Very likely 
 
After a stressful experience during the day 
 
 Not likely Somewhat likely  Moderately likely   Very 
likely 
 
After a stressful experience in the evening 
 
 Not likely Somewhat likely  Moderately likely  Very 
likely 
 
After getting bad news during the day 
 
 Not likely Somewhat likely  Moderately likely  Very 
likely 
 
After watching a frightening movie or TV show 
 
 Not likely Somewhat likely  Moderately likely  Very 
likely 
 
After having a bad day at work 
 
 Not likely Somewhat likely  Moderately likely  Very 
likely 
 
After an argument  
 
 Not likely Somewhat likely  Moderately likely  Very 
likely 
 
Before having to speak in public 
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 Not likely Somewhat likely  Moderately likely  Very 
likely 
 
Before going on vacation the next day 
 
 Not likely Somewhat likely  Moderately likely  Very 
likely 
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PSS 
 
The questions in this scale ask you about your feelings and thoughts during the 
last month. In each case, you will be asked to indicate by writing a number, how 
often you felt or thought a certain way: 
 
0 = Never 1 = Almost Never 2 = Sometimes 3 = Fairly Often 4 = Very Often 
 
1. In the last month, how often have you been upset because of something 
that happened unexpectedly?.....................................  
 
2. In the last month, how often have you felt that you were unable? 
to control the important things in your life?......................................................  
 
3. In the last month, how often have you felt nervous and “stressed”? 
..............  
 
4. In the last month, how often have you felt confident about your ability to 
handle your personal problems?.................................................................  
 
5. In the last month, how often have you felt that things 
were going your way?......................................................................................  
 
6. In the last month, how often have you found that you could not cope 
with all the things that you had to do? .............................................................  
 
7. In the last month, how often have you been able 
to control irritations in your life?.......................................................................  
 
8. In the last month, how often have you felt that you were on top of 
things?.... 
 
9. In the last month, how often have you been angered because of things 
that were outside of your control? .....................................  
 
10. In the last month, how often have you felt difficulties were piling up so 
high that you could not overcome them?............................  
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DASS21  
Please read each statement and insert a number 0, 1, 2 or 3 which indicates how much 
the statement applied to you over the past week.  There are no right or wrong answers.  
Do not spend too much time on any statement. 
The rating scale is as follows: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
 
1 I found it hard to wind down  
2 I was aware of dryness of my mouth  
3 I couldn't seem to experience any positive feeling at all  
4 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
 
5 I found it difficult to work up the initiative to do things  
6 I tended to over-react to situations  
7 I experienced trembling (eg, in the hands)  
8 I felt that I was using a lot of nervous energy  
9 I was worried about situations in which I might panic and make 
a fool of myself 
 
10 I felt that I had nothing to look forward to  
11 I found myself getting agitated  
12 I found it difficult to relax  
13 I felt down-hearted and blue  
14 I was intolerant of anything that kept me from getting on with 
what I was doing 
 
15 I felt I was close to panic  
16 I was unable to become enthusiastic about anything  
17 I felt I wasn't worth much as a person  
18 I felt that I was rather touchy  
19 I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat) 
 
20 I felt scared without any good reason  
21 I felt that life was meaningless  
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NEO-ffi 
 
Below are a number of characteristics which may or may not apply to you. Please 
indicate your degree of agreement based on the following scale. 
 
Disagree 
strongly 
Disagre
e  
Disagree 
more than 
agree  
Agree more 
than 
disagree 
Agree Agree 
strongly 
        1       2            3           4      5           6 
 
1  I am not a worrier.   
2  I like to have a lot of people around me.     
3  I don’t like to waste my time daydreaming.     
4  I try to be courteous to everyone I meet.    
5  I keep my belongings clean and tidy.      
6  I often feel inferior to others.       
7  I laugh easily.         
8  Once I find the right way to do something, I stick to it.   
9  I often get into arguments with my family and co-workers.  
10  I’m pretty good at pacing myself so as to get things done on 
time  
 
11 When I’m under a great deal of stress, sometimes I feel like I’m 
going to  pieces  
 
12  I don’t consider myself to be especially “light-hearted”.   
13  I am intrigued by the patterns I find in nature and art.   
14  Some people think I’m selfish and egotistical.    
15  I am not a very methodical person.      
16  I rarely feel lonely or blue.       
17  I really enjoy talking to people .      
18  I believe letting students hear controversial speakers can only 
confuse and mislead them. 
 
19  I would rather cooperate with others than compete with them.
  
 
20  I try to perform all the tasks assigned to me conscientiously.   
21  I often feel tense and jittery.       
22  I like to be where the action is.       
23  Poetry has little or no effect on me.      
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24 I tend to be cynical and sceptical of others’ intentions.   
25 I have a clear set of goals and work towards them in an orderly 
fashion. 
 
26 Sometimes I feel completely worthless.     
27 I usually prefer to do things alone.      
28 I often try new and foreign foods.      
29 I believe that most people will take advantage of you if you let 
them. 
 
30 I waste a lot of time before settling down to work.    
31 I rarely feel fearful or anxious.       
32 I often feel as if I’m bursting with energy.     
33 I seldom notice the moods or feelings that different 
environments produce. 
 
34 Most people I know like me       
35 I work hard to accomplish my goals.      
36 I often get angry at the way people treat me.     
37 I am a cheerful, high-spirited person...      
38 I believe we should look to our religious authorities for decisions 
on moral issues 
 
39 Some people think of me as cold and calculating.    
40 When I make a commitment, I can always be counted on to 
follow through 
 
41 Too often, when things go wrong, I get discouraged and feel 
like giving up. 
 
42 I am not a cheerful optimist.           
43 Sometimes when I am reading poetry or looking at a work of art, 
I feel a chill or wave of excitement. 
 
44 I’m hard-headed and tough-minded in my attitudes.   
45 Sometimes I’m not as dependable or reliable as I should be.  
46 I am seldom sad or depressed.       
47 My life is fast-paced.        
48 I have little interest in speculating on the nature of the universe      
or the human condition. 
 
49 I generally try to be thoughtful and considerate.    
50 I am a productive person who always gets the job done.   
51 I often feel helpless and want someone else to solve my 
problems  
 
52 I am a very active person.       
Appendices    169 
 
53 I have a lot of intellectual curiosity.      
54 If I don’t like people, I let them know.      
55 I never seem to be able to get organised.     
56 At times I have been so ashamed I just wanted to hide.   
57 I would rather go my own way than be a leader of others.   
58 I often enjoy playing with theories or abstract ideas.   
59 If necessary, I am willing to manipulate people to get what I 
want.  
 
60 I strive for excellence in everything I do.     
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Rumination Scale 
 
People think and do many different things when they feel depressed. Please 
read each of the items below and indicate whether you almost never, 
sometimes, often, or almost always think or do each one when you feel 
down, sad, or depressed. Please indicate what you generally do, not what 
you think you should do. 
 
1= almost never 2= sometimes 3= often 4= almost always 
 
1. Think about how alone you feel……………………………………………… 
2. Think “I won’t be able to do my job if I don’t snap out of this”……………. 
3. Think about your feelings of fatigue and achiness………………………… 
4. Think about how hard it is to concentrate………………………………….. 
5. Think “What am I doing to deserve this?”………………………………….. 
6. Think about how passive and unmotivated you feel……………………… 
7. Analyze recent events to try to understand why you are depressed…… 
8. Think about how you don’t seem to feel anything anymore……………… 
9. Think “Why can’t I get going?”………………………………………………. 
10. Think “Why do I always react this way?”…………………………………. 
11. Go away by yourself and think about why you feel this way…………… 
12. Write down what you are thinking about and analyze it………………… 
13. Think about a recent situation, wishing it had gone better……………… 
14. Think “I won’t be able to concentrate if I keep feeling this way.”………. 
15. Think “Why do I have problems other people don’t have?”…………….. 
16. Think “Why can’t I handle things better?”………………………………… 
17. Think about how sad you feel……………………………………………… 
18. Think about all your shortcomings, failings, faults, mistakes…………… 
19. Think about how you don’t feel up to doing anything…………………… 
20. Analyze your personality to try to understand why you are depressed……. 
21. Go someplace alone to think about your feelings………………………….. 
22. Think about how angry you are with yourself……………………………... 
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Brief-COPE 
These items deal with ways you've been coping with the stress in your life. I 
want to know to what extent you've been doing what each item says.  How 
much or how frequently.  Don't answer on the basis of whether it seems to be 
working or not—just whether or not you're doing it.  Use these response 
choices.  Try to rate each item separately in your mind from the others.  Make 
your answers as true FOR YOU as you can. Please write the appropriate 
number at the end of each question. 
 1 = I haven't been doing this at all; 2 = I've been doing this a little bit  
3 = I've been doing this a medium amount; 4 = I've been doing this a lot  
 
 
1. I've been turning to work or other activities to take my mind off 
thing…..  
2. I've been concentrating my efforts on doing something about the 
situation I'm in…..  
3. I've been saying to myself "this isn't real."… 
4.  I've been using alcohol or other drugs to make myself feel better…. 
5.  I've been getting emotional support from others… 
6.  I've been giving up trying to deal with it…. 
7.  I've been taking action to try to make the situation better…. 
8.  I've been refusing to believe that it has happened… 
9.  I've been saying things to let my unpleasant feelings escape… 
10.  I’ve been getting help and advice from other people… 
11.  I've been using alcohol or other drugs to help me get through it… 
12.  I've been trying to see it in a different light, to make it seem more 
positive… 
13.  I’ve been criticizing myself… 
14.  I've been trying to come up with a strategy about what to do… 
15.  I've been getting comfort and understanding from someone... 
16.  I've been giving up the attempt to cope… 
17.  I've been looking for something good in what is happening… 
18.  I've been making jokes about it… 
19.  I've been doing something to think about it less, such as going to 
movies,  
      watching TV, reading, daydreaming, sleeping, or shopping… 
20.  I've been accepting the reality of the fact that it has happened… 
21.  I've been expressing my negative feelings... 
22.  I've been trying to find comfort in my religion or spiritual beliefs… 
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23.  I’ve been trying to get advice or help from other people about what 
to do... 
`    24.  I've been learning to live with it... 
25.  I've been thinking hard about what steps to take… 
26.  I’ve been blaming myself for things that happened… 
27.  I've been praying or meditating… 
28.  I've been making fun of the situation… 
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PSWQ 
 
 
Please use the scale below to express to what extent each statement is 
typical to you (write the number that represents you the best at the end of 
each statement). 
 
1= not at all typical; 2= a little typical; 3= moderately typical; 4=very typical;                  
5= extremely typical 
 
 1.  If I do not have enough time to do everything, I do not worry about it….. 
 2.  My worries overwhelm me….. 
 3.  I do not tend to worry about things….. 
 4.  Many situations make me worry….. 
 5.  I know I should not worry about things, but I just cannot help it….. 
 6.  When I am under pressure I worry a lot….. 
 7.  I am always worrying about something….. 
 8.  I find it easy to dismiss worrisome thoughts….. 
 9.  As soon as I finish one task, I start to worry about everything else I have 
to do….. 
10.  I never worry about anything…..  
11.  When there is nothing more I can do about a concern, I do not worry 
about it any            more…..  
12.  I have been a worrier all my life….. 
13.  I notice that I have been worrying about things….. 
14.  Once I start worrying, I cannot stop….. 
15.  I worry all the time….. 
16.  I worry about projects until they are all done…..      
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IV. Information Sheet for TSST Study (Chapter 4) 
      
 
 
 
Participant Information Sheet 
 
 
Title: Stress reactivity and insomnia 
 
You are being invited to take part in a research study. Before you decide whether or not 
to take part, it is important for you to understand why the research is being done and 
what it will involve. Please take time to read the following information carefully and 
discuss it with others if you wish. Ask us if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to take part.  
 
The Study 
This study will be conducted through the University of Glasgow Sleep Centre. You have 
been invited to take part in this study based on your responses to previous part of the 
study or because you have passed the screening process. This second part of the study 
(phase 2) in which you are being asked to take part is designed to help us profile the 
relationships between sleep problems, perceived stress, personality and coping styles and 
stress reactivity. Hopefully this type of research will help us improve our understanding of 
insomnia, and give an insight into how insomnia can be prevented.  
 
Do I have to take part? 
Taking part in the research is entirely voluntary. This means that it is up to you to decide 
whether or not you would like to take part. If you do not wish to take part it will not 
affect the case or your rights in any way. If you decide to take part in the study, you can 
keep this information sheet and contact the researcher for further information. If you do 
decide to take part, you can change your mind and withdraw from the study at any time, 
even after the study has finished. 
 
What does taking part involve?  
If you decide to take part all you have to do is come to Psychology Department at the 
University of Glasgow where you will be asked to run through 2 different tasks and 
periodically provide saliva samples. The saliva samples allow us to collect information on 
the activity of certain hormones during the tasks. You will be in the department for 
roughly an hour and this will be paid (£10). 
 
 
Would my results be kept confidential? What will happen to the results of the study? 
All the information that is collected during the course of the study will remain strictly 
confidential. This means that all information will be kept secured in locked filling cabinets 
and only the researcher will be able to access these. You will be given a unique code that 
will ensure confidentiality and anonymity of all your data. Saliva samples will be sent 
securely for analysis, and no genetic data will be collected. The results of this study will be 
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published in a relevant journal so that the general public is also aware of these findings. 
However any information regarding your identity will not be revealed in these.  
 
What are the potential benefits or disadvantages of taking part? 
Taking part will provide us with information of how to improve treatments and aid in 
prevention of insomnia. There are no risks or disadvantages associated with taking part. 
You will also be given advice on how to promote better sleep during times of stress.  
 
Who is organising and paying for the research? 
The research study is organised by Christopher-James Harvey, doctorial research student 
and is funded by The Sackler Institute of Psychobiological Research. 
Educational supervision of this research is provided by Prof Colin Espie and Dr. Jonathan 
Cavanagh 
 
If I decide to take part what happens next? 
If you decide to take part you will be invited to come to the Psychology Department and 
given the opportunity to ask any questions about the research before commencing the 
study.  
 
Thank you for reading this information. If there is anything that is not clear or if you have 
any questions regarding this study you can e-mail the researcher at 
 
c.harvey.1@research.gla.ac.uk or call: 
 
or call Chris on 0141 232 7566 
 
If you would like some independent advice from someone who is not involved in the 
study, please contact Dr Maria Gardani +44 (0)141 232 7700 or 
M.Gardani@clinmed.gla.ac.uk  
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V. Consent Form for TSST Study (Chapter 4) 
                   
 
 
Participant Identification Number for this study: 
 
CONSENT FORM  
Title of Project: Stress reactivity and Insomnia (Phase 1) 
Mr. Christopher-J. Harvey, Prof. Colin Espie, Dr. Jonathan Cavanagh 
                          Please initial box 
 
1. I confirm that I have read and understand the information sheet and received my  
own copy dated 20th April 2010 (version 1) for the above study.  
 
2. I have had the opportunity to consider the information provided, ask questions 
and have had these answered satisfactorily. 
  
 
3. I understand that my participation is voluntary and that I am free to withdraw  
at any time, without giving any reason, without my medical care or legal  
rights being affected. 
 
 
4. I understand that data collected during this study may be looked at by responsible 
individuals from the research team or from regulatory authorities where it is relevant  
to them taking part in research.  
I give permission for these individuals to have access to my records. 
 
 
5.  I consent to the results (in anonymised form) of this study being published in relevant  
journals. 
 
 
6. I agree to be contacted in the future from the Glasgow Sleep Research Centre.  
 
  
 
7. I agree to take part in the above study. 
 
 
 
________________________ ________________                ______________________ 
 
Name of Participant Date Signature 
 
 
 
 
________________________ ________________                  ____________________ 
Researcher Date Signature 
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VI. Instruction Sheet Given to Confederates During 
Training 
 
Materials: 
 2 rooms 
 Audio and visual recording device 
 2 notepads 
 Scripted material: for introduction to tasks, task debriefing procedures 
 Timers with alarms 
 Salivettes for saliva collection 
 Questionnaires (MEQ) 
 Bland reading material 
 
People: 
 Experimenter: Responsible for guiding the subject to and from rooms, 
administering questionnaires, collecting saliva and debriefing participant 
 Confederates- 
o At least 2 
o No prior contact with participant prior to TSST 
o Only one has verbal communication with the participant throughout the 
experiment 
 
Environment: 
 Preparatory/Resting room 
o Somewhat comfortable and secluded 
o Bland reading material 
o Paper and pen with writing desk for participant 
o Used before and after TSST for resting periods and note making 
 
 Testing Room 
o Plain room with a desk and 2 chairs 
o Screen showing recording of participant- as microphone will not be visible 
it is important participants are made aware that the laptop has in build 
microphone 
o Speech and math task conducted in this room.  
 
 
Procedures: 
 
All participants will be tested between 1300 and 1800 hours as this a period of relative 
quiescence of the HPA axis- responsible for cortisol production- thus ensuring that natural 
circadian peaks in cortisol levels do not interfere or present a confound to our results 
 
Participants will be instructed not to eat, smoke or ingest caffeine within at least an hour 
of testing. Participants will be instructed that this will ruin results and can be detected in 
the saliva.  
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Arrival: 
I. Participant will be greeted by the experimenter in the waiting room and escorted 
to the preparatory room 
II. They will be asked to rest for 10 minutes, feeling free to use the reading material 
provided. 
III. Saliva sample is taken at the end of 10 minutes. 
 
 
Speaking task: 
 
I. Researcher gives participant instruction on speaking task- see appendix a. 
II. If Ps asks any questions the researcher should give neutral responses such as ‘Do 
what you think is best’ or ‘I do not have any further details’. 
 
Preparation: 
I. In prep room a timer is set for 10 minutes and Ps is told to make notes on their 
speech and that these, however, will not be allowed into the testing room 
II. After the alarm goes off researcher returns to room and a second saliva sample is 
taken.  
 
Speaking Task: 
 
I. Researcher leads Ps back to testing room, knock on door and waits for reply from 
confederate1. Ps is led inside and researcher remains outside.  
II. Confederates are to remain expressionless throughout this and the math task, and 
only confederate1 is to talk. 
III. Timer is set to 5 minutes and confederate tells Ps to begin. 
IV. Confederate 2 should take notes every minute or so as if noting the Ps 
performance, however these should be kept brief as it is essential that eye contact 
is maintained as continuously as possible.  
V. If Ps stops speaking for more than 20s confederate1 should interject ‘You still have 
more time. Please continue’. 
VI. If Ps asks any questions again replies should be kept as neutral as possible: 
a. ‘Do what you think is best’ 
b. ‘Say what comes into your head’ 
c. ‘Be as creative as you like’ (for example) 
VII. At the sound of the buzzer confederate 1 should say ‘your time is up. Please stop.’ 
 
Math Task: 
 
I. Confederate 1 then tells participant ‘Now we would like you to subtract 13 from 
6233 and keep subtracting from the remainder until we tell you to stop. You 
should be as fast and as accurate as possible’ 
II. Whenever an error is made the Ps must restart. Confederate 1 should say ‘That is 
incorrect. Please begin again at 6233’ 
III. At the end of the 5 minutes the Ps is instructed ‘Your time is up. You may return to 
your room’ 
IV. If Ps asks questions about responses confederate 1 must report ‘I cannot give you 
this information. Someone else will tell you later’ 
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Rest Period: 
I. Participant is led back to resting room where they will rest for 30mins. 
II. Saliva samples will be taken immediately on arrival and then every 10 minutes 
until 30 minutes is up. This will provide in total 5 saliva samples per participant for 
the whole paradigm.  
 
Debriefing: 
 
I. Participant is told nature of study – see appendix B. 
II. Participant meets confederates who explain that they were cold as this was 
necessary for the experiment. If they are unavailable for debriefing the researchers 
explains this to them. 
III. Payment is made.  
 
In-case of Adverse Reaction 
 
If the participant becomes unduly stresses- crying or overly agitated- confederate 1 
should ask ‘Are you OK to continue?’ and then ‘Do you wish to stop?’ 
 
If the participant indicates that they do wish to stop then the researcher in charge should 
be notified immediately, the experiment ended and the participant debriefed and calmed 
down.  
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VII. Transcript of Recording Played to Participants 
Please listen carefully. I am about to explain the task that you are being asked to 
complete. [Pause] 
 
The 2 trained interviewers sitting before you are waiting to assess how outgoing, 
gregarious and comfortable you are in a situation where you need to project an air of 
expertise. This is a type of personality test for a trait known as extroversion. [Pause] 
 
You will be given a hypothetical situation in which you are applying for your ideal job, a 
job which you have dreamed of working in for as many years as you can 
remember.[Pause] 
 
After seeing an advertisement for this job and applying, you have received an invitation to 
attend an interview. [Pause] 
 
The job has a high salary and a lot of other candidates with whom you are competing. 
[Pause] 
 
The final decision will be based on your ability to convince the interviewers that your 
experience, abilities and education make you better suited than all the other candidates. 
You are trying to convince the panel that you are the best candidate for this position. 
[Pause] 
 
You will be given 10 minutes to prepare a detailed speech. You will then return to the 
interview room, which you are in now, to deliver your speech to the interviewers’. The 
purpose of the speech is to explain why you should get the job. The notes you make 
during preparation may not be taken into the interview room, but are merely to help you 
organise your thoughts. [Pause] 
 
Following this you will be given a mental arithmetic task. [Pause] 
 
It is important to remember that these interviewers are specifically trained to monitor 
and assess the rate of your speech for believability and convincingness and to also assess 
non verbal cues. Further it is important to remember that you will be compared against 
those who have already completed this task. [Pause] 
 
Your speech will be recorded to allow us to go back through it to rate the contents and 
non verbal behaviour. [Pause] 
 
You will now be given time to prepare. 
 
You may leave the interview room.  
 
[End] 
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VIII. Normality Values (Kurtosis and Skewness) for the 
Resilient and Vulnerable group (TSST; Chapter 4) 
Mean, Skewness and Kurtosis values for the Resilient group (SPSS output) 
Descriptive Statisticsa 
 
N Mean Skewness Kurtosis 
Statistic Statistic Statistic Std. Error Statistic Std. Error 
PSQI 18 3.5556 .487 .536 -.705 1.038 
ISI 18 3.0556 .898 .536 .170 1.038 
PSS 18 12.5000 1.115 .536 2.210 1.038 
DASSD 18 4.0000 1.265 .536 1.084 1.038 
DASSA 18 3.3333 .760 .536 -.801 1.038 
DASSS 18 7.1111 1.020 .536 1.833 1.038 
NEOO 18 50.1111 -.469 .536 -.060 1.038 
NEOC 18 51.6111 .616 .536 .604 1.038 
NEOE 18 51.5556 .041 .536 -1.101 1.038 
NEOA 18 53.5000 -.839 .536 .070 1.038 
NEON 18 29.3889 -.446 .536 -.934 1.038 
RUMD 18 19.0000 .558 .536 -.452 1.038 
RUMB 18 8.3889 1.521 .536 2.907 1.038 
RUMR 18 9.0556 .774 .536 1.368 1.038 
COPEP 18 10.0000 .136 .536 -.725 1.038 
COPEE 18 11.0000 .539 .536 -1.020 1.038 
WORRY 18 38.3333 .340 .536 -.394 1.038 
FIRST 18 14.8889 .224 .536 -1.271 1.038 
Cortisol_T1 18 5.5322 1.093 .536 .624 1.038 
Cortisol_T2 18 5.4627 .891 .536 .520 1.038 
Cortisol_T3 18 7.5962 1.388 .536 1.572 1.038 
Cortisol_T4 18 7.2493 1.556 .536 2.642 1.038 
Cortisol_T5 18 6.6679 .874 .536 -.179 1.038 
AUCg  18 264.0816 1.561 .536 2.838 1.038 
AUCb  18 221.2876 1.093 .536 .624 1.038 
 AUCi  18 42.7940 -.277 .536 -.246 1.038 
Valid N (listwise) 18      
a. 1= resilient; 2= vulnerable = 1.00 
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Mean, Skewness, Kurtosis values for the Vulnerable Group (SPSS output) 
Descriptive Statisticsa 
 
N Mean Skewness Kurtosis 
Statistic Statistic Statistic Std. Error Statistic Std. Error 
PSQI 16 4.5625 .210 .564 .042 1.091 
ISI 16 4.3750 .657 .564 .670 1.091 
PSS 16 14.7500 -.201 .564 -.463 1.091 
DASSD 16 6.0000 1.122 .564 .525 1.091 
DASSA 16 4.6250 -.127 .564 -1.003 1.091 
DASSS 16 13.0000 .315 .564 .417 1.091 
NEOO 16 53.0000 .854 .564 .635 1.091 
NEOC 16 49.1250 -.079 .564 -.418 1.091 
NEOE 16 49.5625 -.295 .564 -.891 1.091 
NEOA 16 52.5000 -.789 .564 -.243 1.091 
NEON 16 38.7500 -.160 .564 -.998 1.091 
RUMD 16 24.3750 -.427 .564 -1.033 1.091 
RUMB 16 10.1875 1.231 .564 .673 1.091 
RUMR 16 11.4375 .157 .564 .277 1.091 
COPEP 16 12.4375 .027 .564 1.330 1.091 
COPEE 16 14.3125 .024 .564 -1.060 1.091 
WORRY 16 49.0625 -.719 .564 .818 1.091 
FIRST 16 22.4375 .383 .564 -.428 1.091 
Cortisol_T1 16 3.5323 1.480 .564 2.222 1.091 
Cortisol_T2 16 3.6894 .212 .564 -.640 1.091 
Cortisol_T3 16 5.5826 .692 .564 -.723 1.091 
Cortisol_T4 16 5.6311 .892 .564 .111 1.091 
Cortisol_T5 16 5.1627 .836 .564 -.740 1.091 
 AUCg  16 192.5067 .408 .564 -1.239 1.091 
AUCb   16 141.2921 1.480 .564 2.222 1.091 
AUCi  16 51.2146 1.072 .564 .599 1.091 
Valid N (listwise) 16      
a. 1= resilient; 2= vulnerable = 2.00 
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IX. Scatterplots for Whole-Sample Correlations between 
FIRST and Psychological Variables 
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X. Correlation Matrix for Psychological Variables(TSST; 
Chapter 4)  
Correlations 
 
PSQI ISI PSS 
DASS
D DASSA DASSS NEOO NEOC NEOE 
PSQI Pearson 
Correlation 
1 .393* -.009 .060 .090 .208 -.011 -.110 -.024 
Sig. (2-tailed)  .020 .958 .730 .607 .229 .949 .530 .891 
N 35 35 35 35 35 35 35 35 35 
ISI Pearson 
Correlation 
.393* 1 .327 .280 .283 .434** -.140 .196 .051 
Sig. (2-tailed) .020  .055 .103 .100 .009 .423 .260 .772 
N 35 35 35 35 35 35 35 35 35 
PSS Pearson 
Correlation 
-.009 .327 1 .651** .468** .501** -.254 -.077 -.447** 
Sig. (2-tailed) .958 .055  .000 .005 .002 .142 .660 .007 
N 35 35 35 35 35 35 35 35 35 
DASS
D 
Pearson 
Correlation 
.060 .280 .651** 1 .553** .531** -.034 -.259 -.452** 
Sig. (2-tailed) .730 .103 .000  .001 .001 .846 .132 .006 
N 35 35 35 35 35 35 35 35 35 
DASS
A 
Pearson 
Correlation 
.090 .283 .468** .553** 1 .612** .118 -.073 -.309 
Sig. (2-tailed) .607 .100 .005 .001  .000 .499 .677 .071 
N 35 35 35 35 35 35 35 35 35 
DASS
S 
Pearson 
Correlation 
.208 .434** .501** .531** .612** 1 -.077 -.058 -.316 
 
PSQI ISI PSS 
DASS
D DASSA DASSS NEOO NEOC NEOE 
Sig. (2-tailed) .229 .009 .002 .001 .000  .661 .739 .064 
N 35 35 35 35 35 35 35 35 35 
NEOO Pearson 
Correlation 
-.011 -.140 -.254 -.034 .118 -.077 1 -.231 -.191 
Sig. (2-tailed) .949 .423 .142 .846 .499 .661  .182 .272 
N 35 35 35 35 35 35 35 35 35 
NEOC Pearson 
Correlation 
-.110 .196 -.077 -.259 -.073 -.058 -.231 1 .291 
Sig. (2-tailed) .530 .260 .660 .132 .677 .739 .182  .090 
N 35 35 35 35 35 35 35 35 35 
Appendices    188 
 
NEOE Pearson 
Correlation 
-.024 .051 -.447** -.452** -.309 -.316 -.191 .291 1 
Sig. (2-tailed) .891 .772 .007 .006 .071 .064 .272 .090  
N 35 35 35 35 35 35 35 35 35 
NEOA Pearson 
Correlation 
-.180 -.392* -.404* -.507** -.382* -.436** .119 .145 .218 
Sig. (2-tailed) .301 .020 .016 .002 .023 .009 .496 .407 .208 
N 35 35 35 35 35 35 35 35 35 
NEON Pearson 
Correlation 
.193 .234 .645** .637** .443** .649** -.145 -.244 -.497** 
Sig. (2-tailed) .266 .176 .000 .000 .008 .000 .406 .158 .002 
N 35 35 35 35 35 35 35 35 35 
RUMD Pearson 
Correlation 
.243 .247 .348* .331 .512** .561** .103 -.205 -.232 
 
PSQI ISI PSS 
DASS
D DASSA DASSS NEOO NEOC NEOE 
Sig. (2-tailed) .160 .152 .040 .052 .002 .000 .558 .238 .180 
N 35 35 35 35 35 35 35 35 35 
RUMB Pearson 
Correlation 
.131 .284 .495** .591** .616** .629** -.036 -.047 -.276 
Sig. (2-tailed) .454 .098 .003 .000 .000 .000 .837 .789 .108 
N 35 35 35 35 35 35 35 35 35 
RUMR Pearson 
Correlation 
.166 .162 .155 .155 .324 .367* .174 -.127 -.272 
Sig. (2-tailed) .342 .352 .375 .375 .058 .030 .316 .466 .114 
N 35 35 35 35 35 35 35 35 35 
COPE
P 
Pearson 
Correlation 
-.001 .193 .231 .186 .300 .284 .133 -.045 -.027 
Sig. (2-tailed) .996 .266 .181 .285 .080 .098 .445 .797 .876 
N 35 35 35 35 35 35 35 35 35 
COPE
E 
Pearson 
Correlation 
.077 .113 .151 .140 .396* .204 .122 -.139 .073 
Sig. (2-tailed) .660 .516 .386 .422 .019 .240 .485 .426 .679 
N 35 35 35 35 35 35 35 35 35 
WORR
Y 
Pearson 
Correlation 
.263 .407* .374* .196 .248 .562** -.145 .052 -.242 
Sig. (2-tailed) .127 .015 .027 .260 .151 .000 .405 .768 .162 
N 35 35 35 35 35 35 35 35 35 
FIRST Pearson 
Correlation 
.377* .132 .211 .241 .223 .450** .071 -.146 -.226 
Sig. (2-tailed) .026 .450 .224 .162 .199 .007 .685 .403 .191 
N 35 35 35 35 35 35 35 35 35 
*. Correlation is significant at the 0.05 level (2-tailed). 
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**. Correlation is significant at the 0.01 level (2-tailed). 
 
Correlations 
 
NEOA NEON RUMD RUMB RUMR 
COPE
P 
COPE
E 
WORR
Y FIRST 
PSQI Pearson 
Correlation 
-.180 .193 .243 .131 .166 -.001 .077 .263 .377* 
Sig. (2-tailed) .301 .266 .160 .454 .342 .996 .660 .127 .026 
N 35 35 35 35 35 35 35 35 35 
ISI Pearson 
Correlation 
-.392* .234 .247 .284 .162 .193 .113 .407* .132 
Sig. (2-tailed) .020 .176 .152 .098 .352 .266 .516 .015 .450 
N 35 35 35 35 35 35 35 35 35 
PSS Pearson 
Correlation 
-.404* .645** .348* .495** .155 .231 .151 .374* .211 
Sig. (2-tailed) .016 .000 .040 .003 .375 .181 .386 .027 .224 
N 35 35 35 35 35 35 35 35 35 
DASS
D 
Pearson 
Correlation 
-.507** .637** .331 .591** .155 .186 .140 .196 .241 
Sig. (2-tailed) .002 .000 .052 .000 .375 .285 .422 .260 .162 
N 35 35 35 35 35 35 35 35 35 
DASS
A 
Pearson 
Correlation 
-.382* .443** .512** .616** .324 .300 .396* .248 .223 
Sig. (2-tailed) .023 .008 .002 .000 .058 .080 .019 .151 .199 
N 35 35 35 35 35 35 35 35 35 
  
NEOA NEON RUMD RUMB RUMR 
COPE
P 
COPE
E 
WORR
Y FIRST 
DASS
S 
Pearson 
Correlation 
-.436** .649** .561** .629** .367* .284 .204 .562** .450** 
Sig. (2-tailed) .009 .000 .000 .000 .030 .098 .240 .000 .007 
N 35 35 35 35 35 35 35 35 35 
NEOO Pearson 
Correlation 
.119 -.145 .103 -.036 .174 .133 .122 -.145 .071 
Sig. (2-tailed) .496 .406 .558 .837 .316 .445 .485 .405 .685 
N 35 35 35 35 35 35 35 35 35 
NEOC Pearson 
Correlation 
.145 -.244 -.205 -.047 -.127 -.045 -.139 .052 -.146 
Sig. (2-tailed) .407 .158 .238 .789 .466 .797 .426 .768 .403 
N 35 35 35 35 35 35 35 35 35 
NEOE Pearson 
Correlation 
.218 -.497** -.232 -.276 -.272 -.027 .073 -.242 -.226 
Sig. (2-tailed) .208 .002 .180 .108 .114 .876 .679 .162 .191 
N 35 35 35 35 35 35 35 35 35 
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NEOA Pearson 
Correlation 
1 -.337* -.124 -.527** -.208 -.138 -.089 -.107 -.072 
Sig. (2-tailed)  .048 .477 .001 .230 .429 .612 .542 .683 
N 35 35 35 35 35 35 35 35 35 
NEON Pearson 
Correlation 
-.337* 1 .507** .572** .357* .409* .222 .658** .463** 
Sig. (2-tailed) .048  .002 .000 .035 .015 .200 .000 .005 
N 35 35 35 35 35 35 35 35 35 
RUMD Pearson 
Correlation 
-.124 .507** 1 .629** .583** .493** .380* .399* .439** 
Sig. (2-tailed) .477 .002  .000 .000 .003 .024 .018 .008 
N 35 35 35 35 35 35 35 35 35 
RUMB Pearson 
Correlation 
-.527** .572** .629** 1 .428* .394* .203 .409* .327 
Sig. (2-tailed) .001 .000 .000  .010 .019 .243 .015 .055 
N 35 35 35 35 35 35 35 35 35 
RUMR Pearson 
Correlation 
-.208 .357* .583** .428* 1 .694** .650** .196 .363* 
Sig. (2-tailed) .230 .035 .000 .010  .000 .000 .260 .032 
N 35 35 35 35 35 35 35 35 35 
COPE
P 
Pearson 
Correlation 
-.138 .409* .493** .394* .694** 1 .783** .196 .309 
Sig. (2-tailed) .429 .015 .003 .019 .000  .000 .260 .071 
N 35 35 35 35 35 35 35 35 35 
COPE
E 
Pearson 
Correlation 
-.089 .222 .380* .203 .650** .783** 1 .078 .322 
Sig. (2-tailed) .612 .200 .024 .243 .000 .000  .654 .059 
N 35 35 35 35 35 35 35 35 35 
WORR
Y 
Pearson 
Correlation 
-.107 .658** .399* .409* .196 .196 .078 1 .453** 
Sig. (2-tailed) .542 .000 .018 .015 .260 .260 .654  .006 
N 35 35 35 35 35 35 35 35 35 
           
 
 
NEOA NEON RUMD RUMB RUMR 
COPE
P 
COPE
E 
WORR
Y FIRST 
FIRST Pearson 
Correlation 
-.072 .463** .439** .327 .363* .309 .322 .453** 1 
Sig. (2-tailed) .683 .005 .008 .055 .032 .071 .059 .006  
N 35 35 35 35 35 35 35 35 35 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
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XI. Estimated Marginal Means of Cortisol Output: 
Vulnerable, Resilient and poor sleeping Group 
(Chapter 4) 
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XII. Scatter-plot for correlation between Cortisol output 
at time 1 and NEOC (Chapter 4) 
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XIII. Sleep Diary Used in Follow- up (Chapter 4) 
Name_______________________________________ 
 
Week Beginning______________________________ 
 
MEASURING THE PATTERN OF YOUR SLEEP 
 Day 
   1 
Day 
   2 
Day 
   3 
Day 
   4 
Day 
   5 
Day 
   6 
Day 
   7 
 
1.  What time did you wake this morning? 
       
 
2.  At what time did you rise from bed? 
       
 
3.  At what time did you go to bed last night?                      
       
4.  Lights Out:-  At what time did you put the 
light 
     out to go to sleep? 
       
5.  How long did it take you to fall asleep  
     (minutes)?  (After Lights Out) 
       
6.  How many times did you wake up during 
     the night? 
       
7.  How long were you awake during the  
      night (in total)? 
       
8.  About how long did you sleep altogether 
     (hours/mins)? 
       
9. Did you take sleeping pills to help you sleep?    
     (please describe) 
       
10.Did you take alcohol before going to bed? 
     (please describe) 
       
11. Did you take painkillers last evening or 
night? 
      (please describe) 
       
12. Did you take pills for depression or anxiety?                      
(please describe) 
       
MEASURING THE QUALITY OF YOUR SLEEP 
 
1. How well do you feel this morning? 
    0             1            2            3            4 
not at all             moderately                   very 
 
       
 
2. How enjoyable was your sleep last night? 
    0             1            2            3            4 
not at all             moderately                   very  
 
       
 
3. How mentally alert were you in bed last  
    night? 
    0             1            2            3            4 
not at all             moderately                   very 
       
 
4. How physically tense were you in bed last 
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    night? 
0             1            2            3            4 
not at all             moderately                   very 
 
 
In the last week how often have you felt nervous and/or ‘stressed’? 
0             1            2            3            4 
not at all         Fairly Often               Very Often 
 
 
Have there been any events in the last week which have caused increased stress? 
 
 Yes/ no 
 
If so, what? 
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XIV. Mean, Skewness and Kurtosis for follow up data 
(Chapter 4; SPSS output) 
 
 
    
Statistic Statistic Statistic Std. Error Statistic Std. Error 
SOL_1 6 15.8667 .914 .845 .332 1.741 
WAKENING 6 .2000 .000 .845 -3.333 1.741 
WASO_1 6 6.8333 2.165 .845 4.872 1.741 
TST_1 6 480.2333 .166 .845 -2.381 1.741 
TIB_1 6 526.4333 .994 .845 2.872 1.741 
SE_1 6 91.9033 -1.597 .845 2.018 1.741 
ALCH_1 6 1.1000 2.289 .845 5.303 1.741 
PILL_1 6 .0000 . . . . 
FEEL_1 6 3.1333 -.095 .845 -1.825 1.741 
ENJOYABLE_1 6 3.1333 -.115 .845 -2.658 1.741 
ALERT_1 6 1.4333 -.040 .845 -.799 1.741 
TENSE_1 6 .6667 .643 .845 .306 1.741 
STRESSED_1 6 .6667 -.968 .845 -1.875 1.741 
RECODE_Symtpom_1 6 1.3333 .919 .845 -1.205 1.741 
no_nights 6 1.1667 1.095 .845 -1.115 1.741 
FIRST 0      
SOL_2 6 15.4333 .876 .845 -.262 1.741 
WAKENING_2 6 .1667 .456 .845 -2.390 1.741 
WASO_2 6 1.6667 2.023 .845 4.202 1.741 
TST_2 6 437.2333 -.188 .845 -1.637 1.741 
TIB_2 6 477.0333 1.869 .845 4.017 1.741 
SE_2 6 92.5408 -.917 .845 1.341 1.741 
ALCH_2 6 2.1333 1.323 .845 .214 1.741 
PILL_2 6 .0000 . . . . 
FEEL_2 6 2.6000 -.574 .845 -1.633 1.741 
ENJOYABLE_2 6 2.5667 -.302 .845 -1.419 1.741 
ALERT_2 6 1.7000 -.894 .845 1.020 1.741 
TENSE_2 6 1.2000 .076 .845 .115 1.741 
STRESSED_2 6 2.6667 .857 .845 -.300 1.741 
RECODE_Symptom_2 6 .8333 1.207 .845 -.459 1.741 
no_nights_2 6 1.3333 1.270 .845 1.531 1.741 
SOL_CHANGE 6 .4333 .417 .845 -2.097 1.741 
WAKENING_CHANGE 6 .0333 -.440 .845 1.335 1.741 
WASO_CHANGE 6 5.1667 2.307 .845 5.414 1.741 
TST_CHANGE 6 43.0000 .112 .845 -1.437 1.741 
TIB_CHANGE 6 49.4000 -.701 .845 -.217 1.741 
SE_CHANGE 6 -.6375 1.105 .845 -.369 1.741 
PSQI 6 3.8333 .418 .845 -.859 1.741 
ISI 6 3.5000 .876 .845 -.048 1.741 
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PSS 6 9.5000 .509 .845 -1.725 1.741 
DASSD 6 .6667 .968 .845 -1.875 1.741 
DASSA 6 1.3333 1.952 .845 3.657 1.741 
DASSS 6 6.0000 .000 .845 -1.875 1.741 
NEOO 6 45.3333 .128 .845 -.665 1.741 
NEOC 6 54.5000 .313 .845 -1.969 1.741 
NEOE 6 59.0000 -.415 .845 .576 1.741 
NEOA 6 56.1667 -.285 .845 .577 1.741 
NEON 6 25.3333 .651 .845 -1.191 1.741 
RUMD 6 17.5000 1.205 .845 .474 1.741 
RUMB 6 7.6667 .778 .845 -1.680 1.741 
RUMR 6 7.1667 .568 .845 -2.001 1.741 
COPEP 6 9.8333 .226 .845 -1.626 1.741 
COPEE 6 11.1667 .306 .845 -2.545 1.741 
COPEAD 3 8.3333 .331 1.225 . . 
COPEM 3 18.6667 -.230 1.225 . . 
WORRY 6 41.0000 -.371 .845 .932 1.741 
T1C 6 4.9804 1.004 .845 .273 1.741 
T2C 6 5.3388 .278 .845 -1.995 1.741 
T3C 6 10.0160 -.454 .845 -1.436 1.741 
T4C 6 9.6214 -.437 .845 -1.574 1.741 
T5C 6 7.9111 -.125 .845 -2.778 1.741 
AUCg 6 295.4485 -.147 .845 -1.418 1.741 
AUCi  6 79.2783 .186 .845 -1.494 1.741 
stress_change 6 2.0000 .000 .845 -3.333 1.741 
Valid N (listwise) 0      
Table represents kurtosis and skeweness values for data used in the follow up analysis for 
the resilient group. Data with ‘_1’ represent values from the non stress week. ‘_2’ represents 
non stress value. Abbreviations can be found in the abbreviations section. ‘Feel’, 
‘Enjoyable’, ‘Alert’ and ‘Tense’ relate to questions from ‘measuring the quality of your sleep’ 
from the sleep diary. 
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Descriptive Statisticsa 
 
N Mean Skewness Kurtosis 
Statistic Statistic Statistic Std. Error Statistic Std. Error 
SOL_1 8 15.4250 .582 .752 -1.274 1.481 
WAKENING_1 8 .4500 -.292 .752 -1.914 1.481 
WASO_1 8 5.1250 .971 .752 -.046 1.481 
TST_1 8 487.7255 -.410 .752 -.931 1.481 
TIB_1 8 537.0813 -1.019 .752 2.019 1.481 
SE_1 8 90.9238 -.300 .752 -1.101 1.481 
ALCH_1 8 .9000 .212 .752 -2.464 1.481 
PILL_1 8 .0000 . . . . 
FEEL_1 8 2.5000 -.723 .752 -.695 1.481 
ENJOYABLE_1 8 2.7500 -.280 .752 .283 1.481 
ALERT_1 8 1.7000 -.415 .752 1.505 1.481 
TENSE_1 8 .9500 .225 .752 -1.216 1.481 
STRESSED 8 1.0000 .935 .752 .350 1.481 
RECODE_Symtpom_1 8 .3750 1.951 .752 3.205 1.481 
no_nights 8 1.1250 .876 .752 -.706 1.481 
SOL_2 8 28.0000 2.367 .752 5.874 1.481 
WAKENING_2 8 .6000 .000 .752 -1.811 1.481 
WASO_2 8 13.9750 1.767 .752 2.997 1.481 
TST_2 8 420.0500 .114 .752 -1.227 1.481 
TIB_2 8 488.4250 .367 .752 -1.568 1.481 
SE_2 8 86.2470 .089 .752 -1.145 1.481 
ALCH_2 8 .4000 1.440 .752 .000 1.481 
PILL_2 8 .0250 2.828 .752 8.000 1.481 
FEEL_2 8 2.2250 -.868 .752 -.359 1.481 
ENJOYABLE_2 8 2.5500 .759 .752 .443 1.481 
ALERT_2 8 1.7625 .240 .752 -.119 1.481 
TENSE_2 8 1.4750 -1.792 .752 3.701 1.481 
STRESSED_2 8 3.0000 .000 .752 -.700 1.481 
sYMPTOM_2 8 3.8750 1.773 .752 3.404 1.481 
RECODE_Symptom_2 8 1.5000 1.663 .752 3.422 1.481 
no_nights_2 8 2.3750 .644 .752 -2.240 1.481 
SOL_CHANGE 8 -12.5750 -1.622 .752 2.664 1.481 
WAKENING_CHANGE 8 -.1500 -.611 .752 -.021 1.481 
WASO_CHANGE 8 -8.8500 -1.439 .752 1.776 1.481 
TST_CHANGE 8 67.6756 .375 .752 -.725 1.481 
TIB_CHANGE 8 48.6563 .330 .752 -.553 1.481 
SE_CHANGE 8 4.6767 -.075 .752 -.311 1.481 
PSQI 8 4.6250 -.302 .752 -.165 1.481 
ISI 8 4.1250 .874 .752 -.043 1.481 
PSS 8 15.1250 -.426 .752 -1.436 1.481 
DASSD 8 6.7500 .874 .752 -.051 1.481 
DASSA 8 5.5000 -.325 .752 -.037 1.481 
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DASSS 8 14.2500 -.186 .752 -.385 1.481 
NEOO 8 55.2500 .917 .752 .433 1.481 
NEOC 8 47.2500 .269 .752 -.544 1.481 
NEOE 8 49.7500 -.051 .752 -1.082 1.481 
NEOA 8 47.3750 -.194 .752 -1.293 1.481 
NEON 8 41.5000 -1.002 .752 -.164 1.481 
RUMD 8 24.1250 -1.328 .752 1.093 1.481 
RUMB 8 11.0000 1.037 .752 .255 1.481 
RUMR 8 12.1250 .111 .752 .077 1.481 
COPEP 8 13.0000 1.257 .752 1.402 1.481 
COPEE 8 15.1250 -.036 .752 -1.828 1.481 
WORRY 8 47.2500 -1.049 .752 .282 1.481 
T1C 8 3.4024 1.167 .752 2.163 1.481 
T2C 8 3.4448 .247 .752 .094 1.481 
T3C 8 4.9066 .346 .752 -1.796 1.481 
T4C 8 5.0529 .403 .752 -2.073 1.481 
T5C 8 4.8300 1.005 .752 -.035 1.481 
AUCg 8 175.2048 .436 .752 -1.428 1.481 
 meancort  8 4.3273 .537 .752 -1.107 1.481 
AUCi 8 39.1092 .561 .752 -1.259 1.481 
stress_change 8 2.0000 .935 .752 .350 1.481 
Valid N (listwise) 0      
Table represents kurtosis and skeweness values for data used in the follow up analysis for 
the Vulnerable group. Data with ‘_1’ represent values from the non stress week. ‘_2’ 
represents non stress value. Abbreviations can be found in the abbreviations section. 
‘Feel’, ‘Enjoyable’, ‘Alert’ and ‘Tense’ relate to questions from ‘measuring the quality of 
your sleep’ from the sleep diary. 
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XV. Median and Interquartile Ranges for Follow-up Data 
(Chapter 4)  
 
 
N 
Median 
Percentiles 
Valid Missing 25 50 75 
SOL_1 6 0 14.0000 6.4500 14.0000 24.7500 
WAKENING_1 6 0 .2000 .0000 .2000 .4000 
WASO_1 6 0 2.5000 .0000 2.5000 12.0000 
TST_1 6 0 477.5000 452.0000 477.5000 511.1000 
TIB_1 6 0 520.5000 497.9000 520.5000 551.5000 
SE_1 6 0 96.1450 84.1500 96.1450 98.5425 
ALCH_1 6 0 .0000 .0000 .0000 2.1500 
PILL_1 6 0 .0000 .0000 .0000 .0000 
FEEL_1 6 0 3.1000 2.7000 3.1000 3.6500 
ENJOYABLE 6 0 3.2000 2.5500 3.2000 3.6500 
ALERT_1 6 0 1.4000 .6500 1.4000 2.3000 
TENSE_1 6 0 .7000 .2000 .7000 .9500 
STRESSED_1 6 0 1.0000 .0000 1.0000 1.0000 
RECODE_Symtpom_1 6 0 .5000 .0000 .5000 3.2500 
SOL_2 6 0 13.0000 8.9500 13.0000 23.0000 
WAKENING_2 6 0 .1000 .0000 .1000 .4000 
WASO_2 6 0 .5000 .0000 .5000 3.2500 
TST_2 6 0 436.5000 422.7500 436.5000 455.5500 
TIB_2 6 0 468.0000 455.6500 468.0000 494.0000 
SE_2 6 0 93.0764 87.0001 93.0764 99.4929 
ALCH_2 6 0 .0000 .0000 .0000 5.6000 
PILL_2 6 0 .0000 .0000 .0000 .0000 
FEEL_2 6 0 2.8000 1.7500 2.8000 3.2500 
ENJOYABLE_2 6 0 2.6000 2.1500 2.6000 3.0000 
ALERT_2 6 0 1.8000 1.1500 1.8000 2.3000 
TENSE_2 6 0 1.1000 .6000 1.1000 1.9500 
STRESSED_2 6 0 2.5000 2.0000 2.5000 3.2500 
RECODE_Symptom_2 6 0 .0000 .0000 .0000 2.2500 
SOL_CHANGE 6 0 -.3000 -2.8500 -.3000 4.2500 
WAKENING_CHANGE 6 0 .0000 -.1000 .0000 .2500 
WASO_CHANGE 6 0 .0000 -1.2500 .0000 10.5000 
TST_CHANGE 6 0 41.0000 33.7500 41.0000 55.2500 
TIB_CHANGE 6 0 53.9000 28.9000 53.9000 68.7500 
SE_CHANGE 6 0 -2.2851 -3.5646 -2.2851 3.2921 
PSQI 6 0 3.5000 2.7500 3.5000 5.2500 
ISI 6 0 3.0000 1.0000 3.0000 5.7500 
PSS 6 0 8.5000 5.7500 8.5000 14.2500 
DASSD 6 0 .0000 .0000 .0000 2.0000 
DASSA 6 0 .0000 .0000 .0000 3.0000 
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DASSS 6 0 6.0000 3.5000 6.0000 8.5000 
NEOO 6 0 46.0000 38.5000 46.0000 50.5000 
NEOC 6 0 52.5000 46.0000 52.5000 65.5000 
NEOE 6 0 59.5000 55.7500 59.5000 62.0000 
NEOA 6 0 55.5000 52.0000 55.5000 62.0000 
NEON 6 0 23.5000 18.7500 23.5000 32.5000 
RUMD 6 0 15.0000 12.0000 15.0000 23.7500 
RUMB 6 0 6.5000 5.0000 6.5000 11.2500 
RUMR 6 0 6.5000 5.0000 6.5000 10.0000 
COPEP 6 0 9.5000 6.7500 9.5000 13.2500 
COPEE 6 0 10.0000 6.0000 10.0000 17.2500 
WORRY 6 0 42.0000 36.5000 42.0000 44.5000 
T1C 6 0 4.4312 2.9201 4.4312 6.7758 
T2C 6 0 5.2219 3.2989 5.2219 7.2195 
T3C 6 0 10.9337 5.2889 10.9337 14.2871 
T4C 6 0 10.0892 5.6835 10.0892 13.8731 
T5C 6 0 8.2414 3.9344 8.2414 11.7259 
AUCg 6 0 293.3734 179.7381 293.3734 431.7675 
Mean Cort 6 0 8.4682 4.2872 8.4682 10.3294 
AUCi  6 0 62.4507 -6.6585 62.4507 196.4361 
Median and Interquartile ranges for the resilient group in the follow-up section ‘_1’ denotes 
data from the normal weeks diary. ‘_2’ indicates data from the stressful weeks diary. For 
abbreviation list see abbreviation section 
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Statisticsa 
 
N 
Median 
Percentiles 
Valid Missing 25 50 75 
SOL_1 8 0 11.5000 7.6500 11.5000 27.6000 
WAKENING_1 8 0 .5000 .0500 .5000 .8000 
WASO_1 8 0 3.0000 .5000 3.0000 9.5000 
TST_1 8 0 496.5020 437.5500 496.5020 541.0000 
TIB_1 8 0 548.0000 506.0000 548.0000 571.2000 
SE_1 8 0 90.4800 87.1725 90.4800 95.7300 
ALCH_1 8 0 .6000 .0000 .6000 2.0000 
PILL_1 8 0 .0000 .0000 .0000 .0000 
FEEL_1 8 0 2.7000 2.0000 2.7000 3.0000 
ENJOYABLE 8 0 2.9000 2.2500 2.9000 3.1500 
ALERT_1 8 0 1.8000 1.1500 1.8000 2.1500 
TENSE_1 8 0 .9000 .1000 .9000 1.6000 
STRESSED_1 8 0 1.0000 .0000 1.0000 1.7500 
RECODE_Symtpom_1 8 0 .0000 .0000 .0000 .7500 
SOL_2 8 0 18.0000 12.0000 18.0000 32.7500 
WAKENING_2 8 0 .6000 .0500 .6000 1.1500 
WASO_2 8 0 2.8000 .3000 2.8000 24.5000 
TST_2 8 0 415.9998 346.0000 415.9998 496.1000 
TIB_2 8 0 466.0000 411.6000 466.0000 579.5000 
SE_2 8 0 86.4346 82.1235 86.4346 90.2968 
ALCH_2 8 0 .0000 .0000 .0000 1.2000 
PILL_2 8 0 .0000 .0000 .0000 .0000 
FEEL_2 8 0 2.4000 1.7000 2.4000 2.7500 
ENJOYABLE_2 8 0 2.4000 1.9000 2.4000 3.0000 
ALERT_2 8 0 1.7000 .7500 1.7000 2.5750 
TENSE_2 8 0 1.6000 1.2500 1.6000 2.0000 
STRESSED_2 8 0 3.0000 2.2500 3.0000 3.7500 
RECODE_Symptom_2 8 0 1.0000 .2500 1.0000 2.0000 
SOL_CHANGE 8 0 -3.0000 -27.6000 -3.0000 5.0000 
WAKENING_CHANGE 8 0 -.1000 -.3500 -.1000 .0000 
WASO_CHANGE 8 0 -.3000 -20.2500 -.3000 .0000 
TST_CHANGE 8 0 59.2022 -7.2500 59.2022 151.7500 
TIB_CHANGE 8 0 62.0250 -39.7500 62.0250 106.4000 
SE_CHANGE 8 0 5.5859 -2.0702 5.5859 8.3395 
PSQI 8 0 5.0000 3.2500 5.0000 5.7500 
ISI 8 0 3.5000 1.0000 3.5000 7.2500 
PSS 8 0 16.0000 7.2500 16.0000 23.0000 
DASSD 8 0 5.0000 2.0000 5.0000 11.5000 
DASSA 8 0 5.0000 4.0000 5.0000 8.0000 
DASSS 8 0 14.0000 8.5000 14.0000 22.5000 
NEOO 8 0 54.5000 49.0000 54.5000 59.5000 
NEOC 8 0 45.5000 40.0000 45.5000 55.7500 
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NEOE 8 0 49.5000 45.5000 49.5000 54.5000 
NEOA 8 0 48.5000 40.0000 48.5000 54.0000 
NEON 8 0 45.5000 28.7500 45.5000 51.2500 
RUMD 8 0 26.0000 19.5000 26.0000 28.7500 
RUMB 8 0 10.0000 8.0000 10.0000 14.7500 
RUMR 8 0 12.5000 7.2500 12.5000 14.7500 
COPEP 8 0 12.0000 11.0000 12.0000 14.7500 
COPEE 8 0 15.0000 12.2500 15.0000 18.0000 
WORRY 8 0 50.5000 36.7500 50.5000 58.2500 
T1C 8 0 3.0898 2.4785 3.0898 4.0641 
T2C 8 0 3.4804 1.9417 3.4804 4.4878 
T3C 8 0 4.1124 1.9879 4.1124 7.9826 
T4C 8 0 4.0296 1.8734 4.0296 8.8672 
T5C 8 0 3.6473 1.7919 3.6473 8.1455 
AUCg 8 0 151.3170 76.9419 151.3170 280.3642 
Mean cort 8 0 3.7478 1.9243 3.7478 6.7897 
AUCi  8 0 21.7350 -19.2061 21.7350 103.0895 
Median and Interquartile ranges for the Vulnerable group in the follow-up section ‘_1’ 
denotes data from the normal weeks diary. ‘_2’ indicates data from the stressful weeks 
diary. For abbreviation list see abbreviation section 
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XVI. Information sheet for Heart-Rate Study (Chapter 5) 
      
 
 
 
Participant Information Sheet 
 
 
Title: Stress reactivity and Sleep 
 
You are being invited to take part in a research study. You are being invited to take part 
because you responded to one of our advertisements and successfully completed the 
screening interview. Before you decide whether or not to take part, it is important for you 
to understand why the research is being done and what it will involve. Please take time to 
read the following information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear or if you would like more information. Take time to 
decide whether or not you wish to take part.  
 
The Study 
This study will be conducted through the University of Glasgow Sleep Centre and the 
School of Psychology. You have been invited to take part in this study based on your 
responses to the screening process. The study in which you are being asked to take part is 
designed to help us profile the relationships between sleep problems, perceived stress, 
personality and coping styles and stress reactivity. Hopefully this type of research will 
help us improve our understanding of insomnia, and give an insight into how insomnia 
can be prevented.  
 
Do I have to take part? 
Taking part in the research is entirely voluntary. This means that it is up to you to decide 
whether or not you would like to take part. If you do not wish to take part it will not 
affect the case or your rights in any way. If you decide to take part in the study, you can 
keep this information sheet and contact the researcher for further information. If you do 
decide to take part, you can change your mind and withdraw from the study at any time, 
even after the study has finished. 
 
What does taking part involve?  
If you decide to take part all you have to do is come to School of Psychology at the 
University of Glasgow where you will be asked to run through a math task while we 
monitor your heart-rate. Heart rate information will allow us to collect information on the 
activity of your nervous system during the task. You will be in the department for roughly 
an hour and a half 
 
. To measure heart-rate 4 electrodes will be placed on your torso: one below your right 
clavicle (near your shoulder), 2 below your left clavicle and one near the bottom of your 
left rib-cage. These will be connected to an ambulatory track-it device which is a standard 
device tested and used for collecting this kind of information.  
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During the math task you will alternately be presented with relaxing scenes, accompanied 
by soothing music and then with multiple choice math tasks which you need to answer 
within a set time. This takes roughly 45 minutes.  
 
Upon completion of the task you will be asked to fill out some questionnaires relating to 
stress, personality, coping style, sleep, worry, rumination anxiety and depression.  
 
You are free to withdraw from the study at any time and omit any questions which you do 
not feel comfortable with.  
 
 
Would my results be kept confidential? What will happen to the results of the study? 
All the information that is collected during the course of the study will remain strictly 
confidential. This means that all information will be kept secured in locked filling cabinets 
and only the researcher will be able to access these. You will be given a unique code that 
will ensure confidentiality and anonymity of all your data. The results of this study will be 
published in a relevant journal so that the general public is also aware of these findings. 
However any information regarding your identity will not be revealed in these.  
 
What are the potential benefits or disadvantages of taking part? 
Taking part will provide us with information on how to improve treatments and aid in 
prevention of insomnia. There are no risks or disadvantages associated with taking part. 
You will also be given advice on how to promote better sleep during times of stress. If you 
are a first year undergraduate psychology student you will receive 2 course credits or £10. 
Otherwise you will receive £10.  
 
Who is organising and paying for the research? 
The research study is organised by Christopher-James Harvey, doctorial research student 
and is funded by The Sackler Institute of Psychobiological Research. 
Educational supervision of this research is provided by Prof Colin Espie and Dr. Jonathan 
Cavanagh 
 
If I decide to take part what happens next? 
If you decide to take part you will be invited to come to the Psychology Department and 
given the opportunity to ask any questions about the research before commencing the 
study.  
 
Thank you for reading this information. If there is anything that is not clear or if you have 
any questions regarding this study you can e-mail the researcher at 
 
c.harvey.1@research.gla.ac.uk or call: 
 
or call Chris on 0141 232 7566 
 
If you would like some independent advice from someone who is not involved in the 
study, please contact Dr Maria Gardani +44 (0)141 232 7700 or 
M.Gardani@clinmed.gla.ac.uk  
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XVII. Consent Form for HR study (Chapter 5) 
                   
 
 
Participant Identification Number for this study: 
 
CONSENT FORM  
Title of Project: Stress reactivity and Sleep  
                          Please initial box 
 
2. I confirm that I have read and understand the information sheet and received my  
own copy dated 21st September 2011 (version 1) for the above study.  
 
2. I have had the opportunity to consider the information provided, ask questions 
and have had these answered satisfactorily. 
  
 
3. I understand that my participation is voluntary and that I am free to withdraw  
at any time, without giving any reason, without my medical care or legal  
rights being affected. 
 
 
4. I understand that data collected during this study may be looked at by responsible 
Individuals from the research team or from regulatory authorities where it is relevant  
to them taking part in research.  
I give permission for these individuals to have access to my records. 
 
 
5.  I consent to the results (in anonymised form) of this study being published in relevant  
journals. 
 
 
6. I agree to be contacted in the future from the Glasgow Sleep Research Centre.  
 
  
 
8. I agree to take part in the above study. 
 
 
 
________________________ ________________                ______________________ 
 
Name of Participant Date Signature 
 
 
 
 
________________________ ________________                  ____________________ 
Researcher Date Signature 
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XVIII. Stimuli for Baseline/ Relaxation Conditions of Heart-
Rate Study (Chapter 5) 
 
Pier and Clouds, Accompanied by Beethoven’s Sonata 14 (moonlight) in c sharp minor 
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Tree in Field, accompanied by Shostakovich - concerto para piano no 2 - andante 
 
 
Water and Rock. Accompanied by Grieg Solveig's Song- Peter Gynt Op. 23. 
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XIX. Stimulus for Stressor Condition (Chapter 5) 
 
Example question for stress condition 
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Example Question for stress condition 
Example Question for stress condition 
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Feedback screen for correct answer 
Feedback screen for incorrect answer 
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XX. Mean, Kurtosis and Skewness of Psychological 
Variables’ (Chapter 5)  
 
  
Descriptive Statisticsa 
 
N Mean Skewness Kurtosis 
Statistic Statistic Statistic Std. Error Statistic Std. Error 
PSQI 13 3.2308 .430 .616 1.615 1.191 
ISI 13 1.4615 .504 .616 -1.447 1.191 
FIRST 13 14.4615 -1.107 .616 1.225 1.191 
PSS 13 10.3077 -.325 .616 -1.352 1.191 
DASS_D 13 4.1538 1.937 .616 4.287 1.191 
DASS_A 13 4.0000 .740 .616 -1.081 1.191 
DASS_S 13 5.5385 .827 .616 -.286 1.191 
NEO_O 13 50.2308 -.008 .616 -1.027 1.191 
NEO_C 13 50.6923 .394 .616 -.759 1.191 
NEO_E 13 53.2308 -1.133 .616 .643 1.191 
NEO_A 13 55.7692 -.496 .616 -1.159 1.191 
NEO_N 13 30.0000 1.406 .616 1.832 1.191 
RUM_B 13 19.6154 .495 .616 .597 1.191 
RUM_D 13 7.5385 1.094 .616 1.694 1.191 
RUM_R 13 8.0000 1.509 .616 1.982 1.191 
COPE_P 13 11.6923 .329 .616 -.728 1.191 
COPE_E 13 13.0769 .844 .616 -.424 1.191 
Valid N (listwise) 13      
Mean, Kurtosis and Skew for the resilient group. Abbreviations can be found in 
the ‘Abbreviations’ section. Table taken directly from SPSS 
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Descriptive Statisticsa 
 
N Mean Skewness Kurtosis 
Statistic Statistic Statistic Std. Error Statistic Std. Error 
PSQI 18 4.5556 .816 .536 .126 1.038 
ISI 18 5.3333 1.197 .536 1.653 1.038 
FIRST 18 21.7222 .281 .536 -1.551 1.038 
PSS 18 17.9444 .373 .536 -1.039 1.038 
DASS_D 17 7.8824 .905 .550 .450 1.063 
DASS_A 17 5.7647 1.694 .550 2.701 1.063 
DASS_S 17 13.0588 .649 .550 .046 1.063 
NEO_O 18 50.3889 .384 .536 -.124 1.038 
NEO_C 18 47.0000 -.271 .536 -.118 1.038 
NEO_E 18 50.1667 -.260 .536 -.061 1.038 
NEO_A 18 53.8889 -.857 .536 1.009 1.038 
NEO_N 18 37.5000 .246 .536 -.110 1.038 
RUM_B 18 24.2222 .514 .536 -.232 1.038 
RUM_D 18 9.3333 1.223 .536 1.005 1.038 
RUM_R 18 9.6667 .778 .536 -.601 1.038 
COPE_P 18 12.1111 -.487 .536 -.182 1.038 
COPE_E 18 13.3889 -.427 .536 -.542 1.038 
Valid N (listwise) 17      
Mean, Kurtosis and Skew for the vulnerable group. Abbreviations can be found in 
‘Abbreviations’ section. Table take directly from SPSS. 
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XXI. Correlation Table for Psychometric Data (Chapter 5) 
Correlations 
 
AGE PSQI ISI FIRST PSS 
DASS_
D 
DASS_
A 
DASS_
S 
NEO_
O 
AGE Pearson 
Correlation 
1 -.125 -.245 -.175 .014 -.133 -.025 .051 .071 
Sig. (2-tailed)  .502 .183 .347 .939 .485 .898 .788 .704 
N 31 31 31 31 31 30 30 30 31 
PSQI Pearson 
Correlation 
-.125 1 .692** .432* .570** .511** .477** .521** .098 
Sig. (2-tailed) .502  .000 .015 .001 .004 .008 .003 .599 
N 31 31 31 31 31 30 30 30 31 
ISI Pearson 
Correlation 
-.245 .692** 1 .596** .661** .623** .353 .641** .112 
Sig. (2-tailed) .183 .000  .000 .000 .000 .055 .000 .548 
N 31 31 31 31 31 30 30 30 31 
FIRST Pearson 
Correlation 
-.175 .432* .596** 1 .608** .318 .181 .549** .019 
Sig. (2-tailed) .347 .015 .000  .000 .087 .338 .002 .920 
N 31 31 31 31 31 30 30 30 31 
PSS Pearson 
Correlation 
.014 .570** .661** .608** 1 .588** .381* .652** .061 
Sig. (2-tailed) .939 .001 .000 .000  .001 .038 .000 .743 
N 31 31 31 31 31 30 30 30 31 
DASS_
D 
Pearson 
Correlation 
-.133 .511** .623** .318 .588** 1 .402* .426* -.027 
Sig. (2-tailed) .485 .004 .000 .087 .001  .028 .019 .887 
N 30 30 30 30 30 30 30 30 30 
DASS_
A 
Pearson 
Correlation 
-.025 .477** .353 .181 .381* .402* 1 .478** -.153 
Sig. (2-tailed) .898 .008 .055 .338 .038 .028  .008 .420 
N 30 30 30 30 30 30 30 30 30 
DASS_
S 
Pearson 
Correlation 
.051 .521** .641** .549** .652** .426* .478** 1 .103 
Sig. (2-tailed) .788 .003 .000 .002 .000 .019 .008  .587 
N 30 30 30 30 30 30 30 30 30 
NEO_
O 
Pearson 
Correlation 
.071 .098 .112 .019 .061 -.027 -.153 .103 1 
Sig. (2-tailed) .704 .599 .548 .920 .743 .887 .420 .587  
N 31 31 31 31 31 30 30 30 31 
NEO_C Pearson 
Correlation 
.039 -.362* -.160 -.201 -.510** -.423* -.354 -.029 .022 
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Sig. (2-tailed) .834 .045 .390 .277 .003 .020 .055 .880 .908 
N 31 31 31 31 31 30 30 30 31 
NEO_E Pearson 
Correlation 
-.124 .087 -.142 .032 -.266 -.174 -.113 .045 -.062 
Sig. (2-tailed) .507 .642 .445 .863 .148 .359 .552 .811 .739 
N 31 31 31 31 31 30 30 30 31 
NEO_A Pearson 
Correlation 
-.115 -.390* -.395* .103 -.358* -.461* -.325 -.249 .103 
Sig. (2-tailed) .537 .030 .028 .582 .048 .010 .080 .185 .581 
N 31 31 31 31 31 30 30 30 31 
NEO_N Pearson 
Correlation 
.014 .335 .310 .388* .628** .522** .598** .499** -.064 
Sig. (2-tailed) .940 .066 .090 .031 .000 .003 .000 .005 .733 
N 31 31 31 31 31 30 30 30 31 
RUM_
B 
Pearson 
Correlation 
-.242 .395* .627** .340 .471** .548** .377* .419* .224 
Sig. (2-tailed) .191 .028 .000 .061 .007 .002 .040 .021 .227 
N 31 31 31 31 31 30 30 30 31 
RUM_
D 
Pearson 
Correlation 
-.191 .150 .227 .133 .169 .165 .372* .245 -.079 
Sig. (2-tailed) .303 .421 .219 .474 .363 .385 .043 .192 .674 
N 31 31 31 31 31 30 30 30 31 
RUM_
R 
Pearson 
Correlation 
-.225 .138 .347 .221 .041 .246 .056 -.007 .325 
Sig. (2-tailed) .223 .458 .056 .233 .826 .190 .769 .970 .075 
N 31 31 31 31 31 30 30 30 31 
COPE_
P 
Pearson 
Correlation 
-.150 -.152 -.112 .075 -.113 -.077 -.056 -.121 .384* 
Sig. (2-tailed) .421 .414 .550 .687 .545 .684 .771 .524 .033 
N 31 31 31 31 31 30 30 30 31 
COPE_
E 
Pearson 
Correlation 
-.096 .059 .024 -.014 -.152 -.130 .069 .051 .475** 
Sig. (2-tailed) .608 .753 .896 .942 .413 .492 .715 .787 .007 
N 31 31 31 31 31 30 30 30 31 
WORR
Y 
Pearson 
Correlation 
.079 .195 .249 .211 .397* .206 .351 .511** .029 
Sig. (2-tailed) .673 .292 .176 .254 .027 .274 .057 .004 .876 
N 31 31 31 31 31 30 30 30 31 
Correlation matrix generated in SPSS, showing correlation for all psychometric variables 
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XXII. Scatter-plots for Whole-Sample showing relationship 
between FIRST scale and other Psychological Variables 
(Chapter 5)
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XXIII. MRI  Checklist 
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XXIV. Participant Information sheet (Chapter 6) 
   
Study Information Sheet - MRI 
 
 
Title of Project: From Acute to Chronic Insomnia: The Role of the Insula 
(Standard Functional Magnetic Resonance Imaging (fMRI) Study) 
 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve. Please take time 
to read the following information carefully and discuss it with others if you wish. If anything 
is unclear or you would like more information, please ask us. Take time to decide whether 
or not you wish to take part.  
Thank you for reading this.  
 
What is the purpose of this study?  
This study will use functional magnetic resonance imaging (fMRI) to take pictures of the 
activity of your brain while responding to neutral and emotive words in order to 
investigate possible differences between poor and good sleepers. Prior to the scan you will 
be asked to fill out some questionnaires, keep a sleep diary for 2 weeks to assess your 
sleep and wear a small wrist-device which will also monitor your sleep.  
 
Why have I been chosen? 
You have been chosen because you have already volunteered to participate in the Centre 
for Cognitive Neuroimaging Research Panel, coordinated at Psychology Department, or you 
volunteered to participate in research studies using functional magnetic resonance 
imaging, or because you have contacted the University of Glasgow Sleep Centre with an 
interest in taking part in our research.  
 
Who is organizing this study?  
This study is organized by Christopher-James Harvey 
 
What will happen to me if I take part?  
Before you take part a member of staff will ask you some questions to ensure that you 
have no metal within you before you enter the strong magnetic field of the MRI scanner. 
You may be asked to remove coloured contact lenses and to change (we provide training 
suits in case there is metal on your clothes). You will then be asked to lie in the scanner 
and the scanning will start. The scanning can be noisy so we shall give you headphones or 
earplugs to reduce this noise.  If you are very claustrophobic, that is if you feel very 
uncomfortable in small closed environment, then it may not be appropriate for you to be 
scanned. 
 
During the scan you will be view different stimuli through a pair of goggles and fitted with 
earphones. You will also be given 2 button boxes in order to make the responses required 
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during the experiment. We will also monitor and record your physiological responses: This 
will involve placing small sensors (electrodes) on your arms, hands and/or chest. Whatever 
the nature of the task, it will always be explained to you before you sign the consent form, 
and will never involve any painful stimulation. We will repeat the instructions before each 
task. At all times you will remain in contact with us through the intercom and you will have 
a buzzer in your hand, in case you want us to stop the scan and come in the scanner room.  
We will ask you in all cases to try to keep your head as still as possible. To help you do so, 
we will place foam pads under your neck and on the side of your head. 
The scanning session will take about one and a half hours, although you will not actually be 
scanned for more than 60 minutes of this time.  
 
What is the device involved?  
We can learn a great deal about how the brain works by looking at the blood flow to 
different parts of the brain whilst the brain performs different tasks. We measure brain 
function using images taken with a magnetic resonance imaging scanner. This scanner uses 
a strong magnetic field to create detailed images of brain structure and function. By taking 
a series of images whilst you perform a task we can build up a picture of the brain areas 
activated by this type of task. The scan does not involve any injections or X-rays.  
 
What are the possible risks/side effects of taking part?  
 The scanner can be loud when it takes images, and you will be given earplugs and/or 
headphones to block out some of the sound. Also, the scanner space is quite reduced, 
and people who are uncomfortable in small or confined spaces may not be able to 
participate. If this applies to you, remember that you may withdraw from the study at any 
time without explaining why.  MRI is generally thought to be a safe, non-invasive imaging 
technique. There are no known risks or side effects, except that in less than 5% of people 
the scanning might induce a peripheral nerve stimulation (felt as small twitches); this is 
not dangerous but might induce discomfort. In some very rare cases, being in the 
magnetic field may also trigger vertigo (dizziness).  In the unlikely case you experience 
one of these feelings, please alert us and withdraw from the study, should you wish to do 
so. Although there is no evidence of danger, as a natural precaution we do not wish to 
include any women who may either be pregnant or have any reason to believe they may 
be pregnant. 
 
What are the possible benefits of taking part?  
We will reimburse you for your time and travel, and you will have the pleasure of knowing 
that you have made a contribution to our understanding of the relationship between brain 
and behaviour. If you suffer from insomnia you will be offered group therapy aimed at 
treating this.  
 
What happens at the end of the study?  
The results of this study may be published in a journal or used for teaching purposes. The results 
may also be presented at scientific meetings, or in talks at academic institutions. Results will 
always be presented in such a way that data from individual volunteers cannot be identified. 
 
Confidentiality - who will have access to the data?  
The data will be stored on a secure network and only members of the Centre for Cognitive 
Neuroimaging (CCNI) of the Psychology Department at University of Glasgow will have 
access to the data. It is possible that the data may be used by researchers working with 
CCNi for other similar ethically approved research protocols, where the same standards of 
Appendices    222 
 
confidentiality will apply. In all cases your name will not be used and your data will be 
identified only by a 5 digit code. 
 
Will my General Practitioner (GP) be informed?  
This is not a diagnostic scan. Your GP will not be routinely informed if your participation in 
this study has been as a normal volunteer. Brain images will NOT be routinely examined for 
abnormalities by a trained neuro-radiologist. Like faces, brains come in all shapes and 
sizes, however, so that there are many normal variations of what the scan shows. There is 
a chance of less than 1:100 that your scan may, by chance, show a significant abnormality 
of which you are unaware.  
There is no guarantee that abnormalities will be picked up. It is possible, however, that an 
abnormality is detected, by chance, in the scan of a normal volunteer by the radiographer 
or one of the investigators. This is referred to as incidental finding. If this happens, your 
brain scan will be examined by a trained neuro-radiologist who will provide an expert 
opinion on the importance of the incidental finding for your health, and on the potential 
health benefit of disclosing this information to you. There are three possible cases: 
- Unlikely net benefit:  If the incidental finding is a condition not likely to be of 
serious importance for your health, or whose likely health importance cannot be 
ascertained, that finding will not be disclosed to you or your GP. 
- Possible net benefit: If the incidental finding consists of a nonfatal condition that 
could possibly be grave or serious but that cannot be avoided or improved, then when you 
are likely to deem that information important, that finding will be disclosed to you with 
appropriate guidance.  You may also choose not to be informed should such an unlikely 
finding apply to you. In that case, please tick the appropriate box on the consent form. 
- Strong net benefit: In the very unlikely case of a life threatening condition or a 
condition likely to be grave and that can be treated or improved, this information will be 
disclosed to you and you will be appropriately advised. Further action will be decided 
which could involve further imaging and/or a discussion between you and your GP or an 
appropriate clinician.  
 
What if new information becomes available?  
If the new information pertains specifically to the health of the volunteer, the volunteer 
may be informed (see previous paragraph). Otherwise, new information will be published 
through traditional scientific channels (journal articles, conference presentations).  
 
What will happen to the study results?  
In accordance with good research practice, they will be kept securely for a minimum of 10 
years and possibly indefinitely in the CCNi data archive. 
 
Will I receive a financial compensation? 
Yes; you will receive £6 per hour for your participation in this study.  
 
Can I ask questions about the research project? 
Yes; we will answer all questions you may have that are related to the research project to 
which you agree to participate (see contact details below) 
 
Can I withdraw from the study? 
Yes. Your participation to this research project is voluntary, and you may withdraw from 
the research at any time and for any reason, without explaining why, and this will not affect 
your medical care or legal rights. 
 
Appendices    223 
 
Can the investigators interrupt the study? 
The research may be interrupted by the researchers at any time, and for several possible 
reasons such as new requirements for the selection of participants, for example.  
 
Are there compensation arrangements if something goes wrong?  
In the unlikely event of anything untoward happening, the University of Glasgow provides 
insurance for claims.  
  
This research study has been approved by the Ethics Committee of the Faculty of 
Information and Mathematical Sciences at University of Glasgow. 
 
Contact details 
Name    
Address    
Telephone       Email   
 
 
Thank you for considering taking part in this study. Our research depends entirely on the 
goodwill of potential volunteers such as you. If you require any further information, we will 
be pleased to help you in any way we can. 
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XXV. Study Consent (Chapter 6) 
   
STUDY INFORMED CONSENT - MRI 
(This form must be completed prior to any scanning) 
 
Study title: From Acute to Chronic Insomnia: The Role of the Insula 
 
I confirm that I have read and understood the Study Information Sheet provided to 
me for the above study and have had the opportunity to ask questions. 
 
I understand the risks and contraindications including pregnancy. 
 
I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving a reason, without my medical care or legal rights being 
affected. 
 
I understand that this is not a diagnostic scan but that should, by chance, 
something abnormal be noticed, an expert neuro-radiologist will examine my scans. 
There is no guarantee, however, that if there is an abnormality, it will be detected. 
 
I do not wish to be informed if a nonfatal condition likely to be grave or serious but 
that cannot be avoided or ameliorated is discovered in my brain (non mandatory 
for participating). 
 
I understand that the research data may be accessed by researchers working at or 
in collaboration with the CCNi in similar ethically approved studies but that at all 
times my personal data will be kept confidential in accordance with data protection 
guidelines. 
 
I have initialled the above boxes myself and I agree to take part in the study. 
 
 
 
_____________________________________________ 
SIGNATURE OF VOLUNTEER 
 
Name: ___________________________________   Date: ___________________ 
 
 
 
 
_____________________________________________ 
SIGNATURE OF WITNESS 
 
Name: ___________________________________   Date: ___________________ 
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XXVI. Words Used for Chapter 6 Paradigm 
Neutral Sleep Anxiety Positive 
stimulu
s 
 praise 
 nation 
 set 
 intellect 
 drawing 
 playful 
 sandwic
h 
 televisi
on 
 shuffle 
 address 
 turn 
 cream 
bottle 
after 
pear 
balcony 
point 
study 
Saturda
y 
texture 
 
night 
alert 
exhausted 
tossing 
fatigue 
tired 
overactive 
restless 
snoring 
dream 
bed 
sleepy 
arousal 
lethargy 
wakeful 
silence 
pillow 
sheets 
dark 
naps 
 
failure 
stupid 
inferior 
lonely 
inept 
embarrassment 
hated 
criticised 
foolish 
pathetic 
indecisive 
inadequate 
 
confident 
relaxed 
optimistic 
assured 
holiday 
welcome 
melody 
windfall 
bold 
entertainment 
capable 
aloof 
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XXVII. Normality values for Psychological Variables 
(Chapter 6) 
 
Descriptive Statisticsa 
 
N Mean Skewness Kurtosis 
Statistic Statistic Statistic Std. Error Statistic Std. Error 
PSQI 11 4.4545 .092 .661 1.873 1.279 
ISI 11 3.4545 .630 .661 -.906 1.279 
PSS 11 12.9091 .327 .661 -1.428 1.279 
DASSD 11 2.7273 .951 .661 .373 1.279 
DASSA 11 3.2727 .546 .661 -1.686 1.279 
DASSS 11 6.0000 .085 .661 -1.111 1.279 
NEOO 11 50.5455 -.036 .661 .184 1.279 
NEOC 11 56.6364 -.401 .661 -1.077 1.279 
NEOE 11 51.2727 -.734 .661 -.939 1.279 
NEOA 11 58.3636 -.997 .661 .766 1.279 
NEON 11 31.0000 -.204 .661 -.823 1.279 
RUMB 11 20.1818 1.164 .661 1.043 1.279 
RUMD 11 8.0000 1.278 .661 3.379 1.279 
RUMR 11 8.3636 1.764 .661 3.614 1.279 
COPEP 11 10.1818 .508 .661 -1.468 1.279 
COPEE 11 12.9091 -.772 .661 -.565 1.279 
WORRY 11 46.4545 .062 .661 -.729 1.279 
Valid N (listwise) 11      
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Descriptive Statisticsa 
 
N Mean Skewness Kurtosis 
Statistic Statistic Statistic Std. Error Statistic Std. Error 
PSQI 11 4.4545 .092 .661 1.873 1.279 
ISI 11 3.4545 .630 .661 -.906 1.279 
PSS 11 12.9091 .327 .661 -1.428 1.279 
DASSD 11 2.7273 .951 .661 .373 1.279 
DASSA 11 3.2727 .546 .661 -1.686 1.279 
DASSS 11 6.0000 .085 .661 -1.111 1.279 
NEOO 11 50.5455 -.036 .661 .184 1.279 
NEOC 11 56.6364 -.401 .661 -1.077 1.279 
NEOE 11 51.2727 -.734 .661 -.939 1.279 
NEOA 11 58.3636 -.997 .661 .766 1.279 
NEON 11 31.0000 -.204 .661 -.823 1.279 
RUMB 11 20.1818 1.164 .661 1.043 1.279 
RUMD 11 8.0000 1.278 .661 3.379 1.279 
RUMR 11 8.3636 1.764 .661 3.614 1.279 
COPEP 11 10.1818 .508 .661 -1.468 1.279 
COPEE 11 12.9091 -.772 .661 -.565 1.279 
WORRY 11 46.4545 .062 .661 -.729 1.279 
Valid N (listwise) 11      
Means, standard deviation and normality values for the psychological variables, for the resilient 
group. It can be seen that DASSD is not normal and so was log transformed. 
 
Descriptive Statisticsa 
 
N Mean Skewness Kurtosis 
Statistic Statistic Statistic Std. Error Statistic Std. Error 
PSQI 12 4.6667 .846 .637 .996 1.232 
ISI 12 4.1667 .357 .637 -.839 1.232 
PSS 12 17.0000 .602 .637 .108 1.232 
DASSD 12 10.5000 1.164 .637 .458 1.232 
DASSA 12 4.6667 1.288 .637 1.922 1.232 
DASSS 12 12.6667 .921 .637 1.882 1.232 
NEOO 12 51.4167 .494 .637 -1.073 1.232 
NEOC 12 46.3333 -.784 .637 2.432 1.232 
NEOE 12 43.6667 .338 .637 .020 1.232 
NEOA 12 54.1667 -.907 .637 2.691 1.232 
NEON 12 41.6667 .515 .637 -.603 1.232 
RUMB 11 25.2727 .089 .661 -1.264 1.279 
RUMD 11 10.4545 .446 .661 -.064 1.279 
RUMR 11 11.0000 .424 .661 -1.469 1.279 
COPEP 12 12.5833 -.356 .637 -.509 1.232 
COPEE 12 14.0000 -.277 .637 .799 1.232 
WORRY 12 48.6667 .845 .637 -.557 1.232 
Means, standard deviations and normality values for the vulnerable group 
MN 
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XXVIII. Correlation Matrix for Psychological Variables (Chapter 6) 
 
Correlations 
 PSQI ISI FIRST PSS DASSD DASSA DASSS NEOO NEOC 
PSQI Pearson Correlation 1 .664** .166 .220 -.123 .115 .066 -.018 -.362 
Sig. (2-tailed)  .000 .428 .292 .557 .586 .754 .931 .075 
N 25 25 25 25 25 25 25 25 25 
ISI Pearson Correlation .664** 1 .245 .305 .280 .367 .277 -.059 -.378 
Sig. (2-tailed) .000  .238 .139 .175 .071 .180 .780 .063 
N 25 25 25 25 25 25 25 25 25 
FIRST Pearson Correlation .166 .245 1 .565** .420* .326 .527** .103 -.483* 
Sig. (2-tailed) .428 .238  .003 .037 .112 .007 .625 .014 
N 25 25 25 25 25 25 25 25 25 
PSS Pearson Correlation .220 .305 .565** 1 .620** .483* .659** .244 -.370 
Sig. (2-tailed) .292 .139 .003  .001 .015 .000 .240 .069 
N 25 25 25 25 25 25 25 25 25 
DASSD Pearson Correlation -.123 .280 .420* .620** 1 .297 .721** .286 -.156 
Sig. (2-tailed) .557 .175 .037 .001  .150 .000 .166 .456 
N 25 25 25 25 25 25 25 25 25 
DASSA Pearson Correlation .115 .367 .326 .483* .297 1 .606** .303 -.359 
Sig. (2-tailed) .586 .071 .112 .015 .150  .001 .141 .078 
N 25 25 25 25 25 25 25 25 25 
DASSS Pearson Correlation .066 .277 .527** .659** .721** .606** 1 .316 -.210 
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Sig. (2-tailed) .754 .180 .007 .000 .000 .001  .124 .314 
N 25 25 25 25 25 25 25 25 25 
NEOO Pearson Correlation -.018 -.059 .103 .244 .286 .303 .316 1 .054 
Sig. (2-tailed) .931 .780 .625 .240 .166 .141 .124  .799 
N 25 25 25 25 25 25 25 25 25 
NEOC Pearson Correlation -.362 -.378 -.483* -.370 -.156 -.359 -.210 .054 1 
Sig. (2-tailed) .075 .063 .014 .069 .456 .078 .314 .799  
N 25 25 25 25 25 25 25 25 25 
NEOE Pearson Correlation -.159 -.351 -.518** -.231 -.410* -.272 -.403* -.145 .456* 
Sig. (2-tailed) .447 .086 .008 .267 .042 .188 .046 .488 .022 
N 25 25 25 25 25 25 25 25 25 
NEOA Pearson Correlation -.235 -.117 -.215 -.090 -.014 -.127 -.216 .144 .475* 
Sig. (2-tailed) .257 .578 .301 .668 .946 .547 .300 .491 .016 
N 25 25 25 25 25 25 25 25 25 
NEON Pearson Correlation .176 .227 .669** .675** .481* .599** .690** .218 -.519** 
Sig. (2-tailed) .399 .276 .000 .000 .015 .002 .000 .295 .008 
N 25 25 25 25 25 25 25 25 25 
RUMB Pearson Correlation -.243 .069 .452* .539** .613** .408* .573** .223 -.020 
Sig. (2-tailed) .253 .749 .026 .007 .001 .048 .003 .294 .927 
N 24 24 24 24 24 24 24 24 24 
RUMD Pearson Correlation -.137 -.010 .590** .702** .427* .490* .490* .308 -.225 
Sig. (2-tailed) .523 .962 .002 .000 .037 .015 .015 .144 .291 
N 24 24 24 24 24 24 24 24 24 
RUMR Pearson Correlation -.254 -.051 .335 .383 .566** .178 .329 .254 -.002 
Sig. (2-tailed) .231 .812 .109 .065 .004 .404 .117 .231 .991 
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N 24 24 24 24 24 24 24 24 24 
COPEP Pearson Correlation .080 .163 .375 .252 .262 .275 .251 -.040 -.195 
Sig. (2-tailed) .705 .435 .064 .224 .205 .183 .226 .851 .351 
N 25 25 25 25 25 25 25 25 25 
COPEE Pearson Correlation .152 .260 .242 .522** .313 .487* .398* .157 -.214 
Sig. (2-tailed) .468 .209 .243 .007 .128 .014 .049 .453 .305 
N 25 25 25 25 25 25 25 25 25 
WORRY Pearson Correlation -.106 -.010 .392 .557** .184 .364 .304 -.204 -.206 
Sig. (2-tailed) .615 .962 .052 .004 .378 .073 .139 .329 .322 
N 25 25 25 25 25 25 25 25 25 
Zscore(DASSD) Pearson Correlation -.121 .154 .149 .665** .794** .478* .660** .459* -.120 
Sig. (2-tailed) .563 .462 .477 .000 .000 .016 .000 .021 .569 
N 25 25 25 25 25 25 25 25 25 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
Correlations 
 NEOE NEOA NEON RUMB RUMD RUMR COPEP COPEE 
PSQI Pearson 
Correlation 
-.159 -.235 .176 -.243 -.137 -.254 .080 .152 
Sig. (2-tailed) .447 .257 .399 .253 .523 .231 .705 .468 
N 25 25 25 24 24 24 25 25 
ISI Pearson 
Correlation 
-.351 -.117 .227 .069 -.010 -.051 .163 .260 
Sig. (2-tailed) .086 .578 .276 .749 .962 .812 .435 .209 
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N 25 25 25 24 24 24 25 25 
FIRST Pearson 
Correlation 
-.518** -.215 .669** .452* .590** .335 .375 .242 
Sig. (2-tailed) .008 .301 .000 .026 .002 .109 .064 .243 
N 25 25 25 24 24 24 25 25 
PSS Pearson 
Correlation 
-.231 -.090 .675** .539** .702** .383 .252 .522** 
Sig. (2-tailed) .267 .668 .000 .007 .000 .065 .224 .007 
N 25 25 25 24 24 24 25 25 
DASSD Pearson 
Correlation 
-.410* -.014 .481* .613** .427* .566** .262 .313 
Sig. (2-tailed) .042 .946 .015 .001 .037 .004 .205 .128 
N 25 25 25 24 24 24 25 25 
DASSA Pearson 
Correlation 
-.272 -.127 .599** .408* .490* .178 .275 .487* 
Sig. (2-tailed) .188 .547 .002 .048 .015 .404 .183 .014 
N 25 25 25 24 24 24 25 25 
DASSS Pearson 
Correlation 
-.403* -.216 .690** .573** .490* .329 .251 .398* 
Sig. (2-tailed) .046 .300 .000 .003 .015 .117 .226 .049 
N 25 25 25 24 24 24 25 25 
NEOO Pearson 
Correlation 
-.145 .144 .218 .223 .308 .254 -.040 .157 
Sig. (2-tailed) .488 .491 .295 .294 .144 .231 .851 .453 
N 25 25 25 24 24 24 25 25 
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NEOC Pearson 
Correlation 
.456* .475* -.519** -.020 -.225 -.002 -.195 -.214 
Sig. (2-tailed) .022 .016 .008 .927 .291 .991 .351 .305 
N 25 25 25 24 24 24 25 25 
NEOE Pearson 
Correlation 
1 .290 -.572** -.478* -.241 -.443* -.291 -.225 
Sig. (2-tailed)  .159 .003 .018 .256 .030 .159 .279 
N 25 25 25 24 24 24 25 25 
NEOA Pearson 
Correlation 
.290 1 -.249 .021 -.028 -.096 -.350 -.334 
Sig. (2-tailed) .159  .229 .924 .895 .657 .086 .102 
N 25 25 25 24 24 24 25 25 
NEON Pearson 
Correlation 
-.572** -.249 1 .584** .639** .339 .323 .355 
Sig. (2-tailed) .003 .229  .003 .001 .105 .116 .081 
N 25 25 25 24 24 24 25 25 
RUMB Pearson 
Correlation 
-.478* .021 .584** 1 .702** .762** .168 .179 
Sig. (2-tailed) .018 .924 .003  .000 .000 .432 .403 
N 24 24 24 24 24 24 24 24 
RUMD Pearson 
Correlation 
-.241 -.028 .639** .702** 1 .680** .371 .382 
Sig. (2-tailed) .256 .895 .001 .000  .000 .074 .065 
N 24 24 24 24 24 24 24 24 
RUMR Pearson 
Correlation 
-.443* -.096 .339 .762** .680** 1 .271 .184 
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Sig. (2-tailed) .030 .657 .105 .000 .000  .200 .390 
N 24 24 24 24 24 24 24 24 
COPEP Pearson 
Correlation 
-.291 -.350 .323 .168 .371 .271 1 .723** 
Sig. (2-tailed) .159 .086 .116 .432 .074 .200  .000 
N 25 25 25 24 24 24 25 25 
COPEE Pearson 
Correlation 
-.225 -.334 .355 .179 .382 .184 .723** 1 
Sig. (2-tailed) .279 .102 .081 .403 .065 .390 .000  
N 25 25 25 24 24 24 25 25 
WORRY Pearson 
Correlation 
-.282 .083 .638** .599** .584** .302 .108 .209 
Sig. (2-tailed) .172 .693 .001 .002 .003 .152 .608 .317 
N 25 25 25 24 24 24 25 25 
Zscore(DASS
D) 
Pearson 
Correlation 
-.214 .016 .463* .596** .518** .524** .198 .461* 
Sig. (2-tailed) .304 .938 .020 .002 .009 .009 .342 .020 
N 25 25 25 24 24 24 25 25 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
Correlations 
 WORRY Zscore(DASSD) 
PSQI Pearson Correlation -.106 -.121 
Sig. (2-tailed) .615 .563 
N 25 25 
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ISI Pearson Correlation -.010 .154 
Sig. (2-tailed) .962 .462 
N 25 25 
FIRST Pearson Correlation .392 .149 
Sig. (2-tailed) .052 .477 
N 25 25 
PSS Pearson Correlation .557** .665** 
Sig. (2-tailed) .004 .000 
N 25 25 
DASSD Pearson Correlation .184 .794** 
Sig. (2-tailed) .378 .000 
N 25 25 
DASSA Pearson Correlation .364 .478* 
Sig. (2-tailed) .073 .016 
N 25 25 
DASSS Pearson Correlation .304 .660** 
Sig. (2-tailed) .139 .000 
N 25 25 
NEOO Pearson Correlation -.204 .459* 
Sig. (2-tailed) .329 .021 
N 25 25 
NEOC Pearson Correlation -.206 -.120 
Sig. (2-tailed) .322 .569 
N 25 25 
NEOE Pearson Correlation -.282 -.214 
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Sig. (2-tailed) .172 .304 
N 25 25 
NEOA Pearson Correlation .083 .016 
Sig. (2-tailed) .693 .938 
N 25 25 
NEON Pearson Correlation .638** .463* 
Sig. (2-tailed) .001 .020 
N 25 25 
RUMB Pearson Correlation .599** .596** 
Sig. (2-tailed) .002 .002 
N 24 24 
RUMD Pearson Correlation .584** .518** 
Sig. (2-tailed) .003 .009 
N 24 24 
RUMR Pearson Correlation .302 .524** 
Sig. (2-tailed) .152 .009 
N 24 24 
COPEP Pearson Correlation .108 .198 
Sig. (2-tailed) .608 .342 
N 25 25 
COPEE Pearson Correlation .209 .461* 
Sig. (2-tailed) .317 .020 
N 25 25 
WORRY Pearson Correlation 1 .257 
Sig. (2-tailed)  .214 
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N 25 25 
Zscore(DASSD) Pearson Correlation .257 1 
Sig. (2-tailed) .214  
N 25 25 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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XXIX. Scatterplot Showing Relationship Between FIRST 
and other Psychological Variables in the Whole 
Sample 
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XXX. Whole Brain Report (Chapter 6) 
analyse/Project0071/group/spmT_0002.img,1 
Type: T 
df: 22 
Threshold 
-- p value = 0.001 
-- intensity = 3.505 
-- cluster size = 20 
Number of clusters found: 16 
---------------------- 
Cluster 1 
Number of voxels: 4237 
Peak MNI coordinate: 40  24   2 
Peak MNI coordinate region:  // Right Cerebrum // Frontal 
Lobe // Inferior Frontal Gyrus // Gray Matter // brodmann 
area 47 // Insula_R (aal) 
Peak intensity: 6.2282 
# voxels        structure 
 4237    --TOTAL # VOXELS-- 
 3495    Sub-lobar 
 2442    Gray Matter 
 2194    Right Cerebrum 
 1565    Left Cerebrum 
 1338    White Matter 
 1004    Lentiform Nucleus 
  986   Extra-Nuclear 
  981   Thalamus 
  850   Putamen 
  659   Thalamus_R (aal) 
  556   Putamen_R (aal) 
  477   Midbrain 
  463   Putamen_L (aal) 
  440   Thalamus_L (aal) 
  340   Insula 
  278   Insula_R (aal) 
  265   Right Brainstem 
  238   Frontal Lobe 
  210   Left Brainstem 
  195   Inferior Frontal Gyrus 
  190   Insula_L (aal) 
  186   Caudate_R (aal) 
  179   Ventral Lateral Nucleus 
  166   Medial Dorsal Nucleus 
  117   brodmann area 13 
  115   Pulvinar 
  111   Caudate_L (aal) 
  107   Caudate 
   92   Lateral Globus Pallidus 
   88   Pallidum_R (aal) 
   76   Caudate Body 
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   63   Pallidum_L (aal) 
   61   Medial Globus Pallidus 
   61   Ventral Anterior Nucleus 
   52   Claustrum 
   49   Red Nucleus 
   48   brodmann area 47 
   43   Ventral Posterior Lateral Nucleus 
   39   Sub-Gyral 
   39   Frontal_Inf_Tri_L (aal) 
   35   Lateral Posterior Nucleus 
   32   Subthalamic Nucleus 
   31   Caudate Head 
   25   Mammillary Body 
   24   Frontal_Inf_Oper_L (aal) 
   23   Frontal_Inf_Tri_R (aal) 
   20   Lateral Dorsal Nucleus 
   20   Ventral Posterior Medial Nucleus 
   19   Cerebro-Spinal Fluid 
   17   brodmann area 45 
   14   Lateral Ventricle 
   13   Rolandic_Oper_L (aal) 
   11   Frontal-Temporal Space 
   10   Hippocampus_R (aal) 
   10   Superior Temporal Gyrus 
   10   Temporal Lobe 
   10   Frontal_Inf_Oper_R (aal) 
   10   Substania Nigra 
    9   Midline Nucleus 
    7   Subcallosal Gyrus 
    6   brodmann area 22 
    5   Lateral Geniculum Body 
    5   Third Ventricle 
    4   Frontal_Inf_Orb_L (aal) 
    4   Limbic Lobe 
    3   brodmann area 44 
    3   Precentral Gyrus 
    3   Inter-Hemispheric 
    3   Olfactory_R (aal) 
    2   Parahippocampa Gyrus 
    2   brodmann area 27 
    2   Temporal_Pole_Sup_L (aal) 
    1   Frontal_Inf_Orb_R (aal) 
    1   Middle Frontal Gyrus 
---------------------- 
Cluster 2 
Number of voxels: 58 
Peak MNI coordinate: 0 -48  -4 
Peak MNI coordinate region:  // Left Cerebellum // Cerebellum 
Anterior Lobe // Culmen // undefined // undefined // 
Vermis_4_5 (aal) 
Peak intensity: 4.378 
# voxels        structure 
   58   --TOTAL # VOXELS-- 
   58   Culmen 
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   58   Cerebellum Anterior Lobe 
   53   Left Cerebellum 
   44   Vermis_4_5 (aal) 
   14   Cerebelum_4_5_L (aal) 
    5   Right Cerebellum 
---------------------- 
Cluster 3 
Number of voxels: 21 
Peak MNI coordinate: 14 -70  -4 
Peak MNI coordinate region:  // Right Cerebrum // Occipital 
Lobe // Lingual Gyrus // Gray Matter // brodmann area 18 // 
Lingual_R (aal) 
Peak intensity: -4.08 
# voxels        structure 
   21   --TOTAL # VOXELS-- 
   21   Lingual Gyrus 
   21   Lingual_R (aal) 
   21   Occipital Lobe 
   21   Right Cerebrum 
   13   Gray Matter 
   10   brodmann area 18 
    8   White Matter 
---------------------- 
Cluster 4 
Number of voxels: 41 
Peak MNI coordinate: -20 -30  -2 
Peak MNI coordinate region:  // Left Cerebrum // Sub-lobar // 
Thalamus // Gray Matter // undefined // undefined 
Peak intensity: 4.7261 
# voxels        structure 
   41   --TOTAL # VOXELS-- 
   34   Left Cerebrum 
   31   Sub-lobar 
   24   Gray Matter 
   19   Thalamus 
   11   White Matter 
    9   Extra-Nuclear 
    9   Thalamus_L (aal) 
    8   Hippocampus_L (aal) 
    5   Midbrain 
    5   Left Brainstem 
    3   Parahippocampa Gyrus 
    3   Limbic Lobe 
    3   Lateral Geniculum Body 
    2   brodmann area 27 
    1   Pulvinar 
---------------------- 
Cluster 5 
Number of voxels: 24 
Peak MNI coordinate: -30 -54  -2 
Peak MNI coordinate region:  // Left Cerebrum // Temporal 
Lobe // Sub-Gyral // White Matter // undefined // undefined 
Peak intensity: -4.5078 
# voxels        structure 
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   24   --TOTAL # VOXELS-- 
   24   Sub-Gyral 
   24   White Matter 
   24   Left Cerebrum 
   19   Lingual_L (aal) 
   15   Occipital Lobe 
    9   Temporal Lobe 
    1   Fusiform_L (aal) 
---------------------- 
Cluster 6 
Number of voxels: 451 
Peak MNI coordinate: 58 -10   4 
Peak MNI coordinate region:  // Right Cerebrum // Temporal 
Lobe // Superior Temporal Gyrus // White Matter // undefined 
// Temporal_Sup_R (aal) 
Peak intensity: -7.3446 
# voxels        structure 
  451   --TOTAL # VOXELS-- 
  451   Right Cerebrum 
  326   Temporal Lobe 
  289   Superior Temporal Gyrus 
  251   Temporal_Sup_R (aal) 
  241   White Matter 
  174   Gray Matter 
  126   Heschl_R (aal) 
  116   Sub-lobar 
  113   Insula 
   87   brodmann area 22 
   65   Insula_R (aal) 
   62   brodmann area 13 
   39   Transverse Temporal Gyrus 
   20   brodmann area 41 
   10   Precentral Gyrus 
    9   Frontal Lobe 
    5   Rolandic_Oper_R (aal) 
    2   brodmann area 6 
---------------------- 
Cluster 7 
Number of voxels: 471 
Peak MNI coordinate: -52 -16   8 
Peak MNI coordinate region:  // Left Cerebrum // Temporal 
Lobe // Superior Temporal Gyrus // White Matter // undefined 
// Heschl_L (aal) 
Peak intensity: -7.2773 
# voxels        structure 
  471   --TOTAL # VOXELS-- 
  471   Left Cerebrum 
  260   Temporal Lobe 
  231   White Matter 
  222   Gray Matter 
  200   Sub-lobar 
  182   Insula 
  180   Superior Temporal Gyrus 
  176   Temporal_Sup_L (aal) 
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  150   Heschl_L (aal) 
  117   brodmann area 13 
   75   Transverse Temporal Gyrus 
   66   Insula_L (aal) 
   50   brodmann area 41 
   45   Rolandic_Oper_L (aal) 
   44   brodmann area 22 
   22   Extra-Nuclear 
   11   Precentral Gyrus 
   11   Frontal Lobe 
    5   brodmann area 43 
    1   Sub-Gyral 
    1   brodmann area 42 
---------------------- 
Cluster 8 
Number of voxels: 71 
Peak MNI coordinate: -36   0   4 
Peak MNI coordinate region:  // Left Cerebrum // Sub-lobar // 
Claustrum // Gray Matter // undefined // undefined 
Peak intensity: 4.8635 
# voxels        structure 
   71   --TOTAL # VOXELS-- 
   71   Left Cerebrum 
   71   Sub-lobar 
   48   White Matter 
   48   Insula 
   32   Insula_L (aal) 
   23   Gray Matter 
   20   Rolandic_Oper_L (aal) 
   17   brodmann area 13 
   17   Extra-Nuclear 
    6   Claustrum 
    3   Putamen_L (aal) 
---------------------- 
Cluster 9 
Number of voxels: 33 
Peak MNI coordinate: 54  12   6 
Peak MNI coordinate region:  // Right Cerebrum // Frontal-
Temporal Space // undefined // undefined // undefined // 
Frontal_Inf_Oper_R (aal) 
Peak intensity: 4.6859 
# voxels        structure 
   33   --TOTAL # VOXELS-- 
   33   Right Cerebrum 
   33   Frontal_Inf_Oper_R (aal) 
   26   Frontal Lobe 
   17   Precentral Gyrus 
   15   brodmann area 44 
   15   Gray Matter 
   10   White Matter 
    8   Inferior Frontal Gyrus 
    7   Frontal-Temporal Space 
---------------------- 
Cluster 10 
Appendices    246 
 
Number of voxels: 20 
Peak MNI coordinate: -4  48  14 
Peak MNI coordinate region:  // Left Cerebrum // Frontal Lobe 
// Medial Frontal Gyrus // Gray Matter // brodmann area 10 // 
Cingulum_Ant_L (aal) 
Peak intensity: -4.7151 
# voxels        structure 
   20   --TOTAL # VOXELS-- 
   20   Left Cerebrum 
   17   Frontal Lobe 
   17   Medial Frontal Gyrus 
   13   Cingulum_Ant_L (aal) 
   11   Gray Matter 
    9   White Matter 
    8   brodmann area 10 
    7   Frontal_Sup_Medial_L (aal) 
    3   Anterior Cingulate 
    3   brodmann area 32 
    3   Limbic Lobe 
---------------------- 
Cluster 11 
Number of voxels: 5942 
Peak MNI coordinate: 46 -12  48 
Peak MNI coordinate region:  // Right Cerebrum // Frontal 
Lobe // Precentral Gyrus // White Matter // undefined // 
Precentral_R (aal) 
Peak intensity: 6.7446 
# voxels        structure 
 5942    --TOTAL # VOXELS-- 
 4163    Right Cerebrum 
 4117    Frontal Lobe 
 2867    White Matter 
 2561    Gray Matter 
 1749    Left Cerebrum 
 1363    Precentral Gyrus 
 1291    Parietal Lobe 
 1224    brodmann area 6 
 1165    Precentral_R (aal) 
  925   Middle Frontal Gyrus 
  920   Postcentral_R (aal) 
  807   Postcentral Gyrus 
  725   Precentral_L (aal) 
  670   Medial Frontal Gyrus 
  653   Sub-Gyral 
  592   Cingulate Gyrus 
  517   Supp_Motor_Area_L (aal) 
  504   Limbic Lobe 
  497   Supp_Motor_Area_R (aal) 
  348   Inferior Frontal Gyrus 
  331   Frontal_Sup_R (aal) 
  258   brodmann area 32 
  255   Cingulum_Mid_R (aal) 
  254   Inferior Parietal Lobule 
  249   brodmann area 4 
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  218   Superior Frontal Gyrus 
  193   Parietal_Inf_R (aal) 
  193   brodmann area 40 
  192   brodmann area 3 
  154   Frontal_Mid_R (aal) 
  146   Parietal_Sup_R (aal) 
  138   SupraMarginal_R (aal) 
  133   Frontal_Sup_L (aal) 
  121   brodmann area 9 
  116   Frontal_Mid_L (aal) 
  109   brodmann area 24 
   99   brodmann area 2 
   96   Cingulum_Mid_L (aal) 
   92   Frontal_Inf_Oper_R (aal) 
   56   Postcentral_L (aal) 
   52   brodmann area 7 
   49   Superior Parietal Lobule 
   28   Inter-Hemispheric 
   27   Precuneus 
   23   Frontal_Inf_Oper_L (aal) 
   23   brodmann area 5 
   20   brodmann area 8 
   12   Frontal_Sup_Medial_L (aal) 
    8   brodmann area 1 
    7   brodmann area 45 
    6   Anterior Cingulate 
    6   brodmann area 44 
    6   Cingulum_Ant_R (aal) 
    1   Frontal_Inf_Tri_R (aal) 
    1   Rolandic_Oper_L (aal) 
    1   Paracentral_Lobule_L (aal) 
    1   Precuneus_R (aal) 
---------------------- 
Cluster 12 
Number of voxels: 1349 
Peak MNI coordinate: -50 -26  44 
Peak MNI coordinate region:  // Left Cerebrum // Parietal 
Lobe // Postcentral Gyrus // White Matter // undefined // 
Parietal_Inf_L (aal) 
Peak intensity: 6.1829 
# voxels        structure 
 1349    --TOTAL # VOXELS-- 
 1348    Left Cerebrum 
 1334    Parietal Lobe 
  830   White Matter 
  513   Parietal_Inf_L (aal) 
  467   Gray Matter 
  426   Postcentral Gyrus 
  355   Parietal_Sup_L (aal) 
  281   Postcentral_L (aal) 
  257   Inferior Parietal Lobule 
  240   Sub-Gyral 
  227   Precuneus 
  204   brodmann area 7 
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  185   Superior Parietal Lobule 
  119   brodmann area 2 
  112   brodmann area 40 
   62   SupraMarginal_L (aal) 
   33   Precuneus_L (aal) 
   27   Occipital_Mid_L (aal) 
   20   brodmann area 3 
   14   Frontal Lobe 
   10   brodmann area 4 
    7   Precentral Gyrus 
    6   Supramarginal Gyrus 
    2   Rolandic_Oper_L (aal) 
    2   Occipital_Sup_L (aal) 
    1   brodmann area 1 
    1   brodmann area 5 
---------------------- 
Cluster 13 
Number of voxels: 56 
Peak MNI coordinate: -2 -88  26 
Peak MNI coordinate region:  // Left Cerebrum // Occipital 
Lobe // Cuneus // Gray Matter // brodmann area 19 // Cuneus_L 
(aal) 
Peak intensity: -4.4678 
# voxels        structure 
   56   --TOTAL # VOXELS-- 
   55   Cuneus 
   55   Occipital Lobe 
   45   Cuneus_L (aal) 
   40   Left Cerebrum 
   32   Gray Matter 
   18   brodmann area 19 
   18   White Matter 
   15   Right Cerebrum 
   13   brodmann area 18 
   11   Cuneus_R (aal) 
    1   brodmann area 7 
    1   Inter-Hemispheric 
---------------------- 
Cluster 14 
Number of voxels: 140 
Peak MNI coordinate: 38  34  22 
Peak MNI coordinate region:  // Right Cerebrum // Frontal 
Lobe // Middle Frontal Gyrus // White Matter // undefined // 
Frontal_Mid_R (aal) 
Peak intensity: 5.7978 
# voxels        structure 
  140   --TOTAL # VOXELS-- 
  140   Frontal Lobe 
  140   Right Cerebrum 
  137   White Matter 
  100   Middle Frontal Gyrus 
   89   Frontal_Mid_R (aal) 
   51   Frontal_Inf_Tri_R (aal) 
   40   Sub-Gyral 
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    3   brodmann area 46 
    3   Gray Matter 
---------------------- 
Cluster 15 
Number of voxels: 269 
Peak MNI coordinate: -8 -42  34 
Peak MNI coordinate region:  // Left Cerebrum // Limbic Lobe 
// Cingulate Gyrus // White Matter // undefined // 
Cingulum_Mid_L (aal) 
Peak intensity: -5.499 
# voxels        structure 
  269   --TOTAL # VOXELS-- 
  213   Limbic Lobe 
  209   Cingulate Gyrus 
  145   Left Cerebrum 
  144   Cingulum_Mid_L (aal) 
  125   Gray Matter 
  117   brodmann area 31 
  110   Right Cerebrum 
   98   White Matter 
   66   Cingulum_Mid_R (aal) 
   44   Precuneus_R (aal) 
   30   Precuneus 
   27   Parietal Lobe 
   15   Frontal Lobe 
   14   Inter-Hemispheric 
   13   Cingulum_Post_L (aal) 
   11   Paracentral Lobule 
    8   brodmann area 7 
    5   Sub-Gyral 
    2   Precuneus_L (aal) 
---------------------- 
Cluster 16 
Number of voxels: 95 
Peak MNI coordinate: 28 -60  48 
Peak MNI coordinate region:  // Right Cerebrum // Parietal 
Lobe // Superior Parietal Lobule // Gray Matter // brodmann 
area 7 // Angular_R (aal) 
Peak intensity: 4.3743 
# voxels        structure 
   95   --TOTAL # VOXELS-- 
   95   Parietal Lobe 
   95   Right Cerebrum 
   63   White Matter 
   47   Angular_R (aal) 
   38   Superior Parietal Lobule 
   34   Sub-Gyral 
   32   Gray Matter 
   30   brodmann area 7 
   20   Precuneus 
   15   Parietal_Sup_R (aal) 
    7   Occipital_Sup_R (aal) 
    7   Occipital_Mid_R (aal) 
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    3   Inferior Parietal Lobule 
    2   brodmann area 39  
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XXXI. Insula ROI Definition(chapter 6) 
 
 
 
Centre co-ordinate of left insula: -45, 5, -4; Diameter of 10mm 
 
      “     “       “         “ Right Insula: 47, 5, -1; Diameter of 10mm 
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XXXII. Between Group Whole Brain Report (Chapter 6) 
Threshold 
-- p value = 0.001 
-- intensity = 3.505 
-- cluster size = 5 
Number of clusters found: 5 
---------------------- 
Cluster 1 
Number of voxels: 7 
Peak MNI coordinate: -50 -48  44 
Peak MNI coordinate region:  // Left Cerebrum // Parietal Lobe // 
Inferior Parietal Lobule // Gray Matter // brodmann area 40 // 
Parietal_Inf_L (aal) 
Peak intensity: -3.7651 
# voxels        structure 
    7   --TOTAL # VOXELS-- 
    7   Inferior Parietal Lobule 
    7   Left Cerebrum 
    7   Parietal Lobe 
    7   Parietal_Inf_L (aal) 
    4   White Matter 
    3   brodmann area 40 
    3   Gray Matter 
---------------------- 
Cluster 2 
Number of voxels: 22 
Peak MNI coordinate: 52 -46  48 
Peak MNI coordinate region:  // Right Cerebrum // Parietal Lobe // 
Inferior Parietal Lobule // White Matter // undefined // Parietal_Inf_R 
(aal) 
Peak intensity: -4.9938 
# voxels        structure 
   22   --TOTAL # VOXELS-- 
   22   Inferior Parietal Lobule 
   22   Parietal Lobe 
   22   Parietal_Inf_R (aal) 
   22   Right Cerebrum 
   14   Gray Matter 
   14   brodmann area 40 
    8   White Matter 
---------------------- 
Cluster 3 
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Number of voxels: 6 
Peak MNI coordinate: -42 -58  50 
Peak MNI coordinate region:  // Left Cerebrum // Parietal Lobe // 
Inferior Parietal Lobule // Gray Matter // brodmann area 40 // 
Parietal_Inf_L (aal) 
Peak intensity: -3.6952 
# voxels        structure 
    6   --TOTAL # VOXELS-- 
    6   Inferior Parietal Lobule 
    6   Left Cerebrum 
    6   Parietal Lobe 
    6   Parietal_Inf_L (aal) 
    4   Gray Matter 
    4   brodmann area 40 
    1   White Matter 
---------------------- 
Cluster 4 
Number of voxels: 24 
Peak MNI coordinate: -28 -36  52 
Peak MNI coordinate region:  // Left Cerebrum // Parietal Lobe // 
Postcentral Gyrus // Gray Matter // brodmann area 3 // Postcentral_L 
(aal) 
Peak intensity: 5.1318 
# voxels        structure 
   24   --TOTAL # VOXELS-- 
   24   Left Cerebrum 
   24   Parietal Lobe 
   24   Postcentral Gyrus 
   24   Postcentral_L (aal) 
   12   Gray Matter 
   12   White Matter 
   11   brodmann area 3 
    1   brodmann area 40 
---------------------- 
Cluster 5 
Number of voxels: 5 
Peak MNI coordinate: -6 -34  68 
Peak MNI coordinate region:  // Left Cerebrum // Frontal Lobe // 
Paracentral Lobule // Gray Matter // brodmann area 6 // 
Paracentral_Lobule_L (aal) 
Peak intensity: -3.8157 
# voxels        structure 
    5   --TOTAL # VOXELS-- 
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    5   Frontal Lobe 
    5   Left Cerebrum 
    5   Paracentral Lobule 
    5   Paracentral_Lobule_L (aal) 
    3   White Matter 
    2   brodmann area 6 
    2   Gray Matter 
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XXXIII. Parietal ROI (Chapter 6) 
 
 
 
 
Centre co-ordinate of Left inferior parietal lobule: -46, -49, 47; Diameter: 10mm 
Centre co-ordinate of Right inferior parietal lobule: 53, -49, 50; Diameter: 10mm 
Appendices    256 
 
XXXIV. Whole group correlation matrix including Beta 
values (Chapter 6) 
 
 
PSQ
I ISI 
FIRS
T PSS 
DASS
D 
DASS
A 
DASS
S 
NEO
O 
NEO
C 
NEO
E 
PSQI Pearson 
Correlati
on 
1 .739
**
 
.157 .125 -.089 .003 .004 .069 -
.551** 
-.060 
Sig. (2-
tailed) 
 
.000 .444 .543 .666 .989 .983 .736 .004 .770 
N 26 26 26 26 26 26 26 26 26 26 
ISI Pearson 
Correlati
on 
.739
**
 
1 .232 .219 .265 .244 .203 .021 -
.532** 
-.247 
Sig. (2-
tailed) 
.000 
 
.254 .283 .190 .230 .320 .921 .005 .223 
N 26 26 26 26 26 26 26 26 26 26 
FIRST Pearson 
Correlati
on 
.157 .232 1 .557
**
 
.421* .315 .521** .106 -
.412* 
-
.509*
*
 
Sig. (2-
tailed) 
.444 .254 
 
.003 .032 .117 .006 .606 .037 .008 
N 26 26 26 26 26 26 26 26 26 26 
PSS Pearson 
Correlati
on 
.125 .219 .557** 1 .611** .493* .663** .220 -.233 -.244 
Sig. (2-
tailed) 
.543 .283 .003 
 
.001 .011 .000 .281 .253 .230 
N 26 26 26 26 26 26 26 26 26 26 
DASSD Pearson 
Correlati
on 
-
.089 
.265 .421* .611
**
 
1 .286 .714** .287 -.146 -
.400* 
Sig. (2-
tailed) 
.666 .190 .032 .001 
 
.157 .000 .155 .476 .043 
N 26 26 26 26 26 26 26 26 26 26 
DASSA Pearson 
Correlati
on 
.003 .244 .315 .493
*
 
.286 1 .611** .264 -.185 -.291 
Sig. (2-
tailed) 
.989 .230 .117 .011 .157 
 
.001 .192 .364 .150 
N 26 26 26 26 26 26 26 26 26 26 
Appendices    257 
 
DASSS Pearson 
Correlati
on 
.004 .203 .521** .663
**
 
.714** .611** 1 .293 -.114 -
.411* 
Sig. (2-
tailed) 
.983 .320 .006 .000 .000 .001 
 
.146 .581 .037 
N 26 26 26 26 26 26 26 26 26 26 
NEOO Pearson 
Correlati
on 
.069 .021 .106 .220 .287 .264 .293 1 -.051 -.118 
Sig. (2-
tailed) 
.736 .921 .606 .281 .155 .192 .146 
 
.805 .565 
N 26 26 26 26 26 26 26 26 26 26 
NEOC Pearson 
Correlati
on 
-
.551
**
 
-
.532
**
 
-
.412* 
-
.233 
-.146 -.185 -.114 -.051 1 .287 
Sig. (2-
tailed) 
.004 .005 .037 .253 .476 .364 .581 .805 
 
.155 
N 26 26 26 26 26 26 26 26 26 26 
NEOE Pearson 
Correlati
on 
-
.060 
-
.247 
-
.509** 
-
.244 
-.400* -.291 -.411* -.118 .287 1 
Sig. (2-
tailed) 
.770 .223 .008 .230 .043 .150 .037 .565 .155 
 
N 26 26 26 26 26 26 26 26 26 26 
NEOA Pearson 
Correlati
on 
-
.163 
-
.072 
-.213 -
.098 
-.012 -.137 -.221 .154 .346 .297 
Sig. (2-
tailed) 
.425 .725 .297 .634 .954 .504 .277 .453 .083 .141 
N 26 26 26 26 26 26 26 26 26 26 
NEON Pearson 
Correlati
on 
.087 .148 .660** .679
**
 
.473* .606** .694** .194 -.352 -
.579*
*
 
Sig. (2-
tailed) 
.671 .469 .000 .000 .015 .001 .000 .342 .077 .002 
N 26 26 26 26 26 26 26 26 26 26 
RUMB Pearson 
Correlati
on 
-
.156 
.104 .454* .522
**
 
.613** .383 .559** .234 -.069 -
.459* 
Sig. (2-
tailed) 
.457 .622 .023 .007 .001 .059 .004 .260 .744 .021 
N 25 25 25 25 25 25 25 25 25 25 
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RUMD Pearson 
Correlati
on 
-
.166 
-
.055 
.584** .705
**
 
.422* .497* .495* .287 -.127 -.251 
Sig. (2-
tailed) 
.427 .795 .002 .000 .036 .011 .012 .164 .546 .226 
N 25 25 25 25 25 25 25 25 25 25 
RUMR Pearson 
Correlati
on 
-
.296 
-
.120 
.325 .394 .554** .202 .338 .223 .089 -
.455* 
Sig. (2-
tailed) 
.150 .569 .113 .051 .004 .334 .099 .284 .671 .022 
N 25 25 25 25 25 25 25 25 25 25 
COPEP Pearson 
Correlati
on 
-
.055 
.039 .358 .271 .247 .305 .266 -.076 -.021 -.313 
Sig. (2-
tailed) 
.790 .851 .073 .180 .223 .129 .189 .711 .920 .119 
N 26 26 26 26 26 26 26 26 26 26 
COPEE Pearson 
Correlati
on 
.121 .226 .242 .521
**
 
.312 .482* .397* .152 -.165 -.225 
Sig. (2-
tailed) 
.555 .267 .234 .006 .121 .013 .045 .457 .419 .269 
N 26 26 26 26 26 26 26 26 26 26 
WORRY Pearson 
Correlati
on 
-
.160 
-
.069 
.384 .564
**
 
.178 .380 .314 -.221 -.089 -.296 
Sig. (2-
tailed) 
.434 .736 .052 .003 .384 .056 .119 .277 .666 .142 
N 26 26 26 26 26 26 26 26 26 26 
par_left Pearson 
Correlati
on 
-
.185 
-
.051 
-
.601** 
-
.426
*
 
-.291 -.217 -.359 -.471* .235 .340 
Sig. (2-
tailed) 
.386 .812 .002 .038 .168 .309 .085 .020 .269 .104 
N 24 24 24 24 24 24 24 24 24 24 
par_right Pearson 
Correlati
on 
.130 .158 -.393 -
.231 
-.226 .102 -.139 -.078 .408* .184 
Sig. (2-
tailed) 
.544 .462 .058 .277 .289 .636 .518 .718 .048 .389 
N 24 24 24 24 24 24 24 24 24 24 
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left_PG_be
ta 
Pearson 
Correlati
on 
.148 .319 .535** .317 .438* .415* .405* -.033 -.341 -
.418* 
Sig. (2-
tailed) 
.491 .129 .007 .131 .032 .044 .050 .877 .103 .042 
N 24 24 24 24 24 24 24 24 24 24 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
Correlations 
 
NEOA NEON RUMB RUMD RUMR 
COPE
P 
COPE
E 
WORR
Y 
par_lef
t 
PSQI Pearson 
Correlation 
-.163 .087 -.156 -.166 -.296 -.055 .121 -.160 -.185 
Sig. (2-tailed) .425 .671 .457 .427 .150 .790 .555 .434 .386 
N 26 26 25 25 25 26 26 26 24 
ISI Pearson 
Correlation 
-.072 .148 .104 -.055 -.120 .039 .226 -.069 -.051 
Sig. (2-tailed) .725 .469 .622 .795 .569 .851 .267 .736 .812 
N 26 26 25 25 25 26 26 26 24 
FIRST Pearson 
Correlation 
-.213 .660** .454* .584** .325 .358 .242 .384 -.601** 
Sig. (2-tailed) .297 .000 .023 .002 .113 .073 .234 .052 .002 
N 26 26 25 25 25 26 26 26 24 
PSS Pearson 
Correlation 
-.098 .679** .522** .705** .394 .271 .521** .564** -.426* 
Sig. (2-tailed) .634 .000 .007 .000 .051 .180 .006 .003 .038 
N 26 26 25 25 25 26 26 26 24 
DASSD Pearson 
Correlation 
-.012 .473* .613** .422* .554** .247 .312 .178 -.291 
Sig. (2-tailed) .954 .015 .001 .036 .004 .223 .121 .384 .168 
N 26 26 25 25 25 26 26 26 24 
DASSA Pearson 
Correlation 
-.137 .606** .383 .497* .202 .305 .482* .380 -.217 
Sig. (2-tailed) .504 .001 .059 .011 .334 .129 .013 .056 .309 
N 26 26 25 25 25 26 26 26 24 
DASSS Pearson 
Correlation 
-.221 .694** .559** .495* .338 .266 .397* .314 -.359 
Sig. (2-tailed) .277 .000 .004 .012 .099 .189 .045 .119 .085 
N 26 26 25 25 25 26 26 26 24 
NEOO Pearson 
Correlation 
.154 .194 .234 .287 .223 -.076 .152 -.221 -.471* 
Sig. (2-tailed) .453 .342 .260 .164 .284 .711 .457 .277 .020 
N 26 26 25 25 25 26 26 26 24 
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NEOC Pearson 
Correlation 
.346 -.352 -.069 -.127 .089 -.021 -.165 -.089 .235 
Sig. (2-tailed) .083 .077 .744 .546 .671 .920 .419 .666 .269 
N 26 26 25 25 25 26 26 26 24 
NEOE Pearson 
Correlation 
.297 -.579** -.459* -.251 -.455* -.313 -.225 -.296 .340 
Sig. (2-tailed) .141 .002 .021 .226 .022 .119 .269 .142 .104 
N 26 26 25 25 25 26 26 26 24 
NEOA Pearson 
Correlation 
1 -.256 .027 -.035 -.105 -.356 -.335 .072 -.091 
Sig. (2-tailed)  .208 .900 .870 .618 .074 .095 .726 .674 
N 26 26 25 25 25 26 26 26 24 
NEON Pearson 
Correlation 
-.256 1 .566** .643** .351 .339 .355 .644** -.432* 
Sig. (2-tailed) .208  .003 .001 .085 .090 .075 .000 .035 
N 26 26 25 25 25 26 26 26 24 
RUMB Pearson 
Correlation 
.027 .566** 1 .687** .735** .142 .177 .578** -.168 
Sig. (2-tailed) .900 .003  .000 .000 .498 .398 .002 .443 
N 25 25 25 25 25 25 25 25 23 
RUMD Pearson 
Correlation 
-.035 .643** .687** 1 .684** .381 .382 .589** -.223 
Sig. (2-tailed) .870 .001 .000  .000 .060 .060 .002 .307 
N 25 25 25 25 25 25 25 25 23 
RUMR Pearson 
Correlation 
-.105 .351 .735** .684** 1 .297 .184 .316 .011 
Sig. (2-tailed) .618 .085 .000 .000  .150 .379 .123 .961 
N 25 25 25 25 25 25 25 25 23 
COPEP Pearson 
Correlation 
-.356 .339 .142 .381 .297 1 .707** .136 -.269 
Sig. (2-tailed) .074 .090 .498 .060 .150  .000 .509 .205 
N 26 26 25 25 25 26 26 26 24 
COPEE Pearson 
Correlation 
-.335 .355 .177 .382 .184 .707** 1 .209 -.355 
Sig. (2-tailed) .095 .075 .398 .060 .379 .000  .305 .089 
N 26 26 25 25 25 26 26 26 24 
WORRY Pearson 
Correlation 
.072 .644** .578** .589** .316 .136 .209 1 -.179 
Sig. (2-tailed) .726 .000 .002 .002 .123 .509 .305  .402 
N 26 26 25 25 25 26 26 26 24 
par_left Pearson 
Correlation 
-.091 -.432* -.168 -.223 .011 -.269 -.355 -.179 1 
Sig. (2-tailed) .674 .035 .443 .307 .961 .205 .089 .402  
N 24 24 23 23 23 24 24 24 24 
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par_right Pearson 
Correlation 
-.092 -.390 -.034 -.151 .097 -.027 .065 -.229 .566** 
Sig. (2-tailed) .671 .060 .877 .491 .661 .900 .763 .282 .004 
N 24 24 23 23 23 24 24 24 24 
left_PG_b
eta 
Pearson 
Correlation 
-.244 .610** .385 .418* .340 .166 .120 .239 -.010 
Sig. (2-tailed) .251 .002 .070 .047 .112 .438 .575 .260 .962 
N 24 24 23 23 23 24 24 24 24 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
Correlations 
 par_right left_PG_beta 
PSQI Pearson Correlation .130 .148 
Sig. (2-tailed) .544 .491 
N 24 24 
ISI Pearson Correlation .158 .319 
Sig. (2-tailed) .462 .129 
N 24 24 
FIRST Pearson Correlation -.393 .535** 
Sig. (2-tailed) .058 .007 
N 24 24 
PSS Pearson Correlation -.231 .317 
Sig. (2-tailed) .277 .131 
N 24 24 
DASSD Pearson Correlation -.226 .438* 
Sig. (2-tailed) .289 .032 
N 24 24 
DASSA Pearson Correlation .102 .415* 
Sig. (2-tailed) .636 .044 
N 24 24 
DASSS Pearson Correlation -.139 .405* 
Sig. (2-tailed) .518 .050 
N 24 24 
NEOO Pearson Correlation -.078 -.033 
Sig. (2-tailed) .718 .877 
N 24 24 
NEOC Pearson Correlation .408* -.341 
Sig. (2-tailed) .048 .103 
N 24 24 
NEOE Pearson Correlation .184 -.418* 
Sig. (2-tailed) .389 .042 
N 24 24 
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NEOA Pearson Correlation -.092 -.244 
Sig. (2-tailed) .671 .251 
N 24 24 
NEON Pearson Correlation -.390 .610** 
Sig. (2-tailed) .060 .002 
N 24 24 
RUMB Pearson Correlation -.034 .385 
Sig. (2-tailed) .877 .070 
N 23 23 
RUMD Pearson Correlation -.151 .418* 
Sig. (2-tailed) .491 .047 
N 23 23 
RUMR Pearson Correlation .097 .340 
Sig. (2-tailed) .661 .112 
N 23 23 
COPEP Pearson Correlation -.027 .166 
Sig. (2-tailed) .900 .438 
N 24 24 
COPEE Pearson Correlation .065 .120 
Sig. (2-tailed) .763 .575 
N 24 24 
WORRY Pearson Correlation -.229 .239 
Sig. (2-tailed) .282 .260 
N 24 24 
par_left Pearson Correlation .566** -.010 
Sig. (2-tailed) .004 .962 
N 24 24 
par_right Pearson Correlation 1 -.099 
Sig. (2-tailed)  .647 
N 24 24 
left_PG_beta Pearson Correlation -.099 1 
Sig. (2-tailed) .647  
N 24 24 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
NB: par_left= left inferior parietal lobule; par_right= right inferior 
parietal lobule; PG= left postcentral gyrus 
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XXXV. Between group correlations (chapter 6) 
 
 
Resilient group correlations 
 
PSQI ISI 
FIRS
T PSS 
DASS
D 
DASS
A 
DASS
S 
NEO
O 
NEO
C 
NEO
E 
PSQI Pearson 
Correlatio
n 
1 .789*
*
 
.107 .286 -.017 .166 -.008 .173 -.358 -.025 
Sig. (2-
tailed) 
 
.001 .728 .344 .955 .588 .979 .573 .230 .935 
N 13 13 13 13 13 13 13 13 13 13 
ISI Pearson 
Correlatio
n 
.789*
*
 
1 .224 .047 -.107 .268 -.117 .057 -.432 -.051 
Sig. (2-
tailed) 
.001 
 
.461 .878 .729 .375 .704 .853 .140 .869 
N 13 13 13 13 13 13 13 13 13 13 
FIRST Pearson 
Correlatio
n 
.107 .224 1 .569* .575* .431 .608* .440 -.215 -.162 
Sig. (2-
tailed) 
.728 .461 
 
.042 .040 .141 .027 .133 .480 .598 
N 13 13 13 13 13 13 13 13 13 13 
PSS Pearson 
Correlatio
n 
.286 .047 .569* 1 .754** .363 .442 .382 -.518 -.047 
Sig. (2-
tailed) 
.344 .878 .042 
 
.003 .223 .130 .197 .070 .880 
N 13 13 13 13 13 13 13 13 13 13 
DASSD Pearson 
Correlatio
n 
-.017 -.107 .575* .754*
*
 
1 .698** .736** .576* -.404 -.124 
Sig. (2-
tailed) 
.955 .729 .040 .003 
 
.008 .004 .040 .171 .688 
N 13 13 13 13 13 13 13 13 13 13 
DASSA Pearson 
Correlatio
n 
.166 .268 .431 .363 .698** 1 .719** .569* -.497 -.196 
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Sig. (2-
tailed) 
.588 .375 .141 .223 .008 
 
.006 .042 .084 .521 
N 13 13 13 13 13 13 13 13 13 13 
DASSS Pearson 
Correlatio
n 
-.008 -.117 .608* .442 .736** .719** 1 .779** -.155 -.081 
Sig. (2-
tailed) 
.979 .704 .027 .130 .004 .006 
 
.002 .612 .792 
N 13 13 13 13 13 13 13 13 13 13 
NEOO Pearson 
Correlatio
n 
.173 .057 .440 .382 .576* .569* .779** 1 -.305 -.383 
Sig. (2-
tailed) 
.573 .853 .133 .197 .040 .042 .002 
 
.311 .196 
N 13 13 13 13 13 13 13 13 13 13 
NEOC Pearson 
Correlatio
n 
-.358 -.432 -.215 -.518 -.404 -.497 -.155 -.305 1 .211 
Sig. (2-
tailed) 
.230 .140 .480 .070 .171 .084 .612 .311 
 
.489 
N 13 13 13 13 13 13 13 13 13 13 
NEOE Pearson 
Correlatio
n 
-.025 -.051 -.162 -.047 -.124 -.196 -.081 -.383 .211 1 
Sig. (2-
tailed) 
.935 .869 .598 .880 .688 .521 .792 .196 .489 
 
N 13 13 13 13 13 13 13 13 13 13 
NEOA Pearson 
Correlatio
n 
-.386 -.339 .112 -.378 -.285 -.066 .050 -.258 .312 -.090 
Sig. (2-
tailed) 
.193 .258 .716 .203 .346 .831 .871 .394 .299 .770 
N 13 13 13 13 13 13 13 13 13 13 
NEON Pearson 
Correlatio
n 
.098 .051 .754** .650* .768** .603* .620* .563* -.448 -.535 
Sig. (2-
tailed) 
.751 .869 .003 .016 .002 .029 .024 .045 .125 .059 
N 13 13 13 13 13 13 13 13 13 13 
RUMB Pearson 
Correlatio
n 
-.172 -.160 .509 .301 .536 .266 .256 .220 -.075 -.611* 
Sig. (2-
tailed) 
.575 .601 .076 .318 .059 .380 .398 .470 .807 .027 
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N 13 13 13 13 13 13 13 13 13 13 
RUMD Pearson 
Correlatio
n 
-.103 -.174 .463 .645* .910** .562* .534 .449 -.321 -.375 
Sig. (2-
tailed) 
.737 .569 .111 .017 .000 .046 .060 .124 .285 .207 
N 13 13 13 13 13 13 13 13 13 13 
RUMR Pearson 
Correlatio
n 
-.112 -.257 .035 .299 .520 .225 .055 .131 -.055 -.449 
Sig. (2-
tailed) 
.715 .396 .910 .321 .068 .459 .858 .670 .857 .124 
N 13 13 13 13 13 13 13 13 13 13 
COPEP Pearson 
Correlatio
n 
.268 .193 .035 .292 .383 .280 .127 -.001 .099 .030 
Sig. (2-
tailed) 
.377 .529 .910 .334 .196 .354 .680 .998 .748 .923 
N 13 13 13 13 13 13 13 13 13 13 
COPEE Pearson 
Correlatio
n 
.214 .082 .238 .602* .605* .356 .369 .268 -.043 .041 
Sig. (2-
tailed) 
.483 .789 .433 .030 .028 .232 .215 .375 .889 .894 
N 13 13 13 13 13 13 13 13 13 13 
WORRY Pearson 
Correlatio
n 
-.354 -.380 .388 .408 .411 .080 .047 -.070 -.098 -.428 
Sig. (2-
tailed) 
.236 .201 .190 .166 .163 .795 .879 .820 .749 .145 
N 13 13 13 13 13 13 13 13 13 13 
par_left Pearson 
Correlatio
n 
-.186 .098 -.644* -
.682* 
-.509 -.327 -.614* -.570 .141 .288 
Sig. (2-
tailed) 
.564 .761 .024 .015 .091 .300 .034 .053 .662 .363 
N 12 12 12 12 12 12 12 12 12 12 
par_right Pearson 
Correlatio
n 
.357 .376 -.024 -.168 .034 .257 .129 .062 .363 .129 
Sig. (2-
tailed) 
.255 .229 .941 .602 .917 .420 .688 .847 .246 .690 
N 12 12 12 12 12 12 12 12 12 12 
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left_PG_bet
a 
Pearson 
Correlatio
n 
.279 .497 .143 -.165 .270 .502 .188 .146 -.001 -.232 
Sig. (2-
tailed) 
.379 .100 .657 .609 .396 .096 .558 .651 .997 .469 
N 12 12 12 12 12 12 12 12 12 12 
 
 
 
 
Resilient 
 
NEOA NEON RUMB RUMD RUMR 
COPE
P 
COPE
E 
WORR
Y 
par_lef
t 
PSQI Pearson 
Correlation 
-.386 .098 -.172 -.103 -.112 .268 .214 -.354 -.186 
Sig. (2-tailed) .193 .751 .575 .737 .715 .377 .483 .236 .564 
N 13 13 13 13 13 13 13 13 12 
ISI Pearson 
Correlation 
-.339 .051 -.160 -.174 -.257 .193 .082 -.380 .098 
Sig. (2-tailed) .258 .869 .601 .569 .396 .529 .789 .201 .761 
N 13 13 13 13 13 13 13 13 12 
FIRST Pearson 
Correlation 
.112 .754** .509 .463 .035 .035 .238 .388 -.644* 
Sig. (2-tailed) .716 .003 .076 .111 .910 .910 .433 .190 .024 
N 13 13 13 13 13 13 13 13 12 
PSS Pearson 
Correlation 
-.378 .650* .301 .645* .299 .292 .602* .408 -.682* 
Sig. (2-tailed) .203 .016 .318 .017 .321 .334 .030 .166 .015 
N 13 13 13 13 13 13 13 13 12 
DASSD Pearson 
Correlation 
-.285 .768** .536 .910** .520 .383 .605* .411 -.509 
Sig. (2-tailed) .346 .002 .059 .000 .068 .196 .028 .163 .091 
N 13 13 13 13 13 13 13 13 12 
DASSA Pearson 
Correlation 
-.066 .603* .266 .562* .225 .280 .356 .080 -.327 
Sig. (2-tailed) .831 .029 .380 .046 .459 .354 .232 .795 .300 
N 13 13 13 13 13 13 13 13 12 
DASSS Pearson 
Correlation 
.050 .620* .256 .534 .055 .127 .369 .047 -.614* 
Sig. (2-tailed) .871 .024 .398 .060 .858 .680 .215 .879 .034 
N 13 13 13 13 13 13 13 13 12 
NEOO Pearson 
Correlation 
-.258 .563* .220 .449 .131 -.001 .268 -.070 -.570 
Sig. (2-tailed) .394 .045 .470 .124 .670 .998 .375 .820 .053 
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N 13 13 13 13 13 13 13 13 12 
NEOC Pearson 
Correlation 
.312 -.448 -.075 -.321 -.055 .099 -.043 -.098 .141 
Sig. (2-tailed) .299 .125 .807 .285 .857 .748 .889 .749 .662 
N 13 13 13 13 13 13 13 13 12 
NEOE Pearson 
Correlation 
-.090 -.535 -.611* -.375 -.449 .030 .041 -.428 .288 
Sig. (2-tailed) .770 .059 .027 .207 .124 .923 .894 .145 .363 
N 13 13 13 13 13 13 13 13 12 
NEOA Pearson 
Correlation 
1 .033 .244 -.241 -.097 -.520 -.584* .308 -.094 
Sig. (2-tailed)  .915 .421 .427 .752 .069 .036 .306 .771 
N 13 13 13 13 13 13 13 13 12 
NEON Pearson 
Correlation 
.033 1 .741** .787** .458 .131 .216 .637* -.619* 
Sig. (2-tailed) .915  .004 .001 .116 .669 .479 .019 .032 
N 13 13 13 13 13 13 13 13 12 
RUMB Pearson 
Correlation 
.244 .741** 1 .728** .766** .075 .112 .785** -.368 
Sig. (2-tailed) .421 .004  .005 .002 .808 .715 .001 .239 
N 13 13 13 13 13 13 13 13 12 
RUMD Pearson 
Correlation 
-.241 .787** .728** 1 .761** .484 .567* .557* -.339 
Sig. (2-tailed) .427 .001 .005  .002 .094 .043 .048 .281 
N 13 13 13 13 13 13 13 13 12 
RUMR Pearson 
Correlation 
-.097 .458 .766** .761** 1 .382 .338 .592* -.078 
Sig. (2-tailed) .752 .116 .002 .002  .198 .259 .033 .810 
N 13 13 13 13 13 13 13 13 12 
COPEP Pearson 
Correlation 
-.520 .131 .075 .484 .382 1 .794** -.089 .152 
Sig. (2-tailed) .069 .669 .808 .094 .198  .001 .772 .636 
N 13 13 13 13 13 13 13 13 12 
COPEE Pearson 
Correlation 
-.584* .216 .112 .567* .338 .794** 1 -.019 -.303 
Sig. (2-tailed) .036 .479 .715 .043 .259 .001  .950 .339 
N 13 13 13 13 13 13 13 13 12 
WORRY Pearson 
Correlation 
.308 .637* .785** .557* .592* -.089 -.019 1 -.416 
Sig. (2-tailed) .306 .019 .001 .048 .033 .772 .950  .179 
N 13 13 13 13 13 13 13 13 12 
par_left Pearson 
Correlation 
-.094 -.619* -.368 -.339 -.078 .152 -.303 -.416 1 
Sig. (2-tailed) .771 .032 .239 .281 .810 .636 .339 .179  
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N 12 12 12 12 12 12 12 12 12 
par_right Pearson 
Correlation 
-.269 -.105 -.135 .093 .110 .794** .496 -.469 .301 
Sig. (2-tailed) .399 .746 .676 .774 .734 .002 .101 .124 .342 
N 12 12 12 12 12 12 12 12 12 
left_PG_b
eta 
Pearson 
Correlation 
-.230 .224 .304 .294 .234 .469 .322 -.069 .025 
Sig. (2-tailed) .473 .483 .337 .353 .463 .124 .307 .831 .939 
N 12 12 12 12 12 12 12 12 12 
 
 
 
 
 
 par_right left_PG_beta 
PSQI Pearson Correlation .357 .279 
Sig. (2-tailed) .255 .379 
N 12 12 
ISI Pearson Correlation .376 .497 
Sig. (2-tailed) .229 .100 
N 12 12 
FIRST Pearson Correlation -.024 .143 
Sig. (2-tailed) .941 .657 
N 12 12 
PSS Pearson Correlation -.168 -.165 
Sig. (2-tailed) .602 .609 
N 12 12 
DASSD Pearson Correlation .034 .270 
Sig. (2-tailed) .917 .396 
N 12 12 
DASSA Pearson Correlation .257 .502 
Sig. (2-tailed) .420 .096 
N 12 12 
DASSS Pearson Correlation .129 .188 
Sig. (2-tailed) .688 .558 
N 12 12 
NEOO Pearson Correlation .062 .146 
Sig. (2-tailed) .847 .651 
N 12 12 
NEOC Pearson Correlation .363 -.001 
Sig. (2-tailed) .246 .997 
N 12 12 
NEOE Pearson Correlation .129 -.232 
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Sig. (2-tailed) .690 .469 
N 12 12 
NEOA Pearson Correlation -.269 -.230 
Sig. (2-tailed) .399 .473 
N 12 12 
NEON Pearson Correlation -.105 .224 
Sig. (2-tailed) .746 .483 
N 12 12 
RUMB Pearson Correlation -.135 .304 
Sig. (2-tailed) .676 .337 
N 12 12 
RUMD Pearson Correlation .093 .294 
Sig. (2-tailed) .774 .353 
N 12 12 
RUMR Pearson Correlation .110 .234 
Sig. (2-tailed) .734 .463 
N 12 12 
COPEP Pearson Correlation .794** .469 
Sig. (2-tailed) .002 .124 
N 12 12 
COPEE Pearson Correlation .496 .322 
Sig. (2-tailed) .101 .307 
N 12 12 
WORRY Pearson Correlation -.469 -.069 
Sig. (2-tailed) .124 .831 
N 12 12 
par_left Pearson Correlation .301 .025 
Sig. (2-tailed) .342 .939 
N 12 12 
par_right Pearson Correlation 1 .488 
Sig. (2-tailed)  .107 
N 12 12 
left_PG_beta Pearson Correlation .488 1 
Sig. (2-tailed) .107  
N 12 12 
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Vulnerable Group Correlations 
 
PSQI ISI 
FIRS
T PSS 
DASS
D 
DASS
A 
DASS
S 
NEO
O 
NEO
C 
NEO
E 
PSQI Pearson 
Correlatio
n 
1 .681
*
 
.031 -.119 -.235 -.178 -.085 -.037 -.731** .031 
Sig. (2-
tailed) 
 
.010 .921 .699 .440 .561 .782 .905 .005 .921 
N 13 13 13 13 13 13 13 13 13 13 
ISI Pearson 
Correlatio
n 
.681* 1 .173 .318 .347 .217 .349 -.013 -.610* -.327 
Sig. (2-
tailed) 
.010 
 
.571 .289 .245 .477 .243 .966 .027 .275 
N 13 13 13 13 13 13 13 13 13 13 
FIRST Pearson 
Correlatio
n 
.031 .173 1 .691*
*
 
.116 .623* .375 .066 .144 -.390 
Sig. (2-
tailed) 
.921 .571 
 
.009 .706 .023 .206 .832 .639 .188 
N 13 13 13 13 13 13 13 13 13 13 
PSS Pearson 
Correlatio
n 
-.119 .318 .691** 1 .628* .658* .789** .061 .256 -.236 
Sig. (2-
tailed) 
.699 .289 .009 
 
.022 .015 .001 .842 .398 .438 
N 13 13 13 13 13 13 13 13 13 13 
DASSD Pearson 
Correlatio
n 
-.235 .347 .116 .628* 1 .237 .706** .302 .191 -.357 
Sig. (2-
tailed) 
.440 .245 .706 .022 
 
.436 .007 .316 .532 .231 
N 13 13 13 13 13 13 13 13 13 13 
DASSA Pearson 
Correlatio
n 
-.178 .217 .623* .658* .237 1 .600* -.076 .080 -.411 
Sig. (2-
tailed) 
.561 .477 .023 .015 .436 
 
.030 .805 .796 .163 
N 13 13 13 13 13 13 13 13 13 13 
DASSS Pearson 
Correlatio
n 
-.085 .349 .375 .789*
*
 
.706** .600* 1 -.034 .224 -.459 
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Sig. (2-
tailed) 
.782 .243 .206 .001 .007 .030 
 
.912 .461 .115 
N 13 13 13 13 13 13 13 13 13 13 
NEOO Pearson 
Correlatio
n 
-.037 -
.013 
.066 .061 .302 -.076 -.034 1 .163 .103 
Sig. (2-
tailed) 
.905 .966 .832 .842 .316 .805 .912 
 
.594 .738 
N 13 13 13 13 13 13 13 13 13 13 
NEOC Pearson 
Correlatio
n 
-
.731*
*
 
-
.610
*
 
.144 .256 .191 .080 .224 .163 1 .001 
Sig. (2-
tailed) 
.005 .027 .639 .398 .532 .796 .461 .594 
 
.997 
N 13 13 13 13 13 13 13 13 13 13 
NEOE Pearson 
Correlatio
n 
.031 -
.327 
-.390 -.236 -.357 -.411 -.459 .103 .001 1 
Sig. (2-
tailed) 
.921 .275 .188 .438 .231 .163 .115 .738 .997 
 
N 13 13 13 13 13 13 13 13 13 13 
NEOA Pearson 
Correlatio
n 
.039 .160 .091 .232 .211 -.185 -.208 .455 .189 .354 
Sig. (2-
tailed) 
.900 .601 .767 .446 .489 .544 .495 .118 .536 .235 
N 13 13 13 13 13 13 13 13 13 13 
NEON Pearson 
Correlatio
n 
-.041 .119 .513 .649* .305 .719** .658* -.093 .045 -.437 
Sig. (2-
tailed) 
.895 .698 .073 .016 .311 .006 .014 .762 .883 .135 
N 13 13 13 13 13 13 13 13 13 13 
RUMB Pearson 
Correlatio
n 
-.230 .336 .360 .684* .696* .529 .733** .242 .243 -.176 
Sig. (2-
tailed) 
.472 .286 .250 .014 .012 .077 .007 .448 .447 .584 
N 12 12 12 12 12 12 12 12 12 12 
RUMD Pearson 
Correlatio
n 
-.336 -
.029 
.623* .708*
*
 
.212 .482 .362 .127 .360 .078 
Sig. (2-
tailed) 
.285 .930 .030 .010 .508 .113 .248 .695 .250 .809 
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N 12 12 12 12 12 12 12 12 12 12 
RUMR Pearson 
Correlatio
n 
-.520 -
.068 
.330 .402 .560 .182 .412 .304 .450 -.375 
Sig. (2-
tailed) 
.083 .835 .295 .196 .058 .571 .183 .336 .142 .229 
N 12 12 12 12 12 12 12 12 12 12 
COPEP Pearson 
Correlatio
n 
-.522 -
.229 
.081 .071 .051 .358 .171 -.167 .326 -.364 
Sig. (2-
tailed) 
.067 .452 .793 .819 .868 .230 .577 .587 .277 .222 
N 13 13 13 13 13 13 13 13 13 13 
COPEE Pearson 
Correlatio
n 
-.030 .380 .358 .402 .278 .660* .437 -.005 -.237 -.492 
Sig. (2-
tailed) 
.923 .201 .229 .173 .357 .014 .135 .988 .435 .088 
N 13 13 13 13 13 13 13 13 13 13 
WORRY Pearson 
Correlatio
n 
.001 .191 .689** .725*
*
 
.104 .698** .493 -.388 .003 -.149 
Sig. (2-
tailed) 
.998 .532 .009 .005 .737 .008 .087 .191 .992 .627 
N 13 13 13 13 13 13 13 13 13 13 
par_left Pearson 
Correlatio
n 
-.219 -
.127 
-.357 -.205 -.085 -.189 -.065 -.610* -.040 .106 
Sig. (2-
tailed) 
.495 .694 .255 .524 .792 .557 .841 .035 .902 .744 
N 12 12 12 12 12 12 12 12 12 12 
par_right Pearson 
Correlatio
n 
-.003 .055 .253 -.059 -.041 .044 .062 -.302 .073 -.252 
Sig. (2-
tailed) 
.993 .865 .427 .856 .899 .892 .848 .340 .822 .429 
N 12 12 12 12 12 12 12 12 12 12 
left_PG_bet
a 
Pearson 
Correlatio
n 
.068 .296 .320 .441 .331 .467 .314 -.104 -.284 -.287 
Sig. (2-
tailed) 
.833 .350 .311 .151 .293 .126 .320 .748 .372 .366 
N 12 12 12 12 12 12 12 12 12 12 
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Correlationsa 
 
NEOA NEON RUMB RUMD RUMR 
COPE
P 
COPE
E 
WORR
Y 
par_lef
t 
PSQI Pearson 
Correlation 
.039 -.041 -.230 -.336 -.520 -.522 -.030 .001 -.219 
Sig. (2-tailed) .900 .895 .472 .285 .083 .067 .923 .998 .495 
N 13 13 12 12 12 13 13 13 12 
ISI Pearson 
Correlation 
.160 .119 .336 -.029 -.068 -.229 .380 .191 -.127 
Sig. (2-tailed) .601 .698 .286 .930 .835 .452 .201 .532 .694 
N 13 13 12 12 12 13 13 13 12 
FIRST Pearson 
Correlation 
.091 .513 .360 .623* .330 .081 .358 .689** -.357 
Sig. (2-tailed) .767 .073 .250 .030 .295 .793 .229 .009 .255 
N 13 13 12 12 12 13 13 13 12 
PSS Pearson 
Correlation 
.232 .649* .684* .708** .402 .071 .402 .725** -.205 
Sig. (2-tailed) .446 .016 .014 .010 .196 .819 .173 .005 .524 
N 13 13 12 12 12 13 13 13 12 
DASSD Pearson 
Correlation 
.211 .305 .696* .212 .560 .051 .278 .104 -.085 
Sig. (2-tailed) .489 .311 .012 .508 .058 .868 .357 .737 .792 
N 13 13 12 12 12 13 13 13 12 
DASSA Pearson 
Correlation 
-.185 .719** .529 .482 .182 .358 .660* .698** -.189 
Sig. (2-tailed) .544 .006 .077 .113 .571 .230 .014 .008 .557 
N 13 13 12 12 12 13 13 13 12 
DASSS Pearson 
Correlation 
-.208 .658* .733** .362 .412 .171 .437 .493 -.065 
Sig. (2-tailed) .495 .014 .007 .248 .183 .577 .135 .087 .841 
N 13 13 12 12 12 13 13 13 12 
NEOO Pearson 
Correlation 
.455 -.093 .242 .127 .304 -.167 -.005 -.388 -.610* 
Sig. (2-tailed) .118 .762 .448 .695 .336 .587 .988 .191 .035 
N 13 13 12 12 12 13 13 13 12 
NEOC Pearson 
Correlation 
.189 .045 .243 .360 .450 .326 -.237 .003 -.040 
Sig. (2-tailed) .536 .883 .447 .250 .142 .277 .435 .992 .902 
N 13 13 12 12 12 13 13 13 12 
NEOE Pearson 
Correlation 
.354 -.437 -.176 .078 -.375 -.364 -.492 -.149 .106 
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Sig. (2-tailed) .235 .135 .584 .809 .229 .222 .088 .627 .744 
N 13 13 12 12 12 13 13 13 12 
NEOA Pearson 
Correlation 
1 -.232 .041 .264 -.008 -.116 -.134 -.015 -.345 
Sig. (2-tailed)  .445 .899 .408 .980 .707 .663 .960 .272 
N 13 13 12 12 12 13 13 13 12 
NEON Pearson 
Correlation 
-.232 1 .294 .409 .157 .263 .510 .709** -.121 
Sig. (2-tailed) .445  .353 .186 .625 .385 .075 .007 .709 
N 13 13 12 12 12 13 13 13 12 
RUMB Pearson 
Correlation 
.041 .294 1 .586* .694* -.002 .219 .347 .113 
Sig. (2-tailed) .899 .353  .045 .012 .995 .494 .270 .741 
N 12 12 12 12 12 12 12 12 11 
RUMD Pearson 
Correlation 
.264 .409 .586* 1 .592* .105 .157 .631* .067 
Sig. (2-tailed) .408 .186 .045  .043 .744 .626 .028 .845 
N 12 12 12 12 12 12 12 12 11 
RUMR Pearson 
Correlation 
-.008 .157 .694* .592* 1 .114 .003 .079 .263 
Sig. (2-tailed) .980 .625 .012 .043  .724 .993 .808 .435 
N 12 12 12 12 12 12 12 12 11 
COPEP Pearson 
Correlation 
-.116 .263 -.002 .105 .114 1 .651* .307 -.232 
Sig. (2-tailed) .707 .385 .995 .744 .724  .016 .307 .468 
N 13 13 12 12 12 13 13 13 12 
COPEE Pearson 
Correlation 
-.134 .510 .219 .157 .003 .651* 1 .500 -.477 
Sig. (2-tailed) .663 .075 .494 .626 .993 .016  .082 .117 
N 13 13 12 12 12 13 13 13 12 
WORRY Pearson 
Correlation 
-.015 .709** .347 .631* .079 .307 .500 1 -.014 
Sig. (2-tailed) .960 .007 .270 .028 .808 .307 .082  .967 
N 13 13 12 12 12 13 13 13 12 
par_left Pearson 
Correlation 
-.345 -.121 .113 .067 .263 -.232 -.477 -.014 1 
Sig. (2-tailed) .272 .709 .741 .845 .435 .468 .117 .967  
N 12 12 11 11 11 12 12 12 12 
par_right Pearson 
Correlation 
-.362 -.248 .374 .038 .433 -.227 -.290 .022 .484 
Sig. (2-tailed) .248 .437 .258 .911 .184 .477 .360 .945 .110 
N 12 12 11 11 11 12 12 12 12 
left_PG_b
eta 
Pearson 
Correlation 
-.080 .649* .339 .301 .263 -.362 .005 .390 .351 
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Sig. (2-tailed) .805 .022 .308 .369 .434 .248 .987 .210 .263 
N 12 12 11 11 11 12 12 12 12 
 
 
 
 
Correlationsa 
 par_right left_PG_beta 
PSQI Pearson Correlation -.003 .068 
Sig. (2-tailed) .993 .833 
N 12 12 
ISI Pearson Correlation .055 .296 
Sig. (2-tailed) .865 .350 
N 12 12 
FIRST Pearson Correlation .253 .320 
Sig. (2-tailed) .427 .311 
N 12 12 
PSS Pearson Correlation -.059 .441 
Sig. (2-tailed) .856 .151 
N 12 12 
DASSD Pearson Correlation -.041 .331 
Sig. (2-tailed) .899 .293 
N 12 12 
DASSA Pearson Correlation .044 .467 
Sig. (2-tailed) .892 .126 
N 12 12 
DASSS Pearson Correlation .062 .314 
Sig. (2-tailed) .848 .320 
N 12 12 
NEOO Pearson Correlation -.302 -.104 
Sig. (2-tailed) .340 .748 
N 12 12 
NEOC Pearson Correlation .073 -.284 
Sig. (2-tailed) .822 .372 
N 12 12 
NEOE Pearson Correlation -.252 -.287 
Sig. (2-tailed) .429 .366 
N 12 12 
NEOA Pearson Correlation -.362 -.080 
Sig. (2-tailed) .248 .805 
N 12 12 
NEON Pearson Correlation -.248 .649* 
Sig. (2-tailed) .437 .022 
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N 12 12 
RUMB Pearson Correlation .374 .339 
Sig. (2-tailed) .258 .308 
N 11 11 
RUMD Pearson Correlation .038 .301 
Sig. (2-tailed) .911 .369 
N 11 11 
RUMR Pearson Correlation .433 .263 
Sig. (2-tailed) .184 .434 
N 11 11 
COPEP Pearson Correlation -.227 -.362 
Sig. (2-tailed) .477 .248 
N 12 12 
COPEE Pearson Correlation -.290 .005 
Sig. (2-tailed) .360 .987 
N 12 12 
WORRY Pearson Correlation .022 .390 
Sig. (2-tailed) .945 .210 
N 12 12 
par_left Pearson Correlation .484 .351 
Sig. (2-tailed) .110 .263 
N 12 12 
par_right Pearson Correlation 1 .111 
Sig. (2-tailed)  .732 
N 12 12 
left_PG_beta Pearson Correlation .111 1 
Sig. (2-tailed) .732  
N 12 12 
 
: 
NB: Par_left = left inferior parietal lobule; Par_right= right inferior 
parital lobule; left_PG_beta= left postcentral gyrus 
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